mifepristone has been researched along with Pregnancy in 2127 studies
*Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 162 (7.62) | 18.7374 |
| 1990's | 596 (28.02) | 18.2507 |
| 2000's | 585 (27.50) | 29.6817 |
| 2010's | 495 (23.27) | 24.3611 |
| 2020's | 289 (13.59) | 2.80 |
| Authors | Studies |
|---|---|
| Croxatto, H; Heikinheimo, O; Kontula, K; Lähteenmäki, P; Luukkainen, T; Spitz, I | 1 |
| Edwards, JP; Gottardis, MM; Jones, TK; Pathirana, C; Pooley, CL; Schrader, WT; Tegley, CM; Wang, MW; West, SJ; Zhi, L | 1 |
| Crombie, DL; Edwards, JP; Goldman, ME; Jones, TK; Marschke, KB; Pooley, CL; Wang, MW | 1 |
| Du, J; Fung, S; Goos-Nilsson, A; Grynfarb, M; Hickman, B; Jacobson, PB; Lane, B; Link, JT; Nguyen, P; Patel, J; Reisch, TJ; Rotert, G; Schmidt, JM; Sorensen, B; Swanson, S; Tian, Z; von Geldern, TW; Wang, J; Wilcox, D; Zinker, B | 1 |
| Baker, CC; Chen, MJ; Creinin, MD; Hou, MY; Mastey, N; Matulich, MC; Melo, J; Uhm, S; Wilson, SF | 1 |
| Lama, L; Pokhrel, M; Sharma, J; Tiwari, S | 1 |
| Hu, S; Yu, Q | 1 |
| Bi, SJ; Chen, YY; Feng, LM; Fu, RJ; Huang, YX; Tang, YP; Xu, DQ; Yue, SJ | 1 |
| Benson, LS; Lokken, EM; Micks, EA; Shay, RL | 1 |
| Arena, A; Bachrach, L; Beaman, J; Biggs, MA; Gold, M; Grossman, D; Hannum, C; Ho, S; Morris, N; Raifman, S; Schwarz, EB | 1 |
| Chen, X; Li, F; Shi, B; Shou, Y; Zhu, R | 1 |
| Boesen, MP; Brinch, S; Hansen, P; Krogsgaard, MR; Larvad, P | 1 |
| Kallfa, E; Lauszus, FF; Ravn, P | 1 |
| Alves, T; Andrade, L; Cardoso, A; Dulce Madeira, M; Pereira, PA; Rocha, R; Sá, S | 1 |
| Enzelsberger, SH; Hermann, P; Oppelt, P; Shebl, O; Trautner, PS; Wagner, H; Wetzlmair, D | 1 |
| Cameron, S; Evans, E; Johnstone, A; McCabe, K; Reynolds-Wright, JJ | 2 |
| Durocher, J; Frye, LJ; Kilfedder, C; Srinivasan, K; Winikoff, B | 1 |
| Bercu, C; Carbone, S; Egwuatu, I; Gerdts, C; Grosso, B; Jayaweera, R; Kristianingrum, IA; Moseson, H; Motana, R; Nmezi, S; Zurbriggen, R | 1 |
| Ahmed, A; Beeson, L; Bender-Atik, R; Bhatia, K; Bottomley, C; Brewin, J; Cheed, V; Cheong, Y; Choudhary, M; Chu, J; Coomarasamy, A; Deb, S; Devall, A; Gallos, I; Gupta, P; Hamilton, J; Hardy, P; Hassan, I; Hinshaw, K; Hodge, F; Horne, A; Izzat, F; Jeve, Y; Jones, L; Kumar, C; Naftalin, J; Nunes, N; Ogwulu, CO; Oliver, A; Papadopoulos, JF; Pringle, S; Quenby, S; Roberts, T; Ross, J; Shahid, A; Small, R; Sun, Y; Underwood, M; Watkins, L; Williams, E | 1 |
| Check, DL; Check, JH | 1 |
| Biggs, MA; Ehrenreich, K; Grossman, D | 1 |
| Darling, EK; Dunn, S; Gayowsky, A; Kaczorowski, J; Laba, TL; Law, MR; McGrail, K; Norman, WV; Schummers, L | 1 |
| Mullock, A; Parsons, JA; Romanis, EC | 1 |
| Cheng, Q; Shi, Q; Xiao, C; Xu, J | 1 |
| Barar, R; Biggs, MA; Blanchard, K; Ehrenreich, K; Grossman, D; Kapp, N; Moayedi, G; Morris, N; Perritt, J; Ralph, LJ; Raymond, EG; White, K | 1 |
| Rubin, R | 1 |
| Bergen, S; Chavkin, W; Dragoman, M; Fofie, C | 1 |
| Amico, JR; Gilbert, AL | 1 |
| Sarpatwari, A; Zettler, PJ | 1 |
| Gilbert, L; Poehailos, K | 1 |
| Foster, AM; LaRoche, KJ; Persaud, M; Wylie, A | 1 |
| Aslam, M; Foster, AM; Messier, K; Shabir, N | 1 |
| Barar, R; Biggs, MA; Blanchard, K; Ehrenreich, K; Grossman, D; Kapp, N; Morris, N; Perritt, J; Ralph, L; White, K | 1 |
| Borisova, AV; Doronina, OK; Radzinsky, VE; Startseva, NM; Teplov, KV | 1 |
| Bazer, FW; Halloran, KM; Johnson, GA; Moses, RM; Seo, H; Stenhouse, C; Wu, G | 1 |
| Diao, WY; Du, L; Du, YH; Gemzell-Danielsson, K; Ho, PC; Li, RHW; Zhang, L | 1 |
| Boucoiran, I; Ferreira, E; St-Pierre, ÉR; Vlad, S | 1 |
| Adashi, EY; Cohen, IG; O'Mahony, DP; Rajan, RS | 1 |
| Carvajal, D; Dehlendorf, C; Fields, AB; Logan, R; Maldonado, L; McNeil, S; Perez, C; Razon, N; Wulf, S | 1 |
| Bazer, FW; Gaddy, D; Halloran, KM; Johnson, GA; Moses, RM; Seo, H; Stenhouse, C; Suva, LJ; Wu, G | 1 |
| Basky, G; Vogel, L | 1 |
| Barrett, J; Ennis, M; Guilbert, E; Renner, R; Roy, G | 1 |
| Dong, L; Huang, H; Jiang, Z; Xia, L; Xia, Y; Yan, Y; Zhao, P | 1 |
| Lohr, PA; Shochet, T; Whitehouse, KC | 1 |
| Davis, J; Fontanilla, T; Friedlander, EB; Horiuchi, W; Kaneshiro, B; Raidoo, S; Salcedo, J; Soon, R; Tschann, M | 1 |
| Boraas, CM; Coplon, L; Gold, M; Kaneshiro, B; Koenig, LR; Raymond, EG; Upadhyay, UD; Winikoff, B | 2 |
| Braat, DDM; Coppus, SFPJ; Hamel, CC; Snijders, MPLM; Vandenbussche, FPHA; Vart, P | 1 |
| Carson, A; Dunn, S; Ennis, M; Guilbert, E; Kean, L; Martin-Misener, R; Norman, WV; Pymar, H; Renner, R | 1 |
| Duan, Z; He, X; Jiang, J; Liang, R; Ma, MY; Tian, Y; Wang, J; Yu, SS; Zhou, Q; Zhou, R | 1 |
| Cerrillos, L; Diaz-Acedo, R; Fobelo-Lozano, MJ; Garcia-Jimenez, R; Ostos, R; Valero, I; Weber-Fernandez, AM | 1 |
| Cameron, S; French, RS; Lewandowska, M; Lohr, PA; Meiksin, R; Palmer, MJ; Reiter, J; Salaria, N; Scott, RH; Wellings, K | 1 |
| Bai, M; Chen, M; Jiang, H; Li, P; Lin, N; Lu, S; Ma, Z; Sun, D; Zeng, Q; Zeng, S; Zheng, C; Zhou, H | 1 |
| Devane, C; Dunn, S; Guilbert, E; Jeong, D; Munro, S; Norman, WV; Soon, JA; Stroulia, E | 1 |
| Braun, J; Franke, JF; Hammer, K; Kerschke, L; Klockenbusch, W; Köster, HA; Möllers, M; Möllmann, U; Oelmeier, K; Schmitz, R | 1 |
| Jiang, W; Pei, Y; Qian, Y; Zheng, C | 1 |
| Cameron, S; Morroni, C; Reynolds-Wright, JJ; Woldetsadik, MA | 1 |
| Bokobza, C; Csaba, Z; Faivre, V; Gressens, P; Guenoun, D; Morin, C; Sautet, I; Schwendimann, L; Van Steenwinckel, J; Young-Ten, P | 1 |
| Cottrill, A; Dethier, D; Fortin, J; Fulcher, IR; Gilbert, A; Goldberg, AB; Hofer, RK; Janiak, E; Roncari, D | 1 |
| Cabedo-Ferreiro, R; Falguera-Puig, G; Gómez-Masvidal, M; Manresa-Domínguez, JM; Montero-Pons, L; Reyes-Lacalle, A; Vicente-Hernández, MM | 1 |
| Cohen, RH; Teal, SB | 2 |
| Biggs, MA; Blanchard, K; Bustamante, CK; Choimorrow, SY; Ehrenreich, K; Grossman, D; Hauser, D; Hernandez, Y; Kapp, N; Kromenaker, T; Moayedi, G; Morris, N; Perritt, JB; Ralph, L; Raymond, EG; Valladares, ES; White, K | 1 |
| Abernathy, A; Flynn, AN; Koelper, NC; McAllister, A; Roe, AH; Sammel, MD; Schreiber, CA; Sonalkar, S | 1 |
| Huang, H; Li, J; Liu, H; Lu, J; Wang, R; Yang, Y | 1 |
| Barker, E; Latta, K; Laursen, L; Testani, E; York, SL | 1 |
| Fitzgerald, K; Laursen, L; Whitaker, AK; Young, D | 1 |
| Nieman, LK | 1 |
| Gutman, SM; Harvie, HS; Koelper, NC; Loza-Avalos, SE; Nagendra, D; Schreiber, CA; Sonalkar, S | 1 |
| Chu, Z; Han, H; Jia, L; Li, J; Tian, F; Yan, P; Zhang, J; Zhang, Y | 1 |
| Heikinheimo, O; Kemppainen, V; Mentula, M; Palkama, V | 1 |
| Cao, C; Chen, M; Hu, Z; Shu, C; Yang, X; Zhou, Q | 1 |
| Feng, LY; Hsieh, YP; Li, JH; Wang, YJ; Wu, LT | 1 |
| De Gennaro, E; Driul, L; Floris, S; Restaino, S; Sorrentino, F; Stabile, G; Vizzielli, G; Zinicola, G | 1 |
| Beestrum, M; Dungan, J; Kiley, J; Nosal, C; Turner, A | 1 |
| Du, S; Li, R; Long, Q; Tang, F; Wu, S; Zhao, Y | 1 |
| Allen, RH; Janiak, E; Johns, SL; Lee, CM; Stulberg, DB | 1 |
| Mazer-Amirshahi, M; Ye, P | 1 |
| Constant, D; Endler, M; Gemzell Danielsson, K; Gomperts, R; Grossman, D; Petro, G; Weinryb, M | 1 |
| Blumenthal, PD; Henkel, A | 1 |
| Cameron, ST; Morroni, C; Reynolds-Wright, JJ; Woldetsadik, MA | 1 |
| Guowen, LI; Huifeng, W; Jie, LI; Lijun, YU; Tiantian, Z; Yuan, G; Zhifeng, C | 1 |
| Shaker, M; Smith, A | 1 |
| De Feo, V; Grandone, E; Nappi, L; Sorrentino, F; Stabile, G; Vasciaveo, L; Zanzarelli, E | 1 |
| Bao, X; Huang, J; Huang, Y; Yang, R; Ye, S | 1 |
| Bettahar, K; Deruelle, P; Koch, A | 1 |
| Choobun, T; Maneeon, R | 1 |
| Bao, J; Garfield, RE; Huang, Q; Li, P; Liu, H; Ye, A | 1 |
| Chen, KM; He, WR; Jiang, T; Liu, ZR; Wang, L; Wang, XW; Wei, H; Yi, C; Zeng, Y; Zhang, XF; Zheng, YH | 1 |
| Munro, S; Norman, WV; Soon, JA; Zusman, EZ | 1 |
| Bryant, AG; Givens, M; Hagey, JM | 1 |
| An, J; Chen, R; Lu, Y; Su, R; Wang, W | 1 |
| Barna, T; Benyhe, S; Gáspár, R; Mirdamadi, M; Samavati, R; Schaffer, A; Szécsi, M; Szűcs, E; Szűcs, KF | 1 |
| Huang, RJ; Li, J; Ma, J; Xue, RH; Yao, YL; Zhang, L | 1 |
| Hancock, JM; Li, R; Li, Y; Lydon, JP; Martin, TE; Viswanathan, S; Ye, X; Zheng, Y | 1 |
| Biggs, MA; Grossman, D; Serrano, S; Valladares, ES | 1 |
| Cameron, S; Reynolds-Wright, JJ; Tai, NQR | 1 |
| Cirucci, C; Francis, C; Harrison, D | 1 |
| Bellini, R; Biagioli, M; Bordoni, M; Catalanotti, B; Di Giorgio, C; Distrutti, E; Fiorucci, S; Lupia, A; Marchianò, S; Massa, C; Monti, MC; Moraca, F; Morretta, E; Roselli, R; Sepe, V; Urbani, G; Zampella, A | 1 |
| Jurek, T; Szpot, P; Wachełko, O; Zawadzki, M | 1 |
| Feng, H; Li, X; Li, Y; Liao, X; Su, Q; Tian, T | 1 |
| Arnalsteen, C; Bettahar, K; Deshaies, A; Hauss, AS; Jochum, F; Kiehl, A; Koch, A; Martel, C | 1 |
| Arena, A; Casadio, P; Degli Esposti, E; Lenzi, J; Lenzi, M; Moro, E; Perrone, A; Seracchioli, R; Zanello, M | 1 |
| Baum, SE; Grossman, D; Potter, JE; Sierra, G; Vizcarra, E; White, K | 1 |
| Speer, L | 1 |
| Frye, LJ; Gawron, LM; Kaiser, JE; Sexsmith, CD; Shochet, T; Turok, D; Winikoff, B | 1 |
| Kazemian, A; Kowalewski, MP; Rehrauer, H; Tavares Pereira, M | 1 |
| Gong, Y; Hu, YF; Huang, GY; Li, W; Sheng, F; Wu, MY; Yang, Y; Zhang, LL; Zhang, P; Zou, L | 1 |
| Liu, N; Ray, JG | 1 |
| Dorogin, A; Khader, N; Mitchell, JA; Shchuka, VM; Shynlova, O | 1 |
| Boerma, C; Brandell, K; Cameron, S; Gemzell-Danielsson, K; Gibson, G; Heikinheimo, O; Hognert, H; Reynolds-Wright, JJ; Tuladhar, H | 1 |
| Fortin, J; Gelfand, D; Gilbert, AL; Goldberg, AB; Roncari, D | 1 |
| Cohen, D; Golden, L | 1 |
| Baker, CN | 1 |
| Ganatra, B; Grossman, A; Lavelanet, A; Prata, N; Rehnström Loi, U; Williams, N | 1 |
| Dethier, D; Kahili-Heede, M; Kaneshiro, B; Pearlman Shapiro, M | 1 |
| Rebouché, R | 1 |
| Ault, TA; Braxton, DR; Fong, TL; Marcus, AO; Watson, RA | 1 |
| Dunn, S; Guilbert, ER; Munro, SB; Norman, WV | 1 |
| Mamatsashvili, L; Platais, I; Tsereteli, N; Tsereteli, T; Tsertsvadze, G | 1 |
| Dickinson, JE; Doherty, DA | 2 |
| Lenharo, M | 1 |
| Beasley, A; Brandi, K; Castle, J; Creinin, MD; Gerdts, C; Gil, L; Grant, M; Grossman, D; Lockley, A; Mark, A; Perritt, J; Raymond, EG; Shochet, T; Truan, D; Upadhyay, UD | 1 |
| Eckersberger, E; Kapp, N; Mao, B; Menzel, J; Pearson, E; Rathavy, T; Saphonn, V | 1 |
| Burns, MM; Fay, KE; Feng, C | 1 |
| Gemzell-Danielsson, K; Maltzman, LL; Marions, L; Podolskyi, V | 1 |
| Li, W; Li, X; Liao, C; Tang, P; Wang, Y; Yang, Y; Ye, H | 1 |
| Flink-Bochacki, R; Phillips, AM; Rachad, S | 1 |
| Luo, ZY; Shen, HL; Su, RD; Wang, K; Wang, WR; Zhuang, LL | 1 |
| Tanne, JH | 3 |
| Afolabi, K; Asmani, C; Bhattarai, B; Chanza, H; Conneh-Duworko, MJ; Dhakal, NP; Dlamini-Nqeketo, S; Elamin, H; Ganatra, B; Grossman, A; Hailu, BG; Kabuteni, TJ; Läser, L; Lavelanet, A; Moses, F; Ojo, OA; Ouedraogo, L; Phiri, H; Prata, N; Rahman, MM; Rehnström Loi, U; Tehoungue, BZ; Williams, N; Zulu, T | 1 |
| Hamburg, M; Sharfstein, J | 1 |
| Mariner, WK | 1 |
| Du, H; Hao, Y; Jiang, M; Li, D; Liang, X; Lv, J; Ma, Y; Song, Y; Wang, S; Zhang, L | 1 |
| Bennett, IM; Coeytaux, FM; Fiastro, AE; Godfrey, EM; Jacob-Files, E; Ruben, MR; Young, E | 1 |
| Jaffe, S | 1 |
| Anger, HA; Raymond, EG | 1 |
| Aaron, DG; Brown, TR; Sinha, MS | 1 |
| Brun, R; Eckstein, SM; Perotto, L; von Felten, S; Vorburger, D | 1 |
| French, V | 1 |
| Gluck, AR | 1 |
| Balachander, S; Mol, BW; Oltman, J; Woolner, AMF | 1 |
| Gudu, W; Shimeles, T; Sium, AF | 1 |
| Boyd, K; Grant, M; Koenig, LR; Raymond, EG; Shochet, T; Upadhyay, U; Weaver, MA | 1 |
| Blair, R; Costescu, D; Davis, R; Guarna, G; Kotait, M; Vu, N; Yakoub, D | 1 |
| Fortin, J; Goldberg, AB; Hoe, E; Janiak, E; Neill, S | 1 |
| Fortin, J; Goldberg, A; Janiak, E; Mokashi, M; Neill, S | 1 |
| Bercu, C; Egwuatu, I; Gerdts, C; Grosso, B; Jayaweera, R; Kristianingrum, IA; Moseson, H; Motana, R; Nmezi, S; Zurbriggen, R | 1 |
| Camilleri, C; Sammut, S | 1 |
| Al Wattar, BH; de Braud, LV; Jurkovic, D; Rogozińska, E; Solangon, SA | 1 |
| Boos, EW; Dusetzina, SB; Horta, M; Leech, AA; Thompson, I | 1 |
| Raymond, EG; Shochet, T; Weaver, MA | 1 |
| Baker, CC; Creinin, MD; Flynn, AN; Han, G; Wu, BT | 1 |
| Brooks, M; Dineley, B; Ennis, M; Guilbert, E; Kean, L; Norman, WV; Pymar, H; Renner, R | 1 |
| Chen, Y; Xu, Y; Yang, P; Zhang, L | 1 |
| Bettencourt-Silva, B; Brás, F; Cunha, AI; Furtado, JM; Lopes-Guerra, C; Miguelote, R; Miranda, C; Rego, MT; Sousa-Santos, R | 1 |
| Fraz, F; Liu, SM; Shaw, KA | 1 |
| Dasgupta, J; Dasgupta, S; Goswami, B; Mondal, J | 1 |
| Gemzell-Danielsson, K; Gomperts, R; Marions, L; Podolskyi, V | 1 |
| Błaszczak-Świątkiewicz, K; Elger, W; Krupa, A; Mnich, E; Nair, H; Oettel, M; Shaked, Z; Sieroszewski, P; Wierzbicki, M | 1 |
| Akter, S; Khan, KK; Mirza, N; Mirza, TT; Sarna, IZ; Shamsi, S; Sharmin, F | 1 |
| Ambrosini, G; Andrisani, A; Bordin, L; Conley, J; Marin, L; Sabbadin, C; Vio, C | 1 |
| Brill, G; Huybrechts, KF; Hwang, CS; Kesselheim, AS; Rome, BN; Sarpatwari, A | 1 |
| Kopp Kallner, H | 1 |
| Meegan, MA | 1 |
| Bercu, C; Egwuatu, I; Gerdts, C; Grosso, B; Jayaweera, R; Kristianingrum, IA; Moseson, H; Nmezi, S; Zurbriggen, R | 1 |
| Meng, W; Ta, N; Wang, F | 1 |
| Ho, PC; Lui, MW | 1 |
| Abdullahi, ZG; Bello, N; Igashi, JB; Koledade, AK; Maikudi, HA; Mohammed, U; Shittu, OS | 1 |
| Barbour, K; Betstadt, S; Harrington, A; McQuade, M | 1 |
| Agostini, A; Bombas, T; Cameron, S; Fiala, C; Gemzell Danielsson, K; Lertxundi, R; Lubusky, M; Parachini, M; Saya, L; Trumbic, B | 1 |
| Abbas, DF; Blum, J; Dragoman, M; Karki, A; Karki, C; Sharma, J; Shochet, T; Shrestha, A; Tamang, A; Tuladhar, H; Winikoff, B | 1 |
| Cleeve, A; Fønhus, MS; Lavelanet, A | 1 |
| Berer, M | 4 |
| Aburto-Arciniega, MB; Arce Cedeño, A; Bonifaz Alfonzo, L; Díaz Olavarrieta, C; Fajardo Dolci, GE; Guevara-Guzmán, R; Phillips, VJ; Sanhueza-Smith, P; Villa, AR | 1 |
| Cui, S; Liu, J; Qiu, J; Yan, L; Zhang, Y | 1 |
| Barinov, SV; Kadcyna, TV; Lazareva, OV; Medyannikova, IV; Shamina, IV; Shkabarnya, LL; Tirskaya, YI | 1 |
| Babich, DA; Baev, OR; Prikhodko, AM; Sukhikh, GT; Tysyachniy, OV | 1 |
| Du, X; Duan, J; Huang, YM; Wang, Y; Yang, Y | 1 |
| Bessenaar, T; Eckersberger, E; Griffin, R; Kapp, N; Methazia, J | 1 |
| Georgiou, EX; Johnson, MR; Lai, PF; Tribe, RM | 1 |
| Cahill, EP; Conti, J | 1 |
| Cameron, S; Hasler, E; Lohr, PA; Schmidt-Hansen, M | 1 |
| Chen, MJ; Creinin, MD | 3 |
| Bertholdt, C; David, MG; Gabriel, P; Morel, O; Perdriolle-Galet, E | 1 |
| Coppus, SF; Hamel, CC; Snijders, MP; van den Berg, J; Vandenbussche, FP | 2 |
| Altman, D; Ehrnstén, L; Kopp Kallner, H; Ljungblad, A | 1 |
| Chen, MJ; Creinin, MD; Dalton, L; Hou, MY; Steward, R | 2 |
| Guo, MN; Ma, SF; Song, HR; Wang, J; Yun, Q; Zhang, WN | 1 |
| Bergeson, K; Kline, RJ; Prasad, S | 1 |
| Dineley, B; Munro, S; Norman, WV | 1 |
| Devane, C; Dunn, S; Guilbert, É; Munro, S; Norman, WV; Soon, JA; Wagner, MS; Wilcox, ES | 2 |
| Foster, AM; LaRoche, KJ; Wynn, LL | 1 |
| Abu-Rafea, B; Babwah, AV; Bhattacharya, M; de Oliveira, V; Radovick, S; Schaefer, J; Vilos, AG; Vilos, GA | 1 |
| Diedrich, JT; Drey, EA; Newmann, SJ | 1 |
| Chong, E; Dzuba, IG; Hannum, C; Lichtenberg, ES; Lugo Hernández, EM; Ngoc, NTN; Patel, A; Rzayeva, G; Sanhueza Smith, P; Tsertsvadze, G; Winikoff, B | 1 |
| Blum, J; Frye, LJ; Kilfedder, C; Winikoff, B | 1 |
| Foster, AM; Grossman, D; Mark, A; Prager, SW; Winikoff, B | 1 |
| Cameron, S; Hasler, E; Lord, J; Schmidt-Hansen, M | 1 |
| Cameron, S; Hasler, E; Hawkins, JE; Lohr, PA; Lord, J; Schmidt-Hansen, M; Williams, K | 1 |
| Aiken, ARA; Beasley, A; Brooks, IHM; Dermish, AI; Goyal, V; Kumar, B; Potter, JE; Schutt-Ainé, A; Wallace, R | 1 |
| Bousieguez, M; Bracken, H; Ha, DQ; Linh, NTH; Ngoc, NTN; Ortiz, MA; Paredes, NR; Quyet, VB; Winikoff, B | 1 |
| Gambir, K; Ganatra, B; Kim, C; Necastro, KA; Ngo, TD | 1 |
| Grossman, D; Harris, LH | 1 |
| Atrio, J; Chen, M; Harvie, HS; Koelper, N; Loza-Avalos, SE; Nagendra, D; Schreiber, CA; Sonalkar, S | 1 |
| Davenport, M; Delgado, G; Harrison, M | 1 |
| Butterfield-Kalk, CR | 1 |
| Valley, MT | 1 |
| Foster, AM; LaRoche, KJ | 1 |
| Atrio, JM; Creinin, MD; Koelper, N; McAllister, A; Sammel, MD; Schreiber, CA; Sonalkar, S | 1 |
| Doctoroff, J; Foster, AM; Mark, A; Yalahow, A | 1 |
| Alam, B; Kaler, A; Mumtaz, Z | 1 |
| Farez, R; Heinlein, M; Jacques, L; Kaljo, K; Nugent, M; Pan, A; Ralph, J | 1 |
| Bullard, KA; Cisternas, C; Gerdts, C; Grosso, B; Moseson, H; Vera, V | 1 |
| Axelsson, PB; Helm, P; Løkkegaard, ECL | 1 |
| Grossman, D; Landau, C; Raifman, S; Sella, S; Wingo, E | 1 |
| Beaman, J; Prifti, C; Schwarz, EB; Sobota, M | 1 |
| Brega, ES; Dikke, GB; Gus, AI; Kochev, DM; Lunkov, SS; Pekarev, OG; Sukhikh, GT | 1 |
| Choi, J; Park, YG; Seol, JW | 1 |
| Bousiéguez, M; Castañeda Vivar, JJ; Castillo, PW; Dzuba, IG; Lugo Hernández, EM; Sanhueza Smith, P | 1 |
| Parsons, JA | 1 |
| Jasmin Friedrich, S; Lidegaard, Ø; Meaidi, A | 1 |
| Blumenthal, PD; Henkel, A; Lerma, K; Shaw, KA | 1 |
| Abubeker, FA; Kim, C; Lavelanet, A; Rodriguez, MI | 1 |
| Nash, E | 1 |
| Barnhart, K | 1 |
| Bodor, N | 1 |
| Ferguson, I; Scott, H | 1 |
| Berkley, HH; Greene, HL; Wittenberger, MD | 1 |
| Brooks, M; Devane, C; Dunn, S; Guilbert, E; Leduc-Robert, G; Mills, M; Munro, S; Norman, WV; Soon, JA; Wagner, MS; Wahl, K; Wilcox, ES; Zannier, E | 1 |
| Agostini, A; Frantz, S; Herman-Demars, H; Quaranta, LM; Sicot, M; Zinovieva, E | 1 |
| Bajracharya, N; Bharati, S; Bhattachan, K; Dangal, G; Karki, A; Poudel, R; Pradhan, H; Shrestha, R; Tiwari, K | 1 |
| Mihalceanu, E; Onofriescu, M; Pintilie, R; Pristavu, A; Socolov, D; Vinturache, A | 1 |
| Benyhe, S; Gáspár, R; Kothencz, A; Mirdamadi, M; Szécsi, M; Szűcs, E | 1 |
| Cameron, S; Hasler, E; Lohr, PA; Nevill, M; Pandey, A; Schmidt-Hansen, M; Taylor, P | 1 |
| Brown, BL; Sarpatwari, A; Wood, SF | 1 |
| Egwuatu, I; Filippa, S; Gerdts, C; Grosso, B; Jayaweera, R; Keefe-Oates, B; Kristianingrum, I; Moseson, H; Motana, R; Nmezi, S; Raifman, S; Zurbriggen, R | 1 |
| Allaouidine, C; Chinery, L; Gülmezoglu, AM; Larson, M; Tomazzini, A | 1 |
| Akiba, N; Fujii, T; Iriyama, T; Kawana, K; Kumasawa, K; Nagamatsu, T; Osuga, Y; Samejima, T; Sayama, S; Taguchi, A | 1 |
| Sultana, N | 1 |
| Acharya, R; RamaRao, S; Shukla, A; Vázquez-Quesada, L; Vieitez, I | 1 |
| Chen, M; Song, L; Wei, T; Wu, L; Xiong, W; Yan, A; Zeng, M; Zhang, J; Zu, Q | 1 |
| Cameron, S; Fletcher, J; Hasler, E; Lord, J; O'Shea, LE | 1 |
| Creinin, MD; Perriera, L | 1 |
| Fuleihan, C | 1 |
| Chen, ZQ; Gao, CY; Kuang, N; Long, SY; Luo, L; Tian, HJ; Xiong, X; Yan, P; Ying, DM; Zhang, ZJ | 1 |
| Cameron, S; Hasler, E; Lohr, PA; Lord, J; O'Shea, LE | 1 |
| Bessenaar, T; Dragoman, MV; Duong, LD; Gautam, J; Grossman, D; Gulmezoglu, M; Habib, N; Hong, M; Kapp, N; Nguyen, MH; Tamang, A; Yoko, JL | 1 |
| Flynn, AN; Koelper, N; McAllister, A; Roe, AH; Sammel, MD; Schreiber, CA | 1 |
| Li, C; Liu, X; Zhang, T; Zhou, L | 1 |
| Anger, HA; Baldwin, MK; Banks, J; Bednarek, P; Boraas, C; Chong, E; Coplon, L; Grant, M; Haskell, S; Kaneshiro, B; Platais, I; Raymond, EG; Shochet, T; Tocce, K | 1 |
| Bagga, R; Bharati, J; Choudhary, N; Jain, S; Rajkumar Kopp, C; Saha, PK; Sharma, B; Singla, R | 1 |
| Kleiverda, G; Leusink, P | 1 |
| Okada, H; Yasuda, K; Yoshida, A | 1 |
| Bellussi, F; Berghella, V; Cohen, M; Edelman, A; Haas, DM | 1 |
| Aqtar, F; Averbach, S; Crouthamel, B; Hurst, S; Paul, D; Pearson, E; Silverman, J; Tilford, S | 1 |
| Cottrill, AA; Janiak, E; Rasmussen, KN; Stulberg, DB | 1 |
| Anger, HA; Baldwin, MK; Banks, J; Bednarek, PH; Boraas, CM; Chong, E; Coplon, L; Grant, MS; Haskell, S; Platais, I; Priegue, E; Raidoo, S; Raymond, E; Shochet, T; Soon, R; Thompson, F; Tocce, K; Winikoff, B | 1 |
| Bowen, E; Kaneshiro, B; Kerestes, C; Lacar, L; Murayama, S; Natavio, M; Platais, I; Raidoo, S; Seamon, E; Soon, R; Stowers, P; Tyson, J | 1 |
| Bell, J; Byl, N; Mohammed, S; Prager, S; Tufa, TH; Wondafrash, M | 1 |
| Daniel, S; Grossman, D; Schulkin, J | 1 |
| Glaser, K; Whitehair, J | 1 |
| Kaneshiro, B; Raidoo, S; Stowers, P | 1 |
| Allanson, ER; Copson, S; Criddle, S; Dickinson, JE; Doherty, DA; Jennings, B; Spilsbury, K; Wong, AM | 1 |
| Early, J; Macnaughton, H; Nothnagle, M | 1 |
| Calloway, D; Janiak, E; Stulberg, DB | 1 |
| Cole, E; Fox, D | 1 |
| Brubaker, L; Prine, L; Riker, L; Rubin, SE; Srinivasulu, S; Yavari, R | 1 |
| Flynn, AN; Jiang, E; Koelper, N; Martin, B; McAllister, A; Roe, AH; Schreiber, CA | 1 |
| Chaiten, L; Kaye, J; Reeves, R | 1 |
| Aultman, K; Beran, BD; Cirucci, CA; Harrison, DJ; Lockwood, MD; Seiler, S | 1 |
| Biggs, MA; Grossman, D; Raifman, S; Ralph, L | 1 |
| Agostini, A; Baumstarck, K; Cardinale, C; Fabre, C; Hamdaoui, N | 1 |
| Ahmed, A; Beeson, LE; Bender-Atik, R; Bhatia, K; Bottomley, C; Brewin, J; Cheed, V; Cheong, Y; Choudhary, M; Chu, JJ; Coomarasamy, A; Debs, S; Devall, AJ; Gallos, ID; Gupta, P; Hamilton, J; Hardy, P; Hassan, I; Hinshaw, K; Hodge, FS; Horne, AW; Izzat, F; Jeve, Y; Jones, LL; Kumar, CS; La Fontaine Papadopoulos, JH; Naftalin, J; Nunes, N; Okeke Ogwulu, CB; Oliver, A; Pringle, S; Quenby, S; Roberts, TE; Ross, J; Shahid, A; Small, R; Underwood, M; Watkins, L; Williams, EV; Yongzhong, S | 1 |
| Rafie, S; Stone, RH | 1 |
| Blaylock, R; Chang, JJ; Lohr, PA; Meurice, ME; Whitehouse, KC | 1 |
| Donovan, MK; Ghorashi, AR; Ma, J; Rikelman, J; Singh, D; Thompson, A | 1 |
| Blumenthal, PD; Fok, WK; Lerma, K; Shaw, KA | 1 |
| Aiken, ARA; Gomperts, R; Starling, JE | 1 |
| Beeson, LE; Coomarasamy, A; Devall, AJ; Do, V; Gallos, ID; Ghosh, J; Gülmezoglu, AM; Jeffery, HC; Lavelanet, A; Papadopoulou, A; Price, MJ; Tobias, A; Tunçalp, Ö | 1 |
| Gee, R; Harte, K; Horgan, P; Thompson, M | 1 |
| Boydell, N; Cameron, ST; Harden, J; Reynolds-Wright, JJ | 1 |
| Binder, C; Blank, DA; Crossley, KJ; Gill, AW; Hooper, SB; Kluckow, M; McGillick, EV; Polglase, GR; Roberts, C; Stenning, FJ; Te Pas, AB; Wallace, EM | 1 |
| Anger, HA; Banks, J; Boraas, C; Coplon, L; Grant, M; Haskell, S; Platais, I; Raymond, EG; Shochet, T; Tocce, K; Winikoff, B | 1 |
| Chen, S; Hu, Q; Li, C; Li, J; Luo, L; Yang, X; Zhang, X | 1 |
| Koenig, LR; Meckstroth, KR; Upadhyay, UD | 1 |
| Blumenthal, PD; Jones, RK; Mark, A; Nichols, MD; Reeves, MF; Saporta, VA | 1 |
| Brahmi, D; Castleman, L; Grossman, D; Jackson, E; Kapp, N | 1 |
| Blanchard, K; Devjee, J; Fetters, T; Lince-Deroche, N; Moodley, J; Sinanovic, E | 1 |
| Chaturachinda, K | 1 |
| Bianchi, PKFDC; Gonçalez, PO; Kfoury Junior, JR; Leandro, RM; Poscai, AN; Yoshinaga, T | 1 |
| Cameron, S; Glasier, A; Harden, J; Lawton, J; Purcell, C | 1 |
| Aiken, ARA; Digol, I; Gomperts, R; Trussell, J | 1 |
| Huang, JY; Kuo, PL; Su, MT; Tsai, YC; Tseng, JT; Wang, CY | 1 |
| Bateson, D; Black, KI | 1 |
| Fyfe, R; Murray, H | 1 |
| Gupta, A; Sharma, C; Soni, A; Verma, A; Verma, S | 1 |
| Beal, MW; Eagen-Torkko, MK; Simmonds, KE | 1 |
| Choi, HJ; Chung, TW; Ha, KT; Jung, YS; Kim, KJ; Lee, SO; Park, MJ | 1 |
| Cheng, H; Du, L; Li, S; Li, YY; Xu, H; Yin, ZY; Zhang, B; Zhang, XP; Zhou, XY | 1 |
| Alaniz, VI; Pitotti, JA; Teal, S; Tocce, K | 1 |
| Haverinen, A; Heikinheimo, O; Jahangiri, R; Männistö, J; Mentula, M; Niinimäki, M | 1 |
| Che, Y; Chen, K; Cheng, L; Shen, J; Showell, E | 2 |
| Heikinheimo, O; Korjamo, R; Mentula, M | 1 |
| Church, K; Dijkerman, S; Footman, K; Nuremowla, S; Reiss, K; Scott, R; Taleb, F | 1 |
| Chen, MJ; Kendall, PD | 1 |
| Blumenthal, PD; Hopkins, FW; Hugin, M; Lerma, K; Scrivner, KJ; Shaw, JG; Shaw, KA | 1 |
| Jahn, GA; Pennacchio, GE; Soaje, M; Villegas-Gabutti, CM; Vivas, L | 1 |
| Ho, PC | 1 |
| Baev, OR; Kozlova, OA; Rumyantseva, VP; Sukhikh, GT; Tysyachnyu, OV | 1 |
| Camden, AJ; Chadchan, SB; DeMayo, FJ; Kommagani, R; Lydon, JP; O'Malley, BW; Szwarc, MM | 1 |
| Lerma, K; Shaw, KA | 2 |
| Baldwin, MK; Kapp, N; Rodriguez, MI | 1 |
| Aiken, ARA; Gomperts, R; Guthrie, KA; Schellekens, M; Trussell, J | 1 |
| Guilbert, E; Jones, HE; Lichtenberg, ES; Norman, WV; O'Connell White, K; Paul, M | 1 |
| Brown, N; Herington, JL; Lei, W; Mahadevan-Jansen, A; O'Brien, C; Paria, BC; Reese, J; Robuck, MF; Slaughter, JC | 1 |
| Aiken, ARA | 1 |
| Coeytaux, F; Murtagh, C; Raymond, EG; Wells, E; Winikoff, B | 1 |
| Alam, A; Bracken, H; Das, TR; Lotarevich, T; Reichenbach, L | 1 |
| Huang, L; Liu, L; Qian, Z; Qin, J; Zhou, F | 1 |
| Bi, RY; Gan, YH; Kou, XX; Li, CS; Meng, Z; Wang, XD; Xue, XT; Zhou, YH | 1 |
| Boobekova, A; Davletova, A; Johnson, BR; Kazakbaeva, C; Kondrateva, Y; Landoulsi, S; Lazdane, G; Maksutova, E; Monolbaev, K; Seuc Jo, AH | 1 |
| Dunford, A; Fyfe, R | 1 |
| Boraas, C; Bousieguez, M; Comendant, R; Gillespie, G; Grant, M; Hodorogea, S; Platais, I; Raymond, EG; Sagaidac, I; Sanhueza, P; Tan, YL; Van Pratt, E; Weaver, MA; Winikoff, B | 1 |
| Ahmed, A; Ahmmed, F; Al Haque, N; Alam, A; Huda, FA; Karim, F; Mahmood, HR; Sarker, BK | 1 |
| Berer, M; Hoggart, L | 1 |
| Benavides, E; Frapp, S; Grant, M; Hannum, C; Raymond, EG; Reis, M; Sacks, DN; Tan, YL; Weaver, MA | 1 |
| Meirik, O; My Huong, NT; Shah, IH; Shrestha, P; Tamang, A; Thapa, K; Wang, D; Warriner, IK | 1 |
| Garratt, D; Turner, JV | 2 |
| Bouchard, P; Chabbert-Buffet, N; Daraï, E; Kolanska, K | 1 |
| Blum, M; Darney, PD; Grossman, D; Harper, CC; Maharjan, D; Puri, M; Regmi, K; Rocca, CH; Shrestha, P | 1 |
| Vogel, L | 1 |
| Aiken, ARA; Lohr, PA; Scott, JG; Starling, JE | 1 |
| Bracken, H; Raymond, EG; Shochet, T | 1 |
| Lajko, A; Meggyes, M; Polgar, B; Szereday, L | 1 |
| Aabø, RS; Iversen, OE; Janbu, T; Løkeland, M; Pay, ASD; Økland, I | 1 |
| Brooks, M; Dunn, S | 1 |
| Atrio, J; Barnhart, KT; Creinin, MD; Ratcliffe, SJ; Schreiber, CA; Sonalkar, S | 1 |
| Davis, AR; Westhoff, CL | 1 |
| Blanchard, K; Constant, D; Grossman, D; Harries, J; Kluge, J; Lince-Deroche, N; Sinanovic, E | 1 |
| Kida, N; Kido, T; Murata, H; Okada, H; Sumi, GI; Yasuda, K | 1 |
| Gonzales, K; Lalitsasivimol, D; McEwen, BS; Milner, TA; Newell, AJ; Wagner, CK; Waters, EM; Willing, J | 1 |
| Anger, H; Bousiéguez, M; Coutiño, D; Dabash, R; Peña, M; Sanhueza, P; Winikoff, B | 1 |
| Grossman, D; White, K | 1 |
| Amico, JR; Cheng, TL; Godfrey, EM | 1 |
| Aryal, S; Sharma, B; Shrestha, D | 1 |
| Di Carlo, C; Ferrara, C; Morra, I; Perriera, L; Saccone, G; Sansone, A; Sglavo, G | 1 |
| Gao, J; Liu, HN; Ma, X; Wang, H; Wang, XQ; Wang, YY; Xia, HF; Zhang, L | 1 |
| Du, M; Gu, Y; Huang, J; Jin, M; Wan, B; Xue, M; Ye, W; Yu, H; Zhang, J; Zhang, Y | 1 |
| Abele, H; Breisch, J; Hoopmann, M; Kagan, KO; Prodan, N; Wagner, P | 1 |
| Gallinand, AC; Laviolle, B; Lavoué, V; Le Lous, M; Nyangoh Timoh, K; Peltier, L | 1 |
| Abbas, D; Blum, J; Dragoman, M; Louie, K; Platais, I; Shochet, T; Tsereteli, T; Winikoff, B | 1 |
| Li, L; Liu, EX; Liu, Y; Qiu, YH; Xiong, YH; Yang, L | 1 |
| Baum, SE; Grossman, D; Hopkins, K; Potter, JE; White, K | 1 |
| H Al Wattar, B; Khan, KS; Murugesu, N; Tobias, A; Zamora, J | 1 |
| Friedrich, S; Gerds, TA; Lidegaard, O; Meaidi, A | 1 |
| Lyu, Y; Shang, L; Wang, Y | 1 |
| Black, KI; de Costa, CM; Russell, DB | 1 |
| Casson, M; Murray, ME; Pudwell, J; Waddington, A | 1 |
| Badmus, OO; Olatunji, LA | 1 |
| Kovač, V; Reljič, M; Serdinšek, T | 1 |
| Hardy-Fairbanks, AJ; Kerestes, CA; Stockdale, CK; Zimmerman, MB | 1 |
| Ralph, JA; Shulman, LP | 1 |
| Brooks, M; Devane, C; Dunn, S; Guilbert, E; Kendall, T; Munro, S; Norman, WV; Renner, R; Soon, JA; Waddington, A; Wagner, MS | 1 |
| Dunn, S; Genkin, I; Hum, S; Warden, S | 1 |
| Diamond-Smith, N; Percher, J; Saxena, M; Srivastava, A | 1 |
| Creinin, MD; Hsia, JK; Lohr, PA; Taylor, J | 1 |
| Baldwin, M; Bednarek, P; Castillo, PW; Chong, E; Coplon, L; Fontanilla, T; Kaneshiro, B; Keady, M; Lotarevich, T; Mary, M; Mathieu, N; Platais, I; Priegue, E; Raymond, E; Schnyer, A; Tschann, M; Winikoff, B | 1 |
| Dhiman, B; Jamwal, A; Jindal, N; Kandoria, M; Rao, R | 1 |
| Cameron, S; Gemzell-Danielsson, K; Rowlands, S | 1 |
| Hickey, M; Kim, BV; Lemmers, M; Mol, BWJ; Neilson, JP; Vazquez, JC; Verschoor, MA | 1 |
| Gayle, HD; Henney, JE | 1 |
| Check, D; Check, JH | 1 |
| Blumenthal, PD; Lerma, K | 1 |
| Pathania, K; Rana, UB; Sharma, P | 1 |
| Grossman, D; Upadhyay, UD | 1 |
| Cleeve, A; Endler, M; Gemzell-Danielsson, K | 1 |
| Aisemberg, J; Bariani, MV; Billi, SC; Franchi, AM; Vercelli, CA; Wolfson, ML | 1 |
| Cheng, L; Gemzell-Danielsson, K; Rabe, T | 1 |
| Bannikov, V; Lishchuk, V; Maistruk, G; Posohova, S; Raghavan, S; Shochet, T; Winikoff, B; Zhuk, S | 1 |
| Chen, OJ; Cheng, LN; Hou, SP; Huang, LH; Teng, YC | 1 |
| Shankhwar, P; Singh, N; Singh, U; Srivastava, D; Verma, ML | 1 |
| Cameron, S | 1 |
| Banerjee, AK; Emembolu, JO; Habiba, M | 1 |
| Chen, J; Guo, Q; Huang, B; Qiu, L; Ren, Z; Wan, R; Wang, M; Wang, X; Wang, Y; Ying, J; Yu, H; Yu, J | 1 |
| Driák, D; Sehnal, B; Svandová, I | 1 |
| Burke, A; Edelman, AB; Perritt, JB | 1 |
| Feng, X; Keller-Wood, M; Reini, SA; Richards, E; Wood, CE | 1 |
| Blumenthal, PD; Shaw, JG; Shaw, KA; Topp, NJ | 1 |
| Bascom, JL; Bissell, MJ; Fata, JE; Hirai, Y; Koh, E; Lo, A; Mori, H; Radisky, DC; Roosta, N | 1 |
| Ali, R; Arnesen, M; Dean, G; Lichtenberg, ES; Louie, KS; Porsch, L; Raymond, EG; Weaver, MA | 1 |
| Borgatta, L; Hou, M; Hou, MY; Sonalkar, S | 1 |
| Dzuba, IG; Peña, M; Winikoff, B | 1 |
| Gawron, LM; Kiley, JW | 1 |
| Ben-Meir, A; Elami-Suzin, M; Freeman, MD; Laufer, N; Porat, N; Rojansky, N | 1 |
| Chávez-Mendoza, A; Espejel-Nuñez, A; Estrada-Gutiérrez, G; Flores-Espinosa, P; Flores-Pliego, A; Maida-Claros, R; Morales-Méndez, I; Paredes-Vivas, Y; Pineda-Torres, M; Sosa-González, I; Vega-Sánchez, R; Zaga-Clavellina, V | 1 |
| Langdana, F; Maharaj, D; Searle, L; Tait, J | 1 |
| Chai, J; Ho, PC | 1 |
| Guo, Y; Jiang, G; Li, X; Li, Y; Wang, B; Wang, L; Yao, C; Zhang, M; Zhao, X; Zhou, X | 1 |
| Akins, ML; Auchus, RJ; Ehinger, N; House, M; Mahendroo, M; McIntire, D; Milne, GL; Paria, BC; Reese, J; Socrate, S; Timmons, BC | 1 |
| Huang, L; Qian, Z; Zhuang, Y | 1 |
| Chaudhuri, P; Das, C; Mandal, A; Mazumdar, A | 1 |
| Cook, R; Dunn, S | 1 |
| Hosie, MJ; Penny, CB; Theron, KE | 2 |
| Andreeva, A; Marinov, B | 1 |
| Chernev, A; Chernev, T; Manueljan, M | 1 |
| Colleselli, V; D'Costa, E; Mangesius, S; Schreiber, CA; Seeber, BE; Wildt, L | 1 |
| Edwards, P; Free, C; Le, HT; Ngo, TD; Nguyen, TH; Nguyen, YB; Pham, KH | 1 |
| Fox, MC; Krajewski, CM | 1 |
| Kagami, K; Nishigori, H | 1 |
| Karasu, T; Konje, JC; Marczylo, EL; Marczylo, TH; Oloto, E; Taylor, AH | 1 |
| Bhatt, AJ; Famuyide, M; Feng, Y | 1 |
| Gao, WN; Guo, Y; Huang, GY; Liu, YF; Tang, X; Wang, LJ; Yang, W; Zhang, MM | 1 |
| Atanasova, M; Nikolov, A | 1 |
| Diop, A; Okonofua, F; Shittu, O; Shochet, T; Winikoff, B | 1 |
| Aliberti, C; Bastianelli, C; Farris, M; Parachini, M | 1 |
| Chen, J; Gao, Y; Jia, L; Liu, Z; Shao, J; Wang, J; Xu, J; Yu, S | 1 |
| Anserini, P; Calanni, L; Ferrero, S; Gianola, G; Morotti, M; Venturini, PL | 1 |
| Begum, F; Chaudhury, P; Dissanayake, M; Tank, J; Yasmin, H; Zaidi, S | 1 |
| Bjørge, L; Engeland, A; Iversen, OE; Løkeland, M; Økland, I | 1 |
| Huang, XZ; Ling, J; Tan, J; Wu, QY; Xue, Q | 1 |
| Dickinson, JE; Doherty, DA; Jennings, BG | 1 |
| Goldberg, AB | 1 |
| Bracken, H; Lohr, PA; Morroni, C; Taylor, J; Winikoff, B | 1 |
| Liu, S; Qin, HM; Wang, J; Wang, XQ; Yan, Q; Zhao, Y | 1 |
| Constant, D; de Tolly, K; Harries, J; Myer, L | 1 |
| Bartos, A; Cha, J; Dey, SK; Egashira, M; Fujii, T; Fukayama, M; Haraguchi, H; Hiraoka, T; Hirota, Y; Koga, K; Matsumoto, L; Matsuo, M; Osuga, Y; Saito-Fujita, T; Yamauchi, N | 1 |
| Bregonzio, C; de Di Nasso, EG; Gamboa, DF; Pennacchio, GE; Soaje, M; Valdez, SR | 1 |
| Di Carlo, C; Ferrara, C; Morra, I; Nappi, C; Savoia, F; Sglavo, G | 1 |
| Li, X; Liu, H; Mei, Q; Zhou, H | 1 |
| Averbeck, M; Lehmann, I; Petzold, S; Polte, T; Simon, JC | 1 |
| Goldthwaite, LM; Teal, SB | 1 |
| Aguarón Benítez, G; Callejón Rodríguez, C; Gómez García, MT; González Merlo, G; Nogueira García, J; Ruiz Sánchez, E | 1 |
| Aliyeva, F; Chong, E; Louie, KS; Rzayeva, G; Tsereteli, T; Winikoff, B | 1 |
| Heikinheimo, O; Kalso, E; Mentula, M | 1 |
| Bertelsen, CB; Bor, P | 1 |
| Bryant, AG; Regan, E; Stuart, G | 1 |
| Essén, B; Gemzell-Danielsson, K; Iyengar, K; Iyengar, S; Klingberg-Allvin, M; Paul, M | 1 |
| Amelkina, O; Elger, W; Garfield, R; Killeen, Z; Meister, R; Nickisch, K; Santhamma, B; Schneider, B | 1 |
| Bombas, T; Cameron, S; Fiala, C; Gemzell-Danielsson, K; Parachini, M; Saya, L | 1 |
| Chaar, B; Lee, RY; Moles, R | 1 |
| Ginsburg, DS; Pabona, JM; Simmen, FA; Simmen, RC; Zhang, D | 1 |
| Arenas-Hernandez, M; Gomez-Lopez, N; Hajar, O; Mitchell, BF; Olson, DM; Taggart, MJ; Tanaka, S; Tong, WC | 1 |
| Chen, DJ; Chen, WL; Li, CL; Liu, MX; Song, LP; Wang, Y; Zhang, ZF | 1 |
| Chong, E; Frye, LJ; Winikoff, B | 1 |
| Bouschbacher, L; Collin, P; de Malartic, CM; Maatouk, A; Morel, O; Welter, E | 1 |
| Coppus, SF; de Heus, R; Snijders, MP; van den Bent, JM; van den Berg, J; Vandenbussche, FP | 1 |
| Bettahar, K; Nisand, I | 1 |
| Hickey, M; Moore, P | 1 |
| Benson, L; Fiala, C; Gemzell-Danielsson, K; Heikinheimo, O; Oppegaard, KS; Qvigstad, E | 1 |
| Furuse, T; Hino, T; Irie, M; Ishino, F; Kaneko-Ishino, T; Kashimura, M; Nakamura, K; Naruse, M; Oda, K; Ono, R; Wakana, S; Yamada, I; Yokoyama, M | 1 |
| Hu, Y; Huo, ZH; Liu, CM; Liu, SG; Ma, X; Qi, L; Xia, HF; Yin, KL; Zhang, N | 1 |
| Borgatta, L; Hou, MY; McClusky, J; Sonalkar, S | 1 |
| Bracken, H; Conkling, K; Karki, C; Tuladhar, H; Winikoff, B | 1 |
| Blumenthal, PD; Hopkins, FW; Hugin, M; Shaw, JG; Shaw, KA; Velasquez, G | 1 |
| Platais, I | 1 |
| Barros Pereira, I; Carvalho, RM; Graça, LM | 1 |
| Cleland, K; Gatter, M; Nucatola, DL | 1 |
| Chen, JG; Chen, T; Chen, WZ; Ding, MX; Ding, Y; Han, L; Zhou, FY | 1 |
| Ashley, C; Jiang, Q; Kushner, DM; Medlin, EE; Yang, L; Zheng, Y | 1 |
| Borgatta, L; Edelman, A; Mark, AG | 1 |
| Chen, WL; Jin, L; Li, L; Liu, XY; Peng, P | 1 |
| Berer, M; Ganatra, B; Guest, P | 1 |
| Cockroft, M; Delvaux, T; Ith, L; Petitet, PH | 1 |
| Avagyan, G; Chong, E; Louie, KS; Tsereteli, T; Vardanyan, S; Winikoff, B | 1 |
| Aranguré Peraza, AG; Bousiéguez, M; Dzuba, IG; García Martinez, ML; Peña, M; Sanhueza Smith, P; Shochet, T; Winikoff, B | 1 |
| Lama, K; Puri, M; Shrestha, P; Tamang, A | 1 |
| Fichez, A; Huissoud, C; Lamblin, G; Le Gall, J; Philip, CA | 1 |
| Bartz, D; Fortin, J; Goldberg, AB; Maurer, R; Pocius, KD | 1 |
| Acharya, R; Filippi, V; Powell-Jackson, T; Ronsmans, C | 1 |
| Agmon, A; Amer-Alshiek, J; Grisaru, D; Shiekh, O | 1 |
| Au, HK; Chien, LW; Liu, CF; Tzeng, CR | 1 |
| Almeida, H; Gaio, AR; Guedes-Martins, L; Macedo, F; Reynolds, A; Saraiva, JP | 1 |
| Chelli, H; Dabash, R; Hajri, S; Raghavan, S; Shochet, T; Winikoff, B | 1 |
| Bornstein, J; Kais, M; Masri, I; Odeh, M; Tendler, R | 1 |
| Aggarwal, D; Kapoor, G; Salhan, S; Sarda, N | 1 |
| Bhatt, AJ; Feng, Y | 1 |
| Ahn, C; An, BS; Jeung, EB; Lee, D; Yang, H | 1 |
| Blumenthal, PD; Grimes, DA; Grossman, D; Harris, L; Reeves, M; White, K; Winikoff, B | 1 |
| Wagner, CK; Willing, J | 1 |
| Chong, E; Gold, M | 1 |
| Cleland, K; Smith, N | 1 |
| Goldstone, P; Grossman, D | 1 |
| Harvey, P | 1 |
| Sheldon, WR; Winikoff, B | 1 |
| Abbas, D; Chong, E; Raymond, EG | 1 |
| Grossman, D; Raymond, EG; Wiebe, E; Winikoff, B | 1 |
| Foster, AM; Jackson, CB; LaRoche, KJ; Simmonds, K; Taylor, D | 1 |
| Dzuba, IG; Grossman, D; Schreiber, CA | 1 |
| Westhoff, C; Winikoff, B | 1 |
| Castle, J; Chong, E; Dean, G; Frye, LJ; Kuehl, L; Winikoff, B | 1 |
| Blanchard, K; de Menezes, ID; Devjee, J; Fetters, T; Lince-Deroche, N; Moodley, J; Nkonko, E; Sudhinaraset, M; Trueman, K | 1 |
| Bednarek, PH; Chen, BA; Dean, G; Drey, EA; Dutton, C; Fitzmaurice, GM; Fortin, JA; Goldberg, AB; Lichtenberg, ES; Maurer, R; McKetta, S; Winikoff, B | 1 |
| Barnard, S; Kim, C; Ngo, TD; Park, MH | 1 |
| Ali, RF; Anderson, NC; Dehlendorf, CE; Fox, EE; Lichtenberg, ES; Reed, RD | 1 |
| Dalton, VK; Wallett, S | 1 |
| Al-Azemi, M; Raghupathy, R | 1 |
| Creinin, MD; Monmaney, JA; Reeves, MF | 1 |
| Chang, Q; Di, W; Dong, B; Huang, Z; Jing, X; Li, Y; Qian, J; Ren, M; Shen, H; Shi, H; Song, W; Wu, S; Yao, C; Zheng, S | 1 |
| Chen, YP; Tsui, KH; Wang, PH | 1 |
| Chen, DJ; Deng, YF; Li, CL; Liu, KJ; Mo, XT; Song, LP | 1 |
| Burke, AE; Whaley, NS | 1 |
| Chaudhuri, P; Datta, S | 1 |
| Gilstrop, M; Sciscione, A | 1 |
| Diao, H; Dudley, EA; El Zowalaty, AE; Li, R; Xiao, S; Ye, X; Zhao, F | 1 |
| Bardy, F; David, P; Dunbavand, A; Opatowski, M; Saurel-Cubizolles, MJ | 2 |
| Coppus, SFPJ; Gordon, BBM; Snijders, MPML; van den Berg, J; Vandenbussche, FPHA | 1 |
| Boutas, I; Kalampokas, E; Kalampokas, T; Panoulis, K | 1 |
| Anslinger, K; Bayer, B; Ditsch, N; Hofmann, S; Jeschke, U; Kost, B; Kuhn, C; Vattai, A; Ziegelmüller, B | 1 |
| Blumenthal, PD | 2 |
| Ho, PC; Lo, SS | 1 |
| Cui, J; Cui, W; Shao, X; Wen, P | 1 |
| Boubli, L; Bretelle, F; Chau, C; Couteau, C; D'Ercole, C; Guidicelli, B | 1 |
| Dang, Q; Liu, HL; Wang, QM | 1 |
| Abreu, P; Alfirevic, Z; Navaratnam, K; Sharp, A | 1 |
| Mizuno, M | 1 |
| Najera, DB | 1 |
| Jiang, Q; Liu, F; Lv, YE; Yang, L; Zheng, Y | 1 |
| Delgado, G | 1 |
| Zhang, S; Zhang, Y; Zhou, H | 1 |
| Frank, K; Gerychová, R; Huser, M; Janků, P; Ventruba, P | 1 |
| Demars, HH; Hassoun, D; Hiên, H; Périn, I | 1 |
| Geller, S; Park, J; Robinson, N; Turner, J; Wessels, U | 1 |
| Aranguré-Peraza, AG; Bousiéguez, M; Culwell, KR; Goldberg, AB; Jamshidi, R; Kaplan, C; Louie, KS; Lugo-Hernández, EM; Memmel, L; Raymond, EG; Sanhueza, P; Sonalkar, S; Tan, YL; Weaver, MA; Winikoff, B | 2 |
| Casey, FE; Moreno-Ruiz, NL; Perritt, JD; Reeves, MF; Ye, PP | 1 |
| Candelas, JA; Domínguez, A; Douthwaite, M; Eckhardt, C; Ngo, TD; Reichwein, B | 1 |
| Capmas, P; Debras, E; Fernandez, H; Houllier, M; Pourcelot, AG | 1 |
| Dyer, C | 1 |
| Blum, J; Blumenthal, PD; Martin, R; Nga, NT; Ngoc, NT; Sheldon, WR; Van Thanh, L; Winikoff, B | 1 |
| Hou, MY | 1 |
| Cansino, C; Chen, MJ; Creinin, MD; Hou, MY; Rounds, KM | 1 |
| Chaumont, A; El-Haddad, J; Foster, AM; LaRoche, KJ; Vogel, KI | 1 |
| Ephrem-Duron, J; Gallot, D; Laurichesse-Delmas, H; Pereira, B; Stadler, A | 1 |
| Agostini, A; Auquier, P; Baumstarck, K; Cohen-Solal, E; Maruani, J; Ohannessian, A | 1 |
| Iyengar, K; Iyengar, SD | 1 |
| Cooperrider, J; Custer, M; Dobyns, AE; Elsissy, JG; Heuerman, AC; Kirby, MA; Strilaeff, R; Stutz, KN; Yellon, SM | 1 |
| Drazen, JM; Greene, MF | 1 |
| Rosenthal, DL | 1 |
| Zhang, YX | 1 |
| Grebennikova, G; Lotarevich, T; Platais, I; Tsereteli, T; Winikoff, B | 1 |
| Cano, JK; Foster, AM | 1 |
| Arnott, G; El-Haddad, J; Foster, AM; Sheinfeld, L | 1 |
| Bronson, H; Fang, X; Ishiguro, T; Olson, DM; Takeda, J | 1 |
| Bragg, B; Chawla, K; Hladky, K; Mark, K | 1 |
| Chelli, H; Dabash, R; Hajri, S; Haleb, D; Hassairi, AE; Koenig, L; Labassi, H; Sfar, E; Shochet, T; Temimi, F; Winikoff, B | 1 |
| Immonen, E; Nissi, R; Santala, M; Talvensaari-Mattila, A | 1 |
| Ben-Meir, A; Elami-Suzin, M; Freeman, MD; Porat, N; Rojansky, N; Winograd, O | 1 |
| Bartosik, T; Brunner, C; Ciresa-Koenig, A; Colleselli, V; Marth, C; Nell, T; Seeber, B; Wildt, L | 1 |
| Combellick, SL; Johns, NE; Keder, LM; Kohn, JE; Roberts, SC; Upadhyay, UD | 1 |
| Constant, D; Grossman, D; Harries, J; Malaba, T; Myer, L; Patel, M; Petro, G | 1 |
| He, FF; Jiang, WX; Shen, Q; Shen, ZJ; Tao, XJ; Zhao, CC; Zhu, XQ | 1 |
| Bartz, D; Fortin, J; Goldberg, AB; Maurer, R; Pocius, KD; Stenquist, A | 1 |
| Brolin, L; Hedqvist, M; Larsson, M; Tydén, T | 1 |
| Chen, C; Jiang, Y; Lin, F; Wang, X; Wu, S | 1 |
| Aronsson, A; Benson, L; Cameron, S; Gemzell-Danielsson, K; Heller, R; Hognert, H; Jawad, I; Kopp Kallner, H; Lindh, I; Nyrelli, C | 1 |
| He, H; Li, CL; Liao, YM; Mo, XT; Song, LP; Tang, SY; Zhou, LJGY | 1 |
| Jahn, GA; Pennacchio, GE; Soaje, M; Villegas-Gabutti, C | 1 |
| Dragoman, MV; Dung, DL; Grossman, D; Habib, N; Huong, NM; Kapp, N; Tamang, A | 1 |
| Abbas, DF; Blum, J; Chi, HT; Martin, R; Nga, NT; Ngoc, NT; Winikoff, B | 1 |
| Norman, WV; Soon, JA | 1 |
| Qureshi, S; Sankhwar, PL; Singh, N; Singh, U; Verma, ML | 1 |
| Abrahamyan, R; Avagyan, G; Chong, E; Louie, KS; Tsereteli, T; Winikoff, B | 1 |
| Sheldon, S | 1 |
| Akerkar, R; Bjørge, L; Bjørge, T; Iversen, OE; Løkeland, M | 1 |
| Blum, J; Blumenthal, PD; Bracken, H; Dabash, R; Ngoc, NTN; Platais, I; Raymond, EG; Sheldon, WR; Shochet, T; Weaver, MA; Winikoff, B | 1 |
| Berta, G; Bogdan, A; Szekeres-Bartho, J | 1 |
| Bai, H; Cui, R; Lu, J; Zhang, Z | 1 |
| Blumenthal, PD; Long, D; Madan, Y; Mundy, G; Sotheary, K | 1 |
| Bateson, D; Brassil, A; Dawson, AJ; Doab, A; Estoesta, J; Nicolls, R; Sullivan, EA | 1 |
| Goldstone, P; Hawtin, K; Walker, C | 1 |
| Bermúdez, SB; Esteve, JL; Gallego, FG; González, LV; Llorente, MP; Sala, ES; Texidó, CS | 1 |
| Griffiths, S; Porter, C; Singh, M | 1 |
| Byun, HS; Choi, KC; Hyun, SH; Jeung, EB; Lee, BM; Lee, GS | 1 |
| Dorogin, A; Lye, SJ; Shynlova, O; Tsui, P | 1 |
| Davies, S; Gemzell-Danielsson, K; Gomperts, RJ; Jelinska, K; Kleiverda, G | 1 |
| Baum, M; Goldenberg, M; Machtinger, R; Schiff, E; Seidman, DS; Vitner, D | 1 |
| Lei, W; Li, XJ; Liu, HJ; Ni, H; Rengaraj, D; Yang, ZM; Yu, XJ | 1 |
| Dehlendorf, CE; Grumbach, K | 1 |
| Gemzell-Danielsson, K; Lalitkumar, S | 1 |
| Blanchard, K; Blumenthal, P; Grossman, D | 1 |
| Chen, BA; Creinin, MD | 2 |
| Deis, R; Ezquer, M; Gabutti, CV; Maldonado, C; Soaje, M | 1 |
| Creinin, MD; Kudva, A; Reeves, MF | 1 |
| Arthur, P; Mitchell, BF; Taggart, MJ; Wong, S; Zielnik, B | 1 |
| Misra, A; van Bogaert, LJ | 1 |
| Jansen, NE; Pasker-De Jong, PC; Zondervan, HA | 1 |
| Jones, HE; Lichtenberg, ES; O'Connell, K; Paul, M; Westhoff, CL; Wiegerinck, MM | 1 |
| Davies, S; Gemzell, K; Gomperts, R; Jelinska, K; Kleiverda, G | 1 |
| Ford, SM; Lim, K; Scherf, C; Willmott, FJ | 1 |
| Creinin, MD; Crowden, WA; Dzuba, IG; Goldberg, AB; Gonzales, J; Howe, M; Moskowitz, J; Prine, L; Shannon, CS; Winikoff, B | 1 |
| Chai, J; Chen, QF; Cheng, LN; Ho, PC; Hong, QQ; Ng, E; Tang, OS | 1 |
| Chen, AM; Cheng, YM; Gao, ES; Luo, L; Yuan, W; Zhu, QX | 1 |
| Haldane, J | 1 |
| Arya, VK; Bagga, R; Choudhary, N; Kaur Dhaliwal, L; Mahajan, U; Rani Gupta, K; Suri, V; Vijayverghia, R | 1 |
| Shannon, C; Winikoff, B | 2 |
| Bartsch, C; Baumann, G; Dschietzig, T; Stangl, K | 1 |
| Borgatta, L; Mottl-Santiago, J; Savla, A; Soodoo, N; Strafford, MA | 1 |
| Cotte, M; Lefebvre, P; Monniez, N; Norel, G | 1 |
| Parsons, JH; Samuel, MI | 1 |
| Chang, HM; Lin, CY; Shen, CJ; Tsai, EM | 1 |
| Bracken, H; Comendant, R; Digol, I; Friptu, V; Raghavan, S; Ungureanu, S; Winikoff, B | 1 |
| Liao, MC; Wang, LJ; Zhang, XY | 1 |
| Anh, ND; Dickson, K; Erdenetungalag, R; Fang, AH; Horga, M; Kalmar, L; Kapamadzija, A; Marions, L; Mittal, S; My Huong, NT; Peregoudov, A; Piaggio, G; Pretnar-Darovec, A; Tai, NV; Tang, OS; Tuyet, HT; von Hertzen, H; Wojdyla, D; Wu, SC | 1 |
| Chawdhary, R; Pradhan, N; Rana, A | 1 |
| Harada, C; Hayashi, M; Kobayashi, K; Kuroda, J; Kusama, H; Nagasawa, T; Okuhara, Y; Onozato, T; Tamura, T; Terashima, Y; Yokoi, R | 1 |
| Swica, Y; Winikoff, B | 1 |
| Au, HK; Chien, LW; Liu, WM; Tzeng, CR | 1 |
| Bloigu, A; Gissler, M; Heikinheimo, O; Hemminki, E; Niinimäki, M; Pouta, A; Suhonen, S | 1 |
| Rocca, MS; Wehner, NG | 1 |
| Bracken, H; Karki, C; Kushwaha, A; Manandhar, D; Pokharel, H; Winikoff, B | 1 |
| Huang, L; Li, L; Zhou, Z | 1 |
| Hartikainen, AL; Karinen, P; Niinimäki, M; Pouta, A | 1 |
| Finer, LB; Henshaw, SK; Jones, RK; Kost, K; Singh, S | 1 |
| Bartz, D; Goldberg, A | 1 |
| Diedrich, J; Vargas, J | 1 |
| Coyaji, K; Elul, B; Ganatra, B; Kalyanwala, S; Tewari, S | 1 |
| Goodyear-Smith, F; Knowles, A | 1 |
| Charnock-Jones, DS; Ghosh, D; Sengupta, J; Sharkey, AM; Smith, SK | 1 |
| Espinoza, J; Navarrete, E; Perusquía, M | 1 |
| Broekhuizen, FF | 1 |
| Lièvre, M; Sitruk-Ware, R | 2 |
| Atalla, R; Morgan, M | 1 |
| Akin, A; Aksan, G; Aktün, H; Dabash, R; Dilbaz, B; Doğan, B; Dursun, P; Kiran, S; Winikoff, B | 1 |
| Hapangama, D; Neilson, JP | 1 |
| Järvelä, IY; Niinimäki, M; Ruokonen, A; Tapanainen, JS | 1 |
| Chai, J; Elovitz, MA; Gonzalez, JM; Ofori, E; Xu, H | 1 |
| Taneepanichskul, S | 1 |
| Cleland, K; Cullins, V; Fjerstad, M; Lichtenberg, ES; Sivin, I; Trussell, J | 2 |
| Finer, LB; Wei, J | 1 |
| Fujiwara, H; Kudo, Y; Miyoshi, H; Urabe, S; Yamaoka, K | 1 |
| Ben-Meir, A; Erez, Y; Feigenberg, T; Hamani, Y; Laufer, N; Rojansky, N | 1 |
| Brockman, DE; Grigsby, PL; Hinton, AC; Hinton, RB; Ittenbach, RF; Myatt, L; Pitzer, BA | 1 |
| Kalu, G; Narang, L | 1 |
| Faĭzrakhmanova, FM; Pogorel'tsev, VI; Smirnova, GA | 1 |
| Anderson, L; Geisert, R; Lucy, M; Mathew, D; Okamura, C; Sellner, E | 1 |
| Huang, GY; Wang, W; Wu, YX; Zheng, CH | 1 |
| Armstrong, N; Deverill, M; Hewison, J; Howel, D; Kelly, T; Lie, ML; May, CR; Robson, SC; Stamp, E | 1 |
| Creemers, JW; Ebbers, S; Lotgering, FK | 1 |
| Asoh, K; Kobayashi, S; Matsumoto, N; Mizuno, M; Takagi, M; Takeba, Y; Tsuzuki, Y; Yamamoto, H | 1 |
| Schaff, EA | 1 |
| Dong, B; Li, D; Manconi, F; Sun, B; Wang, G; Zhang, Y | 1 |
| Han, W; He, B; Wang, J; Wang, N; Zhang, S; Zhao, H | 1 |
| Ben Regaya, L; Bibi, M; Bouguizane, S; Chaieb, A; Fathallah, K; Fekih, M; Khairi, H | 1 |
| Fitzgibbon, A; Furedi, A; Lohr, PA; Riley, L; Wade, J | 1 |
| Bracken, H; Clark, W; Lichtenberg, ES; Schweikert, S; Tanenhaus, J; Winikoff, B | 1 |
| Appleman, LJ; Im, A | 1 |
| Borrás, A; Carceller, A; Coll, O; Gómez, O; Gratacós, E; Palacio, M; Rabanal, A | 1 |
| Chen, BA; Creinin, MD; Hayes, J; Hohmann, HL; Perriera, LK; Reeves, MF | 1 |
| Glazier, JD; Greenwood, SL; Sibley, CP; Speake, PF | 1 |
| Bentz, AI; Burd, I; Chai, J; Cohen, AS; Elovitz, MA; Gonzalez, J; Le Roux, PD; Monnerie, H; Yudkoff, M | 1 |
| Creinin, MD; Lohr, PA; Reeves, MF | 1 |
| Gemzell, K; Heikinheimo, O; Piaggio, G; Templeton, A; Van Look, P; von Hertzen, H | 1 |
| Hayes, JL; Kapp, N; Lohr, PA; Ngo, TD | 1 |
| Fiala, C; Gemzell-Danielsson, K; Kopp Kallner, H; Stephansson, O | 1 |
| Chun, J; Cui, J; Diao, H; Xiao, S; Xu, Y; Ye, X | 1 |
| Chen, CY; Chiang, HK; Chou, SY; Chow, PK; Hsu, CS; Hsu, MI | 1 |
| Choe, YS; Jang, MC; Kim, OS; Ko, WS; Pyo, HS; Tran, NT | 1 |
| Brownell, P; Dickinson, JE; McGinnis, K; Nathan, EA | 1 |
| Bennasar, M; Berge, R; Eixarch, E; Font, C; Illa, M; Palacio, M | 1 |
| Elsandabesee, D; Wedisinghe, L | 1 |
| Badis, CM; Bechir, Z; Dalenda, C; Ezzeddine, S; Fathia, B; Hela, C; Ines, N; Malika, A | 1 |
| Cong, J; Dong, J; Godfrey, EM; VonHertzen, H; Wang, C; Wu, S | 1 |
| Ho, PC; Lee, VC; Ng, EH | 1 |
| Napolitano, R; Thilaganathan, B | 1 |
| Cheon, YP; Kim, CH | 1 |
| Fiala, C; Gemzell-Danielsson, K; Hämäläinen, JM; Heikinheimo, O; Sääv, I | 1 |
| Fan, L; Zou, LY | 1 |
| Day, M | 1 |
| Fernandez, H; Gervaise, A | 1 |
| Bjørge, L; Dahle, GS; Ertzeid, L; Iversen, OE; Løkeland, M; Nappen, MH | 1 |
| Chen, AM; Cheng, YM; Gao, ES; Luo, L; Miao, MH; Yuan, W | 1 |
| Hamoda, H; Templeton, A | 1 |
| Chen, Q; Cheng, L; Fang, A; Hou, S; Zhang, L | 2 |
| de Costa, C; Downing, S; Leamy, J; McNamee, H; Penney, D; Russell, DB | 1 |
| Cheng, L; Cleland, K; Raymond, E; Trussell, J; Zhu, H | 1 |
| Borrás, A; Gómez, O; Martínez, JM; Puerto, B; Sanz, M | 1 |
| Bayalag, M; Cabezas, E; Chaturachinda, K; Fang, AH; Gemzell-Danielsson, K; Hinh, ND; Huong, NT; Khomassuridge, A; Mittal, S; Ng, EH; Peregoudov, A; Piaggio, G; Pinter, B; Puscasiu, L; Savardekar, L; Shenoy, S; Tuyet, HT; Velasco, A; von Hertzen, H | 1 |
| Mei-Ling, L; Meng-Chun, J; Xin-Quan, S | 1 |
| Feng, LM; Yang, BJ; Zhao, H | 1 |
| Dahiya, K; Mann, S; Nanda, S | 1 |
| Laker, R; Parry, LJ; Shynlova, O; Simpson, E; Vodstrcil, LA; Westcott, K; Wlodek, ME | 1 |
| Dalve-Endres, A; Diedrich, JT; Drey, EA; Meckstroth, K; Newmann, SJ; Steinauer, JE | 1 |
| Brouns, JF; Burger, MP; van Wely, M; van Wijngaarden, WJ | 1 |
| Brouns, JF; Burger, MP; van Wijngaarden, WJ | 1 |
| Atwood, CS; Bowen, RL; Gallego, MJ; Kaltcheva, MM; Porayette, P; Vadakkadath Meethal, S | 1 |
| Kang, Y; Li, G; Mao, G; Ouyang, H; Tai, P; Wang, B; Wang, J; Wen, J; Xia, G; Zou, Q | 1 |
| Falkay, G; Gáspár, R; Hajagos-Tóth, J; Kormányos, Z; Pál, A | 1 |
| Jia, M; Pei, K; Shi, X; Yu, C | 1 |
| Hewison, J; Howel, D; Kelly, T; Robson, S; Suddes, J | 1 |
| Anderson, LL; Geisert, RD; Green, JC; Lucy, MC; Mathew, DJ; Okamura, CS; Sellner, EM | 1 |
| Chen, M; Dasgupta, C; Xue, Q; Zhang, L | 1 |
| Gould, C; Meites, E; Zane, S | 1 |
| Spitz, IM | 2 |
| Briody, V; Chien, EK; Ji, H; Long, V | 1 |
| Duan, L; Ge, J; Liao, H; Wei, Q; Zeng, W; Zhou, Y | 1 |
| Joensuu-Manninen, H; Kuvaja, P; Talvensaari-Mattila, A | 1 |
| Bornstein, J; Kais, M; Odeh, M; Ophir, E; Sosnovsky, V; Tendler, R | 1 |
| Alpert, L; Barajas, A; Bracken, H; Clark, W; Lichtenberg, ES; Schweikert, SM; Tanenhaus, J; Winikoff, B | 1 |
| Chia, KV; Church, E; Sengupta, S | 1 |
| Ho, PC; Lee, VC; Ng, EH; Tang, OS; Yeung, WS | 1 |
| Guo, SW; Liu, M; Liu, X; Shen, F | 1 |
| Check, D; Check, JH; Dix, E; Wilson, C | 1 |
| Chi, X; Guo, Y; Jiang, G; Li, X; Liu, R; Ma, R; Wang, B; Wang, L; Yao, C; Zhang, W; Zhou, X | 1 |
| Akgul, Y; Akins, ML; Holt, R; Mahendroo, M; Timmons, BC | 1 |
| Both, MI; Kapp, N; Medema, S; Thomee, E; Wildhagen, MF; Wildschut, H | 1 |
| Kobayashi, K; Miwa, H; Yasui, M | 1 |
| Boersma, AA; Kleiverda, G; Meyboom-de Jong, B | 1 |
| Creinin, MD; Kollitz, KM; Lohr, PA; Meyn, LA | 1 |
| Edelman, A; Kaneshiro, B; Ponce de Leon, RG; Sneeringer, RK | 1 |
| Bagchi, IC; Bagchi, MK; Cooke, PS; DeMayo, FJ; Kannan, A; Li, Q; Lydon, JP; Srivastava, D; Yamagishi, H | 1 |
| Cao, YP; Liu, ZH; Yang, XL | 1 |
| Barbier, M; Dréan, Y; Lalou, Y; Lanta, S; Mention, JE | 1 |
| Jones, RK; Kooistra, K | 1 |
| Goel, N; Mehta, S; Rajaram, S | 1 |
| Bracken, H; Hassoun, D; Winikoff, B | 1 |
| Cullins, V; Fjerstad, M; Lichtenberg, ES; Sivin, I; Trussell, J | 1 |
| Kauppila, T; Kivinen, S; Suhonen, S; Tikka, M | 1 |
| de Costa, CM | 3 |
| Faundes, A | 2 |
| Attri, S; Goel, A; Mittal, S; Singal, N; Taneja, BK | 1 |
| Esen, UI | 1 |
| Baird, DT; Huong, NT; Meirik, O; Shah, I; Tamang, A; Thapa, K; Wang, D; Warriner, IK | 1 |
| Blum, J; Dabash, R; Diop, A; Nga, NT; Ngoc, NT; Raghavan, S; Winikoff, B | 1 |
| Chen, TH; Chu, YC; Hou, GQ; Hsieh, JC; Kuan, LC; Kuo, TC; Li, YT; Lin, M; Lin, TC; Tang, HH | 1 |
| Balducci, J; Garfield, RE; Kuon, RJ; Maul, H; Shi, L; Shi, SQ; Sohn, C | 1 |
| Abass, T; Adewale, A; Garba, D; Hammed, A; Mairiga, AG; Mohammed, AB; Okonofua, FE | 1 |
| Gissler, M; Heikinheimo, O; Hemminki, E; Mentula, M; Niinimäki, M; Suhonen, S | 1 |
| Grimes, DA; Raymond, EG | 2 |
| Boulot, P; Cayrac, M; Faillie, JL; Flandrin, A | 1 |
| Aggarwal, P; Dadhwal, V; Mittal, S | 1 |
| Greasley, K | 1 |
| Free, C; Ngo, TD; Park, MH; Shakur, H | 1 |
| Messenger, H; Mulligan, E | 1 |
| Sendekie, TY; White, MT; Woldetsadik, MA; Zegeye, DT | 1 |
| Borgatta, L; Kapp, N | 1 |
| Hague, K; Humphries, M; Massey, L | 1 |
| Chen, M; Dong, D; Du, J; Ge, YB; Gu, L; Liu, XY; Sun, P | 1 |
| Chen, QJ; Cheng, LN; Hong, QQ; Hou, SP; Huang, YM; Meads, C; Zhu, HP | 1 |
| Bauville, E; Bernard, O; Boyer, L; Briand, E; Grouin, A; Lavoué, V; Lemeut, P; Morcel, K; Poulain, P; Vandenbroucke, L | 1 |
| Lyus, R | 1 |
| de la Peña, A; Espinoza, J; Perusquía, M | 1 |
| Blanchard, K; Buchacker, T; Grindlay, K; Grossman, D; Lane, K | 1 |
| Brown, A; Cornwell, T; Skarra, DV; Solodushko, V; Taylor, MS | 1 |
| Heikinheimo, O; Mentula, M; Suhonen, S | 1 |
| Li, W; Yang, B; Yang, X; Zhang, M; Zhang, Y | 1 |
| Sarkar, NN | 1 |
| Chen, OJ; Chen, QF; Cheng, LN; Fang, AH; Hou, SP; Huang, YM | 1 |
| Creinin, MD; Ratcliffe, S; Schreiber, CA; Sober, S | 1 |
| Murphy, CR; Parker, SL; Ramírez-Pinilla, MP; Thompson, MB | 1 |
| Blum, J; Minh, NTH; Nga, NTB; Ngoc, NTN; Phan, VQ; Raghavan, S; Shochet, T; Winikoff, B | 1 |
| Bagga, R; Choudhary, N; Dhaliwal, LK; Raveendran, A; Saha, SC | 1 |
| Camacho-Arroyo, I; Carrillo-Martínez, GE; Gómora-Arrati, P; González-Arenas, A; González-Flores, O; Roldán-Roldán, G | 1 |
| Gemzell-Danielsson, K; Gomperts, R; Jelinska, K; Kleiverda, G; Petow, SA; Steen, L | 1 |
| Veena, P | 1 |
| Lam, TH; She, S; Xia, W | 1 |
| Ahuja, K; Dahiya, K; Dhingra, A; Duhan, N; Nanda, S | 1 |
| Achilles, SL; Creinin, MD; Hayes, JL; Reeves, MF | 1 |
| Paul, A; Sharma, D; Singhal, SR | 1 |
| Chen, FH; Li, CW; Li, JP; Li, X; Lu, WG; Yuan, FL; Zhao, YQ | 1 |
| Gillott, DJ; Matah, A; Ojha, K; Talaulikar, VS; Valcarcel, E; Wood, P | 1 |
| Ngo, TD; Park, MH | 1 |
| Chen, X; Huang, L; Zhuang, Y | 1 |
| Dayananda, I; Fitzmaurice, G; Fortin, JM; Goldberg, AB; Jackson, AV | 1 |
| Campana, A; Cheng, L; Gülmezoglu, AM; Hofmeyr, GJ; Kapp, N; Kulier, R | 1 |
| Chen, AM; Cheng, YM; Gao, ES; Liang, H; Luo, L; Yuan, W | 1 |
| Kestler, E | 1 |
| Kelly, T; Lie, M; May, C; Robson, S | 1 |
| Li, W; Sackoff, J; Yunzal-Butler, C | 1 |
| Gold, M; Page, C; Stumbar, S | 1 |
| Gui, J; Huang, G; Li, J; Xiong, F; Yang, W | 1 |
| Heikinheimo, O; Mentula, M | 1 |
| Avraham, S; Duvdevani, NR; Frenkel, Y; Gat, I; Haas, J; Seidman, DS | 1 |
| Chong, E; Nguyen, NN; Tsereteli, T; Winikoff, B | 1 |
| Ngo, TD; Nguyen, TH; Park, MH | 1 |
| Fan, H; Guo, W; Hou, Y; Hu, Y; Li, P; Zhao, G | 1 |
| Bussieres, L; Camus, E; Fauconnier, A; Huchon, C; Machevin, E; Torre, A | 1 |
| de Weerd, S; Stibbe, KJ | 1 |
| Liao, AH; Wang, Y; Zeng, B; Zhang, Y | 1 |
| Huang, ZR; Li, B; Zhuge, T | 1 |
| Deng, WB; Feng, XH; Jia, B; Lei, W; Liu, JL; Ni, H; Su, RW; Wang, TS; Yang, ZM; Yue, SL; Zhao, ZA | 1 |
| Condon, JC; Gerard, RD; Mendelson, CR; Renthal, NE; Williams, KC | 1 |
| Foster, AM; Jackson, CB | 1 |
| Chen, Y; Huang, L; Wang, Y; Zhou, F; Zhuang, Y | 1 |
| Borgatta, L; Finneseth, M; Hou, MY; Mark, A; Roncari, D; Sonalkar, S; Vragovic, O | 1 |
| Blum, J; Chelli, H; Conkling, K; Dabash, R; Hajri, S; Ngoc, Nt; Raghavan, S; Winikoff, B | 1 |
| Blot, P; Ceccaldi, PF; Ducarme, G; Guibourdenche, J; Luton, D; Nicolas, M; Saada, J | 1 |
| Creanga, AA; Pazol, K; Zane, SB | 1 |
| Aguarón Benitez, G; Barberá Belda, B; Callejón Rodríguez, C; Gómez García, MT; González Merlo, G | 1 |
| Dhakal, N; Giri, A; Maharjan, M; Tuladhar, AS; Tuladhar, H | 1 |
| Guo, B; Li, DD; Li, SJ; Liu, JX; Tian, XC; Wang, ST; Yue, ZP; Zhang, XM | 1 |
| Arnesen, M; Blum, J; Blumenthal, PD; Fischer, D; Lichtenberg, ES; Lynd, K; Shochet, T; Winikoff, B | 1 |
| Raymond, EG; Shannon, C; Weaver, MA; Winikoff, B | 1 |
| Carrette, M; de Costa, CM | 1 |
| Goldstone, P; Michelson, J; Williamson, E | 2 |
| Sheldon, W; Winikoff, B | 1 |
| Cheng, YM; Gao, ES; Huang, GY; Huo, XX; Liang, H; Luo, L; Miao, MH; Yuan, W | 1 |
| Adevai, T; Jensen, J; Martin, L; Micks, E; Riefenberg, S; Shekell, T; Stanley, J; Zelinski, M | 1 |
| Ball, C; Chong, E; Crowden, WA; Dean, G; Dzuba, IG; Goldberg, AB; Lichtenberg, ES; Sacks, D; Swica, Y; Winikoff, B | 1 |
| Chai, J; Ho, PC; Wong, CY | 1 |
| He, B; Lv, F; Wang, J; Wang, L; Wang, N; Xu, X; Zhang, S | 1 |
| Batur, P | 1 |
| Bloigu, A; Gissler, M; Heikinheimo, O; Hemminki, E; Männistö, J; Mentula, M; Niinimäki, M | 1 |
| Li, Z; Min, W; Xing, A; Yao, Q | 1 |
| Chong, E; Gold, M; Middleton, T; Prine, L; Schreiber, CA; Swica, Y; Winikoff, B | 1 |
| Guo, Y; Jiang, G; Li, X; Li, Y; Wang, B; Wang, L; Yao, C; Zhao, X; Zhou, X | 1 |
| Davenport, ML; Delgado, G | 1 |
| Dorogin, A; Li, Y; Lye, SJ; Nedd-Roderique, T; Shynlova, O | 1 |
| Creinin, MD | 4 |
| Brahmi, D; Jackson, E; Kapp, N; Tang, J; Whyte, P | 1 |
| Cleland, K; Creinin, MD; Nshom, M; Nucatola, D; Trussell, J | 1 |
| Bouaziz, H; Guerci, P; Morel, O; Mory, S; Nelis, UM; Raft, J; Vial, F | 1 |
| McCarthy, M | 1 |
| Baker, PN; Farrow, SN; Jones, RL; Nugent, JL; Palin, V; Ray, DW; Sibley, CP; Wareing, M | 1 |
| Chen, DJ; Du, PL; Li, CL; Liu, MX; Liu, Q; Sheng, XJ; Wei, M; Weng, HN | 1 |
| Amar, E; Barjhoux, CE; Bernard, N; Bos-Thompson, MA; Carlier, P; Descotes, J; Elefant, E; Tebacher, M; Vial, T | 1 |
| Dorogin, A; Li, Y; Lye, SJ; Nedd-Roderique, T; Nguyen, T; Shynlova, O | 1 |
| Jymagylova, D; Kamilov, A; Kasimova, F; Kurbanbekova, D; Raghavan, S; Tsereteli, T; Winikoff, B; Yusupov, D | 1 |
| Hsieh, TH; Kuo, YM; Lin, CH; Lin, YC; Lin, YJ; Sze, CI | 1 |
| Ellertson, C; Waldman, SN | 1 |
| Honkanen, H; von Hertzen, H | 2 |
| Chen, G; Fu, G; Liu, Y; Zhang, Y | 1 |
| Ku, CY; Sanborn, BM | 1 |
| Daley, S | 1 |
| Simons, M | 1 |
| Ellertson, C; Norris Turner, A | 1 |
| Fielding, SL; Nam, NY; Schaff, EA | 1 |
| Ambardekar, S; Bopardikar, A; Coyaji, K; Ellertson, C; Elul, B; Krishna, U; Otiv, S; Raote, V; Winikoff, B | 1 |
| Aubeny, E; Bureau, A; Eucher, M; Gabeaud, P; Heard, I; Husson, T; Meng, L; Riotte, S | 1 |
| Herrmann, W | 1 |
| Debu, E; Dufour, B; Fontan, JE; Langlade, A; Majorel, P; Scheller, E; Weber, B | 1 |
| Dong, YL; Gangula, PR; Kondapaka, SB; Vegiraju, S; Wimalawansa, SJ; Yallampalli, C | 1 |
| Frydman, R; Paoli, C; Pourade, A; Taylor, S | 1 |
| He, CH; Shi, YE; Ye, ZH; Zhang, GQ | 1 |
| Fang, X; Mitchell, BF; Wong, S | 3 |
| Chen, YX; Li, FF; Tang, JH | 1 |
| He, P; Sun, K; Yang, K | 1 |
| Ho, PC; Lee, SW; Tang, OS | 1 |
| Bingshun, W; Changhai, H; Ersheng, G; Exiang, Z; Jie, Y; Mauck, C; Youlun, G | 1 |
| Creinin, MD; Fox, MC; Harwood, B | 1 |
| Fielding, SL; Schaff, EA; Westhoff, C | 2 |
| Bygdeman, M; Danielsson, KG | 1 |
| Andersen, B; Clevin, L; Grønlund, A; Grønlund, L; Lidegaard, Ø; Palmgren, N | 1 |
| Bridges, PJ; Ching, L; LeaMaster, BR; Sasser, RG; Vincent, DL; Weems, CW; Weems, YS | 1 |
| Auwerx, J; Lydon, J; O'Malley, BW; Picard, F; Schoonjans, K; Wanatabe, M | 1 |
| Alder, J; Bitzer, J; Holzgreve, W; Horner, E; Schwendke, A; Zarkadas, M | 1 |
| Wyser-Pratte, RC | 1 |
| Ashok, PW; Flett, GM; Templeton, A; Wagaarachchi, PT | 3 |
| Baird, DT; Bartley, J | 1 |
| Piaggio, G; Von Hertzen, H; Xiao, BL; Zhao, H | 1 |
| Bagchi, IC; Bagchi, MK; Cheon, YP; DeMayo, FJ; Li, Q; Xu, X | 1 |
| Omokanye, S | 1 |
| Lo, SS | 1 |
| Body, G; de Poncheville, L; Lansac, J; Marret, H; Perrotin, F | 1 |
| Heikinheimo, O; Honkanen, H; Jänne, OA; Raivio, T; Ranta, S | 1 |
| Chia, KV; Ogbo, VI | 1 |
| Gasparyan, ND; Kareva, EN; Podval'nyuk, VV; Sergeev, PV | 1 |
| Piskorowskyj, N; Vyjayanthi, S | 1 |
| Ma, DM; Sun, HL; Yang, ML | 1 |
| Dai, M; Liu, Q; Peng, D; Zi, X | 1 |
| Ma, L; Su, Y; Sun, Y | 1 |
| Haukkamaa, M; Heikinheimo, O; Suhonen, S; Tikka, M | 1 |
| Bernard, JP; Fischer, C; Senat, MV; Ville, Y | 1 |
| Creinin, MD; Holovanisin, M; Janczukiewicz, L; Meyn, L; Potter, C; Pymar, HC; Schwartz, JL | 1 |
| Nash, ES | 1 |
| Li, H; Sun, Y; Yang, J | 1 |
| Anobile, CJ; Lahiri, S; Ledger, WL; Stewart, P | 1 |
| Creinin, MD; Murthy, A | 1 |
| Freundl, G; Gnoth, C; Halbe, E | 1 |
| Benson, J; Clark, KA; Dudley, S; Gerhardt, A; Randall, L | 1 |
| Lichtenberg, ES | 1 |
| Joffe, C; Weitz, TA | 1 |
| Ashok, PW; Flett, GM; Hamoda, H; Templeton, A | 5 |
| Tenore, JL | 1 |
| Jia, JJ; Wang, ZN | 1 |
| Dong, YL; Gangula, PR; Thota, C; Yallampalli, C | 1 |
| Hausknecht, R | 2 |
| Lewis, AW; Randel, RD; Weems, CW; Weems, YS | 1 |
| Nilas, L; Petersen, MB; Rørbye, C | 1 |
| Liggitt, D; Nelson, AM; Ware, CB | 1 |
| Chauhan, M; Dong, YL; Vegiraju, S; Yallampalli, C | 1 |
| Bygdeman, M; Fiala, C; Gemzell-Danielsson, K; Safar, P | 1 |
| Basu, R; Gundlach, T; Tasker, M | 1 |
| An, BS; Choi, KC; Hong, EJ; Hwang, WS; Jeung, EB; Kang, SK; Lee, GS | 1 |
| Cao, XM; Cheng, LN; Ding, WH; Gui, YL; He, CH; Huang, J; Huang, ZJ; Lei, ZW; Mei, QM; Ni, FX; Piaggio, G; Ren, FM; Song, LJ; von Hertzen, H; Wang, RF; Weng, LJ; Wu, SC; Xiao, BL; Zhang, LJ; Zhao, H; Zheng, N; Zhu, MH | 1 |
| Cao, Y; Chen, D; Dai, B; Duan, E; Li, S; Liu, W; Yang, Y | 1 |
| Allouche, C; Camus, E; Chevret, S; Coiffic, J; de Poncheville, L; de Tayrac, R; Fernandez, H; Garbin, O; Le Goueff, F; Lucot, JP; Rozenberg, P; Tardif, D | 2 |
| Christenson, RK; Vallet, JL | 1 |
| Darney, PD; Meckstroth, KR | 1 |
| Bagchi, IC; Bagchi, MK; Cheon, YP; Xu, X | 1 |
| Bartfai, G; Erdenetungalag, R; Gemzell-Danielsson, K; Gopalan, S; Honkanen, H; Horga, M; Jerve, F; Mittal, S; Ngoc, NT; Peregoudov, A; Piaggio, G; Prasad, RN; Pretnar-Darovec, A; Shah, RS; Song, S; Tang, OS; von Hertzen, H; Wu, SC | 1 |
| Ge, Q; Li, X; Wu, Y; Xiao, B | 1 |
| Backe, B; Heimstad, R | 1 |
| Baird, DT; Brown, A; Cameron, S; Morrow, S; Williams, A | 1 |
| Atlas, M; Goldenberg, M; Machtinger, R; Seidman, DS; Soriano, D; Zolti, M | 1 |
| Nilas, L; Nørgaard, M; Rørbye, C; Vestermark, V | 1 |
| Fang, RY; He, QJ; Wang, WF; Wu, HH; Yang, B | 1 |
| Chan, CC; Ho, PC; Lee, SW; Ng, EH; Tang, OS | 1 |
| Garfield, RE; Marx, SG; Maul, H; Saade, GR; Shi, L | 1 |
| Augestad, G; Bjørge, L; Helland, H; Iversen, OE; Johnsen, SL; Midbøe, G; Strray-Pedersen, S; Økland, I | 1 |
| Westhoff, C | 1 |
| Wu, SC; Xiao, BL | 1 |
| Ashok, PW; Dow, J; Flett, GM; Hamoda, H; Templeton, A | 1 |
| Langille, BL; Lye, SJ; Mitchell, JA; Shynlova, O; Tsampalieros, A | 1 |
| Anjos-Valotta, EA; Barja-Fidalgo, C; DeFreitas, MS; Moura, AS; Rodrigues, AL; Sannomyia, P; Silva, SV; Souza, EP | 1 |
| Fletcher, J; Sharma, A; Stewart, P | 1 |
| Heikinheimo, O; Honkanen, H; Rutanen, EM | 1 |
| Baird, DT; Brenner, RM; Critchley, HO; Kelly, RW | 1 |
| Garfield, RE; Given, RL; Shi, L; Shi, SQ; von Hertzen, H | 1 |
| Piaggio, G; von Hertzen, H | 1 |
| Gangula, PR; Kondapaka, SB; Lanlua, P; Wimalawansa, SJ; Yallampalli, C | 1 |
| Chan, CC; Cheung, AN; Ho, PC; Lao, TT; Sung, EO | 1 |
| Coughlin, LB; Haddad, NG; Long, A; Roberts, D | 1 |
| Tinelli, A; Tinelli, FG; Tinelli, R | 1 |
| Bagchi, IC; Bagchi, MK; Cheon, YP; DeMayo, FJ | 1 |
| Bugg, G; Greenland, H; Ogunbiyi, I; Tasker, M | 1 |
| Nilas, L; Nørgaard, M; Rørbye, C | 3 |
| Piaggio, G; von Hertzen, H; Xiao, B; Zhao, H | 2 |
| Bilian, X; Heng, Z; Linan, C; Piaggio, G; von Hertzen, H | 1 |
| Bilian, X; Cheng, L; Heng, Z; Piaggio, G; von Hertzen, H | 1 |
| Dhawan, L; Ghosh, D; Lalitkumar, PG; Sengupta, J | 1 |
| Blum, J; Chélli, H; Gueddana, N; Hajri, S; Mansour, FB; Winikoff, B | 1 |
| Grimes, DA; Smith, MS; Witham, AD | 1 |
| Aubény, E; Dagousset, I; Fourrier, E; Taurelle, R | 1 |
| Calhoun, BC; Harrison, DJ | 1 |
| Sherwood, OD; Zhao, S | 1 |
| Cacciatore, B; Heikinheimo, O; Kajanoja, P; Leminen, A; Rutanen, EM | 1 |
| Coyaji, K; Ellertson, C; Hedley, A; Ngoc, NT; Trussell, J; Turner, AN; Winikoff, B | 1 |
| Amin, P; Kiran, U; Penketh, RJ | 2 |
| Vason, ES | 1 |
| Campana, A; Cheng, LN; Gülmezoglu, AM; Hofmeyr, GJ; Kulier, R | 2 |
| Hu, ZY; Tao, SX; Wei, P; Yi-Xun, L; Zhang, XS | 1 |
| Haukkamaa, M; Heikinheimo, O; Suhonen, S | 1 |
| Junqing, W; Lin, L; Wei, Y; Weidong, C; Xianmi, W; Yimin, C | 1 |
| Acharya, G; Bråthen, A; Haugen, M; Maltau, JM; Nilsen, I | 1 |
| Carles, G; El Guindi, W; Largeaud, M; Montoya, Y; Perotti, F; Seve, B | 1 |
| Scherer, D; Zinaich, S | 1 |
| Je, HD; Li, Y; Malek, S; Morgan, KG | 1 |
| Liu, AM | 1 |
| Sparrow, MJ | 1 |
| Creinin, MD; Grimes, DA | 1 |
| Fielding, SL; Schaff, EA | 2 |
| Chwalisz, K; Haendler, B; Hess-Stumpp, H; Lessey, BA; Yamanouchi, H | 1 |
| Chen, HJ; Hwang, JL; Lin, YH | 1 |
| Byrne, JD; Challis, JR; Fassett, MJ; Fraser, M; Goodwin, TM; Wing, DA | 1 |
| Berlanda, N; Fedele, L | 1 |
| Deis, RP; Soaje, M | 3 |
| Liu, Z; Pan, Y; Zhu, C | 1 |
| Esen, U; Ghosh, PS; Obafunwa, J; Orife, SU | 1 |
| Fielding, SL; Godfrey, EM; Mawson, JT; Schaff, EA; Stanwood, NL | 1 |
| Croxatto, HB; d'Arcangues, C; Fuentealba, B; Massai, MR; Pavez, M | 1 |
| Kumar, PG; Laloraya, M; Nautiyal, J | 1 |
| Chen, A; Cheng, Y; Gao, E; Luo, L; Meirik, O; Wang, X; Wu, SZ; Yuan, W; Zhou, L | 1 |
| Li, ZH; Quan, S | 1 |
| Nothnagle, M; Taylor, JS | 1 |
| Blum, J; Durocher, JM; Mai, TT; Ngoc, NT; Nhan, VQ; Winikoff, B | 1 |
| Bartsch, C; Baumann, G; Dschietzig, T; Stangl, K; Stangl, V | 1 |
| Bruinse, HW; Christiaens, GC; De Heus, R; Graziosi, GC; Mol, BW | 1 |
| Hu, CF; Long, X; Wu, KM; Zeng, J; Zeng, N; Zhang, LM | 1 |
| Han, XJ; Liao, AH; Wu, SY; Wu, XR; Xiao, DZh; Xiong, CL | 1 |
| de Lapasse, C; Gallot, D; Houlle, C; Laurichesse-Delmas, H; Lémery, D; Sapin, V; Saulnier, JP; Ughetto, S; Vanlieferinghen, P; Vendittelli, F | 1 |
| Creinin, MD; Meyn, LA; Rossi, B | 1 |
| Willems, FE | 1 |
| Bagga, R; Chaudhary, N; Kalra, J | 1 |
| Gingras, S; Hoffmeyer, A; Ihle, JN; Piekorz, RP; Weinstein, Y | 1 |
| Hajri, S | 1 |
| Hwang, AC; Stewart, FH; Taylor, D | 1 |
| Martikainen, H; Niinimäki, M; Talvensaari-Mattila, A | 1 |
| Blum, J; Chélli, H; Dabash, R; Gueddana, N; Hajri, S; Maazoun, L; Saadi, H; Winikoff, B | 1 |
| Kimura, T; Koyama, M; Koyama, S; Murata, Y; Nakamura, H; Ogita, K; Shimoya, K; Tomiie, M; Tsutsui, T; Yoshida, S | 1 |
| Burton, JL; Chang, LC; Madsen, SA; Toelboell, T; Weber, PS | 1 |
| Aubény, E; Coyaji, K; Ellertson, C; Hedley, A; Ngoc, NT; Trussell, J; Turner, AN; Winikoff, B | 1 |
| Fairley, TE; Mackenzie, F; Mackenzie, M; Owen, P | 1 |
| Hong, L; Liu, YJ | 1 |
| Balasubramanian, S; Creinin, MD; Harwood, B; Shore, E | 1 |
| Huang, DM; Huang, GY; Liu, YJ; Lu, FE; Nardo, LG | 1 |
| Berkane, N; Boog, G; Maria, B; Uzan, S; Verstraete, L | 1 |
| Heikinheimo, O; Honkanen, H; Ranta, S; Ylikorkala, O | 1 |
| Blumenthal, PD; Goldberg, R; Hausknecht, R; Oyer, D; Sankey, H; Schaff, E; Shannon, CS; Winikoff, B; Wolff, J | 1 |
| Baldauf, JJ; Hamid, D; Nisand, I; Weingertner, AS | 1 |
| Archambault, EZ; Boatright, NK; Fray, J; Hicks, E; Kirchain, S; McCune, SA; Sharkey, LC; Simpson, GI | 1 |
| Fassett, M; Guberman, C; Wing, DA | 1 |
| Espey, E; Leeman, L | 1 |
| Creinin, M; Schreiber, C | 1 |
| Harris, RC; Yao, B; Zhang, MZ | 1 |
| Flett, GM; Hamoda, H | 1 |
| Bjørge, L; Iversen, OE; Sørensen, EC | 1 |
| Akmal, A; Asrat, T; Beharry, K; Chang, E; Gorenberg, D; Nishihara, KC; Waltzman, J | 1 |
| Ashima, T; Shalini, R; Vinita, A | 1 |
| Chen, YJ; Ho, ES; Lin, SK | 1 |
| Catalano, R; Charnock-Jones, DS; Evans, A; Sharkey, AM; Smith, SK | 1 |
| Ghosh, D; Sengupta, J | 2 |
| Bukowski, R; Doret, M; Garfield, RE; Longo, M; Maner, WL; Maul, H; Saade, GR | 1 |
| Baird, DT; Critchley, HO; Henderson, TA; Kelly, RW; Milne, SA; Saunders, PT | 1 |
| Bergthold, L; Gemperli, MP; Phillips, KA; Sakowski, J; Stewart, FH; Van Bebber, S | 1 |
| Creinin, MD; Harwood, B; Murthy, AS; Schreiber, C | 1 |
| Chen, GS; Liao, Z; Ou, GZ | 1 |
| Baunot, N; Faucher, P; Madelenat, P | 1 |
| Creinin, MD; Harwood, B; Murthy, AS; Schreiber, CA | 1 |
| Amant, F; Berteloot, P; De Greef, I; Deprest, J; Timmerman, D | 1 |
| Fields, PA; Lee, HY; Sherwood, OD; Zhao, S | 1 |
| Lee, HY; Sherwood, OD | 1 |
| Kase, Y; Takeda, S; Takei, H; Yamamoto, M | 1 |
| Tonti-Filippini, N | 1 |
| Bibi, M; Chaieb, A; Essaidi, H; Fekih, M; Hidar, S; Jerbi, M; Khairi, H; Sahraoui, W | 1 |
| Hirst, JJ; Olson, DM; Palliser, HK; Parkington, HC; Peri, KG; Young, IR | 1 |
| Rose, SB; Shand, C; Simmons, A; Sparrow, MJ | 1 |
| Chan, CC; Ho, PC; Kan, AS; Tang, OS | 1 |
| Creatsas, G; Dendrinos, S; Kalabalikis, G; Katsorchis, T; Makrakis, E; Papasteriades, C | 1 |
| Al Mutawa, E; Azizieh, F; Makhseed, M; Raghupathy, R; Szekeres-Bartho, J | 1 |
| Miech, RP | 2 |
| Fiala, C; Gemzell-Danielsson, K; Stephansson, O; Swahn, ML | 1 |
| Dahiya, K; Hooda, R; Khosla, AH; Madan, S; Sangwan, K | 1 |
| Murray, S; Wooltorton, E | 1 |
| Choudhary, N; Gopalan, S; Saha, SC | 1 |
| Rosenberg, D | 1 |
| Barakonyi, A; Kozma, N; Miko, E; Palkovics, T; Papp, O; Par, G; Polgar, B; Szekeres-Bartho, J; Szereday, L; Varga, P | 1 |
| Lu, S; Wang, Z; Wu, R | 1 |
| Heaney, RP | 1 |
| Herranz, G | 1 |
| Costantino, SN; Gentile, T; Nuñez, GG; Sarchi, MI; Venturiello, SM | 1 |
| Giudicelli, Y; Malagrida, L; Rozenberg, P; Salomon, LJ; Szekeres-Bartho, J; Ville, Y | 1 |
| Vathy, I; Velísek, L | 1 |
| Chien, P; Guest, J; Kosseim, ML; Thomson, M | 1 |
| Agarwal, S; Batra, A; Kumar, S; Mittal, S | 1 |
| Darney, PD | 1 |
| Conard, LA; Gold, MA | 1 |
| Li, GM; Li, LH; Librach, CL; Xiao, R; Yie, SM | 1 |
| Guenther, H | 1 |
| Knudsen, UB; Kristiansen, FV; Rasmussen, A; Ravn, P | 1 |
| Bakour, SH; Khan, KS; Thompson, PK | 1 |
| Fielding, SL; Middleton, T; Scahill, M; Schaff, E; Shannon, C; Westheimer, E; Wilkinson, T; Winikoff, B | 1 |
| Chekhranova, MK; Iatsyshina, SB; Karpova, SK; Morozova, MS; Pankov, IuA; Sazina, ET; Zaĭtseva, TS | 1 |
| Arvidsson, C; Gemzell-Danielsson, K; Hellborg, M | 1 |
| Cao, YJ; Duan, EK; Li, J; Liu, WM; Peng, S; Wang, L; Yang, YJ; Yuan, JG; Zhou, JX | 1 |
| Ganatra, B; Manning, V; Pallipamulla, SP | 1 |
| Tamang, A; Tamang, J | 1 |
| Akin, A; Akin, L; Kocoglu, GO | 1 |
| Pradhan, P | 1 |
| Clark, WH; Fiala, C; Gemzell-Danielsson, K; Hassoun, D; Winikoff, B | 1 |
| Greene, MF | 1 |
| Bhatnagar, J; Cheung, M; Dassey, DE; Fischer, M; Guarner, J; Hacker, JK; Iton, A; Poukens, V; Reagan, S; Shieh, WJ; Van Meter, SH; Whiteman, DB; Zaki, SR | 1 |
| Kotsuji, F; Nishijima, K; Shukunami, K | 1 |
| Bettahar-Lebugle, K; Garbin, O; Nisand, I; Vayssiere, C | 1 |
| Gupta, A; Mao, Q; Unadkat, JD; Vethanayagam, RR; Wang, H; Zhang, Y; Zhou, L | 1 |
| Goel, N; Rajaram, S; Singh, KC; Ummat, S | 1 |
| Fraser, IS; Jin, J; Weisberg, E | 1 |
| van Gend, D | 2 |
| Bretelle, F; Gamerre, M; Guidicelli, B; Heckenroth, H; Mazouni, C; Porcu, G; Provensal, M | 1 |
| Zinn, C | 1 |
| Burgermeister, J | 1 |
| Bonner, R | 1 |
| Prothro, G | 1 |
| Borgatta, L; Chen, AY; Mottl-Santiago, J; Vragovic, O; Wasserman, S | 1 |
| Lawton, BA; Rose, SB; Shepherd, J | 1 |
| Scuder, AC | 1 |
| Franklin, SO; Jimenez, R | 1 |
| Baulieu, EE | 11 |
| Sicard, D | 1 |
| Adamson, SL; Challis, JR; Lye, SJ; Rac, VE; Rurak, D; Scott, CA; Small, C | 1 |
| Goh, SE; Thong, KJ | 1 |
| Borgatta, L; Ellis, SC; Kapp, N; Stubblefield, P | 1 |
| Coyte, PC; Daniel, I; Dunn, S; Isaacksz, S; Laporte, A; Limacher, JJ; Payne, GJ | 2 |
| Fewell, JE; Moore, SL | 1 |
| Carroll, C; Chien, EK; Clark, K; Feltovich, H; Janowski, J; Ji, H | 1 |
| Kleiverda, G | 1 |
| Butzow, R; Mikkola, TS; Väisänen-Tommiska, M; Ylikorkala, O | 1 |
| Librach, CL; Xiao, R; Yie, SM | 1 |
| Fujimoto, J | 1 |
| Goodyear-Smith, F; Knowles, A; Masters, J | 1 |
| Dunn, S; Guilbert, E; Jacot, F; Shannon, C; Sheldon, WR; Wiebe, E; Winikoff, B | 1 |
| Couzin, J | 1 |
| Shorto, R | 1 |
| Grossman, N | 1 |
| Shannon, CS | 1 |
| Li, YP; Liang, Y; Mei, L; Tong, L; Wu, SC; Yan, L; Zhang, JQ; Zou, Y | 1 |
| Jouppila, P; Martikainen, H; Niinimäki, M; Talvensaari-Mattila, A | 1 |
| Belton, S | 1 |
| Baird, D; von Hertzen, H | 1 |
| Davey, A | 1 |
| Marions, L | 1 |
| Aronsson, A; Bygdeman, M; Gemzell-Danielsson, K | 1 |
| Schaff, E | 1 |
| Cahill, S; Castleman, L; Gallo, MF; Mitchell, EM | 1 |
| Sitruk-Ware, R | 3 |
| Cheng, L | 2 |
| Fiala, C; Gemzel-Danielsson, K | 1 |
| Bosković, V; Dukanac, J; Jeremić, K; Ljubić, A; Radunović, N; Stojnić, J; Tulić, I | 1 |
| Hickey, M; Neilson, JP; Vazquez, J | 1 |
| Grimes, DA | 4 |
| Crockett, SA | 1 |
| Diaz-Olavarrieta, C; Foster, AM; Rouhana, A; Schaffer, K; Trussell, J; Wynn, L | 1 |
| Khomasuridze, AG; Parculi, MG; Parunashvili, NR; Sulamanidze, ShD; Tsertsvadze, GL | 1 |
| Blumenthal, P; Creinin, M; Shulman, L | 1 |
| Akinfenwa, O; Dorman, E; Erskine, K; Parisaei, M; Sanu, O | 1 |
| Hassoun, D; Périn, I | 1 |
| Read, CM | 1 |
| Macdonald, J; Shand, C; Sparrow, M | 1 |
| Economides, DL; El-Matary, A; Navaratnarajah, R | 1 |
| Afadapa, FK; Elsapagh, K | 1 |
| Berthier, A; Chouchene, S; Diguet, A; Marpeau, L; Patrier, S; Sentilhes, L; Verspyck, E | 1 |
| Dulitzky, M; Goldenberg, M; Machtinger, R; Schiff, E; Seidman, DS; Soriano, D; Stockheim, D; Wiser, A | 1 |
| Glavas, MM; Weinberg, J; Yu, WK | 1 |
| Chao, A; Chao, AS; Wang, ST; Wang, TH | 1 |
| Winikoff, B | 2 |
| Bregonzio, C; Deis, RP; Penissi, A; Soaje, M; Valdez, S | 1 |
| Ho, PC; Tang, OS | 3 |
| Rose, SB; Shand, C; Simmons, A | 1 |
| Creinin, MD; Harwood, BJ; Reeves, MF; Schreiber, CA | 1 |
| Afable-Munsuz, A; Gould, H; Moore, C; Phillips, KA; Stewart, F; Van Bebber, SL | 1 |
| Creinin, MD; Hanusa, BH; Rothschild, AJ; Sit, D; Wisner, KL | 1 |
| Chen, FM; Chen, TH; Kuo, TC; Li, YT; Lin, M; Tsai, CW; Wu, SF | 1 |
| Chen, FM; Chen, ML; Chen, TH; Kuo, TC; Li, SC; Li, YT | 1 |
| Ishii, S; Kawaminami, M; Kurusu, S | 1 |
| Chiu, CF; Chung, LW; Hsieh, CY; Yeh, SP | 1 |
| Ambardekar, S; Bracken, H; Coyaji, K; Krishna, U; Mandlekar, A; Raote, V; Winikoff, B | 1 |
| Barreau, F; Bueno, L; Cartier, C; Ferrier, L; Fioramonti, J; Laroute, V; Leveque, M; Moriez, R; Rosztoczy, A | 1 |
| Chen, SL; He, JX; Qiu, YW; Song, HD | 1 |
| Chen, CY; Chiang, HK; Chou, SY; Chow, PK; Hsu, CS; Wang, CC | 1 |
| McGill, J; Shetty, A | 1 |
| Gamerre, M; Guidicelli, B; Mazouni, C; Pellegrin, V; Voiret, C | 1 |
| Borgatta, L; Kapp, N; Moreno-Ruiz, NL; Wiebe, ER; Winikoff, B; Yanow, S | 1 |
| Dempsey-Fanning, A; Teal, SB; Westhoff, C | 1 |
| Bermudez, SB; Carbonell, JL; Gallego, FG; González, LV; Llorente, MP; Sala, ES; Texido, CS | 1 |
| Chien, PF; Guest, J; Kosseim, ML; Thomson, MA | 1 |
| Banfi, R; Cerri, R; Menichetti, M; Pavone, E | 1 |
| Clark, WH; Gold, M; Grossman, D; Winikoff, B | 1 |
| Croxatto, HB; Garfield, R; Ortiz, ME; Ortiz, RE; Zepeda, AJ | 1 |
| Bednarek, P; Creinin, MD; Lintu, H; Meyn, LA; Schreiber, CA; Wagner, MS | 1 |
| Ambardekar, S; Bracken, H; Coyaji, K; Ngoc, NT; Schaff, E; Westheimer, E; Winikoff, B | 1 |
| Hertelendy, F; Zakar, T | 1 |
| Heydanus, R; Papatsonis, DN; Verhulsdonk, MT | 1 |
| Blanchard, K; McLeod, S; Schaffer, K; Winikoff, B | 1 |
| Arbel, R; Brzezinski, A; Haimov-Kochman, R; Laufer, N; Sciaky-Tamir, Y; Yagel, S | 1 |
| Heikinheimo, O; Nuutila, M; Väyrynen, W | 1 |
| Breto, A; Esteve, JL; García, R; Llorente, M | 1 |
| Anand, A; Elul, B; Kalyanwala, S; Mundle, S; Ughade, S | 1 |
| Chollet, A; Cirillo, R; Missotten, M; Page, P; Quattropani, A; Scheer, A; Schwarz, MK; Tos, EG | 1 |
| Asaria, S; Barnett, S; Espey, E; Gopman, S; Leeman, L; Ogburn, J | 1 |
| Billi, S; Farina, MG; Franchi, AM; Guadagnoli, T; Leguizamón, G; Ribeiro, ML; Weissmann, C | 1 |
| Huang, GY; Liu, XY; Zhang, MM | 1 |
| Ducza, E; Falkay, G; Gál, A; Gálik, M; Gáspár, R; Klukovits, A; Kolarovszki-Sipiczki, Z; Minorics, R | 1 |
| Carrette, M; de Costa, CM; de Costa, NR; McNamee, HM; Russell, DB | 2 |
| Dorogin, A; Langille, BL; Lye, SJ; Shynlova, O; Tsui, P | 1 |
| Glavind-Kristensen, M; Knudsen, UB; Nilas, L; Vejborg, T | 1 |
| Draper, H; Lye, SJ; MacPhee, DJ; Shynlova, O; White, BG; Williams, SJ | 1 |
| Hattori, MA; He, PJ; Hirata, M; Yamauchi, N | 1 |
| Bjørge, L; Iversen, OE; Midbøe, G; Myking, O; Parashar, P | 1 |
| Duncan, WC; Hillier, SG; Lamont, MC; Mary, N; Myers, M; Thong, KJ; van den Driesche, S | 1 |
| Gourgoulianis, KI; Hatzoglou, CH; Kallitsaris, A; Messinis, IE; Molyvdas, PA; Verikouki, CH | 1 |
| Eskild, A; Jerve, F; Jørgensen, H; Melseth, E; Nielsen, CS; Qvigstad, E | 1 |
| Fassett, MJ; Wing, DA | 1 |
| Baker, ER; George, KE; Kapp, N; Lauria, MR; Mackenzie, T; Prairie, BA | 1 |
| Bhatnagar, J; Blossom, DB; Cohen, AL; D'Angeli, MA; Duchin, JS; Fischer, M; Guarner, J; Jernigan, J; Killgore, G; Kwan-Gett, TS; McDonald, LC; Reagan, S; Shieh, WJ; Zaki, SR; Zane, SB | 1 |
| Li, Q; Liu, M; Mu, YL; Yang, ZL; Yin, FB | 1 |
| Fu, MF; Li, CL; Li, M; Wei, M | 1 |
| Al-Hendy, A; Fouad, H; Garfield, RE; Harirah, HM; Salama, SA; Shi, L; Shi, SQ; Wentz, MJ | 1 |
| Lee, EW; Leung, PC; Mao, Q; Ross, DD; Unadkat, JD; Wang, H; Zhou, L | 1 |
| Borgatta, L; Kapp, N; Moreno, N; Stubblefield, P; Vragovic, O | 1 |
| Heikinheimo, O; Leminen, R; Suhonen, S | 1 |
| Gemzell-Danielsson, K; Hayes, JL; Lohr, PA | 1 |
| Hosie, MJ; Penny, CB; Scholtz, KE | 1 |
| Chen, TH; Kuo, TC; Li, YT | 1 |
| Simmen, FA; Simmen, RC; Velarde, MC; Zeng, Z | 1 |
| Falkay, G; Gálik, M; Gáspár, R; Kolarovszki-Sipiczki, Z | 1 |
| Koizumi, M; Yada, T | 1 |
| Amram, D; Bos-Thompson, MA; Faillie, JL; Hillaire-Buys, D; Roux, C | 1 |
| Lipp, A | 1 |
| Dutta, G; Keller-Wood, M; Reini, SA; Wood, CE | 1 |
| Fassett, MJ; Lachelin, GC; McGarrigle, HH; Wing, DA | 1 |
| Henry-Suchet, J; Loffredo, V; Loysel, T; Paris, FX; Pez, JP; Tesquier, L | 1 |
| Baulieu, EE; Herrmann, W; Philibert, D; Riondel, A; Sakiz, E; Teutsch, G; Wyss, R | 2 |
| Blaustein, JD; Brown, TJ | 1 |
| Gaillard, RC; Herrmann, W | 1 |
| Bygdeman, M; Kovacs, L; Resch, BA; Rowe, PJ; Sas, M; Swahn, ML; Ugocsai, G | 1 |
| Chernev, T; Karag'ozov, I | 1 |
| Crombie, DL; Hayes, JS; Heap, RB; Wang, MW | 2 |
| Byam-Smith, M; Garfield, RE; Glassman, W | 1 |
| Baird, DT; Norman, JE; Thong, KJ | 2 |
| Fougeyrollas, B; Spira, A; Thonneau, P | 1 |
| Baird, DT; Lynch, P; Thong, KJ | 2 |
| Hart, LG; Mattis, R; Rosenblatt, RA | 1 |
| Brennand, JE; Calder, AA; Greer, IA; Kelly, RW; Leask, R | 1 |
| Heikinheimo, O | 3 |
| Bieńkiewicz, A | 1 |
| Fougeyrollas, B; Goepp, A; Hercberg, S; Maria, B; Meyer, L; Poirel, H; Spira, A; Thonneau, P | 1 |
| Baird, DT; Sukcharoen, N; Thong, KJ | 1 |
| Norman, JE | 1 |
| Chwalisz, K; Elger, W; Osawa, Y; Shimizu, Y; Yarborough, CP | 1 |
| de Gooyer, ME; Deckers, GH; Dijkema, R; Kloosterboer, HJ; Orlemans, EO; Schoonen, WG | 1 |
| Chwalisz, K; Einspanier, A; Fritzemeier, KH; Fuhrmann, U; Garfield, RE; Stöckemann, K | 1 |
| Peyron, R; Silvestre, L; Ulmann, A | 1 |
| Prasad, KS; Rao, AJ; Sharma, SC; Subbarayan, VS | 1 |
| Creveling, CR; Inoue, K | 1 |
| Carson, DD; Chakraborty, I; Das, SK; Dey, SK; Gendler, SJ; Julian, J; Pemberton, L; Pimental, RA; Surveyor, GA; Wegner, CC | 1 |
| Sanchez-Ramos, L | 1 |
| Mattheij, JA; Swarts, JJ; Uilenbroek, JT; van der Schoot, P | 1 |
| Brennand, JE; Cabrol, D; Calder, AA; Carbonne, B; Maria, B | 1 |
| el-Refaey, H; Hinshaw, K; Rispin, R; Templeton, A | 1 |
| Ho, PC; Ma, HK; Tsang, SS | 1 |
| Cottrell, BH | 1 |
| Potts, M | 2 |
| Brogden, RN; Faulds, D; Goa, KL | 1 |
| Cheng, LN; Du, MK; Lu, YL; Sang, GW; Shao, QX; Weng, LJ; Wu, XZ | 1 |
| Sang, GW; Shao, QX; Weng, LJ | 1 |
| Cen, HX; Jin, YC; Xu, MF | 1 |
| Bagchi, IC; Bagchi, MK; Bardin, CW; Ding, YQ | 1 |
| Asribekova, MK; Astakhova, TM; Goncharova, VN; Karpova, SK; Morozova, MS; Murashko, LE; Zaĭtseva, TS | 1 |
| Mitchell, DR | 1 |
| Bardin, CW; Kaplan-Kraicer, R; Shalgi, R | 1 |
| Jing, X; Weng, L | 1 |
| Liu, B; Sun, J; Tao, W | 1 |
| Dawood, MY | 1 |
| Anzaldua, R; Camacho-Arroyo, I; Castro, I; Cerbón, MA; Garcia, GA; Gutiérrez-Sagal, R; Orozco, C; Pasapera, AM; Pérez-Palacios, G | 1 |
| el-Refaey, H; Templeton, A | 4 |
| Deis, RP; Stocco, CO; Tellería, CM | 1 |
| Serfaty, D | 1 |
| Bokström, H; Norström, A; Wiqvist, N | 1 |
| Bokström, H; Norström, A | 1 |
| Chowdhury, SR; Singh, MM; Srivastava, SR; Srivastava, UK | 1 |
| Howie, PW; Thong, KJ; Wilson, T | 1 |
| Henshaw, R; Naji, S; Russell, I; Templeton, A | 1 |
| Cook, MJ; Haluska, GJ; Kaler, CA; Novy, MJ | 1 |
| Brooks, AN; Cooper, ES; Greer, IA; Miller, MR | 1 |
| Kelsey, JJ; Prevost, RR | 1 |
| Healy, DL | 3 |
| Gibson, M; Omar, HA; Ramirez, R | 1 |
| Deis, RP; Telleria, CM | 2 |
| Henshaw, RC; Naji, SA; Russell, IT; Templeton, AA | 3 |
| Abdalla, M; Calder, L; el-Refaey, H; Rajasekar, D; Templeton, A | 1 |
| Ajzen, H; Boim, MA; Draibe, SA; Ramos, OL; Schor, N; Ulmann, A | 1 |
| Hirst, JJ; Mijovic, JE; Olson, DM; Zakar, T | 1 |
| Hendrickx, AG; Otiang-a-Owiti, G; Tarantal, AF | 1 |
| Baulieu, EE; Peyron, R; Ulmann, A | 1 |
| Gorodeski, GI; Sheean, LA; Utian, WH | 2 |
| Bourget, P; Fernandez, H; Frydman, R; Lelaidier, C; Saint-Mleux, CB | 1 |
| Peplow, PV | 3 |
| Krisinger, J; Leung, PC; Setoyama, T | 1 |
| Gao, Y; Short, RV | 1 |
| Bagchi, IC; Bagchi, MK; Ding, YQ; Zhu, LJ | 1 |
| Philibert, D; Teutsch, G | 1 |
| Silvestre, L; Ulmann, A | 1 |
| Bygdeman, M; Gemzell-Danielsson, K; Gottlieb, C; Swahn, ML | 1 |
| Deckers, GH; Kloosterboer, HJ; Schoonen, WG | 1 |
| Bardin, CW; Croxatto, HB; Heikinheimo, O; Lähteenmäki, P; Spitz, IM | 1 |
| Baird, TL; Pearl, M | 1 |
| Chwalisz, K; Garfield, RE | 1 |
| Ambrus, G; Rao, CV | 1 |
| Compodónico, I; Croxatto, H; lavin, P; Peralta, O; Robinovich, J | 1 |
| Maria, B; Matheron, I | 1 |
| Daffos, F; Hohlfeld, P; Jacquemard, F; Menez, D; Mirlesse, V; Werner, H | 1 |
| Briggs, J; Donaldson, K; McMaster, D | 1 |
| Cohen-Tannoudji, J; Elwardy-Mérézak, J; Lécrivain, JL; Legrand, C; Maltier, JP; Vivat, V | 1 |
| Cailleux-Kreitmann, J; Champion, J | 1 |
| Li, WK; Lin, ZM; Liu, CG; Wang, ZX; Wu, XY; Xu, RY; Xue, T | 1 |
| Baird, DT | 4 |
| Baton, C; Benifla, JL; Bourget, P; Fernandez, H; Frydman, R; Lelaidier, C | 1 |
| Shi, WL; Wang, JD; Zhu, JB; Zhu, PD | 1 |
| Imada, K; Ito, A; Kubo, T; Matsushima, K; Mori, Y; Sato, T | 1 |
| Bates, A; Evans, J; Pinto, A | 1 |
| Beier, S; Elger, W; Fritzemeier, KH; Neef, G; Ottow, E; Wiechert, R | 1 |
| DiPierri, D | 1 |
| Forcelledo, ML; Poyser, NL | 1 |
| Djerassi, C; Jitsukawa, M | 1 |
| De, P; Ghosh, D; Sengupta, J | 2 |
| Bokström, H; Norström, A; Rdestad, A | 1 |
| Psychoyos, A; Rider, V | 1 |
| McRae, AC | 1 |
| Bygdeman, M | 3 |
| Campbell, DM; Hinshaw, K; Knox, FM; Levy, DM; Sutherland, HW | 1 |
| Tulandi, T | 2 |
| Bai, XM; Shi, WL; Wang, JD; Zhang, GQ | 1 |
| Baird, DT; Brooks, AN; Thong, KJ | 1 |
| Presl, J | 2 |
| Lau, OW; Tang, GW; Yip, P | 1 |
| Bachelard, B; Boulot, P; Hedon, B; Hoffet, M; Laffargue, F; Lefort, G; Viala, JL | 1 |
| Hoffmann, B; Nohr, B; Steinetz, BE | 1 |
| Smith, SK | 1 |
| Weiss, BD | 1 |
| Baird, DT; McKinley, C; Thong, KJ | 1 |
| Bardin, CW; Spitz, IM | 2 |
| Bouchard, P; Deng, M; Fernandez, H; Lelaidier, C; Meduri, G; Perrot-Applanat, M | 1 |
| de Souza, P | 1 |
| Baram, TZ; Yi, SJ | 1 |
| el-Refaey, H; Hinshaw, K; Templeton, A | 1 |
| Baird, DT; Cheng, L; Hume, R; Kelly, RW; Thong, KJ | 2 |
| Baulieu, EE; Hodgen, GD; Itskovitz, J; Simon, J; Sinosich, MJ; Ulmann, A; Wolf, JP | 1 |
| Tod, P | 1 |
| Langer, JW | 1 |
| Strobel, E | 1 |
| Bardin, CW; Chang, CC; Wang, WC | 2 |
| Muhl, C | 1 |
| Baram, TZ; Masters, JN; Yi, SJ | 1 |
| Courtieu, C; Déchaud, H; Marès, P; Marsollier, C; Tailland, ML | 1 |
| MacKenzie, IZ | 1 |
| Burnham, JM; Guller, S; Kaplan, P; Krikun, G; Lockwood, CJ; Wozniak, R | 1 |
| Heikinheimo, O; Kekkonen, R | 1 |
| Olund, A; Somell, C | 2 |
| Lye, SJ; Petrocelli, T | 1 |
| Baird, DT; Thong, KJ | 3 |
| Barnard, J; Ulmann, A | 2 |
| Hanft, RS | 1 |
| Fotherby, K; He, CH; Shi, YE; Van Look, PF; Xu, JQ; Ye, ZH; Zhang, GQ | 1 |
| von Werder, K | 1 |
| Christensen, NJ; Rådestad, A; Thyberg, J | 1 |
| Astakhova, TM; Goncharova, VN; Manuilova, IA; Morozova, MS; Pankov, YA; Zaytseva, TS | 1 |
| Deis, RP; Jahn, GA; Rastrilla, AM | 1 |
| Bygdeman, M; Gemzell-Danielsson, K; Svalander, P; Swahn, ML | 1 |
| Chan, YF; Ho, PC; Ma, HK | 1 |
| Ho, PC; Ma, HK | 1 |
| Falkay, G; Kovács, L | 1 |
| Cardenas, H; Croxatto, HB; Forcelledo, ML | 1 |
| Baton, C; Benifla, JL; Bourget, P; Bourrier, MC; Fernandez, H; Frydman, R; Lelaidier, C | 1 |
| Anderson, LL; Gazal, OS; Li, Y; Schwabe, C | 1 |
| Boog, G; Lopez, P; Sagot, P; Winer, N | 1 |
| Baton-Saint-Mleux, C; Bourget, P; Fernandez, H; Frydman, R; Lelaidier, C | 1 |
| Aubény, E; Baulieu, EE; Elkik, F; Leclerc, P; Peyron, R; Renault, M; Silvestre, L; Targosz, V; Ulmann, A | 1 |
| Rosenfield, A | 1 |
| Hamel, RP; Lysaught, MT | 1 |
| Elstein, M; Macrow, P | 1 |
| Delansorne, R; el Alj, A; Ferre, F; Germain, G; Lallaoui, H; Winer, N | 1 |
| Bardin, CW; Kadam, PA; Koide, SS; Vanage, G | 1 |
| Hinko, A; Jeng, YJ; Soloff, MS | 1 |
| Hoffman, RS; Perrone, J | 1 |
| Grunberg, SM | 1 |
| Aguado, LI; Carrizo, DG; Deis, RP; Rastrilla, AM; Stati, AO; Stocco, CO; Tellería, CM | 1 |
| Choolani, M; Prasad, RN; Ratnam, SS; Roy, A | 1 |
| Bognar, I; Kelemen, K; Paal, M; Szekeres-Bartho, J | 1 |
| Rotten, D | 1 |
| Jiao, L; Tang, X; Weng, L | 1 |
| Torres, A; Tucker, DC | 1 |
| Aubény, E; Baulieu, EE; Peyron, R; Renault, M; Silvestre, L; Targosz, V; Turpin, CL; Ulmann, A | 1 |
| Bider, D; Menashe, Y; Pariente, C; Serr, DM; Shalev, J | 1 |
| Anderson, LL; Dlamini, BJ; Li, Y | 1 |
| Chakraborty, I; Das, SK; Dey, SK; Paria, BC; Plowman, G; Wang, XN | 1 |
| Kettel, LM | 1 |
| Kalkhoven, E; van der Burg, B; van der Saag, PT; Wissink, S | 1 |
| Joly, P; Lauret, P; Lecorvaisier-Pieto, C; Noblet, C; Tanasescu, S; Thomine, E | 1 |
| Bell, SC; Sadek, S | 1 |
| Penney, GC; Templeton, A; Webster, D | 1 |
| Chan, YF; Ho, PC; Lau, W | 1 |
| Croxatto, HB; Robbins, A; Spitz, IM | 1 |
| Berry, C; Mathers, AM; Phillips, K | 1 |
| London, S | 1 |
| Edwards, MS | 1 |
| Murray, S; Muse, K | 1 |
| Cabrol, D; Germain, G; Haddad, B | 1 |
| Aflak, N; Chemla, JP; Jannet, D; Marpeau, L; Milliez, J | 1 |
| Bardin, CW; Kaplan-Kraicer, R; Kostovetsky, I; Shalgi, R | 1 |
| Choolani, M; Prasad, RN | 1 |
| Rothchild, I | 1 |
| Falkay, G; Földesi, I; Kovács, L | 1 |
| Gu, QQ; Hendrickx, AG; Lasley, BL; Matlin, SA; Tarantal, AF; Thomas, CA; Van Look, PF; Vince, PM | 1 |
| Dodson, MG; Juneja, SC | 1 |
| Gilula, NB; Risek, B | 1 |
| Branch, DW; Dudley, DJ; Edwin, SS; Mitchell, MD | 1 |
| Glasier, A | 1 |
| Ho, PC; Lao, T; Ngai, SW; Yeung, KC | 1 |
| Garattini, E; Kurosaki, M; Li Calzi, M; Terao, M; Zanotta, S | 1 |
| Bardin, CW; Dao, B; Koide, SS; Marshall, A; Vanage, G | 1 |
| Baird, DT; Critchley, HO; Drudy, TA; Jones, RL; Kelly, RW; Lea, RG | 1 |
| Brooks, AN; Cooper, ES; Greer, IA | 1 |
| Bieńkiewicz, A; Kuś, E; Welfel, J | 1 |
| Baird, DT; Benton, L; Cameron, ST; Glasier, AF; Logan, J | 1 |
| Clark, S; Ellertson, C; Winikoff, B | 2 |
| Aigner, S; Hausknecht, V; Krikun, G; Lockwood, CJ; Papp, C; Schatz, F | 1 |
| Bardin, CW; Dao, B; Koide, SS; Li, XJ; Vanage, G | 1 |
| Buhimschi, IA; Chwalisz, K; Garfield, RE; Liao, QP; Saade, G | 1 |
| Giannetti, V | 1 |
| Baulieu, EE; Cadepond, F; Ulmann, A | 1 |
| Chaouat, G; Delage, G; Frydman, R; Lelaidier, C; Menu, E; Rongières-Bertrand, C | 1 |
| Cabezas, E; Coyaji, KJ; Du, MK; Ellertson, C; Eschen, A; Gu, S; Krishna, UR; Sivin, I; Winikoff, B; Xiao, B | 1 |
| Ghosh, D; Lasley, BL; Nayak, NR; Sengupta, J | 1 |
| Van Look, PF; von Hertzen, H | 1 |
| Eisinger, SH; Franks, P; Schaff, EA; Stadalius, LS | 1 |
| Beato, M; Pecci, A; Pelster, D; Scholz, A | 1 |
| Abankwa, A; Aflak, N; Carbonne, B; Jannet, D; Marpeau, L; Milliez, J | 1 |
| Ghosh, D; Kumar, PG; Sengupta, J | 1 |
| Dhara, S; Ghosh, D; Kumar, PG; Nayak, NR; Sengupta, J | 1 |
| Dorozynski, A | 1 |
| Bardin, CW; O'Connor, BM; Robbins, A; Spitz, I | 1 |
| Dombay, Gy; Par, G; Smart, YC; Szekeres-Bartho, J; Volgyi, Z | 1 |
| Delannoy, P; Hamr, A; Kolínská, J; Verbert, A | 1 |
| Sang, G; Shao, Q; Wu, Y | 1 |
| Koide, SS; Li, XJ; Yu, H | 1 |
| Bygdeman, M; Danielsson, KG; Swahn, ML | 1 |
| Henshaw, RC; Howie, FL; Naji, SA; Russell, IT; Templeton, AA | 1 |
| Anderson, MR; Gold, M; Luks, D | 1 |
| Fisher, S; Gissmann, L; Kaufmann, AM; Michelin, D; Potkul, RK; Qiao, L; Schreckenberger, C; Street, D | 1 |
| Han, X; Weng, L; Xiao, B | 1 |
| Lu, X; Zhang, J; Zhou, J | 1 |
| Schneider, AP | 1 |
| Casner, P | 1 |
| Fowler, PA; McNeilly, AS | 1 |
| Hahlin, M; Nielsen, S; Platz-Christensen, JJ | 1 |
| Ghosh, D; Nayak, NR; Sengupta, J | 1 |
| Henshaw, RC | 1 |
| Bell, SM; Evans, AJ; Healy, DL; Lavelle, AL; Mamers, PM; Rusden, JR | 1 |
| Coutifaris, C; Hoyer, JR; Omigbodun, A; Tessler, C; Ziolkiewicz, P | 1 |
| Gibori, G; Sugino, N; Telleria, CM | 1 |
| Carón, RW; Deis, RP | 1 |
| Ho, PC; Lee, SW; Liu, KL; Ngai, SW; Wong, GC | 1 |
| Rao, AJ; Shanker, YG | 1 |
| Hilton, M; Schuster-Woldan, N; Wilson, T | 1 |
| Li, E; Su, H; Weng, L | 1 |
| Chen, S; Gao, W; Li, L | 1 |
| Pan, J; Sun, L | 1 |
| Deis, RP; Mezzadri, MR; Telleria, CM | 1 |
| London, SN; Mahajan, DK | 1 |
| Lenz, T | 1 |
| Bergsjø, P; Iversen, OE | 1 |
| Chi, CW; Ho, CK; Wang, SY; Yu, KJ | 1 |
| Bardin, CW; Benton, L; Robbins, A; Spitz, IM | 1 |
| Astruc, M; Boulot, P; Charlier, C; Giacalone, PL; Hoffer, MC; Zimbris, L | 1 |
| Jurkovic, D | 1 |
| Cheng, L; Gao, PP; Ho, PC; Lee, S; Tang, OS | 1 |
| Dai, D; George, P; Mahesh, VB; Ogle, TF | 1 |
| Ballantyne, ES; Blanch, G; Gosden, CM; Holland, K; Neilson, JP; Quenby, S | 1 |
| Benson, GV; Dey, SK; Lim, H; Ma, L; Maas, RL | 1 |
| Ghosh, D; Liu, N; Sengupta, J; Zhu, ZM | 1 |
| Ellertson, C; Simonds, W; Springer, K; Winikoff, B | 1 |
| Anderson, LL; Cho, SJ; Huang, CJ; Li, Y | 1 |
| Anzaldua, SR; Camacho-Arroyo, I; Cerbón, MA; García, GA | 1 |
| Aubeny, E | 3 |
| Webb, AM | 1 |
| Dai, D; George, P; Ogle, TF | 2 |
| Davey, A; Sakiz, E; Sitruk-Ware, R | 1 |
| Calder, AA; Critchley, HO; Elliott, CL; Kelly, RW; Riley, SC | 1 |
| Ewart, WR; Winikoff, B | 1 |
| Ashok, PW; Flett, GM; Templeton, A | 2 |
| French, L; Randel, J | 1 |
| Alfirevic, Z; Baruah, DN; Emery, SJ; Gazvani, MR | 1 |
| Camus, E; Chastang, C; Goffinet, F; Nisand, I; Perdu, M; Philippe, HJ; Rozenberg, P | 1 |
| Boog, G; Faure, JM; Giacalone, PL; Laffargue, F; Targosz, V | 1 |
| Jiang, X; Wang, H; Zhang, Z | 1 |
| Baird, DT; Brown, AH; Martin, CW | 1 |
| Blye, RP; Hild-Petito, S; Reel, JR | 1 |
| Brennand, JE; Calder, AA; Elliott, CL | 1 |
| Ashok, PW; Flett, GM; Penney, GC; Templeton, A | 1 |
| Bygdeman, M; Danielsson, KG; Marions, L; Swahn, ML | 1 |
| Barley, G; O'Brien-Gonzales, A; Westfall, JM | 1 |
| Fang, RY; Yang, B | 1 |
| Blinder, V; Elul, B; Winikoff, B | 1 |
| Coyaji, K; Ellertson, C; Harper, C; Winikoff, B | 1 |
| von Hertzen, H | 2 |
| Challis, JR; Chwalisz, K; Clifton, VL; Patel, FA | 1 |
| Amico, JA; Merchenthaler, I; Shughrue, PJ; Thomas, A | 1 |
| Cabezas, E | 1 |
| Grant, KE; MacKenzie, IZ; Mardon, HJ; McCracken, SA; Redman, CW | 1 |
| Bygdeman, M; Chang, WF; Chen, JK; Gemzell-Danielsson, K; Qian, ML; Song, S; Swahn, ML; Yang, PJ; Yang, QY | 1 |
| Doreau, C; Sarrut, B | 1 |
| Stulac, F | 1 |
| Macrow, PJ | 1 |
| Ulmann, A | 3 |
| Brennand, J; Greer, I | 1 |
| Cheng, L; Gao, PP; Ho, PC; Lee, SW; Tang, OS | 1 |
| Dai, DY; Wu, DX; Zhang, TT | 1 |
| Eisinger, SH; Franks, P; Gore, BZ; Poppema, S; Schaff, EA; Stadalius, LS | 1 |
| Coyaji, K; Ellertson, C; Elul, B; Winikoff, B | 1 |
| del Cerro, MC; Guillamón, A; Numan, M; Numan, MJ; Roach, JK; Segovia, S; Sheehan, TP | 1 |
| Emery, SJ; Gazvani, MR | 1 |
| Dai, D; Ogle, TF | 1 |
| Astley, SJ; Jensen, JT; Morgan, E; Nichols, MD | 1 |
| Inaba, T; Sawada, T; Tamada, H | 1 |
| Chen, GT; Getsios, S; MacCalman, CD | 1 |
| Riskin-Mashiah, S; Wilkins, I | 1 |
| Sibbald, B | 2 |
| Cruickshank, DJ; Gouk, EV; Haslock, J; Khair, A; Knight, J; Lincoln, K | 1 |
| Ashok, PW; Templeton, A | 1 |
| Hahlin, M; Nielsen, S; Platz-Christensen, J | 1 |
| Scheepers, HC; van den Bergh, AS; van Erp, EJ | 1 |
| Ottesen, BS | 1 |
| Larsen, JF; Lidegaard, O | 1 |
| al-Gubory, KH; Bolifraud, P; Kann, G; Martinet, J | 1 |
| Fang, L; Gangula, PR; Kondapaka, S; Wimalawansa, S; Yallampalli, C | 1 |
| Danielsson, KG; Marions, L | 1 |
| Knudsen, UB | 2 |
| Ferriman, A | 1 |
| Aedo, AR; Bygdeman, M; Ekman, G; Stenlund, PM | 1 |
| Brooks, L; Grinsted, J; Grinsted, L; Jacobsen, JD; Nielsen, SP; Sandstrøm, O; Schantz, A | 1 |
| Bygdeman, M; Danielsson, KG; Kovâcs, L; Marions, L; Resch, BA; Swahn, ML; Viski, S | 1 |
| Jain, JK; Meckstroth, KR; Mishell, DR | 1 |
| Creinin, MD; Spitz, IM | 1 |
| Lasley, BL; Overstreet, JW; Stewart, DR; VandeVoort, CA | 1 |
| Ghosh, D; Hendrickx, AG; Lalitkumar, PG; Sengupta, J; Wong, VJ | 1 |
| Bangou, J; Ellertson, C; Elul, B; Guengant, JP | 1 |
| Bourne, T; Jermy, K; Oyelese, O | 1 |
| Duncan, GW | 1 |
| Liu, F; Liu, Y; Tao, G; Wu, Y; Xu, L; Zhang, H | 1 |
| Cao, Z; Han, Z; Yang, Y | 1 |
| Xu, W; Yang, Q; Yang, X | 1 |
| Cao, Z; Han, Z; Li, S; Liu, W; Wang, H; Yang, Y | 1 |
| Dong, YL; Yallampalli, C | 1 |
| Kangawa, K; Makino, I; Makino, Y; Shibata, K | 1 |
| Liu, CQ; Lu, SH; Wang, ZX; Yuan, Y | 1 |
| Chernev, T | 1 |
| Bouchard, P; Christin-Maitre, S; Spitz, IM | 1 |
| Blye, RP; Hild, SA; Hoffman, LH; Reel, JR | 1 |
| Amory, JK; Becker, BJ; Creinin, MD; Kahn, JG; MacIsaa, L; Neuhaus, J; Olkin, I | 1 |
| Eisinger, SH; Fielding, SL; Fuller, L; Schaff, EA; Stadalius, LS | 1 |
| Jørgensen, JJ; Olsen, CD; Wittendorff, HE | 1 |
| Feng, S; Li, M; Yang, X | 1 |
| Cheng, L; Gao, Y; Liu, Y | 1 |
| Calder, AA; Critchley, HO; Denison, FC; Elliott, CL; Kelly, RW; Riley, SC | 1 |
| Clarke, S; Dasmahapatra, R; Westhoff, C; Winikoff, B | 1 |
| Davis, A; De Nonno, L; Westhoff, C | 1 |
| Hoff, T; Koenig, JD; Stewart, FH; Tapias, MP | 1 |
| Elul, B; Pearlman, E; Simonds, W; Sorhaindo, A; Westhoff, C | 1 |
| Coyaji, K | 1 |
| Bygdeman, M; Danielsson, KG; Marions, L | 1 |
| Wu, S | 1 |
| Koonin, LM | 1 |
| Dai, D; Moulton, BC; Ogle, TF | 1 |
| Beckman, LJ; Harvey, SM; Jensen, JT | 1 |
| Bártfai, G | 1 |
| Kass, L; Luque, EH; Montes, GS; Muñoz de Toro, M; Ramos, JG; Rodriguez, H; Varayoud, J | 1 |
| Aguilar, R; Alonso, R; Bellido, C; Garrido-Gracia, JC; González, D; Hernández, G; Sánchez-Criado, JE | 1 |
| Choi, BC; Hill, JA; Polgar, K; Xiao, L | 1 |
| Joffe, C | 1 |
| Newhall, EP; Winikoff, B | 1 |
| Creinin, MD; Pymar, HC | 1 |
| Gemzell-Danielsson, K; Ostlund, E | 1 |
| Bright, N; Coleman, RE; Gillespie, AM; Hancock, BW; Radstone, CR; Tidy, JA | 1 |
| Agarwal, N; Buckshee, K; Sehgal, R; Takkar, D | 1 |
| Fassett, MJ; Mishell, DR; Wing, DA | 1 |
| Ho, PC; Ngai, SW; Tang, OS | 1 |
| Neilson, JP | 1 |
| Eisinger, SH; Ellertson, C; Fielding, SL; Fuller, L; Schaff, EA; Stadalius, LS; Westhoff, C | 1 |
| Tufts, A | 1 |
| Antonijevic, IA; Bicknell, RJ; Douglas, AJ; Leng, G; Russell, JA | 1 |
| Anjum, ZK | 1 |
| Adamson, L; Bocking, AD; Challis, JR; Fraser, M; Lye, SJ; McKeown, KJ; Riggs, KW; Rurak, D; Small, C | 1 |
| Miller, JL | 1 |
| Ekman, G; Eriksson, H; Holmgren, A; Lundberg, M; Sahlin, L; Stjernholm, Y; Wang, H | 1 |
| Nemecek, S | 1 |
| McGaughran, AL | 1 |
| Aubeny, E; Chatellier, G | 1 |
| Darney, PD; Goldberg, AB; Greenberg, MB | 1 |
| Hale, RW; Zinberg, S | 1 |
| Fang, RY; He, QJ; Yang, B; Ying, Y | 1 |
| Fang, RY; He, QJ; Yang, B; Zhou, HJ | 1 |
| Child, TJ; MacKenzie, IZ; Rees, M; Thomas, J | 1 |
| Curry, M; Simpson, D | 1 |
| Check, E | 1 |
| Schultz, S; Whitman, D | 1 |
| Schultz, S | 1 |
| Gibbs, N | 1 |
| France, D; Rosenberg, D | 1 |
| Quindlen, A | 1 |
| Colov, NS; Hansen, PS; Lindhardt, TB; Walker, LR | 1 |
| Richardson, CR | 1 |
| Chen, H; Ma, T; Wu, X; Xu, J | 1 |
| Baird, DT; Bartley, J; Everington, D; Tong, S | 1 |
| De Nonno, LJ; Fielding, S; Schaff, E; Westhoff, C | 1 |
| Dasmahapatra, R; Schaff, E; Westhoffa, C | 1 |
| Hussar, DA | 1 |
| Willke, JC | 1 |
| Rudd, G | 1 |
| El-Refaey, H; Hoffman, L; le Roux, PA; Nooh, R; Pahal, GS; Rodeck, CH | 1 |
| Fan, G; Jin, L; Yang, X | 1 |
| Bridges, PJ; Ching, L; Kim, L; LeaMaster, BR; Vincent, DL; Weems, CW; Weems, YS | 1 |
| Weng, L | 1 |
| Jiang, M; Weng, L; Wu, S; Wu, Y | 1 |
| Li, D; Qiu, X; Zhou, X | 1 |
| Wu, S; Zhang, L; Zhou, X | 1 |
| Chen, X; Huang, L; Shi, Y | 1 |
| Li, R; Wang, Z; Wu, R | 1 |
| Kovács, L; Zalányi, S | 1 |
| Ellertson, C; Elul, B; Hajri, S; Ngoc, NN; Pearlman, E; Slama, CB; Winikoff, B | 1 |
| Gao, Y; He, F; Luo, L | 1 |
| Sun, L; Wang, C; Zheng, Y | 1 |
| Szalavitz, M | 1 |
| Creinin, MD; Fink, W; Pymar, HC; Schwartz, JL | 1 |
| Croxatto, HB; Devoto, L; Durand, M; Ezcurra, E; Larrea, F; Nagle, C; Ortiz, ME; Vantman, D; Vega, M; von Hertzen, H | 1 |
| Chi, L; Spencer, F; Zhu, M | 1 |
| Baird, DT; Brown, A; Glasier, AF; Hapangama, DK | 1 |
| Aschkenazi, S; Ben-Rafael, Z; Levy, T | 1 |
| Allen, RH; De Nonno, L; Fielding, SL; Schaff, EA; Westhoff, C | 1 |
| Boulot, P; Daurés, JP; Faure, JM; Giacalone, PL; Hedon, B; Laffargue, F | 1 |
| Eisinger, S; Fielding, SL; Schaff, EA; Stadalius, L | 1 |
| Fang, R; He, Q; Shentu, J; Wang, L; Zhou, H | 1 |
| Liu, SY; O'Sullivan, CM; Rancourt, DE; Rancourt, SL | 1 |
| Neville, MC; Nguyen, DA; Parlow, AF | 1 |
| Hu, Y; Zhang, N | 1 |
| Ashok, PW; Narvekar, N; Smith, NC; Templeton, A; Wagaarachchi, PT | 1 |
| Creinin, MD; Pymar, HC; Schwartz, JL | 2 |
| Baird, DT; Tang, OS; Thong, KJ | 1 |
| Kamernitskii, AV; Kareva, EN; Kirpichnikova, NV; Kulikova, LE; Levina, IS; Podval'nyuk, VV | 1 |
| Bouftila, B; Clabaut, M | 1 |
| Chedrese, J; Deis, RP; Stocco, CO | 1 |
| Baird, DT; Bartley, J; Brown, A; Elton, R | 1 |
| Baulieu, EE; Hajri, S; Seidman, DS | 1 |
| Liu, CQ; Wang, ZX; Yuan, Y | 1 |
| Wang, L; Zhang, W | 1 |
| Duan, H; Wang, NG | 1 |
| Billig, H; Ling, C | 1 |
| David, HP | 1 |
| Mangla, B | 1 |
| Callahan, JC | 1 |
| Coney, S | 1 |
| Forster, HP | 1 |
| Haas, EM | 1 |
| Woodroffe, C | 1 |
| Fletcher, JC | 1 |
| Seelye, KQ | 1 |
| Kolata, G | 1 |
| Talbot, M | 1 |
| Brody, BA | 1 |
| Le Grand, A | 1 |
| Nathanson, B | 1 |
| Clark, AE | 1 |
| Sachs, A | 1 |
| Nathanson, BN | 1 |
| Silverberg, EA | 1 |
| Smolin, DM | 1 |
| Simmons, PD | 1 |
| Cannold, L | 1 |
| Augestad, G; Bjørge, L; Helland, H; Iversen, OE; Johnsen, SL; Midbøe, G; Stray-Pedersen, S; Økland, I | 1 |
| Cheng, J; Han, X; Weng, L | 1 |
| Cavicchia, JC; Deis, RP; Goyeneche, AA; Stati, AO; Telleria, CM | 1 |
| Cheng, CK; Cheng, KW; Leung, PC | 1 |
| Hausknecht, V; Krikun, G; Lockwood, CJ; Papp, C; Schatz, F | 1 |
| Gao, F; Han, XB; Liu, YX; Xu, FH; Zhou, XC | 1 |
| Child, TJ; MacKenzie, IZ; Rees, M | 1 |
| Ashok, PW; Fitzmaurice, A; Flett, GM; Graham, W; Kidd, A; Templeton, A | 1 |
| Cheng, L; Ho, PC; Lee, SW; Tang, OS; Xu, J | 2 |
| Fielding, S; Fuller, L; Schaff, E; Walker, K | 1 |
| Xia, E; Zhang, J | 1 |
| Huang, L; Shi, Y | 2 |
| Couchenour, RL; Wanner, MS | 1 |
| Garcia, DP | 1 |
| Aavitsland, P | 1 |
| Bjørge, L; Iversen, OE | 1 |
| Fielding, SL; Phelps, RH; Schaff, EA | 1 |
| de Di Nasso, EG; Deis, RP; Soaje, M | 1 |
| Roop, DR; Wang, D; Wang, XJ; Zhou, Z | 1 |
| Auewarakul, P; Cid-Arregui, A; García-Carrancá, A; Juárez, V; Morales-Peza, N | 1 |
| Norel, G | 1 |
| Chung, WC; De Vries, GJ; Lopez, V; Quadros, PS; Wagner, CK | 1 |
| Ellertson, C; Harper, C; Winikoff, B | 1 |
| Guan, M; Wang, N; Zheng, W | 1 |
| Long, W; Wang, W; Yu, Q | 1 |
| Dunn, S; Guilbert, E; Jacot, F; Lugtig, L; Wiebe, E | 1 |
| Ashok, PW; Narvekar, NN; Smith, NC; Templeton, A; Wagaarachchi, PT | 1 |
| Ashok, PW; Smith, NC; Templeton, A; Wagaarachchi, PT | 1 |
| Ho, PC; Tang, OS; Yu Ng, EH | 1 |
| Dutton, C; Harwood, B; Jain, JK; Meckstroth, KR; Mishell, DR | 1 |
| Weimin, W; Wenqing, L | 1 |
| Ashok, PW; Flett, GM; Melvin, L; Stalder, C; Templeton, A; Wagaarachchi, PT | 1 |
| Sexton, C; Sharp, N | 1 |
| Liu, T; Ogle, TF | 1 |
| Lye, SJ; Mitchell, JA | 1 |
| Lee, JN; Tsai, EM; Yang, CH | 1 |
| Henshaw, RC; Templeton, AA | 2 |
| Lincoln, DW | 1 |
| Cohen-Tannoudji, J; Giacobino, JP; Legrand, C; Maltier, JP; Muzzin, P; Revelli, JP; Vivat, V | 1 |
| Aguillaume, CJ; Baulieu, EE; Chemama, L; Renault, M; Rezvani, Y; Silvestre, L; Ulmann, A | 1 |
| Garfield, R; Grover, A; Hertzberg, E; Tabb, T; Thilander, G | 1 |
| Holmgren, K | 1 |
| Baird, DT; Glasier, AF; Norman, JE; Thong, KJ | 1 |
| Calder, AA; Kelly, RW; Leask, R | 1 |
| Guillebaud, J; Heard, M | 2 |
| Distler, W; Vering, A | 1 |
| Burgess, KM; Jenkin, G; Ralph, MM; Thorburn, GD | 1 |
| David, HP; Grimes, DA; Mishell, DR | 1 |
| Fu, Y; Qiao, GM; Shi, WL; Wang, JD; Wang, YQ; Xu, LK; Zhu, PD | 1 |
| Arkaravichien, W; Kendle, KE | 2 |
| Bygdeman, M; Swahn, ML | 6 |
| Greenslade, FC; Leonard, AH; Winkler, J | 1 |
| Holt, R | 1 |
| Heilig, SL | 1 |
| Senderowitz, J | 1 |
| Macklin, R | 1 |
| Buc, NL | 1 |
| Boland, R | 1 |
| Pine, RN | 1 |
| Crane, LH; Martin, L | 2 |
| Baton-Saint-Mleux, C; Bourget, P; Fernandez, H; Frydman, R; Lelaidier, C; Vial, M | 1 |
| Du, M; Fan, H; Gao, J; Huang, Z; Wang, P; Wu, M; Wu, S; Wu, Y; Yao, G; Zheng, S | 1 |
| Elstein, M; Russell, J; Webb, AM | 1 |
| Baird, DT; Dewar, MH; Thong, KJ | 1 |
| Gupta, JK; Johnson, N | 2 |
| el-Refaey, H; Henshaw, R; Hinshaw, K; Smith, N; Templeton, A | 1 |
| Doherty, P | 1 |
| Regelson, W | 1 |
| Bygdeman, M; Rådestad, A | 1 |
| von Brauchitsch, I | 1 |
| Dressel, R; Reiter-Theil, S | 1 |
| Bonelli, RM | 1 |
| Baird, DT; Dewar, M; Glasier, A; Mackie, M; Thong, KJ | 1 |
| Baird, DT; Norman, JE; Rodger, MW; Thong, KJ | 1 |
| Debu, E; Dufour, B; Fontan, JE; Majorel, P; Scheller, E; Weber, B | 1 |
| Dietl, J | 1 |
| Bernadet, P; Boudjemaa, B; Carrie, D; Delay, M; Genestal, M; Livarek, B | 1 |
| Fernandez, H; Frydman, R; Lelaidier, C; Pons, JC | 1 |
| Cole, AP | 1 |
| Diochin, P; Frydman, R; Pons, JC; Rais, S | 1 |
| Christensen, NJ; Heidvall, K; Lindgren, JA; Radestad, A | 1 |
| Henshaw, RC; Murray, GI; Smith, AP; Smith, NC | 1 |
| Blennerhassett, MG; Garfield, RE; Sakai, N | 1 |
| Bachelot, A; Cludy, L; Spira, A | 1 |
| Bautrant, E; Blanc, B; Boubli, L; D'Ercole, C; Eyraud, B; Nadal, F | 1 |
| Cohen-Tannoudji, J; Heilmann, J; Legrand, C; Maltier, JP; Vivat, V | 1 |
| Potvin, W; Varma, DR | 1 |
| Alj, AE; Bienkiewicz, A; Cabrol, D; Carbonne, B; Cedard, L; Dallot, E | 1 |
| Lähteenmäki, P | 1 |
| Baton, C; Bourget, P; Fernandez, H; Frydman, R; Lelaidier, C; Vial, M | 1 |
| Haspels, AA | 2 |
| Elefant, E; Herschkorn, P; Imbert, MC; Papiernik, E; Pons, JC; Roux, C | 1 |
| Barnard, J; Rubin, I; Ulmann, A | 1 |
| Papiernik, E; Pons, JC | 1 |
| Olson, DM; Potestio, FA | 1 |
| Ferguson, J; Hill, NC; MacKenzie, IZ | 1 |
| Templeton, A; Urquhart, DR | 1 |
| Chard, T; Kitau, M; Olajide, F | 1 |
| Fried, G; Meister, B; Rådestad, A | 1 |
| Cingotti, M; Gandour, A; Moxhon, E | 1 |
| Baker, JR; Hansen, KA; Klein, TA; Nieman, LK; Opsahl, MS | 1 |
| Cano, A; Hill, NC; López Bernal, A; Mackenzie, IZ; Rivera, J | 1 |
| Baulieu, EE; Gouézou, M; Kominami, S; Le Goascogne, C; Robel, P; Sananès, N; Takemori, S | 1 |
| Endo, T; Kanayama, K; Masaki, J; Sakuma, Y; Sankai, T; Umezu, M | 1 |
| Grall, F; Sylvestre, L | 1 |
| Tang, GW | 1 |
| Acker, GM; Chaouat, G; Garabédian, M; Kachkache, M; Noun, A | 1 |
| Brennand, JE; Calder, AA | 1 |
| Fintor, L | 1 |
| Cabrol, D; Giovangrandi, Y; Josserand, S; Magnani, M; Matheron, I | 1 |
| Bukovsky, I; Caspi, E; Golan, A; Pansky, M | 1 |
| Mulay, S; Potvin, W; Varma, DR | 1 |
| Ikuta, Y; Matsuura, K; Okamura, H; Oyamada, I; Usuku, G | 1 |
| Anderson, LL; Gazal, OS; Li, YF; Perezgrovas, R; Schwabe, C | 1 |
| Börner, A; Carol, W; Klinger, G; Michels, W; Romero, KR | 1 |
| Grubb, GS | 1 |
| Croxatto, HB; Roblero, LS | 1 |
| Baird, DT; Glasier, AF; Kelly, RW; McNeilly, AS; Norman, JE; Wu, WX | 1 |
| Avrech, OM; Bukovsky, I; Caspi, E; Golan, A; Weinraub, Z | 1 |
| Aubeny, E; Baulieu, EE | 1 |
| Cohn, M; Stewart, P | 1 |
| Maurice, J | 1 |
| Hoffman, M | 1 |
| Bygdeman, M; Gottlieb, C | 1 |
| Muskiet, FA; Slappendel, EJ; van der Schoot, P; Zeegers, TA | 1 |
| Legarth, J; Michelsen, JW; Peen, UB | 1 |
| Baird, DT; Kelly, RW; Norman, JE | 1 |
| Soller, PC | 1 |
| Anderson, LL; Huang, CJ; Klindt, J; Li, YF | 1 |
| Ferguson, J; Hill, NC; MacKenzie, IZ; Selinger, M | 2 |
| Bonoris, E; Cynober, E; el Alj, A; Germain, G | 1 |
| Falkay, G | 1 |
| Bjornsson, S; Cohn, MR; Davey, A; Lees, DA; Lim, BH; Lunan, CB; Stewart, P | 1 |
| Carr, BR; Kutteh, WH; Rainey, WE | 1 |
| Templeton, AA; Urquhart, DR | 5 |
| Belair, L; Djiane, J; Edery, M; Jahn, GA; Kelly, PA | 1 |
| Kunins, H; Rosenfield, A | 1 |
| Bennegård, B; Hahlin, M; Hamberger, L; Sjöblom, P | 1 |
| Bygdeman, M; Gemzell, K; Gottlieb, C; Swahn, ML | 1 |
| Deis, RP; Jahn, GA | 1 |
| Norman, J | 1 |
| Fontan, JE; Weber, B | 1 |
| Martin, L; Vinijsanun, A | 1 |
| Haluska, GJ; Mitchell, MD; Novy, MJ | 1 |
| Croxatto, HB; Forcelledo, ML; Morán, FM | 1 |
| d'Ablaing, G; Grimes, DA; Lacarra, M; Levin, JH; Vermesh, M | 1 |
| Petraglia, F; Vale, W; Vaughan, J | 1 |
| Bygdeman, M; Green, K; Rådestad, A | 1 |
| Bernstein, L; Grimes, DA; Lacarra, M; Mishell, DR; Shoupe, D | 1 |
| Concar, D | 1 |
| Permezel, M | 1 |
| Heikinheimo, O; Lähteenmäki, P; Ylikorkala, O | 1 |
| Jansen, RP | 1 |
| Maria, B | 1 |
| Ferguson, J; Hill, NC; López Bernal, A; Mackenzie, IZ; Selinger, M | 1 |
| Cabrol, D; Cronje, H; Dubois, C; Gonnet, JM; Guillot, M; Maria, B; Moodley, J; Oury, JF; Thoulon, JM; Treisser, A | 1 |
| Baird, DT; Glasier, A; Kelly, RW; McNeilly, AS; Norman, J; Wu, WX | 1 |
| Arai, K; Arakawa, S; Kambegawa, A; Okinaga, S | 1 |
| Bistoletti, P; Olund, A | 1 |
| Chaouat, G; Kinsky, R; Szekeres-Bartho, J | 1 |
| Chaouat, G; Philibert, D; Szekeres-Bartho, J | 1 |
| Bukman, A; Kelly, RW | 1 |
| Ferguson, J; Hill, NC; López Bernal, A; MacKenzie, IZ | 1 |
| Couzinet, B; Le Strat, N; Schaison, G; Silvestre, L | 1 |
| Halbreich, U | 1 |
| Carlström, K; Kindahl, H; Olund, A; Somell, C | 1 |
| Brenner, RM; Haluska, GJ; Novy, MJ; West, NB | 1 |
| Godefroid, RJ | 1 |
| Elie, R; Lanza, E; Lefebvre, Y; Poulin, O; Proulx, L | 1 |
| Baulieu, EE; Chillik, CF; Dubois, C; Hodgen, GD; Ulmann, A; Wolf, JP | 1 |
| Baulieu, EE; Dubois, C; Renault, M; Rezvani, Y; Silvestre, L; Ulmann, A | 1 |
| Segal, SJ | 1 |
| Dykers, JR | 1 |
| Anderson, TL; Dua, L; Hodgen, GD; Matt, DW; Steingold, KA | 1 |
| Concannon, PW; Frank, D; Iyampillai, A; Yeager, A | 1 |
| Bryce, FC; Johnson, N | 1 |
| Chavinie, J; De Plunkett, TL; Epelboin, S; Lewin, F; Mauvais-Jarvis, P; Mowszowicz, I; Sitruk-Ware, R; Thalabard, JC; Tournaire, M; Yaneva, H | 1 |
| Coles, P | 1 |
| Germain, G | 1 |
| Philibert, D; Teutsch, G; Ulmann, A | 1 |
| Bygdeman, M; Gottlieb, C; Green, K; Swahn, ML | 1 |
| Wu, JT; Yang, YQ | 1 |
| Hill, NC; Lopez Bernal, A; MacKenzie, IZ; Rivera, J | 1 |
| Asch, RH; Balmaceda, JP; Rojas, F; Spitz, IM; Tadir, Y; Weckstein, LN | 1 |
| Aldhous, P; Coles, P | 1 |
| Dubois, C; Goepp, A; Maria, B; Stampf, F | 1 |
| Costoff, A; Mills, TM; Ogle, TF | 1 |
| Chaouat, G; Kinsky, R; Szekeres-Bartho, J; Varga, P | 1 |
| Brooks, J; Holland, P; Kelly, R | 1 |
| Baird, DT; Rodger, MW | 3 |
| Bischof, P; Herrmann, WL; Schindler, AM; Sizonenko, PC; Wyss, R | 1 |
| Hull, M; Kenigsberg, D; Porte, J; Spitz, IM | 1 |
| Schaison, G | 1 |
| Grimes, DA; Lacarra, M; Mishell, DR; Shoupe, D | 1 |
| Bischof, P; Herrmann, WL; Sizonenko, MT | 1 |
| Bischof, P; Cedard, L; Germain, G | 1 |
| Buckshee, K; Hingorani, V; Kumar, S; Malhotra, U; Saraya, L; Sunesh, K | 1 |
| Hodgen, GD; Sinosich, MJ; Williams, RF; Wolf, JP | 1 |
| Fukuma, K; Kawano, T; Okamura, H; Tajima, C; Yamamoto, S | 1 |
| Slappendel, EJ; Uilenbroek, JT; van der Schoot, P | 1 |
| Dubois, C; Silvestre, L; Ulmann, A | 1 |
| Andreu, G; Autran, B; Chaouat, G; Debre, P; Denver, L; Szekeres-Bartho, J | 1 |
| Dietl, J; Hirsch, HA; Neeser, E | 1 |
| Maria, B; Soudre, G; Stampf, F | 1 |
| Najbauer, J; Szekeres-Bartho, J; Tigyi, GJ | 1 |
| Wu, XR; Yang, XL | 2 |
| Breuiller, M; el Alj, A; Ferre, F; Germain, G; Jolivet, A | 1 |
| Gaillard-Moguilewsky, M; Hardy, M; Nédélec, L; Nique, F; Philibert, D; Tournemine, C | 1 |
| Carol, W; Klinger, G | 1 |
| Maria, B; Stampf, F | 2 |
| Armbruster, M | 1 |
| Carrizo, DG; Deis, RP; Jahn, GA | 1 |
| Kerrigan, P | 1 |
| Lin, ZM; Liu, GM; Qian, YX; Shen, PJ; Shen, QC; Xu, RY | 1 |
| Belsey, EM; Bygdeman, M; Kovacs, L; Swahn, ML; Ugocsai, G; Van Look, PF | 1 |
| Baird, DT; Logan, AF; Rodger, MW | 1 |
| Heyns, A; Moodley, J; Norman, RJ; Padayachi, T | 2 |
| Menashe, Y; Serr, DM; Shalev, J | 1 |
| Mishell, DR; Shoupe, D; Sitruk-Ware, R; Spitz, IM | 1 |
| Kuttenn, F | 1 |
| Guyer, RL; Koshland, DE | 1 |
| De Grandi, P; Giudici, G | 1 |
| Bischof, P; Cédard, L; Germain, G; Mignot, T; Mouren, M | 1 |
| Zheng, SR | 1 |
| Dubois, C; Ulmann, A | 2 |
| Champion, J; Sperandeo, D | 1 |
| Haisenleder, DJ; Lee, LR; Marshall, JC; Smith, MS | 1 |
| Piiroinen, O; Pulkkinen, MO; Vainikka, J | 1 |
| Bohn, H; Chapman, MG; Chard, T; Grudzinskas, JG; Holly, JM; Howell, RJ; Olajide, F; Wass, JA | 1 |
| Okada, H; Sasaki, J; Yamamoto, T | 1 |
| Psychoyos, A | 1 |
| Capetola, RJ; Hahn, DW; Heap, RB; McGuire, JL; Taussig, MJ; Wang, MW | 1 |
| Willems, F | 1 |
| Chard, T; Grudzinskas, G; Howell, RJ; Olajide, F; Teisner, B | 1 |
| Arai, K; Arakawa, S; Kambegawa, A; Kobayashi, M; Okinaga, S; Tsujii, T | 1 |
| Hendrickx, AG; Lasley, BL; Owiti, GE; Tarantal, AF | 1 |
| Crystal-Kirk, D | 1 |
| Katayama, K; Mochizuki, M; Yamabe, S | 1 |
| Dahm, D | 1 |
| Fujimoto, S; Kobamatsu, Y; Makinoda, S; Mikuni, M; Nakajin, K; Negishi, H; Okuda, T; Sogame, M; Tabata, M | 1 |
| Alfthan, H; Kääriäinen, M; Lähteenmäki, P; Rapeli, T; Ylikorkala, O | 2 |
| Agoestina, T | 1 |
| Baulieu, EE; Philibert, D; Ulmann, A | 1 |
| Baulieu, EE; Bouvier D'Yvoire, M; Cabrol, D; Cedard, L; Mermet, E; Sureau, C | 1 |
| Frydman, R; Taylor, S; Ulmann, A | 1 |
| Anderson, TL; Baulieu, EE; Hodgen, GD; Sinosich, M; Ulmann, A; Wolf, JP | 1 |
| Baulieu, EE; Gouézou, M; Le Goascogne, C; Robel, P; Sananès, N | 1 |
| Bahzad, C; Templeton, AA; Urquhart, DR | 1 |
| Henrion, R | 1 |
| Billardon, C; Bure, J; Errasfa, M; Fradin, A; Junien, JL; Rothhut, B; Russo-Marie, F | 1 |
| Hartwig, W | 1 |
| Goldfien, AC; Jacobson, L; Lykins, D; Riemer, RK; Roberts, JM; Siiteri, PK | 1 |
| Baulieu, EE; Ulmann, A | 2 |
| Garfield, RE | 1 |
| Haspels, AA; van Santen, MR | 2 |
| Baulieu, EE; Dubois, C; Ulmann, A | 1 |
| Fernandez, H; Frydman, R; Pons, JC; Ulmann, A | 1 |
| Bygdeman, M; Van Look, PF | 1 |
| Hodgen, GD; van Uem, JF | 1 |
| Kelly, RW | 1 |
| Jost, A | 1 |
| Aubeny, E; Baulieu, EE; Dubois, C; Elia, D; Jourdan, MC; Leton, M; Ulmann, A; Van den Bosch, MC | 1 |
| Olson, DM; Potestio, FA; Zakar, T | 1 |
| Den, K; Ohtani, K; Sakamoto, H; Satoh, N; Takagi, S; Takahashi, T | 1 |
| Fukuma, K; Katabuchi, H; Kawano, T; Okamura, H; Tajima, C | 1 |
| Christensen, NJ; Rådestad, A; Strömberg, L | 1 |
| Batten, BE; Kim, MH; Roh, SI | 1 |
| Brunerie, J; Dubois, C; Durlot, F; Frydman, R | 1 |
| Baird, DT; Cameron, IT; Roberts, I; Rodger, M | 1 |
| Batten, BE; Friedman, CI; Kim, MH; Roh, SI | 1 |
| Croxatto, HB; Fuentealba, B; Nieto, M | 3 |
| Birgerson, L; Odlind, V | 2 |
| Cooke, ID; Dockery, P; Lenton, EA; Li, TC; Rogers, AW | 1 |
| Den, K; Ohtani, K; Sakamoto, H; Suzuki, H; Takagi, S; Takahashi, T | 1 |
| Goepp, A; Maria, B; Stampf, F; Ulmann, A | 1 |
| Dubois, C; Fan, HM; Gao, J; Han, ZB; Meng, U; Qiao, GM; Wu, ME; Wu, YM; Yao, GZ; Zheng, SR | 1 |
| Loriaux, DL; Nieman, LK | 1 |
| Badoc, E; Boulot, P; Hedon, B; Huet, JM; Laffargue, F; Lafont, L; Viala, JL | 1 |
| Couzinet, B; Schaison, G | 1 |
| Baulieu, EE; Garfield, RE | 1 |
| Dubois, C; Philibert, D; Ulmann, A | 1 |
| Baird, DT; Cameron, IT | 1 |
| Gauthier, Y; Schneider, W; Shyamala, G | 1 |
| Anderson, TL; Baulieu, EE; Chillik, CF; Hodgen, GD; Itskovitz, J; Ulmann, A; Weyman, D; Wolf, JP | 1 |
| Cook, MJ; Haluska, GJ; Novy, MJ; Stanczyk, FZ | 1 |
| Mills, TM; Nosek, TM; Ogle, TF | 1 |
| Croxatto, HB; Fernández, O; Roblero, LS | 1 |
| Kelly, RW; Smith, SK | 1 |
| Beier, S; Chwalisz, K; Elger, W; Fähnrich, M; Qing, SS | 1 |
| Beier, S; Chwalisz, K; Elger, W; Fähnrich, M; Hasan, SH; Henderson, D; Neef, G; Rohde, R | 1 |
| Shapiro, BS | 1 |
| Atger, M; Milgrom, E; Misrahi, M | 1 |
| Prapas, I; Psychoyos, A | 1 |
| Djiane, J; Houdebine, LM; Jahn, GA | 1 |
| Baulieu, EE; Garfield, RE; Gasc, JM | 1 |
| Brenner, PF; Mishell, DR; Shoupe, D; Spitz, IM | 1 |
| Baulieu, EE; Couzinet, B; Le Strat, N; Schaison, G; Ulmann, A | 1 |
| Crowley, WF | 1 |
| Dacquin, G; De Brux, J; Henry-Suchet, J; Loffredo, V; Loysel, T; Paris, FX; Pez, JP; Roger, M; Tesquier, L | 1 |
| Baulieu, E | 1 |
| Baird, DT; Cameron, IT; Michie, AF | 1 |
| Aedo, AR; Bygdeman, M; Cekan, SZ; Swahn, ML; Wang, G | 1 |
| Baulieu, EE; Bosc, MJ; Germain, G; Mouren, M; Nicolle, A; Philibert, D | 1 |
| Fraser, HM; Healy, DL | 1 |
| De Brux, J; Henry-Suchet, J; Loffredo, V; Loysel, T; Paris, FX; Pez, JP; Roger, M; Tesquier, L | 1 |
| Haspels, AA; Vervest, HA | 1 |
| Graff, P; Herrmann, WL; Obradovic, D; Schindler, AM; Wyss, R; Zanon, P | 1 |
285 review(s) available for mifepristone and Pregnancy
| Article | Year |
|---|---|
Medical Induction for Mid trimester Abortion: A Hospital-based Descriptive Cross-sectional Study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Cross-Sectional Studies; Female; Hospitals; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 2020 |
[Clinical and diagnostic-imaging findings in patellofemoral instability].
Topics: Abortion, Induced; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Research Design | 2021 |
[Control of the level of human chorionic gonadotropin in urine compared to the level of serum after medically provoked abortion is a safe alternative].
Topics: Abortion, Induced; Abortion, Spontaneous; Chorionic Gonadotropin; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2021 |
A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation.
Topics: Antineoplastic Agents, Hormonal; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Fetus; Gene Expression Regulation; Hormone Antagonists; Humans; Immune Tolerance; Mifepristone; Neoplasms; Placenta; Pregnancy; Pregnancy Proteins; Receptors, Progesterone; Signal Transduction; Suppressor Factors, Immunologic; Tumor Microenvironment | 2021 |
Non-surgical management of tubal ectopic pregnancy: A systematic review and meta-analysis.
Topics: Adult; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic; Pregnancy, Tubal; Treatment Outcome | 2021 |
Community-based distribution of misoprostol for early abortion: Outcomes from a program in Sindh, Pakistan.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Delivery of Health Care; Female; Humans; Mifepristone; Misoprostol; Pakistan; Pregnancy | 2022 |
The next two decades of mifepristone at FDA: History as destiny
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2022 |
Pain management for medical abortion before 14 weeks' gestation.
Topics: Abortion, Induced; Abortion, Spontaneous; Acetaminophen; Female; Humans; Ibuprofen; Mifepristone; Misoprostol; Pain; Pain Management; Pregabalin; Pregnancy | 2022 |
Comparison of vaginal and buccal misoprostol after mifepristone for medication abortion through 70 days of gestation: A retrospective chart review.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Administration, Intravaginal; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Retrospective Studies | 2022 |
Selective progesterone receptor modulators and reproductive health.
Topics: Female; Hormone Antagonists; Humans; Mifepristone; Pregnancy; Progesterone; Receptors, Progesterone; Reproductive Health | 2022 |
Labour induction for termination of pregnancy with severe fetal anomalies after 24 weeks' gestation: a case series and systematic review of the literature.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Gestational Age; Humans; Infant; Labor, Induced; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2022 |
Toxicity of abortifacients: A review for physicians in the post roe era.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Physicians; Pregnancy; United States | 2022 |
Second-trimester abortion care for those with complex medical conditions.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Placenta Accreta; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second | 2022 |
Pain management for medical abortion before 14 weeks' gestation: A systematic review.
Topics: Female; Humans; Ibuprofen; Mifepristone; Misoprostol; Observational Studies as Topic; Pain; Pain Management; Pregnancy | 2022 |
First Trimester Miscarriage.
Topics: Abortion, Spontaneous; Cost-Benefit Analysis; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 2022 |
Whole course of treatment of autoimmune progesterone dermatitis that had spontaneously resolved during pregnancy: A case report and review of the literature.
Topics: Autoimmune Diseases; Contraceptive Agents; Dermatitis; Female; Humans; Mifepristone; Pregnancy; Progesterone | 2022 |
[Medical strategy for abortions between 14 and 16 weeks of gestation].
Topics: Abortion, Induced; Administration, Intravaginal; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy | 2022 |
The efficacy of mifepristone combined with methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis.
Topics: Abdominal Pain; Female; Humans; Methotrexate; Mifepristone; Multicenter Studies as Topic; Pregnancy; Pregnancy, Ectopic | 2022 |
Medical Abortion before Confirmed Intrauterine Pregnancy: A Systematic Review.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Ectopic | 2022 |
No-Test Medication Abortion: A Systematic Review.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Infant; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Ectopic | 2023 |
Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature.
Topics: Abortion, Induced; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Cholestasis; Cushing Syndrome; Female; Humans; Middle Aged; Mifepristone; Pregnancy | 2023 |
Toxicities of herbal abortifacients.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2023 |
Effectiveness of treatment options for tubal ectopic pregnancy: A systematic review and network meta-analysis.
Topics: Female; Humans; Methotrexate; Mifepristone; Network Meta-Analysis; Pregnancy; Pregnancy, Ectopic; Prostaglandins | 2024 |
Effectiveness and safety of misoprostol-only for first-trimester medication abortion: An updated systematic review and meta-analysis.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2023 |
Early pregnancy loss medical management in clinical practice.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Cicatrix; Female; Humans; Mifepristone; Misoprostol; Multicenter Studies as Topic; Pregnancy; Pregnancy, Ectopic; Retrospective Studies | 2023 |
Cervical preparation for second-trimester procedural abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 2023 |
Fertility preservation in pregnant cancer patients after first-trimester abortion: a new challenge with possible solutions.
Topics: Cryopreservation; Female; Fertility Preservation; Humans; Mifepristone; Neoplasms; Ovulation Induction; Pregnancy; Pregnancy Trimester, First; Progesterone | 2023 |
Add-on effect of Guizhi Fuling formula to mifepristone for endometriosis: A meta-analysis of randomized controlled trials.
Topics: Drug Therapy, Combination; Drugs, Chinese Herbal; Endometriosis; Female; Humans; Mifepristone; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
First trimester termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pain Management; Pregnancy; Pregnancy Trimester, First; Vacuum Extraction, Obstetrical | 2020 |
Management of pain associated with up-to-9-weeks medical termination of pregnancy (MToP) using mifepristone-misoprostol regimens: expert consensus based on a systematic literature review.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Anti-Inflammatory Agents, Non-Steroidal; Consensus; Female; Humans; Ibuprofen; Mifepristone; Misoprostol; Pain Management; Pain Measurement; Pregnancy; Pregnancy Trimester, First | 2020 |
A systematic review of the effectiveness, safety, and acceptability of medical management of intrauterine fetal death at 14-28 weeks of gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Dose-Response Relationship, Drug; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic | 2019 |
Reconceptualizing safe abortion and abortion services in the age of abortion pills: A discussion paper.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Contraception; Delivery of Health Care; Female; Health Personnel; Humans; Mifepristone; Misoprostol; Pregnancy; Women's Health Services | 2020 |
Twelve years after abortion decriminalization in Mexico City: Can we still remain an island of liberties?
Topics: Abortion, Induced; Abortion, Legal; Adolescent; Contraception, Postcoital; Female; Health Policy; Health Services Accessibility; Humans; Mexico; Mifepristone; Misoprostol; Pregnancy; Reproductive Rights; Vacuum Curettage; Women's Rights | 2020 |
Self-managed abortion.
Topics: Abortion, Induced; Abortion, Legal; Female; Health Policy; Health Services Accessibility; Humans; Internet; Mifepristone; Misoprostol; Patient Safety; Pregnancy; Self-Management; Telemedicine; United States | 2019 |
Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses.
Topics: Abortifacient Agents; Abortion, Induced; Ambulatory Care; Diagnostic Self Evaluation; Female; Humans; Mifepristone; Misoprostol; Patient Compliance; Patient Preference; Patient Satisfaction; Pregnancy; Pregnancy Tests; Pregnancy Trimester, First; Surveys and Questionnaires; Telephone; Text Messaging; Treatment Outcome; Ultrasonography | 2020 |
Society of Family Planning clinical recommendations: Cervical preparation for dilation and evacuation at 20-24 weeks' gestation.
Topics: Abortifacient Agents; Abortion, Induced; Cervix Uteri; Extraction, Obstetrical; Family Planning Services; Female; Humans; Labor Stage, First; Laminaria; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Preoperative Care; Societies, Medical | 2020 |
Simultaneous compared to interval administration of mifepristone and misoprostol for medical abortion up to 10
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy | 2020 |
Long-acting reversible contraception immediately after medical abortion: systematic review with meta-analyses.
Topics: Abortion, Induced; Female; Humans; Intrauterine Devices; Long-Acting Reversible Contraception; Mifepristone; Postoperative Care; Pregnancy; Pregnancy, Unplanned; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2020 |
Self-administered versus provider-administered medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Patient Safety; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic | 2020 |
Complications of Unsafe and Self-Managed Abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Adult; Diagnosis, Differential; Female; Health Policy; Humans; Mifepristone; Misoprostol; Pregnancy; Self-Management; United States | 2020 |
Trends in medication abortion provision before and after the introduction of mifepristone: A study of the National Abortion Federation's Canadian member services.
Topics: Abortion, Induced; Abortion, Spontaneous; Canada; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2020 |
Women's voices and medical abortions: A review of the literature.
Topics: Abortifacient Agents; Abortion, Induced; Female; Health Services Accessibility; Humans; Mifepristone; Misoprostol; Patient Preference; Pregnancy; Pregnant Women; Qualitative Research | 2020 |
Medication to Manage Abortion and Miscarriage.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy | 2020 |
Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2020 |
Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Developing Countries; Female; Humans; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Treatment Outcome | 2020 |
Expulsion at home for early medical abortion: A systematic review with meta-analyses.
Topics: Abortifacient Agents; Abortion, Induced; Female; Gestational Age; Home Care Services; Humans; Mifepristone; Misoprostol; Pregnancy | 2021 |
Different dosing intervals of mifepristone-misoprostol for second-trimester termination of pregnancy: A meta-analysis and systematic review.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic | 2021 |
Cervical priming before surgical abortion up to 13
Topics: Abortion, Induced; Cervix Uteri; England; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Randomized Controlled Trials as Topic | 2020 |
Cervical priming before surgical abortion between 14 and 24 weeks: a systematic review and meta-analyses for the National Institute for Health and Care Excellence-new clinical guidelines for England.
Topics: Abortion, Induced; Cervix Uteri; England; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2021 |
Cochrane Review Summaries-April 2021.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Randomized Controlled Trials as Topic; Self Administration | 2021 |
Methods for managing miscarriage: a network meta-analysis.
Topics: Abortion, Incomplete; Abortion, Missed; Abortion, Spontaneous; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Network Meta-Analysis; Oxytocics; Placebos; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Suction; Vacuum Curettage; Watchful Waiting | 2021 |
Termination of pregnancy services in Irish general practice from January 2019 to June 2019.
Topics: Abortion, Induced; Adult; Child; Contraception; Female; General Practice; Gestational Age; Humans; Mifepristone; Pregnancy; Retrospective Studies | 2021 |
A research agenda for moving early medical pregnancy termination over the counter.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Approval; Drug Therapy, Combination; Female; Health Knowledge, Attitudes, Practice; Humans; Mifepristone; Misoprostol; Nonprescription Drugs; Pregnancy; Pregnancy Trimester, First; United States; United States Food and Drug Administration | 2017 |
Interventions for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Drug Administration Schedule; Estradiol; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Mifepristone; Norpregnadienes; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Unsafe Sex | 2017 |
Development of medical termination of pregnancy: a review.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Treatment Outcome | 2017 |
Update on second trimester medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Operative Time; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic | 2017 |
Efficacy of medical abortion prior to 6 gestational weeks: a systematic review.
Topics: Abortifacient Agents; Abortion, Induced; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Observational Studies as Topic; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |
Selective progesterone receptor modulators: current applications and perspectives.
Topics: Abortion, Induced; Endometriosis; Female; Humans; Leiomyoma; Mifepristone; Norpregnadienes; Pregnancy; Progesterone; Receptors, Progesterone; Uterine Hemorrhage; Uterine Neoplasms | 2018 |
Low-sensitivity urine pregnancy testing to assess medical abortion outcome: A systematic review.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Tests; Treatment Failure | 2018 |
Providing Abortion Services in the Primary Care Setting.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Communication; Counseling; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Primary Health Care; Women's Health | 2018 |
Interventions for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Drug Administration Schedule; Estradiol; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Mifepristone; Norpregnadienes; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Unsafe Sex | 2019 |
Management of first-trimester miscarriage: a systematic review and network meta-analysis.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Network Meta-Analysis; Pregnancy; Pregnancy Trimester, First; Vacuum Curettage | 2019 |
Adjunctive Agents for Cervical Preparation in Second Trimester Surgical Abortion.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Cervix Uteri; Dilatation; Extraction, Obstetrical; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Preoperative Care | 2019 |
Medical treatment for early fetal death (less than 24 weeks).
Topics: Delivery, Obstetric; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Oxytocics; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic | 2019 |
Therapy Aimed to Suppress the Production of the Immunosuppressive Protein Progesterone Induced Blocking Factor (PIBF) May Provide Palliation and/or Increased Longevity for Patients With a Variety of Different Advanced Cancers - A Review.
Topics: Animals; Female; Hormone Antagonists; Humans; Killer Cells, Natural; Longevity; Mifepristone; Neoplasms; Palliative Care; Placenta; Pregnancy; Pregnancy Proteins; Progesterone; Progestins; Receptors, Progesterone; Suppressor Factors, Immunologic | 2019 |
Current and potential methods for second trimester abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Dilatation; Female; Humans; Mifepristone; Misoprostol; Pain, Postoperative; Pregnancy; Pregnancy Trimester, Second | 2020 |
Online access to abortion medications: a review of utilization and clinical outcomes.
Topics: Abortifacient Agents; Abortion, Induced; Female; Health Services Accessibility; Humans; Internet; Maternal Mortality; Mifepristone; Misoprostol; Pregnancy; Quality of Health Care; Telemedicine | 2020 |
Medical methods for cervical ripening before the removal of intrauterine devices in postmenopausal women: a systematic review.
Topics: Abortifacient Agents; Cervical Ripening; Device Removal; Estradiol; Female; Humans; Intrauterine Devices; Mifepristone; Misoprostol; Postmenopause; Pregnancy; Randomized Controlled Trials as Topic | 2013 |
Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods: release date June 2013 SFP guideline #20133.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Fetal Death; Gestational Age; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 2013 |
Mifepristone-misoprostol dosing interval and effect on induction abortion times: a systematic review.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 2013 |
The unique pharmacological characteristics of mifepristone (RU486): from terminating pregnancy to preventing cancer metastasis.
Topics: Abortifacient Agents, Steroidal; Abortion, Therapeutic; Female; Humans; Liver; Mifepristone; Neoplasm Metastasis; Pregnancy; Pregnancy Complications, Neoplastic | 2014 |
Controversies in family planning: pregnancy termination in women with uterine anatomic abnormalities.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Family Planning Services; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Uterus | 2014 |
[Advantages by medical abortions at home in the first trimester].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Denmark; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Self Administration | 2014 |
An overview of medical abortion for clinical practice.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Aftercare; Chorionic Gonadotropin; Counseling; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Ultrasonography, Prenatal | 2014 |
Pain during medical abortion, the impact of the regimen: a neglected issue? A review.
Topics: Abortion, Induced; Adult; Analgesics; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pain; Pain Management; Pain Measurement; Pregnancy; Prospective Studies | 2014 |
Second-trimester postabortion care for ruptured membranes, fetal demise, and incomplete abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Incomplete; Aftercare; Cohort Studies; Female; Fetal Death; Fetal Membranes, Premature Rupture; Humans; Mifepristone; Misoprostol; Oxytocics; Oxytocin; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic | 2015 |
Continuing pregnancy after mifepristone and "reversal" of first-trimester medical abortion: a systematic review.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Female; Gestational Age; Humans; Mifepristone; Patient Preference; Pregnancy; Pregnancy Trimester, First; Progesterone; Randomized Controlled Trials as Topic | 2015 |
Outpatient medical abortion is safe and effective through 70 days gestation.
Topics: Abortifacient Agents; Abortion, Induced; Ambulatory Care; Female; Gestational Age; Humans; Menstruation; Mifepristone; Misoprostol; Pregnancy; Time Factors; United States | 2015 |
Doctors or mid-level providers for abortion.
Topics: Abortifacient Agents; Abortion, Legal; Abortion, Therapeutic; Allied Health Personnel; Clinical Competence; Cohort Studies; Female; Humans; Midwifery; Mifepristone; Misoprostol; Nurses; Nursing Assistants; Observational Studies as Topic; Physician Assistants; Physicians; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Vacuum Curettage | 2015 |
Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Buccal; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2015 |
Update on medical abortion: simplifying the process for women.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Directive Counseling; Female; Humans; Mifepristone; Misoprostol; Pregnancy; United States; Women's Health | 2015 |
Induction of labor--pharmacology methods.
Topics: Adult; Cervix Uteri; Drug Delivery Systems; Female; Humans; Labor, Induced; Mifepristone; Nitric Oxide Donors; Oxytocics; Oxytocin; Practice Guidelines as Topic; Pregnancy; Pregnancy Outcome; Prostaglandins | 2015 |
The added value of mifepristone to non-surgical treatment regimens for uterine evacuation in case of early pregnancy failure: a systematic review of the literature.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2015 |
Acute trophoblastic pulmonary embolism during conservative treatment of placenta accreta: case report and review of literature.
Topics: Female; Humans; Hysteroscopy; Mifepristone; Placenta Accreta; Pregnancy; Pulmonary Embolism; Uterine Artery Embolization; Young Adult | 2015 |
Emergency contraception: Focus on the facts.
Topics: Contraception; Contraception, Postcoital; Contraceptives, Oral, Hormonal; Cyclooxygenase Inhibitors; Female; Health Services Accessibility; Humans; Intrauterine Devices; Levonorgestrel; Meloxicam; Mifepristone; Norpregnadienes; Ovulation Inhibition; Pregnancy; Thiazines; Thiazoles | 2016 |
Mifepristone (Mifeprex) label changes.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Administration, Intravaginal; Administration, Oral; Animals; Drug Labeling; Female; Humans; Mifepristone; Pregnancy | 2016 |
Update on second-trimester surgical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Observational Studies as Topic; Osmosis; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2016 |
Medical liability insurance as a barrier to the provision of abortion services in family medicine.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Actuarial Analysis; Family Practice; Female; Health Policy; Health Services Accessibility; Humans; Insurance Claim Review; Insurance Coverage; Insurance, Liability; Liability, Legal; Malpractice; Mifepristone; Patient Advocacy; Physician's Role; Pregnancy; Primary Health Care; Professional Autonomy; United States | 2008 |
Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 2008 |
Complications after second trimester surgical and medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Dilatation and Curettage; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 2008 |
Medical management of early pregnancy failure: efficacy.
Topics: Abortifacient Agents; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
Rupture of uterus in the first trimester during medical termination of pregnancy for exomphalos using mifepristone/misoprostol.
Topics: Abdominal Pain; Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Intravaginal; Administration, Oral; Adult; Drug Therapy, Combination; Female; Fetal Diseases; Hernia, Umbilical; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Ultrasonography; Uterine Rupture | 2008 |
Medication abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Counseling; Dilatation and Curettage; Drug Approval; Female; Global Health; Humans; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Patient Selection; Pregnancy | 2009 |
Second-trimester induction of labor.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Dilatation; Drug Therapy, Combination; Female; Gynecologic Surgical Procedures; Humans; Maternal Mortality; Mifepristone; Misoprostol; Pain, Postoperative; Pregnancy; Pregnancy Trimester, Second | 2009 |
Emergency contraception, efficacy and public health impact.
Topics: Contraception, Postcoital; Contraceptives, Postcoital, Synthetic; Female; Health Services Accessibility; Humans; Mifepristone; Pregnancy; Pregnancy, Unplanned; Public Health; Treatment Outcome; United States | 2009 |
Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Pregnancy; Randomized Controlled Trials as Topic | 2009 |
Mifepristone for induction of labour.
Topics: Female; Humans; Labor Stage, First; Labor, Induced; Mifepristone; Oxytocics; Pregnancy; Progesterone; Randomized Controlled Trials as Topic | 2009 |
Mifepristone: ten years later.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy | 2010 |
Mifepristone: pharmacology and clinical impact in reproductive medicine, endocrinology and oncology.
Topics: Abortifacient Agents, Steroidal; Drug Approval; Drug Delivery Systems; Drug Design; Endocrinology; Female; Humans; Medical Oncology; Mifepristone; Pregnancy; Pregnancy Complications, Neoplastic; Reproductive Medicine; Uterine Neoplasms | 2010 |
Cervical preparation for first trimester surgical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Cervical Ripening; Dinoprost; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2010 |
Flexible mifepristone and misoprostol administration interval for first-trimester medical termination.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Meta-Analysis as Topic; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Medical and surgical options for induced abortion in first trimester.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Anesthesia, Obstetrical; Female; Humans; Mifepristone; Misoprostol; Patient Preference; Pregnancy; Pregnancy Trimester, First; Vacuum Curettage | 2010 |
Ectopic pregnancy and emergency contraceptive pills: a systematic review.
Topics: Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Mifepristone; Pregnancy; Pregnancy, Ectopic | 2010 |
Cervical preparation for second trimester dilation and evacuation.
Topics: Abortifacient Agents; Abortion, Induced; Cervix Uteri; Extraction, Obstetrical; Female; Humans; Labor Stage, First; Laminaria; Mifepristone; Misoprostol; Osmosis; Polymers; Pregnancy; Pregnancy Trimester, Second; Preoperative Care; Prostaglandins | 2010 |
Mifepristone: where do we come from and where are we going? Clinical development over a quarter of a century.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Animals; Antineoplastic Agents, Hormonal; Contraceptives, Postcoital, Synthetic; Female; Genital Diseases, Female; Humans; Mifepristone; Pregnancy; Receptors, Progesterone; Women's Health | 2010 |
Use of mifepristone to treat endometriosis: a review of clinical trials and trial-like studies conducted in China.
Topics: China; Clinical Trials as Topic; Endometriosis; Female; Humans; Mifepristone; Pregnancy | 2011 |
Medical methods for mid-trimester termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Prostaglandins A; Randomized Controlled Trials as Topic | 2011 |
Expanding medical abortion: can medical abortion be effectively provided without the routine use of ultrasound?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Ultrasonography, Prenatal | 2011 |
Introduction and provision of medical abortion: a tale of two countries in which technology is necessary but not sufficient.
Topics: Abortion, Induced; Female; France; Humans; Mifepristone; Misoprostol; Pregnancy; United States | 2011 |
Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Ambulatory Care Facilities; Comparative Effectiveness Research; Drug Therapy, Combination; Female; Home Care Services; Humans; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Prospective Studies; Young Adult | 2011 |
Mifepristone in combination with prostaglandins for termination of 10-16 weeks' gestation: a systematic review.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Carboprost; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Prostaglandins; Randomized Controlled Trials as Topic | 2011 |
Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate (Rivanol®): a systematic review of Chinese trials.
Topics: Abortifacient Agents; Abortion, Induced; China; Ethacridine; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic | 2011 |
Medical methods for first trimester abortion.
Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Randomized Controlled Trials as Topic; Tamoxifen | 2011 |
Medical therapy (methotrexate and mifepristone) alone or in combination with another type of therapy for the management of cervical or interstitial ectopic pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adolescent; Adult; Cervix Uteri; Dilatation and Curettage; Female; Humans; Methotrexate; Mifepristone; Myometrium; Pregnancy; Pregnancy Trimester, First; Pregnancy, Ectopic; Spain; Uterine Artery Embolization; Young Adult | 2012 |
First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review.
Topics: Abortifacient Agents; Abortion, Induced; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Treatment Failure | 2013 |
Emergency contraception: separating fact from fiction.
Topics: Abortion, Induced; Contraception, Postcoital; Counseling; Crime Victims; Female; Hospitals; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Nonprescription Drugs; Norpregnadienes; Obesity; Practice Patterns, Physicians'; Pregnancy; Pregnancy, Unplanned; Sex Offenses; United States | 2012 |
A review of evidence for safe abortion care.
Topics: Abortifacient Agents; Abortion, Induced; Analgesia, Obstetrical; Antibiotic Prophylaxis; Female; Gestational Age; Humans; Maternal Death; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome; Ultrasonography, Prenatal; Vacuum Curettage; World Health Organization | 2013 |
The mifepristone-misoprostol regimen for early medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Self Administration | 2001 |
Emergency contraception.
Topics: Age Factors; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Contraindications; Drug Combinations; Drug Interactions; Drug Prescriptions; Emergencies; Female; Fetus; Humans; Intrauterine Devices; Jurisprudence; Mifepristone; Nausea; Pregnancy; Pregnancy Tests; Pregnancy, Unwanted; Smoking; Time Factors; Vomiting | 2002 |
Options for early therapeutic abortion: a comparative review.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Alprostadil; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy, Ectopic; Randomized Controlled Trials as Topic; Treatment Outcome; Vacuum Curettage | 2002 |
[Spontaneous abortions of first trimester pregnancy: is uterine aspiration still in line?].
Topics: Abortifacient Agents; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Vacuum Extraction, Obstetrical | 2002 |
Pharmacoeconomics of medical abortion: a review of cost in the United States, Europe and Asia.
Topics: Abortion, Induced; Adolescent; Adult; Asia; Costs and Cost Analysis; Economics, Pharmaceutical; Europe; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; United States | 2003 |
Methods for cervical ripening and induction of labor.
Topics: Cervical Ripening; Cervix Uteri; Dinoprostone; Female; Hormone Antagonists; Humans; Labor, Induced; Mifepristone; Misoprostol; Oxytocics; Pregnancy; Randomized Controlled Trials as Topic; Uterine Contraction | 2003 |
Prostaglandins for first-trimester termination.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Alprostadil; Cervical Ripening; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Tests; Pregnancy Trimester, First; Prostaglandins, Synthetic; Self Administration | 2003 |
Low dose hormone therapy in reproductive endocrinology in China.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Androgen Antagonists; Contraceptives, Oral; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Hormones; Humans; Mifepristone; Norpregnenes; Pregnancy | 2003 |
Current medical abortion care.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Contraceptives, Postcoital, Synthetic; Female; Humans; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Patient Education as Topic; Pregnancy; Sexual Behavior; Treatment Outcome; United States; Women's Health | 2003 |
Progesterone antagonists and progesterone receptor modulators: an overview.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Depression; Dimerization; Female; Glucocorticoids; Hormone Antagonists; Humans; Logistic Models; Mifepristone; Models, Biological; Myoma; Pregnancy; Progesterone; Receptors, Progesterone | 2003 |
Antiprogestins as a model for progesterone withdrawal.
Topics: Decidua; Embryo Implantation; Endometrium; Female; Hormone Antagonists; Humans; Luteal Phase; Menstruation; Mifepristone; Models, Biological; Pregnancy; Progesterone; Progestins; Receptors, Vascular Endothelial Growth Factor; Up-Regulation | 2003 |
Synergistic effects of antiprogestins and iNOS or aromatase inhibitors on establishment and maintenance of pregnancy.
Topics: Animals; Aromatase Inhibitors; Embryo Implantation; Enzyme Inhibitors; Estrogens; Female; Hormone Antagonists; Humans; Immunohistochemistry; Letrozole; Mifepristone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitriles; Pregnancy; Progestins; Rats; Time Factors; Triazoles | 2003 |
Levonorgestrel and mifepristone in emergency contraception.
Topics: Clinical Trials as Topic; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Mifepristone; Pregnancy; Pregnancy Rate; Pregnancy, Unwanted; Random Allocation; Time Factors | 2003 |
[Induction of labour: which method to use?].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adrenal Cortex Hormones; Alprostadil; Catheterization; Dinoprostone; Estrogens; Female; Humans; Interleukin-8; Labor, Induced; Mifepristone; Oxytocin; Pregnancy; Prostaglandins; Relaxin | 2003 |
Combined estimates of effectiveness of mifepristone 10 mg in emergency contraception.
Topics: Adult; Contraceptives, Oral; Contraceptives, Postcoital, Synthetic; Female; Humans; Mifepristone; Pregnancy; Randomized Controlled Trials as Topic; Time Factors | 2003 |
Meta-analyses of randomized trials comparing different doses of mifepristone in emergency contraception.
Topics: Adult; Contraceptives, Oral; Contraceptives, Postcoital, Synthetic; Dose-Response Relationship, Drug; Female; Humans; Mifepristone; Pregnancy; Randomized Controlled Trials as Topic | 2003 |
Differences in efficacy, differences in providers: results from a hazard analysis of medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Age Factors; Educational Status; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Proportional Hazards Models; Risk Factors; Socioeconomic Factors; Treatment Outcome | 2004 |
Medical abortion with mifepristone: an update.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Counseling; Female; Humans; Mifepristone; Pregnancy | 2003 |
Medical methods for first trimester abortion.
Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Tamoxifen | 2004 |
Induced abortion: an overview for internists.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Costs and Cost Analysis; Female; Humans; Internal Medicine; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Referral and Consultation; Socioeconomic Factors; United States | 2004 |
Medical methods for first trimester abortion.
Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Randomized Controlled Trials as Topic; Tamoxifen | 2004 |
Emerging drugs for endometriosis.
Topics: Adult; Animals; Anti-Inflammatory Agents; Aromatase Inhibitors; Contraceptives, Oral, Hormonal; Cytokines; Danazol; Endometriosis; Estradiol; Estrogen Receptor Modulators; Female; Gestrinone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Hormone Replacement Therapy; Humans; Infertility, Female; Levonorgestrel; Mifepristone; Ovary; Ovulation; Pregnancy; Progestins; Randomized Controlled Trials as Topic | 2004 |
Medical methods for first-trimester abortion.
Topics: Abortifacient Agents; Abortion, Induced; Alprostadil; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Tamoxifen; Treatment Outcome | 2004 |
Care for women choosing medication abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Decision Making; Female; Humans; Mifepristone; Patient Education as Topic; Pregnancy; Uterine Hemorrhage | 2004 |
[Present and potential uses of mifepristone in gynecology, obstetrics and other medical specialties].
Topics: Abortifacient Agents, Steroidal; Adult; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Female; Glucocorticoids; Hormone Antagonists; Humans; Luteolytic Agents; Mifepristone; Pregnancy | 2004 |
Mifepristone in abortion care.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; History, 19th Century; History, 20th Century; History, Ancient; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second | 2005 |
Medical termination of pregnancy in the early first trimester.
Topics: Abortifacient Agents; Abortion, Induced; Antimetabolites; Dilatation and Curettage; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins | 2005 |
Novel antiangiogenic agents for use in contraception.
Topics: Angiogenesis Inhibitors; Animals; Contraception; Embryo Implantation; Endometrium; Female; Humans; Macaca mulatta; Mifepristone; Pregnancy; Vascular Endothelial Growth Factor A | 2005 |
Target-oriented anti-implantation approaches for pregnancy interception: experiences in the rhesus monkey model.
Topics: Animals; Contraception; Contraceptives, Postcoital, Synthetic; Embryo Implantation; Female; Macaca mulatta; Mifepristone; Models, Animal; Pregnancy | 2005 |
Pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii.
Topics: Abortifacient Agents; Abortion, Septic; Clostridium Infections; Cytokines; Female; Humans; Immune System; Immunity, Innate; Mifepristone; Pregnancy; Receptors, Glucocorticoid; Shock, Septic | 2005 |
Progesterone-dependent immunomodulation.
Topics: Abortifacient Agents, Steroidal; Animals; Cytokines; Female; Humans; Immunologic Factors; Killer Cells, Natural; Mice; Mifepristone; Pregnancy; Pregnancy Outcome; Pregnancy Proteins; Progesterone; Signal Transduction; Suppressor Factors, Immunologic | 2005 |
[Anti progestins].
Topics: Abortifacient Agents, Steroidal; Animals; Cushing Syndrome; Endometriosis; Female; Gestrinone; Humans; Meningeal Neoplasms; Meningioma; Menstruation; Mifepristone; Organ Specificity; Pregnancy; Progestins | 2006 |
[Study on Meta analysis regarding the acceptability of medical abortion compared with surgical abortion].
Topics: Abortifacient Agents; Abortion, Induced; Choice Behavior; Controlled Clinical Trials as Topic; Female; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Pregnancy, Unwanted | 2006 |
Mifepristone dose in the regimen with misoprostol for medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Dose-Response Relationship, Drug; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2006 |
Studies on uterine contractility following mifepristone and various routes of misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Administration, Sublingual; Delayed-Action Preparations; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Time Factors; Uterine Contraction | 2006 |
Evidence for shortening the time interval of prostaglandin after mifepristone for medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Female; Humans; MEDLINE; Mifepristone; Misoprostol; Pregnancy; Prostaglandins; Randomized Controlled Trials as Topic; Time Factors | 2006 |
A systematic review of more than one dose of misoprostol after mifepristone for abortion up to 10 weeks of gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Gestational Age; Humans; MEDLINE; Mifepristone; Misoprostol; Pregnancy; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
Mifepristone and misoprostol sequential regimen side effects, complications and safety.
Topics: Abortifacient Agents; Abortion, Induced; Animals; Clinical Trials as Topic; Female; Humans; Mifepristone; Misoprostol; Pelvic Infection; Pregnancy; Uterine Hemorrhage | 2006 |
Medical abortion in early pregnancy: experience in China.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; China; Chorionic Gonadotropin; Dinoprost; Female; Gestational Age; History, 20th Century; Humans; Mifepristone; Pregnancy; Uterine Hemorrhage | 2006 |
Review of medical abortion using mifepristone in combination with a prostaglandin analogue.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Analgesia, Obstetrical; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Prostaglandins; Time Factors; Uterine Contraction; Uterine Hemorrhage; World Health Organization | 2006 |
Medical treatment for early fetal death (less than 24 weeks).
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Randomized Controlled Trials as Topic; Ultrasonography, Prenatal | 2006 |
The use of misoprostol for early pregnancy failure.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Ultrasonography, Prenatal | 2006 |
Clinical applications of mifepristone.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Contraceptive Agents; Female; Genital Diseases, Female; Humans; Mifepristone; Pregnancy | 2006 |
[Combined use of methotrexate and mifepristone for ectopic pregnancy management: a meta- analysis].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adult; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
Alternatives to mifepristone for early medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy Trimester, First | 2007 |
Contemporary management of early pregnancy failure.
Topics: Abortifacient Agents; Abortion, Missed; Combined Modality Therapy; Dilatation and Curettage; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Vacuum Extraction, Obstetrical | 2007 |
Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Office Visits; Pregnancy; Ultrasonography | 2007 |
Progesterone withdrawal: key to parturition.
Topics: Animals; Biomarkers; Female; Mifepristone; Myometrium; Parturition; Pregnancy; Pregnancy, Animal; Progesterone; Rabbits; Rats; Receptors, Progesterone; Sensitivity and Specificity; Sheep | 2007 |
Early medical abortion in Cairns, Queensland: July 2006 - April 2007.
Topics: Abortifacient Agents, Steroidal; Abortion, Therapeutic; Drug and Narcotic Control; Drug Prescriptions; Female; Humans; Mifepristone; Pregnancy; Queensland | 2007 |
Surgical versus medical methods for second trimester induced abortion.
Topics: Abortifacient Agents; Abortion, Induced; Dilatation and Curettage; Dinoprost; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic | 2008 |
A review of developments in medical termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Attitude to Health; Choice Behavior; Drug Administration Schedule; Evidence-Based Medicine; Female; Health Services Needs and Demand; Humans; Mifepristone; Misoprostol; Nurse's Role; Nursing Research; Practice Guidelines as Topic; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Time Factors; United Kingdom | 2008 |
[Multiple usages for antiprogestins].
Topics: Abortifacient Agents, Steroidal; Abortion, Therapeutic; Breast Neoplasms; Female; Hormone Antagonists; Humans; Male; Meningeal Neoplasms; Meningioma; Mifepristone; Neoplasms, Hormone-Dependent; Pregnancy; Progestins; Receptors, Progesterone | 1994 |
Mechanism of action of antiprogestins in the pregnant uterus.
Topics: Animals; Embryo Implantation; Female; Gonanes; Humans; In Vitro Techniques; Labor, Obstetric; Mifepristone; Models, Biological; Pregnancy; Primates; Progestins; Prostaglandins; Uterus | 1995 |
Clinical uses of mifepristone (MFP).
Topics: Abortion, Induced; Animals; Cervix Uteri; Clinical Trials as Topic; Contraceptives, Postcoital; Endometriosis; Female; Humans; Hydrocortisone; Labor, Induced; Mifepristone; Misoprostol; Neoplasms; Pregnancy | 1995 |
Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
Topics: Contraceptives, Postcoital; Female; Humans; Mifepristone; Pregnancy | 1993 |
The combined use of prostaglandin and antiprogestin in human fertility control.
Topics: Abortifacient Agents; Abortion, Induced; Contraceptive Agents; Drug Interactions; Female; Fertility; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progestins; Prostaglandins; Uterine Contraction | 1995 |
Pharmacologic stimulation of uterine contraction.
Topics: Clinical Trials as Topic; Drug Administration Routes; Female; Humans; Labor, Induced; Mifepristone; Oxytocin; Pregnancy; Prostaglandins; Uterine Contraction | 1995 |
[RU 486: current and potential indications. Great expectations and strong resistance].
Topics: Abortion, Induced; Breast Neoplasms; Contraceptives, Postcoital, Synthetic; Female; Humans; Labor, Induced; Meningeal Neoplasms; Mifepristone; Ovulation; Pregnancy | 1995 |
Drug therapy during labor and delivery.
Topics: Abortion, Induced; Cervix Uteri; Female; Humans; Labor, Induced; Labor, Obstetric; Mifepristone; Oxytocics; Oxytocin; Postpartum Hemorrhage; Pregnancy; Pregnancy Trimester, Second; Prostaglandins | 1994 |
Prostaglandins and progesterone receptor antagonists in human fertility regulation.
Topics: Abortion, Induced; Australia; Female; Fertility; Health Care Costs; Humans; Mifepristone; Pregnancy; Prostaglandins; Receptors, Progesterone; Women's Health | 1994 |
RU486: a compound that gets itself talked about.
Topics: Abortion, Induced; Abortion, Legal; Attitude to Health; Contraception; Ethics, Medical; Female; France; Humans; Male; Menstruation; Mifepristone; Pregnancy; Receptors, Progesterone; Terminology as Topic | 1994 |
History and perspectives of antiprogestins from the chemist's point of view.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Drug Evaluation, Preclinical; Female; Forecasting; History, 20th Century; Hormone Antagonists; Humans; Infant, Newborn; Mifepristone; Molecular Structure; Pregnancy; Progestins; Rats; Receptors, Glucocorticoid; Receptors, Progesterone; Structure-Activity Relationship | 1994 |
The use of progesterone antagonists in combination with prostaglandin for termination of pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Cervix Uteri; Clinical Trials as Topic; Dinoprostone; Drug Synergism; Female; Humans; Laminaria; Mifepristone; Misoprostol; Multicenter Studies as Topic; Myometrium; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Progesterone; Randomized Controlled Trials as Topic; Uterine Contraction | 1994 |
Effect of mifepristone on inhibition of ovulation and induction of luteolysis.
Topics: Abortion, Induced; Contraceptives, Postcoital; Corpus Luteum Maintenance; Drug Administration Schedule; Endometrium; Female; Follicular Phase; Humans; Luteal Phase; Menstruation-Inducing Agents; Mifepristone; Ovulation; Pregnancy; Progesterone Congeners; Treatment Failure | 1994 |
Antiprogestins in the induction of labor.
Topics: Animals; Cervix Uteri; Female; Humans; Labor, Induced; Mifepristone; Myometrium; Pregnancy; Progestins; Uterus | 1994 |
[Methods of second trimester pregnancy termination and evacuation of in utero dead fetuses. Value of mifepristone].
Topics: Abortion, Induced; Clinical Protocols; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fetal Death; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Prostaglandins; Time Factors; Treatment Outcome | 1994 |
[RU 486 and sulprostone in pregnancy termination in the 2nd and 3rd trimesters].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Adult; Clinical Protocols; Dinoprostone; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Time Factors | 1994 |
RU 486, mifepristone: a review of a controversial drug.
Topics: Abortion, Induced; Abortion, Legal; Female; Humans; Mifepristone; Politics; Pregnancy; Women's Health; Women's Rights | 1994 |
Medical and surgical treatment of ectopic pregnancy.
Topics: Female; Humans; Laparoscopy; Methotrexate; Mifepristone; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Prostaglandins; Risk Factors; Salpingostomy | 1994 |
RU 486. The progesterone antagonist.
Topics: Abortion, Induced; Animals; Antineoplastic Agents; Breast Neoplasms; Cervix Uteri; Female; Humans; Meningioma; Mifepristone; Pregnancy; Progesterone | 1993 |
Mifepristone (RU 486) for induced abortion.
Topics: Abortion, Induced; Clinical Trials as Topic; Contraceptives, Postcoital; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Vacuum Curettage | 1993 |
Clinical pharmacology of RU 486--an antiprogestin and antiglucocorticoid.
Topics: Abortion, Induced; Animals; Female; Genitalia, Female; Glucocorticoids; Humans; Mifepristone; Molecular Structure; Neoplasms; Pregnancy; Progestins | 1993 |
Mifepristone (RU 486)--a modulator of progestin and glucocorticoid action.
Topics: Abortion, Induced; Animals; Endometrium; Female; Glucocorticoids; Humans; Mifepristone; Pregnancy; Progestins; Prostaglandins; Uterus | 1993 |
Mifepristone/gemeprost to abort early pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1993 |
The unripe cervix and its management for labour induction.
Topics: Administration, Intravaginal; Cervix Uteri; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dilatation and Curettage; Estrogens; Female; Fetal Blood; Forecasting; Gels; Humans; Labor, Induced; Mifepristone; Oxytocics; Pessaries; Pregnancy; Pregnancy Outcome; Prostaglandins; Relaxin | 1993 |
New reproductive genetics: political issues.
Topics: Abortion, Legal; Acquired Immunodeficiency Syndrome; Choice Behavior; Family Planning Services; Female; Financing, Organized; Genetics, Medical; Health Policy; Health Services Accessibility; Humans; Mifepristone; Politics; Power, Psychological; Pregnancy; Prenatal Diagnosis; Reproduction; Social Values; United States; Women's Rights | 1993 |
Mode of action of RU 486.
Topics: Abortion, Induced; Endometrium; Female; Humans; Menstrual Cycle; Mifepristone; Pregnancy; Receptors, Progesterone; Uterine Contraction | 1993 |
[The fundamental basis and obstetrical applications of mifepristone or RU-486 (voluntary interrupted pregnancies excluded)].
Topics: Cervix Uteri; Female; Humans; Labor, Induced; Mifepristone; Pregnancy | 1993 |
[Induced labor by pharmacological methods. Advantages and disadvantages].
Topics: Cesarean Section; Drug Monitoring; Female; Gestational Age; Hormone Antagonists; Humans; Labor, Induced; Mifepristone; Oxytocics; Patient Selection; Pregnancy; Pregnancy Outcome; Prostaglandins | 1995 |
Clinical applications of the antiprogestins.
Topics: Abortifacient Agents, Steroidal; Breast Neoplasms; Clinical Trials as Topic; Contraceptives, Oral, Synthetic; Cushing Syndrome; Endometriosis; Endometrium; Female; Hormone Antagonists; Humans; Leiomyoma; Meningeal Neoplasms; Meningioma; Menstrual Cycle; Mifepristone; Pregnancy; Pregnancy, Ectopic; Premenstrual Syndrome; Progestins; Uterine Neoplasms | 1995 |
The combined use of prostaglandin and antiprogestin in human fertility control.
Topics: Abortifacient Agents; Abortion, Induced; Contraceptive Agents, Female; Female; Hormone Antagonists; Humans; Mifepristone; Pregnancy; Progesterone; Prostaglandins | 1996 |
Antiprogestins: mechanism of action and contraceptive potential.
Topics: Abortifacient Agents, Steroidal; Binding, Competitive; Contraceptive Agents; Contraceptives, Postcoital, Synthetic; Endometrium; Female; Hormone Antagonists; Humans; Luteinizing Hormone; Mifepristone; Ovulation; Pregnancy; Receptors, Glucocorticoid; Receptors, Progesterone; Structure-Activity Relationship | 1996 |
Mifepristone and first trimester abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Developing Countries; Female; Humans; Mifepristone; Patient Acceptance of Health Care; Pregnancy; Pregnancy in Adolescence; Pregnancy Trimester, First; United States | 1996 |
[Mifepristone and misoprostol in therapeutic abortions].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adult; Drug Costs; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Time Factors; Treatment Outcome | 1996 |
The corpus luteum revisited: are the paradoxical effects of RU486 a clue to how progesterone stimulates its own secretion?
Topics: Animals; Corpus Luteum; Female; Hormone Antagonists; Humans; Mifepristone; Pregnancy; Progesterone; Rats; Receptors, Progesterone | 1996 |
Fertility control by emergency contraception.
Topics: Contraceptives, Postcoital; Danazol; Estrogens; Female; Hormone Antagonists; Humans; Intrauterine Devices; Mifepristone; Pregnancy; Progestins | 1996 |
RU486 (mifepristone): mechanisms of action and clinical uses.
Topics: Abortifacient Agents, Steroidal; Clinical Trials as Topic; Female; Genital Neoplasms, Female; Hormone Antagonists; Humans; Infant, Newborn; Male; Menstruation-Inducing Agents; Mifepristone; Neoplasms, Hormone-Dependent; Pregnancy; Receptors, Glucocorticoid; Receptors, Progesterone | 1997 |
Clinical uses of antiprogestogens.
Topics: Abortion, Induced; Antineoplastic Agents; Breast Neoplasms; Contraception; Contraceptives, Oral, Synthetic; Endometrial Neoplasms; Endometriosis; Estrenes; Female; Gonanes; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Progestins; Prostaglandins; Receptors, Progesterone | 1995 |
Hormonal requirement for blastocyst implantation and a new approach for anti-implantation strategy.
Topics: Animals; Contraceptives, Oral, Synthetic; Embryo Implantation; Embryonic and Fetal Development; Embryonic Development; Endometrium; Estrogens; Estrus Synchronization; Female; Fertility; Hormone Antagonists; Humans; Mifepristone; Ovary; Pregnancy; Primates; Progesterone | 1997 |
Medical abortion in early pregnancy: a review of the evidence.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Research Design | 1997 |
Medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Prostaglandins | 1997 |
Medical options for early pregnancy termination.
Topics: Abortifacient Agents; Abortion, Induced; Algorithms; Decision Trees; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Time Factors; Treatment Outcome | 1997 |
RU 486 (mifepristone). A short overview of its mechanisms of action and clinical uses at the end of 1996.
Topics: Animals; Breast Neoplasms; Contraceptives, Oral, Synthetic; Female; Fertility; Glucocorticoids; Hormone Antagonists; Humans; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Progesterone | 1997 |
Mifepristone (RU486): a review.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Breast Neoplasms; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Endometriosis; Female; Humans; Leiomyoma; Mifepristone; Pregnancy; Uterine Neoplasms | 1997 |
Modern management of miscarriage: is there a place for non-surgical treatment?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Missed; Abortion, Spontaneous; Dilatation and Curettage; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1998 |
Methods of abortion in Europe during the first trimester of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Anesthetics; Dilatation and Curettage; Europe; Female; Humans; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Pregnancy Trimester, First | 1997 |
Gestagens, danazol and antiprogestogen in emergency contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Danazol; Emergencies; Estrogen Antagonists; Female; Humans; Menstrual Cycle; Mifepristone; Pregnancy; Pregnancy, Unwanted; Progestins; Time Factors | 1997 |
Research on mifepristone and levonorgestrel in comparison with the Yuzpe regimen.
Topics: Abortifacient Agents, Steroidal; Clinical Trials as Topic; Contraceptives, Postcoital; Drug Therapy, Combination; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Mifepristone; Norgestrel; Pregnancy; Pregnancy, Unwanted; Progesterone Congeners; World Health Organization | 1998 |
Induction of labour: new horizons.
Topics: Abortifacient Agents; Administration, Oral; Cervical Ripening; Female; Gels; Humans; Labor, Induced; Mifepristone; Misoprostol; Oxytocin; Pessaries; Pregnancy; Prostaglandins; Relaxin | 1998 |
Cervical ripening.
Topics: Abortifacient Agents, Steroidal; Cervical Ripening; Dilatation; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Prenatal Diagnosis; Prostaglandins; Relaxin | 1999 |
Use of misoprostol in first and second trimester abortion: a review.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second | 1999 |
[Early medical abortion. An update].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1999 |
[Anti-progesterones].
Topics: Abortifacient Agents, Steroidal; Abortion, Therapeutic; Contraceptive Agents; Contraceptives, Oral, Synthetic; Endometriosis; Female; Humans; Leiomyosarcoma; Meningioma; Mifepristone; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone; Progestins; Receptors, Progesterone; Uterine Neoplasms | 1999 |
Medical termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Alprostadil; Contraindications; Drug Combinations; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Progesterone; Prostaglandins; Uterine Contraction | 2000 |
The efficacy of medical abortion: a meta-analysis.
Topics: Abortifacient Agents; Abortion, Induced; Female; Gestational Age; Humans; MEDLINE; Methotrexate; Mifepristone; Pregnancy; Prostaglandins; Treatment Outcome | 2000 |
Approval of mifepristone (RU 486) in Europe.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Drug Approval; Europe; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 2000 |
Medical abortion regimens: historical context and overview.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; China; Clinical Trials as Topic; Europe; Female; History, 20th Century; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy Trimester, First; United States | 2000 |
Medical abortion in social context.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Methotrexate; Mifepristone; Politics; Pregnancy; United States | 2000 |
Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Forecasting; Humans; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Treatment Outcome | 2000 |
Alternatives to mifepristone regimens for medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Pregnancy | 2000 |
Mifepristone for induction of labour.
Topics: Clinical Trials as Topic; Female; Humans; Labor, Induced; Mifepristone; Oxytocics; Pregnancy; Pregnancy Trimester, Third | 2000 |
Misoprostol and pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Abortion, Missed; Cervical Ripening; Drug Therapy, Combination; Empirical Research; Female; Government Regulation; Humans; Labor, Induced; Methotrexate; Mifepristone; Misoprostol; Mobius Syndrome; Oxytocics; Postpartum Hemorrhage; Pregnancy; Pregnant Women | 2001 |
[Effect of antigestagens on human reproduction].
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Abortion, Therapeutic; Contraceptives, Oral, Hormonal; Endometrial Neoplasms; Endometriosis; Female; Hormone Antagonists; Humans; Labor, Induced; Mifepristone; Pregnancy; Progesterone | 2001 |
Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature.
Topics: Animals; Contraceptives, Postcoital; Estrogens; Ethinyl Estradiol; Female; Hormone Antagonists; Humans; Levonorgestrel; Mifepristone; Pregnancy; Progestins | 2001 |
[Mifepristone--a new antiprogesterone in obstetrics and gynecology].
Topics: Abnormalities, Drug-Induced; Abortifacient Agents, Steroidal; Contraceptives, Oral, Synthetic; Female; Hormone Antagonists; Humans; Labor, Obstetric; Mifepristone; Pregnancy | 2001 |
[Labor induction in women at term with mifepristone and it's safety].
Topics: Abortifacient Agents, Steroidal; Animals; Cervical Ripening; Female; Humans; Labor, Induced; Mifepristone; Pregnancy | 1999 |
Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
Topics: Abortifacient Agents, Steroidal; Contraceptives, Oral, Synthetic; Endometrium; Female; Hormone Antagonists; Humans; Luteolytic Agents; Menstruation-Inducing Agents; Mifepristone; Pregnancy | 2000 |
Hormonal emergency contraception.
Topics: Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Danazol; Drug Administration Schedule; Female; Humans; Levonorgestrel; Mifepristone; Nausea; Pregnancy; Vomiting | 2002 |
[Mifepristone--a controversial drug with great potential].
Topics: Abortifacient Agents, Steroidal; Contraceptives, Oral, Synthetic; Female; Genital Diseases, Female; History, 20th Century; Hormone Antagonists; Humans; Labor, Induced; Mifepristone; Neoplasms; Pregnancy; Pregnancy Complications; Receptors, Progesterone | 2001 |
[Early termination of pregnancy with pharmacological means].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First | 2000 |
Antigestogens: the holy grail of contraception.
Topics: Abortion, Induced; Contraceptive Agents, Female; Contraceptives, Postcoital; Embryo Implantation; Ethics, Medical; Female; Hormone Antagonists; Humans; Menstruation; Mifepristone; Ovulation; Pregnancy; Progestins | 2001 |
Mifepristone: contraceptive and non-contraceptive uses.
Topics: Abortifacient Agents, Steroidal; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Female; Humans; Mifepristone; Pregnancy | 2002 |
Medical abortion in the first trimester.
Topics: Abortifacient Agents; Abortion, Induced; Clinical Protocols; Drug Combinations; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Treatment Outcome | 2002 |
Medical abortion in the second trimester.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Progestins; Prostaglandins | 2002 |
Effect of early pregnancy on a previous lower segment cesarean section scar.
Topics: Adult; Cesarean Section; Chorionic Gonadotropin, beta Subunit, Human; Cicatrix; Female; Humans; Hysterectomy; Methotrexate; Mifepristone; Postoperative Complications; Pregnancy; Trichosanthin; Ultrasonography; Uterine Hemorrhage; Uterine Rupture | 2002 |
Mifepristone. Separating fact from fiction.
Topics: Abortifacient Agents, Steroidal; Ethics, Medical; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1992 |
Human contraception: development of new scientific opportunities.
Topics: Contraception; Contraceptive Agents; Contraceptive Devices, Female; Female; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Male; Mifepristone; Pregnancy; Sperm-Ovum Interactions; Vaccination | 1992 |
Nonsurgical treatment of ectopic pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Administration, Oral; Chorionic Gonadotropin; Danazol; Dinoprostone; Drug Therapy, Combination; Female; Glucose; Humans; Injections, Intralesional; Injections, Intramuscular; Laparoscopy; Methotrexate; Mifepristone; Potassium Chloride; Pregnancy; Pregnancy, Ectopic; Vagina | 1992 |
[Progesterone antagonists--pharmacology and perspectives of use].
Topics: Abortion, Induced; Animals; Breast Neoplasms; Endometrial Neoplasms; Female; Humans; Infant, Newborn; Luteal Phase; Mifepristone; Neoplasms, Hormone-Dependent; Pregnancy; Progesterone; Tumor Cells, Cultured | 1992 |
Prostaglandin analogues and their uses.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Prostaglandins E, Synthetic; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Vacuum Extraction, Obstetrical | 1992 |
RU 486: how abortion politics have impacted on a potentially useful drug of broad medical application.
Topics: Abortion, Induced; Biomedical Research; Breast Neoplasms; Female; Humans; Internationality; Legislation, Drug; Mifepristone; Patient Advocacy; Politics; Pregnancy; Risk Assessment; United States; United States Food and Drug Administration | 1992 |
Abortion: epidemiology, safety, and technique.
Topics: Abortion, Incomplete; Abortion, Induced; Abortion, Septic; Attitude of Health Personnel; Attitude to Health; Clinical Protocols; Ethics, Medical; Female; Health Policy; Humans; Maternal Mortality; Mifepristone; Pregnancy; Pregnancy Outcome; Safety | 1992 |
[RU 486--death hides behind this formula].
Topics: Abortion, Induced; Ethics, Medical; Family Planning Services; Female; France; Germany; Humans; Mifepristone; Pregnancy | 1992 |
[Ethical controversy surrounding RU 486: data and arguments].
Topics: Abortion, Induced; Ethics, Medical; Female; Humans; Mifepristone; Pregnancy | 1992 |
[Mifepristone (RU 486)].
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Animals; Ethics, Medical; Female; Humans; Mifepristone; Pregnancy | 1992 |
[Drug therapy of extrauterine pregnancy].
Topics: Dactinomycin; Dinoprost; Female; Glucose Solution, Hypertonic; Humans; Laparoscopy; Methotrexate; Mifepristone; Potassium Chloride; Pregnancy; Pregnancy, Tubal | 1992 |
RU486 and the early nineties.
Topics: Abortion, Induced; Contraceptive Agents, Female; Female; Glucocorticoids; Humans; Mifepristone; Pregnancy; Progestins | 1991 |
Labor and normal delivery: induction of labor.
Topics: Cervix Uteri; Clinical Trials as Topic; Female; Fetal Membranes, Premature Rupture; Humans; Labor, Induced; Mifepristone; Oxytocin; Pregnancy; Prostaglandins | 1991 |
Nonsurgical management of tubal pregnancy. Necessity in view of the changing clinical appearance.
Topics: Dactinomycin; Dinoprost; Female; Humans; Laparoscopy; Methotrexate; Mifepristone; Potassium Chloride; Pregnancy; Pregnancy, Tubal | 1991 |
Experimental methods of contraception.
Topics: Contraception, Immunologic; Contraceptive Agents; Female; Gonadotropin-Releasing Hormone; Humans; Male; Mifepristone; Pregnancy; Sterilization, Reproductive; Testosterone | 1991 |
Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review.
Topics: Abortion, Induced; Adrenal Cortex; Animals; Contraceptives, Postcoital; Drug Combinations; Endometrium; Female; Humans; Hypothalamo-Hypophyseal System; Mifepristone; Ovary; Pregnancy; Prostaglandins | 1991 |
Progesterone receptor antagonists and prostaglandins in human fertility regulation: a clinical review.
Topics: Abortifacient Agents, Steroidal; Animals; Estrenes; Female; Gonanes; Humans; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Progesterone; Prostaglandins; Receptors, Progesterone | 1990 |
Abortion: a legal and public health perspective.
Topics: Abortion Applicants; Abortion, Induced; Abortion, Legal; Demography; Female; Government Regulation; History, 19th Century; History, 20th Century; Humans; Internationality; Mifepristone; Pregnancy; Public Policy; Risk Assessment; United States | 1991 |
Uterine contractility and interaction between prostaglandins and antiprogestins. Clinical implications.
Topics: Abortion, Induced; Cervix Uteri; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Progestins; Prostaglandins; Uterine Contraction | 1991 |
Antiprogesterones.
Topics: Abortifacient Agents; Cervix Uteri; Contraceptives, Postcoital; Female; Fertilization; Humans; Labor, Obstetric; Menstruation; Mifepristone; Ovulation; Pregnancy; Receptors, Progesterone | 1991 |
The antiprogesterone steroid, RU 486 (mifepristone).
Topics: Abortion, Therapeutic; Animals; Female; Humans; Labor, Induced; Lactation; Macaca fascicularis; Mammary Neoplasms, Experimental; Mifepristone; Pregnancy; Rats | 1990 |
Antiprogesterone RU 486--a drug for non-surgical abortion.
Topics: Female; Humans; Mifepristone; Pregnancy | 1990 |
Unfinished feticide.
Topics: Abortion, Eugenic; Abortion, Induced; Abortion, Legal; Congenital Abnormalities; Ethics, Medical; Female; Fetal Death; France; Humans; Internationality; Liability, Legal; Malpractice; Mifepristone; Pregnancy; Pregnancy, Multiple | 1990 |
[Antiprogesterone, prostaglandin analogues and the early interruption of pregnancy].
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy | 1990 |
Non-invasive methods for termination of second trimester pregnancy.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Prostaglandins | 1990 |
The Albert Lasker Medical Awards. RU-486 as an antiprogesterone steroid. From receptor to contragestion and beyond.
Topics: Awards and Prizes; Biochemical Phenomena; Biochemistry; Chemical Phenomena; Chemistry; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnant Women; Progestins; Risk Assessment | 1989 |
[RU-486: clinical application in gynecology].
Topics: Abortion, Induced; Contraception; Female; Humans; Mifepristone; Pregnancy | 1989 |
Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in women.
Topics: Abortion, Induced; Female; Humans; Menstrual Cycle; Mifepristone; Pregnancy; Progestins | 1989 |
RU-486. Termination of a pregnancy in the privacy of one's home.
Topics: Abortion, Criminal; Contraceptive Agents, Female; Ethics, Medical; Female; Humans; Mifepristone; Pregnancy | 1989 |
Contragestion by the progesterone antagonist RU 486: a novel approach to human fertility control.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Estrenes; Female; Humans; Hydrocortisone; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Progesterone; Receptors, Glucocorticoid | 1987 |
Prospective usefulness of RU 486 in fertility control.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Contraceptives, Postcoital; Estrenes; Female; Glucocorticoids; Humans; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Progesterone | 1987 |
Contragestion by antiprogestin RU 486: a review.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Cervix Uteri; Estrenes; Female; Humans; Menstruation-Inducing Agents; Mifepristone; Pregnancy | 1987 |
[Progress in endocrinology].
Topics: Abortion, Induced; Adrenal Medulla; Adult; Atrial Natriuretic Factor; Caudate Nucleus; Diuresis; Female; Humans; Mifepristone; Parkinson Disease; Pregnancy; Transplantation, Heterotopic | 1988 |
Clinical status of antiprogesterone steroids.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Biological Availability; Clinical Trials as Topic; Contraceptive Agents, Female; Corpus Luteum; Drug Evaluation; Endometrium; Estradiol; Estrenes; Ethics, Medical; Female; Humans; Hydrocortisone; Kinetics; Labor, Induced; Menopause; Menstruation; Menstruation-Inducing Agents; Mifepristone; Ovariectomy; Pituitary Hormones; Pregnancy; Progesterone; Prostaglandins; Receptors, Progesterone; Transcortin | 1985 |
Cellular and molecular bases for dystocia.
Topics: Animals; Cyclic AMP; Dystocia; Estrenes; Estrogens; Female; Glucocorticoids; Humans; Mifepristone; Myometrium; Pregnancy; Progesterone; Synapses; Uterine Contraction | 1987 |
Anti-progesterones for the interruption of pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Androstenols; Drug Therapy, Combination; Estrenes; Female; Humans; Mifepristone; Pregnancy; Prostaglandins | 1988 |
Anti-progesterones in obstetrics, ectopic pregnancies and gynaecological malignancy.
Topics: Animals; Cervix Uteri; Estrenes; Female; Humans; Labor, Induced; Macaca fascicularis; Mifepristone; Neoplasms, Hormone-Dependent; Pregnancy; Pregnancy, Ectopic; Receptors, Progesterone | 1988 |
[Antigestagens].
Topics: Animals; Contraceptives, Oral, Synthetic; Estrenes; Female; Humans; Mifepristone; Pregnancy; Progestins; Structure-Activity Relationship | 1988 |
Antiprogestins and prostaglandins.
Topics: Animals; Estrenes; Female; Humans; Mifepristone; Pregnancy; Progestins; Prostaglandins; Structure-Activity Relationship | 1988 |
Mifegyne (mifepristone), a new antiprogestagen with potential therapeutic use in human fertility control.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Contraceptives, Oral, Synthetic; Estrenes; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Receptors, Progesterone | 1988 |
The antiprogesterone steroid RU 486: a short pharmacological and clinical review, with emphasis on the interruption of pregnancy.
Topics: Abortion, Induced; Estrenes; Female; Humans; Labor, Induced; Microscopy, Electron; Mifepristone; Models, Chemical; Pregnancy | 1987 |
The antiprogestins: a recent advance in fertility regulation.
Topics: Abortifacient Agents, Steroidal; Animals; Contraception; Contraceptives, Oral, Synthetic; Estrenes; Female; Glucocorticoids; Humans; Mifepristone; Pregnancy; Progesterone; Progestins; Receptors, Steroid | 1987 |
The nonsurgical management of ectopic pregnancy.
Topics: Abortifacient Agents, Steroidal; Drug Therapy, Combination; Estrenes; Female; Humans; Leucovorin; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic | 1987 |
386 trial(s) available for mifepristone and Pregnancy
| Article | Year |
|---|---|
Mifepristone prior to osmotic dilators for dilation and evacuation cervical preparation: A randomized, double-blind, placebo-controlled pilot study.
Topics: Abortion, Induced; COVID-19; Dilatation; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Pregnancy Trimester, Second; SARS-CoV-2 | 2022 |
Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCT.
Topics: Abortion, Spontaneous; Cost-Benefit Analysis; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Technology Assessment, Biomedical | 2021 |
Prospective open-label non-inferiority randomised controlled trial comparing letrozole and mifepristone pretreatment in medical management of first trimester missed miscarriage: study protocol.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Letrozole; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
The experience of pain in real-time during medication abortion.
Topics: Abortion, Induced; Acetaminophen; Analgesics; Analgesics, Opioid; Female; Humans; Ibuprofen; Mifepristone; Misoprostol; Oxycodone; Pain; Pregnancy | 2022 |
Predicting the likelihood of successful medical treatment of early pregnancy loss: development and internal validation of a clinical prediction model.
Topics: Abortion, Spontaneous; Colic; Female; Humans; Male; Mifepristone; Models, Statistical; Pregnancy; Probability; Prognosis; Uterine Hemorrhage | 2022 |
Medical management of early pregnancy loss is cost-effective compared with office uterine aspiration.
Topics: Abortion, Spontaneous; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2022 |
Patient-controlled intravenous versus on-demand oral, intramuscular or mcs intravenous administration of oxycodone during medical induced abortion from 64 to 128 days of Gestation: A randomized controlled trial.
Topics: Abortion, Induced; Administration, Oral; Analgesia, Patient-Controlled; Analgesics; Female; Humans; Infant; Infusions, Intravenous; Mifepristone; Misoprostol; Oxycodone; Pain; Pregnancy; Prospective Studies | 2022 |
A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; South Africa; Telemedicine | 2022 |
Evaluation efficacy and safety of epidural analgesia in second-trimester induced labor: A single-center, prospective, non-randomized, controlled study.
Topics: Analgesia, Epidural; Analgesia, Obstetrical; Analgesics; Anti-Bacterial Agents; C-Reactive Protein; Ethacridine; Female; Humans; Labor, Induced; Labor, Obstetric; Mifepristone; Pain; Pregnancy; Pregnancy Trimester, Second; Prospective Studies | 2022 |
The role of mifepristone on first trimester miscarriage treatment - A double-blind randomized controlled trial - MiFirsT.
Topics: Abortion, Missed; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2023 |
Randomized controlled trial comparing efficacy of a combination regime containing two cervical sensitizers (mifepristone + Foley's catheter) versus single agent mifepristone or Foley's catheter for labor induction in women attempting TOLAC at late third t
Topics: Catheters; Cervical Ripening; Female; Fetus; Humans; Labor, Induced; Mifepristone; Oxytocics; Oxytocin; Pregnancy; Pregnancy Trimester, Third | 2023 |
Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Ambulatory Care; Feasibility Studies; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Nepal; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Prospective Studies; Young Adult | 2019 |
The use of an osmotic dilator for induction of miscarriage in patients with the second trimester missed miscarriage.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 2021 |
Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial).
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Adolescent; Adult; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Multicenter Studies as Topic; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Randomized Controlled Trials as Topic; Ultrasonography; Watchful Waiting; Young Adult | 2019 |
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; California; Chorionic Gonadotropin; Double-Blind Method; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Progesterone; Uterine Hemorrhage; Vacuum Curettage; Young Adult | 2020 |
A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestation.
Topics: Abortifacient Agents; Adult; Ambulatory Care; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Treatment Outcome; Ultrasonography; Young Adult | 2020 |
Mifepristone pretreatment followed by misoprostol 200 mcg buccal for the medical management of intrauterine fetal death at 14-28 weeks: A randomized, placebo-controlled, double blind trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Double-Blind Method; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Placenta; Pregnancy | 2020 |
Cost-effectiveness of Mifepristone Pretreatment for the Medical Management of Nonviable Early Pregnancy: Secondary Analysis of a Randomized Clinical Trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cost-Benefit Analysis; Embryo Loss; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies | 2020 |
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Treatment Outcome; Uterine Hemorrhage | 2020 |
Two prophylactic pain management regimens for medical abortion ≤63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pain; Pain Management; Pregnancy | 2021 |
Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 2021 |
Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Double-Blind Method; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Treatment Outcome; Young Adult | 2021 |
The effect of mifepristone pretreatment on bleeding and pain during medical management of early pregnancy loss.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pain; Pregnancy | 2021 |
Pain Associated With Cervical Priming for First-Trimester Surgical Abortion: A Randomized Controlled Trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Anesthesia, Obstetrical; Female; Humans; Mifepristone; Misoprostol; Pain Measurement; Pain, Postoperative; Pain, Procedural; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Single-Blind Method; Young Adult | 2021 |
Cost-effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial.
Topics: Abortifacient Agents; Abortion, Missed; Adolescent; Adult; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Young Adult | 2021 |
Comparison of two home pregnancy tests for self-confirmation of medication abortion status: A randomized trial.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Pregnancy Tests | 2021 |
Mifepristone vs balloon catheter for labor induction in previous cesarean: a randomized controlled trial.
Topics: Adult; Catheterization; Cervical Ripening; Delivery, Obstetric; Female; Gestational Age; Humans; India; Labor Onset; Labor, Induced; Mifepristone; Oxytocics; Oxytocin; Pregnancy; Time Factors; Treatment Outcome | 2017 |
Fast-track vs. delayed insertion of the levonorgestrel-releasing intrauterine system after early medical abortion - a randomized trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Feasibility Studies; Female; Finland; Follow-Up Studies; Humans; Intention to Treat Analysis; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Mifepristone; Misoprostol; Patient Dropouts; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Time Factors; Uterine Hemorrhage; Young Adult | 2017 |
Preoperative effects of mifepristone for dilation and evacuation after 19 weeks of gestation: a randomised controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Cervix Uteri; Combined Modality Therapy; Dilatation; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Treatment Outcome | 2017 |
Outcomes of mifepristone usage for cervical ripening and induction of labour in full-term pregnancy. Randomized controlled trial.
Topics: Cervical Ripening; Delivery, Obstetric; Female; Humans; Labor, Induced; Mifepristone; Oxytocics; Oxytocin; Pregnancy; Term Birth; Treatment Outcome; Uterine Contraction | 2017 |
Comparative satisfaction of receiving medical abortion service from nurses and auxiliary nurse-midwives or doctors in Nepal: results of a randomized trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Midwifery; Mifepristone; Nurses; Patient Satisfaction; Physicians; Pregnancy | 2017 |
Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Administration, Intravaginal; Administration, Oral; Adult; Drug Therapy, Combination; Embryo, Mammalian; Female; Fetal Death; Gestational Sac; Hemorrhage; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Ultrasonography | 2018 |
Safety, Efficacy and Acceptability of Early First Trimester Abortion using Oral Mifepristone and Sublingual Misoprostol.
Topics: Abortion, Induced; Adult; Drug Administration Routes; Female; Humans; Mifepristone; Misoprostol; Nepal; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Prospective Studies | 2018 |
[Chinese Herbs Combined Three-stage Sequential Therapy for Conservative Treatment of Ectopic Pregnancy].
Topics: Abortifacient Agents, Steroidal; Child; Conservative Treatment; Drugs, Chinese Herbal; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic; Treatment Outcome | 2016 |
Clinical effect of mifepristone on patients with ovarian cancer in pregnancy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Chemotherapy, Adjuvant; Female; Humans; Mifepristone; Neoplasm Staging; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy, High-Risk | 2019 |
Safety and efficacy of mifepristone versus dinoprostone gel in induction of labor: A randomized controlled trial.
Topics: Adult; Dinoprostone; Female; Humans; Labor, Induced; Mifepristone; Oxytocics; Pregnancy; Prospective Studies; Treatment Outcome; Young Adult | 2019 |
Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: results of two clinical trials.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Self Administration; Ukraine; Young Adult | 2013 |
Efficacy of misoprostol administration 24 hours after mifepristone for termination of early pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Case-Control Studies; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Young Adult | 2011 |
Prophylactic compared with therapeutic ibuprofen analgesia in first-trimester medical abortion: a randomized controlled trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Analgesia; Analgesics, Non-Narcotic; Female; Humans; Ibuprofen; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Young Adult | 2013 |
Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study.
Topics: Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adolescent; Adult; Boston; Contraception Behavior; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Follow-Up Studies; Health Services Accessibility; Humans; Middle Aged; Mifepristone; Patient Acceptance of Health Care; Patient Satisfaction; Pilot Projects; Pregnancy; Time Factors; Young Adult | 2013 |
Mifepristone followed by misoprostol or oxytocin for second-trimester abortion: a randomized controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Oxytocics; Oxytocin; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Time Factors; Young Adult | 2013 |
Shenghua Decoction reduces uterine bleeding and regulates T-cell paradigm in human deciduas of RU486 medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cytokines; Decidua; Drugs, Chinese Herbal; Female; Forkhead Transcription Factors; GATA3 Transcription Factor; Humans; Mifepristone; Nuclear Receptor Subfamily 1, Group F, Member 3; Pregnancy; T-Box Domain Proteins; T-Lymphocyte Subsets; T-Lymphocytes; Uterine Hemorrhage; Young Adult | 2013 |
Dosing interval of 24hours versus 48hours between mifepristone and misoprostol administration for mid-trimester termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Treatment Outcome; Young Adult | 2014 |
Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Administration, Sublingual; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Time Factors | 2014 |
RU OK? The acceptability and feasibility of remote technologies for follow-up after early medical abortion.
Topics: Abortion, Induced; Adolescent; Adult; Communication; Confidence Intervals; Contraceptives, Postcoital, Synthetic; Female; Follow-Up Studies; Humans; Logistic Models; Middle Aged; Mifepristone; Patient Satisfaction; Pregnancy; Surveys and Questionnaires; Telephone; Text Messaging; United Kingdom; Young Adult | 2014 |
Mobile phone messages to provide support to women during the home phase of medical abortion in South Africa: a randomised controlled trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Administration, Sublingual; Adult; Anxiety; Female; Follow-Up Studies; Humans; Intention to Treat Analysis; Lost to Follow-Up; Mifepristone; Patient Education as Topic; Patient Satisfaction; Pregnancy; Self Administration; Self Care; Social Support; South Africa; Stress, Psychological; Text Messaging; Urban Health; Young Adult | 2014 |
Effectiveness of mifepristone in combination with ethacridine lactate for second trimester pregnancy termination.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; China; Ethacridine; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 2014 |
Same-day and delayed reports of pain intensity in second-trimester medical termination of pregnancy: a brief report.
Topics: Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Pain Measurement; Pain, Postoperative; Pregnancy; Pregnancy Trimester, Second; Prospective Studies | 2014 |
Simplified follow-up after medical abortion using a low-sensitivity urinary pregnancy test and a pictorial instruction sheet in Rajasthan, India--study protocol and intervention adaptation of a randomised control trial.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Aftercare; Female; Home Care Services; Humans; India; Mifepristone; Misoprostol; Patient Education as Topic; Pregnancy; Pregnancy Tests; Young Adult | 2014 |
Effectiveness and Safety of Lower Doses of Mifepristone Combined With Misoprostol for the Termination of Ultra-Early Pregnancy: A Dose-Ranging Randomized Controlled Trial.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Oral; Adult; China; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Time Factors; Treatment Outcome; Young Adult | 2015 |
What happens when we routinely give doxycycline to medical abortion patients?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Antibiotic Prophylaxis; Doxycycline; Female; Follow-Up Studies; Humans; Internet; Medication Adherence; Mifepristone; Nausea; Practice Patterns, Physicians'; Pregnancy; Surveys and Questionnaires; United States; Vomiting; Young Adult | 2015 |
[Association of mifepristone and misoprostol for the medical management of early pregnancy failure].
Topics: Abortion, Spontaneous; Adult; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Oxytocics; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Treatment Outcome | 2014 |
Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Austria; Chorionic Gonadotropin; Diagnostic Self Evaluation; Female; Finland; Follow-Up Studies; Humans; Middle Aged; Mifepristone; Norway; Pregnancy; Pregnancy Tests; Prostaglandins; Sweden; Treatment Outcome; Young Adult | 2015 |
Administration of depot medroxyprogesterone acetate on the day of mifepristone for medical abortion: a pilot study.
Topics: Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Academic Medical Centers; Adolescent; Adult; Boston; Contraception Behavior; Contraceptive Agents, Female; Drug Implants; Female; Follow-Up Studies; Health Services Accessibility; Humans; Medroxyprogesterone Acetate; Mifepristone; Patient Acceptance of Health Care; Patient Satisfaction; Perioperative Care; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Young Adult | 2015 |
A prospective open-label study of home use of mifepristone for medical abortion in Nepal.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Sublingual; Adolescent; Adult; Ambulatory Care Facilities; Female; Follow-Up Studies; Humans; Middle Aged; Mifepristone; Nepal; Pregnancy; Prospective Studies; Self Administration; Young Adult | 2015 |
Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Combined Modality Therapy; Dilatation; Female; Humans; Mifepristone; Misoprostol; Operative Time; Pain, Postoperative; Pregnancy; Pregnancy Trimester, Second; Young Adult | 2015 |
A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Time Factors; Treatment Outcome; Tunisia; Young Adult | 2015 |
Early versus late misoprostol administration after mifepristone for medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Administration Schedule; Female; Fetal Movement; Gestational Age; Humans; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Pregnancy; Prospective Studies; Uterus | 2015 |
Minimal effective dose of mifepristone for medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Dose-Response Relationship, Drug; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Young Adult | 2014 |
A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Choice Behavior; Female; Humans; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Self Administration; United States; Young Adult | 2015 |
Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone Compared With Overnight Osmotic Dilators Alone: A Randomized Controlled Trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Combined Modality Therapy; Dilatation and Curettage; Double-Blind Method; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Second; Preoperative Care; Prospective Studies; Risk Assessment; Surgical Instruments; Time Factors; Treatment Outcome; Young Adult | 2015 |
Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Adult; Age Factors; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Obesity; Parity; Pregnancy; Suction; Uterus | 2016 |
[Efficacy and safety of mifepristone combined with misoprostol for termination of pregnancy between 8 and 16 weeks of gestation].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Treatment Outcome | 2015 |
Mifepristone and misoprostol compared with misoprostol alone for induction of labor in intrauterine fetal death: A randomized trial.
Topics: Adult; Double-Blind Method; Female; Fetal Death; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy | 2015 |
Application prospect and clinical effect analysis of Fu Chan Xue Jing during bleeding after abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drugs, Chinese Herbal; Female; Humans; Menstruation; Mifepristone; Postoperative Hemorrhage; Pregnancy; Uterine Hemorrhage; Young Adult | 2015 |
Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
Topics: Abortion, Therapeutic; Adolescent; Adult; Chi-Square Distribution; Confidence Intervals; Contraceptive Agents, Female; Desogestrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Rate; Risk Assessment; Time Factors; Treatment Failure; Treatment Outcome; Young Adult | 2016 |
A randomized controlled trial evaluating same-day mifepristone and misoprostol compared to misoprostol alone for cervical preparation prior to second-trimester surgical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Gestational Age; Humans; Labor Stage, First; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; United States; Young Adult | 2016 |
Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Chorionic Gonadotropin; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Tests; Ultrasonography; Vietnam; Young Adult | 2016 |
Mifepristone and misoprostol for cervical ripening in surgical abortion between 12 and 14 weeks of gestation: a randomized controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cervical Ripening; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Treatment Outcome; Young Adult | 2016 |
Effect of mifepristone in the different treatments of endometriosis.
Topics: Adult; Combined Modality Therapy; Dysmenorrhea; Dyspareunia; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Gestrinone; Gynecologic Surgical Procedures; Hormone Antagonists; Humans; Laparoscopy; Luteinizing Hormone; Mifepristone; Pelvic Pain; Pregnancy; Progesterone; Progestins; Retrospective Studies; Young Adult | 2016 |
Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia.
Topics: Abortion, Induced; Adolescent; Adult; Aftercare; Female; Gestational Age; Health Education; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Tests; Prospective Studies; Self Administration; Tunisia | 2016 |
Physical symptoms and emotional responses among women undergoing induced abortion protocols during the second trimester.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Intravenous; Administration, Oral; Adult; Diarrhea; Emotions; Female; Humans; Israel; Mifepristone; Misoprostol; Oxytocin; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Psychiatric Status Rating Scales; Shivering | 2016 |
Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Rate; Time Factors; Treatment Outcome; Young Adult | 2016 |
Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Drug Interactions; Female; Humans; Mifepristone; Pregnancy; Pregnancy, Unplanned; Time Factors; Young Adult | 2016 |
Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Oral; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Self Administration; Treatment Outcome; Young Adult | 2017 |
Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days' gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Antiemetics; Clinical Protocols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Ibuprofen; Metoclopramide; Mifepristone; Misoprostol; Pain; Pain Management; Postoperative Nausea and Vomiting; Pregnancy; Research Design; Tramadol; Young Adult | 2016 |
Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Double-Blind Method; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Time Factors; Treatment Outcome | 2016 |
Efficacy of concurrent administration of mifepristone and misoprostol for termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Young Adult | 2017 |
Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Treatment Failure; Ultrasonography; Uterus | 2008 |
Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Dinoprostone; Drug Therapy, Combination; Female; Humans; Length of Stay; Mifepristone; Misoprostol; Polymers; Pregnancy; Pregnancy Trimester, Second; Prospective Studies | 2008 |
Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Administration, Oral; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome; Young Adult | 2008 |
A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Time Factors | 2009 |
Hygroscopic dilator (Dilapan-S) and misoprostol combination for the early first-trimester termination of pregnancy: a pilot study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Dilatation; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pain; Pilot Projects; Polymers; Pregnancy; Pregnancy Trimester, First; Wettability | 2009 |
Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Administration, Sublingual; Adolescent; Adult; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Young Adult | 2009 |
Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Tablets; Treatment Outcome; Treatment Refusal | 2009 |
Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies | 2009 |
Acceptability and feasibility of medical abortion in Nepal.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Drug Therapy, Combination; Family Planning Services; Female; Hospitals, Teaching; Humans; Middle Aged; Mifepristone; Misoprostol; Nepal; Pregnancy; Prospective Studies; Self Administration; Treatment Outcome; Young Adult | 2009 |
Treating miscarriages: a randomised study of cost-effectiveness in medical or surgical choice.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Adolescent; Adult; Cost-Benefit Analysis; Female; Hospital Costs; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Prospective Studies; Young Adult | 2009 |
Mifepristone followed by high-dose oxytocin drip for second-trimester abortion: a randomized, double-blind, placebo-controlled, pilot study.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Missed; Administration, Oral; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Mifepristone; Oxytocin; Pilot Projects; Placebos; Pregnancy; Pregnancy Trimester, Second; Young Adult | 2009 |
Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; England; Female; Humans; Mifepristone; Patient Preference; Pregnancy; Pregnancy Trimester, First; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2009 |
Association of the G2014G genotype in estrogen receptor 1 gene with failure of the mifepristone-induced termination of early pregnancy.
Topics: Abortion, Induced; Adult; Age Distribution; Estrogen Receptor alpha; Female; Gene Frequency; Genotype; Humans; Mifepristone; Polymorphism, Single Nucleotide; Pregnancy; Treatment Failure; Young Adult | 2010 |
Sublingual misoprostol for first trimester termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Sublingual; Adult; Female; Hematocrit; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies | 2010 |
Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Administration, Sublingual; Adult; Democratic People's Republic of Korea; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pilot Projects; Pregnancy; Rural Health Services; Urban Health Services | 2010 |
Two medical abortion regimens for late first-trimester termination of pregnancy: a prospective randomized trial.
Topics: Abdominal Pain; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Young Adult | 2010 |
Gestrinone compared with mifepristone for emergency contraception: a randomized controlled trial.
Topics: Abortifacient Agents, Steroidal; Contraception, Postcoital; Double-Blind Method; Female; Gestrinone; Humans; Mifepristone; Pregnancy; Treatment Outcome | 2010 |
Mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate for the termination of second trimester pregnancy: a prospective, open-label, randomized clinical trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Chi-Square Distribution; China; Ethacridine; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Young Adult | 2010 |
Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Treatment Outcome | 2010 |
Differentially expressed genes in early gestational chorionic villi after administration of mifepristone.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Chorionic Villi; Cluster Analysis; Female; Gene Expression Profiling; Gene Expression Regulation; Gestational Age; Humans; Microarray Analysis; Mifepristone; Pregnancy; Pregnancy Trimester, First; Signal Transduction; Young Adult | 2011 |
[Combination of methotrexate injection through hysteroscopic tubal catheterization and mifepristone per os in the conservative treatment of tubal pregnancy].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hysteroscopy; Injections; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Tubal; Young Adult | 2010 |
Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Sublingual; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Young Adult | 2011 |
Comparison of two dose regimens of misoprostol for second-trimester pregnancy termination.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Surveys and Questionnaires | 2010 |
One- and two-day mifepristone-misoprostol intervals for second trimester termination of pregnancy between 13 and 16 weeks of gestation.
Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Adolescent; Adult; Body Mass Index; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Young Adult | 2010 |
The effects of mifepristone on the expressions of osteopontin, interleukin-6 and leukemia inhibitory factor in the villi of early pregnant women.
Topics: Abortifacient Agents, Steroidal; Adolescent; Adult; Chi-Square Distribution; Chorionic Villi; Female; Gene Expression; Humans; Immunohistochemistry; Interleukin-6; Leukemia Inhibitory Factor; Middle Aged; Mifepristone; Osteopontin; Pregnancy; Pregnancy Trimester, First; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Young Adult | 2010 |
Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Aged; Aged, 80 and over; Dilatation and Curettage; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Prospective Studies; Treatment Outcome; Vacuum Extraction, Obstetrical | 2010 |
Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Drug Therapy, Combination; Feasibility Studies; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Physical Examination; Pregnancy; Prospective Studies; Self Administration; Ultrasonography, Prenatal | 2011 |
A pilot study on the use of letrozole with either misoprostol or mifepristone for termination of pregnancy up to 63 days.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Estradiol; Female; Humans; Hydrocortisone; Letrozole; Mifepristone; Misoprostol; Nitriles; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Progesterone; Triazoles; Young Adult | 2011 |
Up-regulation of Fas/FasL activation contribute to the apoptosis enhancement of RU486 by Gong-Qing Decoction, a traditional Chinese prescription.
Topics: Abortion, Induced; Adult; Apoptosis; Caspase 3; Caspase 8; Drug Therapy, Combination; Drugs, Chinese Herbal; Fas Ligand Protein; Female; Humans; Mifepristone; Phytotherapy; Pregnancy; Up-Regulation; Uterine Hemorrhage; Uterus; Vacuum Curettage; Young Adult | 2011 |
[Therapeutic effect of pelvic methotrexate injection via the posterior fornix for treatment of tubal pregnancy].
Topics: Abortifacient Agents, Nonsteroidal; Adult; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Injections; Methotrexate; Mifepristone; Pelvis; Phytotherapy; Pregnancy; Pregnancy, Tubal; Vagina; Young Adult | 2011 |
Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Eugenic; Administration, Intravaginal; Administration, Oral; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy | 2011 |
Can midlevel health-care providers administer early medical abortion as safely and effectively as doctors? A randomised controlled equivalence trial in Nepal.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Hospitals, District; Hospitals, Rural; Humans; Male; Middle Aged; Mifepristone; Misoprostol; Nepal; Nurse Midwives; Nurse Practitioners; Nurses; Physician Assistants; Physicians; Pregnancy; Pregnancy Trimester, First; Risk Assessment; Therapeutic Equivalency | 2011 |
Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Vietnam; Young Adult | 2011 |
Simultaneous use of mifepristone and misoprostol for early pregnancy termination.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Treatment Outcome | 2011 |
One- and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancy--a randomized trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Time Factors; Treatment Outcome | 2011 |
Ovulation resumption after medical abortion with mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Chorionic Gonadotropin; Female; Humans; Mifepristone; Misoprostol; Ovulation; Pregnancy; Progesterone; Prospective Studies; Regression Analysis; Young Adult | 2011 |
Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Adolescent; Adult; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Pain Measurement; Pregnancy; Pregnancy Trimester, Second; Time Factors; Treatment Outcome; Young Adult | 2011 |
Efficacy and safety of mifepristone and buccal misoprostol versus buccal misoprostol alone for medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Legal; Administration, Oral; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome; Young Adult | 2012 |
Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death: condensation - misoprostol and mifepristone combination is more effective than misoprostol alone in the management of intrauterine death
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Therapy, Combination; Female; Fetal Death; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Treatment Outcome; Young Adult | 2011 |
Risk factors of surgical evacuation following second-trimester medical termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Eugenic; Abortion, Therapeutic; Adolescent; Adult; Dilatation and Curettage; Dose-Response Relationship, Drug; Female; Finland; Follow-Up Studies; Hospitals, University; Humans; Maternal Age; Mifepristone; Misoprostol; Placenta, Retained; Pregnancy; Pregnancy Trimester, Second; Risk Factors; Time Factors; Young Adult | 2012 |
Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Double-Blind Method; Drug Administration Schedule; Female; Hospitals, University; Humans; Ibuprofen; Israel; Logistic Models; Middle Aged; Mifepristone; Misoprostol; Odds Ratio; Pain; Pain Measurement; Placebos; Pregnancy; Prospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult | 2012 |
A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Adolescent; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Treatment Outcome | 2012 |
Immediate versus delayed medical treatment for first-trimester miscarriage: a randomized trial.
Topics: Abortifacient Agents; Abortion, Spontaneous; Adult; Female; Hemorrhage; Humans; Infections; Mifepristone; Misoprostol; Pain; Pregnancy; Pregnancy Trimester, First; Treatment Outcome; Vacuum Curettage | 2012 |
[Clinical efficacy and safety of mifepristone in the treatment of abortive remnants of induced abortion].
Topics: Abortion, Incomplete; Abortion, Induced; Double-Blind Method; Female; Humans; Mifepristone; Pregnancy | 2012 |
Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Gestational Age; Humans; Labor Stage, First; Laminaria; Middle Aged; Mifepristone; Osmolar Concentration; Patient Preference; Polymers; Pregnancy; Time Factors | 2012 |
Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Double-Blind Method; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Tunisia; Vietnam; Young Adult | 2012 |
Modulation of free corticotrophin-releasing hormone, adrenal and placental steroid hormone levels induced by mifepristone during pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adrenal Cortex; Adult; Algorithms; Corticotropin-Releasing Hormone; Dehydroepiandrosterone Sulfate; Estriol; Female; Fetal Blood; Humans; Hydrocortisone; Mifepristone; Paraventricular Hypothalamic Nucleus; Placenta; Pregnancy; Pregnancy Trimester, Third; Progesterone; Receptors, Progesterone | 2012 |
Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Chorionic Gonadotropin; Cohort Studies; Feasibility Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Lost to Follow-Up; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Tests; Pregnancy, Unwanted; Self Care; United States; Young Adult | 2012 |
Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Administration, Oral; Adolescent; Adult; Australia; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Young Adult | 2012 |
Extending outpatient medical abortion services through 70 days of gestational age.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Ambulatory Care Facilities; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Outpatients; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Time Factors; Treatment Outcome; Young Adult | 2012 |
A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Administration, Sublingual; Adult; Double-Blind Method; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Young Adult | 2013 |
Acceptability of home use of mifepristone for medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Attitude of Health Personnel; Cervical Ripening; Choice Behavior; Female; Follow-Up Studies; Georgia; Humans; Mifepristone; New York City; Patient Preference; Philadelphia; Pregnancy; Pregnancy Trimester, First; Preoperative Care; Self Administration; Young Adult | 2013 |
[The lowest dosages of mifepristone and misoprostol to terminate ultra-early pregnancy].
Topics: Abdominal Pain; Abortifacient Agents; Abortion, Induced; Administration, Oral; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Nausea; Patient Satisfaction; Pregnancy; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2012 |
Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Oral; Adult; Family Planning Services; Female; Humans; India; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Prospective Studies; Rural Health; Urban Health | 2002 |
A prospective randomized study on the measured blood loss in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristone.
Topics: Abortifacient Agents, Steroidal; Adult; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Failure; Uterine Hemorrhage | 2002 |
A randomized comparative study on mifepristone alone and in combination with tamoxifen for emergency contraception.
Topics: Adult; Contraceptives, Postcoital, Synthetic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mifepristone; Placebos; Pregnancy; Safe Sex; Tamoxifen; Time Factors | 2002 |
Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Treatment Outcome; Uterine Hemorrhage | 2002 |
Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
Topics: Abortifacient Agents; Abortion, Missed; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Chorionic Gonadotropin; Cross-Over Studies; Denmark; Drug Administration Schedule; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Treatment Outcome | 2002 |
A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pessaries; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Tablets | 2002 |
A randomized double-blind comparison of two single doses of mifepristone for emergency contraception.
Topics: Adult; China; Contraceptives, Postcoital; Double-Blind Method; Female; Humans; Logistic Models; Mifepristone; Placebos; Pregnancy; Safe Sex | 2002 |
Medical termination of missed abortion.
Topics: Abortifacient Agents; Abortion, Missed; Abortion, Therapeutic; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Treatment Outcome; Ultrasonography; Vacuum Curettage | 2002 |
[Clinical observation on effect of xuejie jiawei decoction on vaginal hemorrhagic amount and duration in patients after drug-abortion].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drugs, Chinese Herbal; Female; Humans; Mifepristone; Phytotherapy; Pregnancy; Uterine Hemorrhage | 2001 |
[Observation on treatment of ectopic pregnancy by combination therapy of Chinese herbal medicine with mifepristone or methotrexate].
Topics: Abortifacient Agents; Adult; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Methotrexate; Mifepristone; Phytotherapy; Pregnancy; Pregnancy, Ectopic | 2002 |
[Effects of mifepristone on ultrastructure of placental Hofbauer cells in early human pregnancy].
Topics: Abortion, Induced; Chorionic Villi; Female; Hormone Antagonists; Humans; Microscopy, Electron, Scanning; Mifepristone; Placenta; Pregnancy; Pregnancy Trimester, First; Progesterone | 2003 |
Verifying the effectiveness of medical abortion; ultrasound versus hCG testing.
Topics: Abortifacient Agents; Abortion, Induced; Chorionic Gonadotropin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Treatment Outcome; Ultrasonography; Uterus | 2003 |
[Effects of mifepristone of different doses on emergency contraception, a randomized double-blind study].
Topics: Adult; Contraception; Contraceptives, Postcoital, Synthetic; Dose-Response Relationship, Drug; Double-Blind Method; Emergencies; Female; Humans; Mifepristone; Pregnancy | 2003 |
Medical treatment of ectopic pregnancies: a randomized clinical trial comparing methotrexate-mifepristone and methotrexate-placebo.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Placebos; Pregnancy; Pregnancy, Ectopic; Progesterone; Treatment Outcome | 2003 |
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; Amenorrhea; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Risk Factors; Treatment Outcome | 2003 |
A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Placebos; Pregnancy; Pregnancy Trimester, First; Treatment Outcome | 2003 |
[Development of serial clinical study on mifepristone used as contraception].
Topics: Adult; Contraception; Contraceptives, Oral; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Mifepristone; Pregnancy; Pregnancy Rate | 2003 |
A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Treatment Outcome | 2003 |
The effect of mifepristone on the expression of steroid hormone receptors in human decidua and placenta: a randomized placebo-controlled double-blind study.
Topics: Abortifacient Agents, Steroidal; Adult; Androgen Receptor Antagonists; Decidua; Double-Blind Method; Female; Humans; Immunohistochemistry; Mifepristone; Placebos; Placenta; Pregnancy; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid | 2003 |
Expanded clinical trial of emergency contraception with 10 mg mifepristone.
Topics: Adult; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Dose-Response Relationship, Drug; Female; Humans; Mifepristone; Pregnancy | 2003 |
Combined estimates of effectiveness of mifepristone 10 mg in emergency contraception.
Topics: Adult; Contraceptives, Oral; Contraceptives, Postcoital, Synthetic; Female; Humans; Mifepristone; Pregnancy; Randomized Controlled Trials as Topic; Time Factors | 2003 |
Luteal phase treatment with mifepristone and misoprostol for fertility regulation.
Topics: Adult; Contraception; Contraceptives, Oral; Contraceptives, Postcoital, Synthetic; Drug Therapy, Combination; Female; Humans; Luteal Phase; Mifepristone; Misoprostol; Pregnancy | 2003 |
Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Dilatation and Curettage; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pilot Projects; Pregnancy; Pregnancy Trimester, Second; Treatment Outcome | 2004 |
[Use of Misoprostol for medical abortion: a trial of the acceptability for home use].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Home Nursing; Humans; Mifepristone; Misoprostol; Pregnancy; Self Administration; Surveys and Questionnaires | 2004 |
Medical abortion in combination with laminaria for first-trimester termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Laminaria; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies | 2004 |
Mifepristone: effect on plasma corticotropin-releasing hormone, adrenocorticotropic hormone, and cortisol in term pregnancy.
Topics: Adrenocorticotropic Hormone; Adult; Corticotropin-Releasing Hormone; Female; Hormone Antagonists; Humans; Hydrocortisone; Labor, Obstetric; Mifepristone; Pregnancy; Randomized Controlled Trials as Topic | 2004 |
Low-dose mifepristone for contraception: a weekly versus planned postcoital randomized pilot study.
Topics: Adolescent; Adult; Contraceptives, Postcoital, Synthetic; Drug Administration Schedule; Female; Humans; Menstruation; Mifepristone; Ovulation; Pilot Projects; Pregnancy; Pregnancy, Unwanted; Progesterone; Treatment Failure | 2004 |
Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levonorgestrel; Mifepristone; Pregnancy; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2004 |
Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; Capsules; China; Double-Blind Method; Drug Administration Schedule; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Tablets; Treatment Outcome | 2004 |
Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Patient Participation; Pregnancy; Sensitivity and Specificity; Treatment Outcome; Ultrasonography | 2004 |
[Medical treatment of ectopic pregnancy: a randomized clinical trial comparing metotrexate-mifepristone and methotrexate-placebo].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Gestational Age; Humans; Methotrexate; Mifepristone; Placebos; Pregnancy; Pregnancy, Ectopic; Progesterone | 2004 |
Medical versus surgical abortion efficacy, complications and leave of absence compared in a partly randomized study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Denmark; Female; Humans; Mifepristone; Postoperative Complications; Pregnancy; Sick Leave; Surveys and Questionnaires; Treatment Outcome; Vacuum Curettage | 2004 |
[Clinical observation on treatment of unruptured heterotopic pregnancy by combined use of Chinese and Western medicine].
Topics: Adult; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Medicine, Chinese Traditional; Methotrexate; Mifepristone; Phytotherapy; Pregnancy; Pregnancy, Ectopic | 2004 |
Medical versus surgical abortion: comparing satisfaction and potential confounders in a partly randomized study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Choice Behavior; Female; Gestational Age; Humans; Mifepristone; Patient Satisfaction; Pregnancy; Treatment Failure | 2005 |
Use of mifepristone to ripen the cervix and induce labor in term pregnancies.
Topics: Abortifacient Agents, Steroidal; Administration, Oral; Adult; Cervical Ripening; Double-Blind Method; Drug Administration Schedule; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Prospective Studies; Treatment Outcome | 2005 |
Effect of antiprogesterone mifepristone followed by misoprostol on circulating leptin in early pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Cohort Studies; Corpus Luteum; Double-Blind Method; Estradiol; Female; Humans; Leptin; Mifepristone; Misoprostol; Monitoring, Physiologic; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Pregnancy, Unwanted; Probability; Progesterone; Radioimmunoassay; Risk Assessment; Treatment Outcome | 2005 |
Multicenter trial of a simplified mifepristone medical abortion regimen.
Topics: Abortion, Therapeutic; Administration, Oral; Adult; Combined Modality Therapy; Dilatation and Curettage; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gestational Age; Humans; Logistic Models; Maternal Age; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Probability; Prospective Studies; Risk Assessment; Single-Blind Method; Treatment Outcome | 2005 |
A randomized comparison of oral mifepristone to intravenous oxytocin for labor induction in women with prelabor rupture of membranes beyond 36 weeks' gestation.
Topics: Administration, Oral; Adult; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Neonatal; Labor, Induced; Mifepristone; Oxytocin; Pregnancy | 2005 |
Early medical abortion: a new regimen up to 49 days' gestation.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 2005 |
A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adult; Drug Combinations; Female; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Time Factors | 2005 |
A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Adult; Analgesics; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Treatment Outcome | 2005 |
[The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Gestational Age; Hospitals; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Self Administration; Treatment Outcome | 2005 |
A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Gestational Age; Humans; Menstruation-Inducing Agents; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Time Factors | 2005 |
A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Administration, Sublingual; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Prospective Studies | 2005 |
Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage.
Topics: Abortion, Habitual; Cells, Cultured; Cytokines; Dydrogesterone; Enzyme-Linked Immunosorbent Assay; Female; Hormone Antagonists; Humans; Interferon-gamma; Interleukin-4; Interleukin-6; Mifepristone; Pregnancy; Pregnancy Proteins; Prospective Studies; Suppressor Factors, Immunologic; Th1 Cells; Th2 Cells; Tumor Necrosis Factors; Up-Regulation | 2005 |
A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Administration, Sublingual; Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Treatment Outcome | 2005 |
The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation.
Topics: Abdominal Pain; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Acetaminophen; Administration, Intravaginal; Adult; Anti-Inflammatory Agents, Non-Steroidal; Codeine; Diclofenac; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, Second | 2005 |
Evaluation of the efficacy of mifepristone/misoprostol and methotrexate/misoprostol for medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Chi-Square Distribution; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Treatment Outcome | 2005 |
Randomised controlled trial comparing efficacy of same day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36- to 48-hour protocol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Clinical Protocols; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Treatment Outcome; Uterine Hemorrhage | 2005 |
Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Double-Blind Method; Female; Hemorrhage; Humans; Mifepristone; Misoprostol; Pregnancy; Time Factors | 2005 |
Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Administration, Intravaginal; Adolescent; Adult; Chi-Square Distribution; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Prospective Studies | 2005 |
Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Administration, Topical; Analgesics; Female; Humans; Mifepristone; Misoprostol; Nausea; Pain; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Uterine Hemorrhage; Vagina; Vomiting | 2005 |
Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Female; France; Humans; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pilot Projects; Pregnancy; Sweden | 2005 |
Comparison of three single doses of mifepristone as emergency contraception: a randomised controlled trial.
Topics: Administration, Oral; Adult; Australia; Contraception, Postcoital; Contraceptives, Postcoital, Synthetic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Emergencies; Female; Humans; Menstrual Cycle; Middle Aged; Mifepristone; Pregnancy; Pregnancy Rate; Probability; Reference Values; Risk Assessment; Treatment Outcome | 2005 |
Bleeding after medication-induced termination of pregnancy with two dosing schedules of mifepristone and misoprostol.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Time Factors; Uterine Hemorrhage | 2006 |
Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Treatment Outcome; Uterine Hemorrhage | 2006 |
A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Female; Humans; Incidence; Infections; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Treatment Outcome; Vacuum Curettage | 2006 |
A randomized prospective study of misoprostol or mifepristone followed by misoprostol when needed for the treatment of women with early pregnancy failure.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Missed; Adult; Drug Combinations; Female; Hormone Antagonists; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Treatment Outcome | 2006 |
Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pilot Projects; Pregnancy; Treatment Outcome | 2006 |
Use of mifepristone and sublingual misoprostol for early medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2006 |
Concurrent use of mifepristone and misoprostol for early medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2006 |
Are two doses of misoprostol after mifepristone for early abortion better than one?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Amenorrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Treatment Outcome | 2007 |
Predictors of acceptability of medication abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Parity; Patient Acceptance of Health Care; Pregnancy; Treatment Failure; Uterine Hemorrhage | 2007 |
Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Dilatation and Curettage; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Prospective Studies; Treatment Outcome | 2007 |
Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Treatment Outcome | 2007 |
Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 2007 |
Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Treatment Outcome | 2007 |
Emergency contraception in Cuba with 10 mg of mifepristone.
Topics: Adult; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Cuba; Female; Humans; Menstruation; Mifepristone; Pregnancy; Time Factors; Treatment Outcome | 2007 |
Arrest of preterm labor in rat and mouse by an oral and selective nonprostanoid antagonist of the prostaglandin F2alpha receptor (FP).
Topics: Animals; Biphenyl Compounds; Drug Therapy, Combination; Female; Humans; Mice; Mifepristone; Obstetric Labor, Premature; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin; Ritodrine; Sulfonamides; Tocolytic Agents; Treatment Outcome; Uterine Contraction | 2007 |
Uterine activity after oral mifepristone administration in human pregnancies beyond 41 weeks' gestation.
Topics: Abortifacient Agents, Steroidal; Administration, Oral; Adult; Cervical Ripening; Double-Blind Method; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy, Prolonged; Uterine Contraction | 2008 |
Mifepristone versus laminaria: a randomized controlled trial of cervical ripening in midtrimester termination.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cervical Ripening; Female; Humans; Labor, Induced; Laminaria; Mifepristone; Misoprostol; Pain; Pregnancy; Pregnancy Trimester, Second; Time Factors | 2007 |
Mifepristone in second-trimester medical abortion: a randomized controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adult; Digoxin; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Treatment Outcome | 2007 |
Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Administration, Intravaginal; Adolescent; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Treatment Outcome | 2007 |
Efficacy of simultaneous use of mifepristone and misoprostol for early abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Adolescent; Adult; Drug Administration Schedule; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Oxytocics; Parity; Pregnancy | 2008 |
Alterations in saliva steroid hormone levels after oral mifepristone administration in women with pregnancies of greater than 41 weeks' gestation.
Topics: Administration, Oral; Adult; Cervical Ripening; Estradiol; Estriol; Female; Humans; Hydrocortisone; Labor, Induced; Mifepristone; Pregnancy; Pregnancy, Prolonged; Progesterone; Radioimmunoassay; Saliva; Statistics, Nonparametric | 2008 |
A comparative analysis of fall in haemoglobin following abortions conducted by mifepristone (600 mg) and vacuum aspiration.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Dinoprostone; Drug Combinations; Female; Hemoglobins; Humans; Metrorrhagia; Mifepristone; Multivariate Analysis; Pregnancy; Suction; Vacuum | 1995 |
Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; Alprostadil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pessaries; Pregnancy; Treatment Outcome | 1995 |
Reducing the induction to abortion interval in termination of second trimester pregnancies: a comparison of mifepristone with laminaria tent.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Legal; Adolescent; Adult; Alprostadil; Female; Humans; Laminaria; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Time Factors | 1995 |
Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05--a multicentre randomized clinical trial in China.
Topics: Abdominal Pain; Abortion, Induced; Administration, Oral; Adolescent; Adult; China; Diarrhea; Dinoprost; Dose-Response Relationship, Drug; Female; Humans; Mifepristone; Misoprostol; Pessaries; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage | 1994 |
Methotrexate and misoprostol for abortion at 57-63 days gestation.
Topics: Abortion, Induced; Acetaminophen; Administration, Oral; Adult; Chorionic Gonadotropin; Codeine; Colic; Drug Therapy, Combination; Female; Humans; Ibuprofen; Injections, Intramuscular; Methotrexate; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Time Factors | 1994 |
[Termination of early pregnancy by two regimens of mifepristone with misoprostol: a multicentre clinical trial].
Topics: Abortion, Induced; Adolescent; Adult; Carboprost; Drug Synergism; Female; Humans; Mifepristone; Misoprostol; Pessaries; Pregnancy; Pregnancy Trimester, First | 1994 |
[A study on the optimal regimen of mifepristone with prostaglandin for termination of early pregnancy].
Topics: Abortion, Induced; Adult; Dinoprost; Drug Therapy, Combination; Female; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, First | 1995 |
[The pathological investigations on termination of early pregnancy with mifepristone].
Topics: Abortion, Induced; Adult; Chorionic Villi; Decidua; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 1995 |
Menstrual regulation by mifepristone plus prostaglandin: results from a multicentre trial. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation.
Topics: Abortion, Induced; Alprostadil; Drug Therapy, Combination; Female; Hemoglobins; Humans; Menstrual Cycle; Menstruation Disturbances; Mifepristone; Pregnancy; Prostaglandins E, Synthetic; Treatment Outcome; World Health Organization | 1995 |
Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens.
Topics: Abortion, Induced; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Time Factors | 1995 |
Effects of mifepristone and progesterone on collagen synthesis in the human uterine cervix.
Topics: Abortion, Induced; Adult; Carbon Radioisotopes; Cervix Uteri; Collagen; Female; Humans; Mifepristone; Pregnancy; Progesterone; Proline | 1995 |
Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Anesthesia, General; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Prospective Studies; Vacuum Curettage | 1994 |
Cervical ripening with mifepristone (RU 486) in late first trimester abortion. World Health Organization Task Force on Postovulatory Methods of Fertility Regulation.
Topics: Abortion, Induced; Adult; Cervix Uteri; Double-Blind Method; Female; Humans; Mifepristone; Placebos; Pregnancy | 1994 |
A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae.
Topics: Abortion, Induced; Alprostadil; Female; Humans; Mifepristone; Postoperative Complications; Pregnancy; Vacuum Curettage | 1994 |
Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.
Topics: Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Confidence Intervals; Diarrhea; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Vomiting | 1995 |
[Embryo expulsion induction in first trimester miscarriages. Use of mifepristone (RU 486) in a double blind prospective randomized study].
Topics: Abortion, Incomplete; Abortion, Induced; Administration, Oral; Adult; Double-Blind Method; Emergencies; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Treatment Outcome; Ultrasonography | 1993 |
Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.
Topics: Abortion, Induced; Administration, Oral; Blood Pressure; Drug Combinations; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 1994 |
RU486: the French experience.
Topics: Abdominal Pain; Abortion, Induced; Adult; Alprostadil; Contraindications; Dinoprostone; Female; France; Humans; Hypotension; Mifepristone; Misoprostol; Myocardial Infarction; Pilot Projects; Pregnancy; Uterine Hemorrhage | 1994 |
[RU 486 and sulprostone in pregnancy termination in the 2nd and 3rd trimesters].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Adult; Clinical Protocols; Dinoprostone; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Time Factors | 1994 |
Mifepristone for labour induction after previous caesarean section.
Topics: Adult; Double-Blind Method; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Prospective Studies; Treatment Outcome; Vaginal Birth after Cesarean | 1994 |
A multicentre clinical trial with RU 486 followed by 9-methylene-PGE2 vaginal gel for termination of early pregnancy: a dose-finding study. Indian Council of Medical Research Task Force on Hormonal Contraception.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortion, Induced; Adult; Female; Gels; Humans; Mifepristone; Pregnancy; Vagina | 1994 |
Cervical smooth muscle contractile activity after treatment with mifepristone and progesterone.
Topics: Abortion, Induced; Adult; Cervix Uteri; Dilatation and Curettage; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone | 1994 |
Tissue and serum levels of steroid hormones and RU 486 after administration of mifepristone.
Topics: Abortion, Induced; Adult; Chromatography, High Pressure Liquid; Cytosol; Decidua; Estradiol; Female; Humans; Hydrocortisone; Mifepristone; Pregnancy; Progesterone; Radioimmunoassay; Testosterone | 1994 |
Dose and time dependent rise of plasma cortisol following administration of mifepristone in early pregnancy.
Topics: Abortion, Induced; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Mifepristone; Pregnancy; Pregnancy Trimester, First; Time Factors | 1993 |
The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol.
Topics: Abortion, Induced; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Treatment Outcome | 1993 |
The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
Topics: Abortifacient Agents, Nonsteroidal; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Alprostadil; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pessaries; Pregnancy; Pregnancy Trimester, Second | 1993 |
Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mifepristone; Pessaries; Pregnancy; Treatment Outcome | 1993 |
Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Choice Behavior; Female; Humans; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Pregnant Women; Vacuum Curettage | 1993 |
Pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant women.
Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Female; Humans; Mifepristone; Molecular Structure; Pregnancy | 1993 |
Cervical ripening with mifepristone (RU 486) in first trimester abortion. An electron microscope study.
Topics: Abortion, Induced; Adult; Cervix Uteri; Double-Blind Method; Female; Humans; Microscopy, Electron; Mifepristone; Pregnancy; Pregnancy Trimester, First; Reference Values | 1993 |
The effect of RU486 on progesterone and oestrogen receptor concentration in human decidua on early pregnancy.
Topics: Cell Nucleus; Cytosol; Decidua; Female; Humans; Kinetics; Mifepristone; Pregnancy; Receptors, Estrogen; Receptors, Progesterone | 1993 |
Blood loss in termination of early pregnancy by vacuum aspiration and by combination of mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Adult; Alprostadil; Dose-Response Relationship, Drug; Female; Hemoglobins; Humans; Mifepristone; Pregnancy; Suction; Uterine Hemorrhage | 1993 |
Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Dinoprostone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Humans; Injections, Intramuscular; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Time Factors | 1993 |
Changes in adrenergic receptors in the pregnant human uterine cervix following mifepristone or placebo treatment in the first trimester.
Topics: Adolescent; Adult; Cervix Uteri; Double-Blind Method; Female; Humans; Mifepristone; Placebos; Pregnancy; Pregnancy Trimester, Third; Receptors, Adrenergic | 1993 |
[The value of RU-486 (mifepristone) in medical indications of the induction of labor at term. Results of a double-blind randomized prospective study (RU-486 versus placebo)].
Topics: Adult; Apgar Score; Cervix Uteri; Cesarean Section; Dinoprostone; Double-Blind Method; Female; Gestational Age; Humans; Infant, Newborn; Labor, Induced; Mifepristone; Oxytocics; Oxytocin; Placebos; Pregnancy; Pregnancy Outcome; Prospective Studies; Uterine Contraction | 1993 |
Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial.
Topics: Abortion, Missed; Adult; Double-Blind Method; Female; Humans; Mifepristone; Placebos; Pregnancy; Prospective Studies; Uterine Hemorrhage | 1993 |
Blood loss in termination of early pregnancy with mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Alprostadil; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage | 1995 |
[Histological study of uterine cervix during termination of early pregnancy by mifepristone and prostaglandins].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Carboprost; Cervix Uteri; Drug Synergism; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 1995 |
Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [corrected].
Topics: Abortifacient Agents; Adolescent; Adult; Amenorrhea; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; France; Hemostatic Techniques; Humans; Incidence; Menstruation-Inducing Agents; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Ectopic; Time Factors; Ultrasonography; Uterine Hemorrhage; Uterus | 1995 |
Mifepristone (RU 486) induces parturition in primiparous beef heifers and reduces incidence of dystocia.
Topics: Animals; Cattle; Cattle Diseases; Dystocia; Female; Incidence; Labor, Obstetric; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Radioimmunoassay; Relaxin | 1995 |
A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 1996 |
Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Alprostadil; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1996 |
[Mifepristone and misoprostol in therapeutic abortions].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adult; Drug Costs; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Time Factors; Treatment Outcome | 1996 |
Termination of early human pregnancy with either 50 mg or 200 mg single oral dose of mifepristone (RU486) in combination with either 0.5 mg or 1.0 mg vaginal gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Alprostadil; Double-Blind Method; Drug Combinations; Female; Humans; Mifepristone; Pregnancy; Prospective Studies; Treatment Outcome | 1996 |
Determination of RU486 (mifepristone) in blood by radioreceptorassay; a pharmacokinetic study.
Topics: Biological Availability; Female; Half-Life; Humans; Kinetics; Mifepristone; Myometrium; Pregnancy; Radioligand Assay; Receptors, Progesterone | 1996 |
A randomised study of two doses of gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Alprostadil; Dose-Response Relationship, Drug; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Time Factors | 1996 |
Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective randomised study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adult; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Tablets; Uterine Hemorrhage; Vacuum Extraction, Obstetrical | 1996 |
[Tumor necrosis factor and induced labor].
Topics: Abortifacient Agents, Steroidal; Adult; Animals; Double-Blind Method; Female; Humans; Labor, Induced; Mice; Mifepristone; Oxytocin; Pregnancy; Time Factors; Tumor Necrosis Factor-alpha | 1997 |
Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Adult; China; Cuba; Developing Countries; Female; Humans; India; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Patient Participation; Pregnancy; Pregnant Women; Research Design; Risk Assessment; Treatment Failure | 1997 |
[A phase III multicentre study on medical termination of early pregnancy with two regimens of mifepristone followed by PG05].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Carboprost; Female; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, First | 1996 |
Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Choice Behavior; Female; Follow-Up Studies; Health Status; Humans; Mental Health; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Reproductive Medicine; Vacuum Extraction, Obstetrical | 1997 |
[Emergency contraception with mifepristone and anordrin].
Topics: Adult; Contraceptives, Postcoital, Synthetic; Drug Synergism; Female; Humans; Mifepristone; Norandrostanes; Pregnancy | 1996 |
Unsuccessful treatment of missed abortion with a combination of an antiprogesterone and a prostaglandin E1 analogue.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Administration, Oral; Drug Combinations; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Treatment Failure | 1997 |
Women's satisfaction with medical abortion with RU486.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion Applicants; Abortion, Induced; Adult; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy | 1997 |
Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Premedication; Prospective Studies; Time Factors | 1997 |
[Mifepristone for induction of labor].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adult; Carboprost; Female; Humans; Labor, Induced; Mifepristone; Oxytocin; Pregnancy; Pregnancy Trimester, Third | 1996 |
Early pregnancy termination with mifepristone and misoprostol in the United States.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Receptors, Progesterone; Treatment Failure; United States; Uterine Hemorrhage | 1998 |
[Evaluation of combination RU 486-laminaria tents-misoprostol-peridural anesthesia in second and third trimester induced abortions].
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Analgesia, Epidural; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Laminaria; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Time Factors | 1998 |
Mifepristone in combination with methotrexate for the medical treatment of tubal pregnancy: a randomized, controlled trial.
Topics: Adult; Chorionic Gonadotropin; Drug Therapy, Combination; Female; Hormone Antagonists; Humans; Laparotomy; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Tubal; Progestins | 1998 |
Treating ectopic pregnancy with the combination of mifepristone and methotrexate: a phase II nonrandomized study.
Topics: Abortifacient Agents, Steroidal; Adult; Chorionic Gonadotropin; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic; Risk; Treatment Failure | 1998 |
Cervical ripening with mifepristone before labor induction: a randomized study.
Topics: Abortifacient Agents, Steroidal; Adult; Apgar Score; Cervical Ripening; Double-Blind Method; Female; Humans; Hydrocortisone; Infant, Newborn; Mifepristone; Pregnancy | 1998 |
[Determination of fetal umbilical artery flow velocity during induction of term labor by mifepristone].
Topics: Abortifacient Agents, Steroidal; Adult; Blood Flow Velocity; Female; Humans; Labor, Induced; Mifepristone; Placenta; Pregnancy; Pregnancy Trimester, Third; Random Allocation; Umbilical Arteries | 1997 |
A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Blood Cell Count; Contraceptives, Oral, Combined; Female; Humans; Menstrual Cycle; Methotrexate; Mifepristone; Pessaries; Pregnancy; Prostaglandins; Uterine Hemorrhage | 1998 |
The effects of mifepristone on cervical ripening and labor induction in primigravidae.
Topics: Adolescent; Adult; Cervical Ripening; Double-Blind Method; Female; Gravidity; Humans; Hypoglycemia; Infant, Newborn; Labor, Induced; Maternal-Fetal Exchange; Mifepristone; Pregnancy; Risk Factors | 1998 |
An effective regimen for early medical abortion: a report of 2000 consecutive cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Adolescent; Adult; Analgesia; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Treatment Outcome | 1998 |
Contraceptive efficacy of low doses of mifepristone.
Topics: Adult; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Embryo Implantation; Endometrium; Female; Humans; Menstrual Cycle; Mifepristone; Pregnancy; Reference Values; Treatment Outcome | 1998 |
Blood loss with mifepristone--misoprostol abortion: measures from a trial in China, Cuba and India.
Topics: Abortifacient Agents; Abortion, Therapeutic; Adult; Blood Loss, Surgical; Cuba; Feasibility Studies; Female; Humans; India; Logistic Models; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Software; Uterine Hemorrhage | 1998 |
Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Task Force on Postovulatory Methods of Fertility Regulation.
Topics: Adult; Contraceptives, Postcoital, Synthetic; Dose-Response Relationship, Drug; Drug Administration Schedule; Emergencies; Female; Humans; Mifepristone; Pregnancy | 1999 |
Medical versus surgical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Chi-Square Distribution; Cuba; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Software; Treatment Outcome; Vacuum Curettage | 1998 |
Once-a-month treatment with a combination of mifepristone and the prostaglandin analogue misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Drug Administration Schedule; Drug Combinations; Female; Humans; Luteinizing Hormone; Menstrual Cycle; Menstruation-Inducing Agents; Mifepristone; Misoprostol; Pregnancy; Prostaglandins; Treatment Outcome | 1999 |
A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Missed; Adult; Contraceptives, Oral; Double-Blind Method; Female; Hemoglobins; Humans; Mifepristone; Misoprostol; Placebos; Pregnancy; Time Factors; Uterine Hemorrhage | 1999 |
[Clinical and experimental studies on qumotang for bleeding after medical abortion in 214 cases].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Animals; Drugs, Chinese Herbal; Female; Humans; Mifepristone; Pregnancy; Rabbits; Uterine Contraction; Uterine Hemorrhage | 1997 |
Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Prospective Studies; Self Administration; Ultrasonography; United States; United States Food and Drug Administration; Uterus | 1999 |
Randomised trial comparing expectant with medical management for first trimester miscarriages.
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Ambulatory Care; Chorionic Gonadotropin; Female; Humans; Length of Stay; Mifepristone; Pain; Placenta, Retained; Pregnancy; Pregnancy Trimester, First; Progesterone | 1999 |
Induction of labor with mifepristone--a randomized, double-blind study versus placebo.
Topics: Adult; Apgar Score; Cervical Ripening; Dinoprostone; Double-Blind Method; Female; Fetal Blood; Hormone Antagonists; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Labor, Induced; Mifepristone; Odds Ratio; Pregnancy; Pregnancy Outcome; Prospective Studies; Time Factors; Treatment Outcome | 1999 |
Interruption of early pregnancy with mifepristone in combination with gemeprost.
Topics: Abdominal Pain; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Time Factors; Treatment Outcome; Uterine Hemorrhage | 1999 |
Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Cohort Studies; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Sodium Chloride; Tablets; Treatment Outcome | 1999 |
[Effect of mifepristone on the concentration of epidermal growth factor in serum and villi of early pregnant women].
Topics: Abortifacient Agents, Steroidal; Adult; Chorionic Villi; Epidermal Growth Factor; Estradiol; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone | 1998 |
Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Surveys and Questionnaires; Treatment Outcome | 2000 |
The effect of mifepristone administration on leukocyte populations, matrix metalloproteinases and inflammatory mediators in the first trimester cervix.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Cervix Uteri; Chemokines; Female; Humans; Inflammation; Leukocyte Common Antigens; Leukocyte Elastase; Leukocytes; Matrix Metalloproteinases; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Tissue Inhibitor of Metalloproteinases | 2000 |
Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration.
Topics: Abortion, Induced; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Uterine Hemorrhage; Vacuum Curettage; Vacuum Extraction, Obstetrical | 2000 |
In-depth interviews with medical abortion clients: thoughts on the method and home administration of misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Home Care Services; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Self Medication; Social Support | 2000 |
Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Female; Humans; Mifepristone; Parity; Pessaries; Pregnancy; Pregnancy Trimester, Second; Time Factors | 2000 |
Early abortion by mifepristone (RU 486) followed by vaginal gel (meteneprost) versus oral (misoprostol) prostaglandin.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 1999 |
Mifepristone for preinduction cervical ripening beyond 41 weeks' gestation: a randomized controlled trial.
Topics: Adult; Cervical Ripening; Cesarean Section; Double-Blind Method; Female; Humans; Labor, Induced; Mifepristone; Misoprostol; Oxytocics; Oxytocin; Pregnancy; Pregnancy, Prolonged | 2000 |
Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Diarrhea; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 2000 |
Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Cervix Uteri; Dilatation; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Vagina | 2000 |
Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Time Factors | 2000 |
A multicentre randomized comparative clinical trial of 200 mg RU486 (mifepristone) single dose followed by either 5 mg 9-methylene PGE(2) gel (meteneprost) or 600 microg oral PGE(1) (misoprostol) for termination of early pregnancy within 28 days of missed
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortion, Therapeutic; Adolescent; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Menstrual Cycle; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Pregnancy | 2000 |
A randomized comparison of mifepristone and self-administered oral or vaginal misoprostol for early abortion.
Topics: Abortifacient Agents; Administration, Intravaginal; Administration, Oral; Adult; Female; Humans; Mifepristone; Misoprostol; Pain Measurement; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Self Administration; Time Factors; Treatment Outcome | 2000 |
A comparative study of surgical and medical procedures: 932 pregnancy terminations up to 63 days gestation.
Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Legal; Adolescent; Adult; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Parity; Pregnancy; Retrospective Studies | 2001 |
Termination of early pregnancy in the scarred uterus with mifepristone and misoprostol.
Topics: Abortifacient Agents; Abortion, Therapeutic; Adult; Cesarean Section; Cicatrix; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Uterus | 2001 |
Timing of pain and bleeding after mifepristone-induced abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Administration Schedule; Dysmenorrhea; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Statistics, Nonparametric; Time Factors; Uterine Hemorrhage | 2000 |
Analgesia during at-home use of misoprostol as part of a medical abortion regimen.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Analgesics, Opioid; Female; Gestational Age; Gravidity; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Regression Analysis; Time Factors | 2000 |
[Termination of 10-16 weeks's gestation with mifepristone plus misoprostol: a multicentre randomized clinical trial].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second | 1999 |
Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost. A randomized controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Alprostadil; China; Double-Blind Method; Drug Administration Schedule; Europe; Female; Georgia (Republic); Hong Kong; Humans; India; Mifepristone; Pregnancy; Pregnancy Trimester, First; Slovenia; Treatment Outcome; United States | 2001 |
Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: report of a randomised trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Treatment Outcome | 2001 |
Feasibility of administering mifepristone as a once a month contraceptive pill.
Topics: Adolescent; Adult; Coitus; Contraceptives, Oral; Feasibility Studies; Female; Humans; Luteal Phase; Luteinizing Hormone; Menstrual Cycle; Mifepristone; Ovulation; Pregnancy; Probability; Progesterone; Time Factors; Treatment Failure | 2001 |
First trimester abortion with mifepristone and vaginal misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Denmark; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First | 2001 |
Mifepristone and misoprostol for early abortion when no gestational sac is present.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Chorionic Gonadotropin; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Pregnancy, Ectopic; Prospective Studies; Ultrasonography; Uterus | 2001 |
Lowering the doses of mifepristone and gameprost for early abortion: a randomised controlled trial. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Alprostadil; Double-Blind Method; Female; Humans; Mifepristone; Pregnancy; Treatment Outcome | 2001 |
Mifepristone 100 mg in abortion regimens.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2001 |
Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adult; Alprostadil; Double-Blind Method; Drug Synergism; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 2001 |
Early pregnancy termination with mifepristone and misoprostol in Norway.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Acetaminophen; Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Codeine; Female; Humans; Mifepristone; Misoprostol; Norway; Pain Measurement; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Treatment Outcome | 2001 |
Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Regression Analysis; Treatment Outcome | 2001 |
Mifepristone followed on the same day by vaginal misoprostol for early abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adult; Dilatation and Curettage; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Time Factors; Ultrasonography | 2001 |
[Study on weekly low doses of mifepristone for contraception].
Topics: Adult; Contraception; Contraceptives, Oral, Synthetic; Female; Humans; Mifepristone; Ovulation; Pregnancy | 2001 |
A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Anesthesia, General; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Postoperative Complications; Pregnancy; Treatment Outcome; Vacuum Curettage | 2002 |
The effect of contraceptive pills on the measured blood loss in medical termination of pregnancy by mifepristone and misoprostol: a randomized placebo controlled trial.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Contraceptives, Oral; Female; Hemoglobins; Humans; Mifepristone; Misoprostol; Placebos; Pregnancy; Uterine Hemorrhage | 2002 |
Tissue-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA and their protein expression levels in human decidua after early pregnancy termination by mifepristone plus misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Chromogenic Compounds; Decidua; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Humans; Mifepristone; Misoprostol; Plasminogen Activator Inhibitor 1; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Plasminogen Activator | 2001 |
Mifepristone abortion in minors.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Contraceptives, Postcoital; Drug Administration Schedule; Female; Humans; Mifepristone; New York; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Stress, Physiological; Surveys and Questionnaires | 2001 |
Could American women use mifepristone-misoprostol pills safely with less medical supervision?
Topics: Abortion, Induced; Adolescent; Adult; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Physician's Role; Pregnancy; Pregnancy Tests; Self Administration | 2002 |
Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Hemorrhage; Humans; Methotrexate; Mifepristone; Misoprostol; Pain; Pregnancy | 2002 |
A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Double-Blind Method; Drug Synergism; Female; Humans; Mifepristone; Misoprostol; Nausea; Pregnancy; Prospective Studies | 2002 |
A randomised study comparing a low dose of mifepristone and the Yuzpe regimen for emergency contraception.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Postcoital, Synthetic; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Mifepristone; Ovulation; Patient Satisfaction; Pregnancy; Treatment Outcome | 2002 |
Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Administration, Sublingual; Adult; Drug Synergism; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Pregnancy Trimester, First | 2002 |
Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Dinoprostone; Drug Evaluation; Female; France; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1992 |
A randomized clinical trial of mifepristone (RU486) for induction of delayed menses: efficacy and acceptability.
Topics: Abortion, Induced; Administration, Oral; Adolescent; Adult; Double-Blind Method; Female; Follow-Up Studies; Humans; Menstruation; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First | 1992 |
A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Female; Humans; Middle Aged; Mifepristone; Pessaries; Polymers; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 1992 |
Early changes of affinity and binding sites of progesterone and oestrogen receptors in decidua exposed to RU 486.
Topics: Binding Sites; Cell Nucleus; Cytosol; Decidua; Female; Humans; Mifepristone; Pregnancy; Receptors, Estrogen; Receptors, Progesterone; Time Factors | 1992 |
Labor induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study.
Topics: Adult; Double-Blind Method; Female; Humans; Infant, Newborn; Labor, Induced; Labor, Obstetric; Mifepristone; Pregnancy; Pregnancy Outcome; Treatment Outcome | 1992 |
Clinical trial on termination of early pregnancy with RU486 in combination with prostaglandin.
Topics: Abortion, Incomplete; Abortion, Induced; Administration, Oral; Adolescent; Adult; Carboprost; Female; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, First | 1992 |
Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Danazol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Middle Aged; Mifepristone; Nausea; Pregnancy; Treatment Outcome; Vomiting | 1992 |
What do women want during medical abortion?
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Acetaminophen; Administration, Oral; Adolescent; Adult; Alprostadil; Bias; Codeine; Female; Heroin; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pessaries; Pregnancy | 1992 |
Should we use prostaglandins, tents or progesterone antagonists for cervical ripening before first trimester abortion?
Topics: Abortion, Induced; Adolescent; Adult; Biocompatible Materials; Cervix Uteri; Cohort Studies; Dilatation; Female; Humans; Magnesium Sulfate; Mifepristone; Polyvinyl Alcohol; Pregnancy; Pregnancy Trimester, First; Prostaglandins | 1992 |
Medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Female; Humans; Mifepristone; Pregnancy | 1992 |
Cervical softening with mifepristone (RU 486) after pretreatment with naproxen. A double-blind randomized study.
Topics: Abortion, Induced; Administration, Oral; Adolescent; Adult; Cervix Uteri; Dilatation; Double-Blind Method; Drug Interactions; Female; Humans; Mifepristone; Naproxen; Pregnancy; Pregnancy Trimester, First; Time Factors | 1992 |
Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
Topics: Adolescent; Adult; Contraceptives, Postcoital, Hormonal; Emergencies; Ethinyl Estradiol; Female; Humans; Menstruation; Middle Aged; Mifepristone; Norgestrel; Pregnancy; Pregnancy, Unwanted; Pregnanediol; Progesterone; Random Allocation | 1992 |
Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Amenorrhea; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1992 |
[Voluntary abortion induced by mifepristone-sulprostone combination. Effect of phloroglucinol on the time required for expulsion in multipara women].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Dinoprostone; Drug Therapy, Combination; Female; Humans; Mifepristone; Parity; Phloroglucinol; Pregnancy; Uterine Contraction | 1992 |
[RU 486 (mifepristone) and therapeutic abortions in the second and third trimesters].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Oral; Adult; Cervix Uteri; Dinoprostone; Drug Therapy, Combination; Female; Humans; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third | 1992 |
Production of 12-hydroxyeicosatetraenoic acid in early pregnant uterine cervix--lack of correlation to mifepristone-induced cervical ripening. A double-blind randomized biomechanical and biochemical study.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Abortion, Induced; Adult; Cervix Uteri; Double-Blind Method; Female; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Lipoxygenase; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1992 |
Conditions for choosing between drug-induced and surgical abortions.
Topics: Abortion, Induced; Abortion, Spontaneous; Adolescent; Adult; Anesthesia, General; Anesthesia, Local; Choice Behavior; Female; France; Humans; Mifepristone; Pregnancy; Prospective Studies; Regression Analysis; Socioeconomic Factors; Surveys and Questionnaires; Vacuum Curettage | 1992 |
[Effects of preinduction by mifepristone on therapeutic abortions of the second and third trimesters induced by intravenous sulprostone].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Oral; Adult; Dinoprostone; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Premedication | 1992 |
Mifepristone for induction of labour.
Topics: Double-Blind Method; Drug Evaluation; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Uterine Cervical Incompetence | 1991 |
Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone.
Topics: Abortion, Therapeutic; Administration, Oral; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Monitoring, Physiologic; Pregnancy; Pregnancy Trimester, First; Tablets; Time Factors; Uterine Contraction | 1991 |
Peptide-containing nerves in the human pregnant uterine cervix: an immunohistochemical study exploring the effect of RU 486 (mifepristone).
Topics: Calcitonin; Calcitonin Gene-Related Peptide; Cervix Uteri; Female; Fluorescent Antibody Technique; Galanin; Humans; Mifepristone; Neuropeptide Y; Neuropeptides; Peptides; Pregnancy; Somatostatin; Substance P; Tissue Distribution; Tyrosine 3-Monooxygenase; Vasoactive Intestinal Peptide | 1990 |
Pregnancy termination with mifepristone and gemeprost: a multicenter comparison between repeated doses and a single dose of mifepristone. World Health Organization.
Topics: Abortion, Induced; Adult; Alprostadil; China; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Estradiol; Female; Hemoglobins; Humans; Hydrocortisone; Mifepristone; Peptide Fragments; Pregnancy; Progesterone; Prolactin; Prospective Studies; Random Allocation | 1991 |
Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
Topics: Abortifacient Agents, Nonsteroidal; Administration, Oral; Adolescent; Adult; Alprostadil; Cervix Uteri; Dilatation; Female; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, First; Preoperative Care; Vacuum Curettage | 1991 |
RU486 combined with PG analogs in voluntary termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Prostaglandins, Synthetic; Uterine Hemorrhage | 1991 |
[Use of mifepristone (RU 486) in pregnancy (excluding abortion on demand). The first clinical trials].
Topics: Abortion, Missed; Abortion, Therapeutic; Adult; Clinical Protocols; Female; Fetal Death; Humans; Mifepristone; Pregnancy; Treatment Outcome; Ultrasonography | 1991 |
Hormone analytical and carrier protein alternations following administration of mifepristone (RU 486) for termination of early pregnancy.
Topics: Abortion, Spontaneous; Adult; Carrier Proteins; Chorionic Gonadotropin; Estradiol; Female; Hormones; Humans; Hydrocortisone; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; Sex Hormone-Binding Globulin | 1991 |
[Contraceptive activity of RU486 and oral active prostaglandin combination].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Legal; Administration, Oral; Adult; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1991 |
Pretreatment of the primigravid uterine cervix with mifepristone 30 h prior to termination of pregnancy: a double blind study.
Topics: Abortion, Therapeutic; Adult; Cervix Uteri; Dilatation and Curettage; Double-Blind Method; Drug Administration Schedule; Female; Humans; Mifepristone; Oxytocin; Pregnancy; Pregnancy Trimester, First; Premedication | 1991 |
Mifepristone or vacuum aspiration in termination of early pregnancy.
Topics: Abortion, Incomplete; Abortion, Induced; Female; Hemoglobins; Humans; Mifepristone; Pelvic Inflammatory Disease; Pregnancy; Progesterone; Vacuum Extraction, Obstetrical | 1991 |
Effect of mifepristone on dilatation of the pregnant and non-pregnant cervix.
Topics: Administration, Oral; Adolescent; Adult; Cervix Uteri; Double-Blind Method; Drug Evaluation; Female; Humans; Middle Aged; Mifepristone; Pregnancy; Randomized Controlled Trials as Topic | 1990 |
Mifepristone (RU 486) for cervical priming prior to surgically induced abortion in the late first trimester.
Topics: Abortion, Induced; Cervix Uteri; Dilatation; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1990 |
Acetaminophen as a pain enhancer during voluntary interruption of pregnancy with mifepristone and sulprostone.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Acetaminophen; Dinoprostone; Double-Blind Method; Drug Interactions; Female; Humans; Male; Mifepristone; Pain; Pregnancy | 1990 |
Induced cervical ripening with mifepristone (RU 486) and bioconversion of arachidonic acid in human pregnant uterine cervix in the first trimester. A double-blind, randomized, biomechanical and biochemical study.
Topics: Adolescent; Adult; Arachidonic Acids; Cervix Uteri; Double-Blind Method; Drug Administration Schedule; Female; Humans; In Vitro Techniques; Mifepristone; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic | 1990 |
[Termination of early pregnancy using RU 486 alone or in combination with prostaglandin. The RU 486 Collaboration Group].
Topics: Abortion, Induced; Adult; Dinoprost; Drug Therapy, Combination; Female; Humans; Mifepristone; Multicenter Studies as Topic; Pessaries; Pregnancy; Pregnancy Trimester, First | 1990 |
RU-486 abortion drug. Back-door trial for US?
Topics: California; Clinical Trials as Topic; Female; Humans; Mifepristone; Pregnancy; United States | 1990 |
The use of mifepristone (RU 486) for cervical preparation in first trimester pregnancy termination by vacuum aspiration. World Health Organization. Task Force on Post-ovulatory Methods for Fertility Regulation.
Topics: Abortion, Induced; Adult; Cervix Uteri; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Mifepristone; Multicenter Studies as Topic; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Suction | 1990 |
The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. UK Multicentre Trial.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Legal; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Alprostadil; England; Female; Humans; Middle Aged; Mifepristone; Multicenter Studies as Topic; Pregnancy; Pregnancy Trimester, First; Prostaglandins E, Synthetic; Scotland | 1990 |
The physiological and clinical effects of progesterone inhibition with mifepristone (RU 486) in the second trimester.
Topics: Abortion, Induced; Adult; Dinoprost; Dinoprostone; Double-Blind Method; Ergonovine; Female; Humans; Mifepristone; Oxytocin; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic; Uterine Contraction | 1990 |
Induction of labor with mifepristone (RU 486) in intrauterine fetal death.
Topics: Adult; Double-Blind Method; Drug Tolerance; Female; Fetal Death; Humans; Labor, Induced; Mifepristone; Multicenter Studies as Topic; Oxytocics; Pregnancy; Time Factors | 1990 |
The effect of the anti-progestin mifepristone (RU 486) on plasma prostaglandin metabolite levels in early pregnancy and its influence on pregnancy termination.
Topics: Abortion, Induced; Administration, Oral; Adult; Dinoprost; Dinoprostone; Female; Humans; Mifepristone; Pregnancy | 1990 |
The placental transfer of mifepristone (RU 486) during the second trimester and its influence upon maternal and fetal steroid concentrations.
Topics: Aldosterone; Cortisone; Double-Blind Method; Estradiol; Female; Fetal Blood; Humans; Maternal-Fetal Exchange; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Progesterone; Random Allocation; Steroids | 1990 |
Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Double-Blind Method; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic; Time Factors | 1990 |
Emergency contragestion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Estradiol; Estrenes; Female; Humans; Menstruation-Inducing Agents; Mifepristone; Peptide Fragments; Pregnancy; Progesterone; Uterine Hemorrhage | 1987 |
Early abortion with a single dose of the antiprogestin RU-486.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Clinical Trials as Topic; Estrenes; Female; Humans; Menstrual Cycle; Mifepristone; Peptide Fragments; Pregnancy; Tablets; Time Factors; Uterine Hemorrhage | 1988 |
An antiprogestin steroid and PGE2 for an early pregnancy termination.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Clinical Trials as Topic; Dinoprostone; Female; Hemoglobins; Humans; Hydrocortisone; Mifepristone; Peptide Fragments; Pregnancy; Progesterone | 1989 |
Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Estrenes; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E; Random Allocation; Uterine Contraction | 1989 |
Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost).
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Therapeutic; Adult; Alprostadil; Chorionic Gonadotropin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrenes; Female; Humans; Mifepristone; Pessaries; Pregnancy; Random Allocation | 1989 |
Termination of pregnancy with mifepristone after intra-uterine death. Clinical and hormonal effects.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Adult; Chorionic Gonadotropin; Clinical Trials as Topic; Double-Blind Method; Estradiol; Estrenes; Female; Fetal Death; Humans; Hydrocortisone; Labor, Induced; Mifepristone; Pregnancy; Progesterone; Time Factors | 1989 |
[The medical interruption of pregnancy in France].
Topics: Abortion, Induced; Clinical Trials as Topic; Female; France; Humans; Mifepristone; Pregnancy; Prostaglandins | 1989 |
[Oral administration of an antiprogesterone (Mifepristone, RU 486) for preparing the cervix uteri for pregnancy interruption during the first trimester].
Topics: Abortion, Induced; Administration, Oral; Adult; Cervix Uteri; Dilatation; Double-Blind Method; Drug Evaluation; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic | 1989 |
RU 486 (mifepristone): clinical trials in China.
Topics: Abortion, Induced; Carboprost; Female; Humans; Mifepristone; Multicenter Studies as Topic; Pregnancy; Randomized Controlled Trials as Topic | 1989 |
Contragestion with RU 486: a new approach to postovulatory fertility control.
Topics: Animals; Clinical Trials as Topic; Female; Humans; Mifepristone; Pregnancy; Progesterone; Terminology as Topic | 1989 |
Clinical trials with RU 486 (mifepristone): an update.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Clinical Trials as Topic; Dinoprostone; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 1989 |
Mifepristone and induction of labour in second half of pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Clinical Trials as Topic; Estrenes; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Random Allocation | 1988 |
Clinical status of antiprogesterone steroids.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Biological Availability; Clinical Trials as Topic; Contraceptive Agents, Female; Corpus Luteum; Drug Evaluation; Endometrium; Estradiol; Estrenes; Ethics, Medical; Female; Humans; Hydrocortisone; Kinetics; Labor, Induced; Menopause; Menstruation; Menstruation-Inducing Agents; Mifepristone; Ovariectomy; Pituitary Hormones; Pregnancy; Progesterone; Prostaglandins; Receptors, Progesterone; Transcortin | 1985 |
Contragestion with late luteal administration of RU 486 (Mifepristone).
Topics: Abortion, Induced; Adult; Clinical Trials as Topic; Estrenes; Female; Humans; Mifepristone; Pregnancy | 1988 |
Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Estrenes; Female; Humans; Labor, Obstetric; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Random Allocation | 1988 |
Induced cervical ripening with Mifepristone in first trimester abortion. A double-blind randomized biomechanical study.
Topics: Abortion, Induced; Adult; Cervix Uteri; Combined Modality Therapy; Dilatation and Curettage; Double-Blind Method; Estrenes; Female; Humans; Mifepristone; Pregnancy; Random Allocation; Vacuum Curettage | 1988 |
Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Cervix Uteri; Dilatation and Curettage; Double-Blind Method; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Preoperative Care; Progesterone; Random Allocation | 1988 |
The antiprogestational agent RU 486 as an abortifacient in early human pregnancy: a comparison of three dose regimens.
Topics: Abortion, Induced; Adult; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Estrenes; Female; Humans; Mifepristone; Pregnancy; Time Factors | 1988 |
Fertility control with RU 486.
Topics: Abortifacient Agents; Animals; Clinical Trials as Topic; Contraceptive Agents, Female; Estrenes; Female; Humans; Mifepristone; Mitochondria; Pregnancy; Progestins; Uterus | 1987 |
Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
Topics: Abortion, Induced; Adult; Androstenols; Chorionic Gonadotropin; Estradiol; Estrenes; Female; Gestational Age; Humans; Mifepristone; Potassium; Pregnancy; Progesterone; Random Allocation; Urea | 1987 |
Pregnancy termination with a high and medium dosage regimen of RU 486.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Evaluation; Estrenes; Female; Humans; Hydrocortisone; Mifepristone; Pregnancy; Receptors, Progesterone; Uterine Hemorrhage; Vomiting | 1986 |
Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost).
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Administration, Intravaginal; Alprostadil; Drug Combinations; Estrenes; Female; Hemorrhage; Humans; Mifepristone; Nausea; Pregnancy; Pregnancy Trimester, First | 1986 |
1460 other study(ies) available for mifepristone and Pregnancy
| Article | Year |
|---|---|
Plasma concentrations and receptor binding of RU 486 and its metabolites in humans.
Topics: Binding, Competitive; Biotransformation; Cytosol; Estrenes; Female; Glucocorticoids; Humans; Kinetics; Mifepristone; Placenta; Pregnancy; Receptors, Glucocorticoid; Uterus | 1987 |
Preparation, resolution, and biological evaluation of 5-aryl-1, 2-dihydro-5H-chromeno[3,4-f]quinolines: potent, orally active, nonsteroidal progesterone receptor agonists.
Topics: Administration, Oral; Animals; Benzopyrans; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Embryo Implantation; Female; Humans; Mammary Glands, Animal; Mice; Mice, Inbred ICR; Mitosis; Molecular Conformation; Organ Size; Ovariectomy; Pregnancy; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Stereoisomerism; Uterus | 1998 |
Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore.
Topics: Administration, Oral; Animals; Cell Line; Cercopithecus; Embryo Implantation; Female; Gonanes; Hormone Antagonists; Humans; Mice; Pregnancy; Quinolines; Receptors, Progesterone; Structure-Activity Relationship | 1998 |
Antidiabetic activity of passive nonsteroidal glucocorticoid receptor modulators.
Topics: Alkaline Phosphatase; Animals; Benzylamines; Cells, Cultured; Cricetinae; Cricetulus; Dexamethasone; Female; Genes, Reporter; Glucocorticoids; Hepatocytes; Humans; Hypoglycemic Agents; Hypothalamo-Hypophyseal System; Male; Mice; Pituitary-Adrenal System; Pregnancy; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Sulfonamides; Transcriptional Activation; Tyrosine Transaminase; Uterus | 2005 |
Effect of mifepristone and lithospermum combination regimen on medical abortion in early pregnancy rats.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Lithospermum; Mifepristone; Misoprostol; Pregnancy; Rats; Rats, Sprague-Dawley | 2021 |
Network pharmacology-based study on immunomodulatory mechanism of danggui-yimucao herb pair for the treatment of RU486-induced abortion.
Topics: Abortifacient Agents; Abortion, Induced; Animals; Drugs, Chinese Herbal; Female; Herb-Drug Interactions; Humans; Male; Mice; Mifepristone; Molecular Structure; Network Pharmacology; Pregnancy; Progesterone; Th1 Cells; Th2 Cells | 2022 |
Same-day mifepristone prior to second-trimester induction termination with misoprostol: A retrospective cohort study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2022 |
Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pharmacy; Postal Service; Pregnancy; Prospective Studies | 2022 |
Predictive value of peripheral blood α1-acid glycoprotein in medical abortion outcomes with mifepristone and relativity of concentration.
Topics: Abortion, Incomplete; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Orosomucoid; Pregnancy | 2022 |
Behavioral and brain morphological analysis of non-inflammatory and inflammatory rat models of preterm brain injury.
Topics: Animals; Brain; Disease Models, Animal; Female; Hippocampus; Hypoxia-Ischemia, Brain; Infant, Premature, Diseases; Male; Mifepristone; Morris Water Maze Test; Open Field Test; Pregnancy; Premature Birth; Rats; Rats, Wistar; Reflex; Spatial Memory | 2021 |
Bleeding pattern after medical management of early pregnancy loss with mifepristone-misoprostol and its prognostic value: a prospective observational cohort study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prognosis; Prospective Studies; Uterine Hemorrhage | 2022 |
Adherence to treatment and prevalence of side effects when medical abortion is delivered via telemedicine: a prospective observational cohort study during COVID-19.
Topics: Abortion, Induced; Anti-Bacterial Agents; Antiemetics; COVID-19; Female; Headache; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Prevalence; Prospective Studies; Referral and Consultation; Telemedicine; Telephone | 2022 |
A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globally.
Topics: Abortion, Induced; Costs and Cost Analysis; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2021 |
Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls.
Topics: Abortifacient Agents; Abortion, Induced; Argentina; Cohort Studies; COVID-19; Female; Humans; Mifepristone; Misoprostol; Nigeria; Pregnancy; Prospective Studies; Self Administration; Self-Management; Surveys and Questionnaires | 2022 |
Making the case for advance provision of mifepristone and misoprostol for abortion in the United States.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; United States | 2022 |
Abortion Safety and Use with Normally Prescribed Mifepristone in Canada.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Mifepristone; Ontario; Pregnancy; Pregnancy Trimester, Second; Young Adult | 2022 |
The Excessive Regulation of Early Abortion Medication in the UK: The Case for Reform.
Topics: Abortion, Induced; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pharmaceutical Preparations; Pregnancy | 2022 |
Accuracy of self-assessment of gestational duration among people seeking abortion.
Topics: Abortion, Induced; Abortion, Spontaneous; COVID-19; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Self-Assessment | 2022 |
Expanding Access to Medication Abortions.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Legal; Adolescent; Adult; COVID-19; Criminal Law; Drug Prescriptions; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pandemics; Pharmaceutical Services, Online; Pharmacists; Pregnancy; Pregnancy Trimester, First; Risk Evaluation and Mitigation; Self Administration; Self Medication; Self-Management; Telemedicine; United States; United States Food and Drug Administration; Young Adult | 2022 |
Integrating self-managed medication abortion with medical care.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Self-Management | 2022 |
Dilation and evacuation with an abdominal cerclage at 21 weeks gestation: A case report.
Topics: Abortion, Induced; Dilatation; Female; Humans; Laminaria; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 2022 |
State Restrictions on Mifepristone Access - The Case for Federal Preemption.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Civil Rights; Federal Government; Female; Government Regulation; Humans; Legislation, Drug; Mifepristone; Pregnancy; Public Health; Reproductive Rights; State Government; United States; United States Food and Drug Administration | 2022 |
Risks of and Indications for Mifepristone for Medication Abortion.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Pregnancy | 2022 |
Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.
Topics: Abortion, Induced; Abortion, Spontaneous; Canada; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Primary Health Care | 2022 |
A cross-sectional survey of U.S. abortion patients' interest in obtaining medication abortion over the counter.
Topics: Abortion, Induced; Abortion, Spontaneous; Adolescent; Appointments and Schedules; Cross-Sectional Studies; Female; Humans; Mifepristone; Pregnancy; Surveys and Questionnaires; United States | 2022 |
Mifepristone versus balloon catheter for labor induction: a cohort study.
Topics: Cervical Ripening; Cesarean Section; Cohort Studies; Female; Humans; Labor, Induced; Mifepristone; Oxytocics; Pregnancy; Retrospective Studies; Urinary Catheterization; Urinary Catheters | 2022 |
Progesterone and interferon tau regulate expression of polyamine enzymes during the ovine peri-implantation period†.
Topics: Agmatine; Animals; Corn Oil; Endometrium; Female; Interferon Type I; Mifepristone; Polyamines; Pregnancy; Pregnancy Proteins; Progesterone; Proteins; Putrescine; RNA, Messenger; Sheep; Sheep, Domestic; Uterus | 2022 |
Mifepristone-Misoprostol Use for Second- and Third-Trimester Medical Termination of Pregnancy in a Canadian Tertiary Care Centre.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Canada; Cohort Studies; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Tertiary Care Centers | 2022 |
Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰.
Topics: Abortion, Induced; Abortion, Spontaneous; Family Practice; Female; Humans; Mifepristone; Pregnancy; Primary Health Care; Risk Evaluation and Mitigation; United States | 2022 |
In brief: Mifepristone by mail for pregnancy termination.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Community Pharmacy Services; Female; Humans; Mifepristone; Patient Safety; Postal Service; Pregnancy; Risk Evaluation and Mitigation; Tablets; Treatment Outcome | 2022 |
Effects of progesterone and interferon tau on ovine endometrial phosphate, calcium, and vitamin D signaling†.
Topics: Animals; Calcium; Corn Oil; Endometrium; Female; Interferon Type I; Mifepristone; Phosphates; Pregnancy; Pregnancy Proteins; Progesterone; Proteins; RNA, Messenger; Sheep; Sheep, Domestic; Vitamin D | 2022 |
How the pandemic is transforming abortion access.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Canada; COVID-19; Female; Health Services Accessibility; Humans; Mifepristone; Pandemics; Pregnancy; Surveys and Questionnaires; Telemedicine | 2022 |
Second- and Third-Trimester Medical Abortion Providers and Services in 2019: Results From the Canadian Abortion Provider Survey.
Topics: Abortion, Induced; Canada; Cross-Sectional Studies; Female; Humans; Mifepristone; Misoprostol; Physicians, Family; Pregnancy; Pregnancy Trimester, Third | 2022 |
Tiaojing Cuyun Recipe Enhances Pregnancy Outcome via the VEGF/PI3K/AKT/eNOS Signaling Pathway in EID Mice.
Topics: Animals; Drugs, Chinese Herbal; Embryo Implantation; Endometrium; Female; Mice; Mifepristone; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Pregnancy; Pregnancy Outcome; Progesterone; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor A | 2022 |
Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Tests | 2022 |
Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study.
Topics: Abortion, Induced; Abortion, Spontaneous; Cohort Studies; COVID-19; Female; Humans; Mifepristone; Pandemics; Pregnancy; Pregnancy, Ectopic; Retrospective Studies | 2022 |
Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey.
Topics: Abortion, Induced; Abortion, Spontaneous; Canada; Cross-Sectional Studies; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2022 |
Methotrexate/mifepristone-combined with embryo removal in the treatment of caesarean scar pregnancy.
Topics: Cesarean Section; Cicatrix; Female; Humans; Infant, Newborn; Methotrexate; Mifepristone; Pregnancy; Retrospective Studies; Treatment Outcome | 2022 |
Combination of mifepristone and misoprostol vs misoprostol monotherapy for treatment of second-trimester pregnancy loss.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Cross-Sectional Studies; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2022 |
Should COVID-specific arrangements for abortion continue? The views of women experiencing abortion in Britain during the pandemic.
Topics: COVID-19; Female; Humans; Mifepristone; Misoprostol; Pandemics; Pregnancy; United Kingdom | 2022 |
Up-regulation of hepatic CD36 by increased corticosterone/cortisol levels via GR leads to lipid accumulation in liver and hypertriglyceridaemia during pregnancy.
Topics: Animals; CD36 Antigens; Corticosterone; Fatty Acids; Female; Humans; Hydrocortisone; Hypertriglyceridemia; Lipids; Liver; Mice; Mifepristone; Pregnancy; Pregnancy Complications; Receptors, Glucocorticoid; Up-Regulation | 2022 |
A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study.
Topics: Abortion, Induced; Canada; Female; Humans; Male; Mifepristone; Physicians, Family; Pregnancy; Surveys and Questionnaires | 2022 |
Termination of pregnancy in the second trimester - the course of different therapy regimens.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2022 |
Astilbin improves pregnancy outcome in rats with recurrent spontaneous abortion by regulating Th1/Th2 balance.
Topics: Abortion, Spontaneous; Animals; Female; Flavonols; Humans; Hydroxyurea; Interleukin-10; Interleukin-2; Interleukin-4; Mifepristone; Placenta; Prednisone; Pregnancy; Pregnancy Outcome; Rats; Rats, Sprague-Dawley; T-Box Domain Proteins; Th1 Cells; Th2 Cells | 2022 |
The Impact of Mouse Preterm Birth Induction by RU-486 on Microglial Activation and Subsequent Hypomyelination.
Topics: Animals; Animals, Newborn; Female; Humans; Inflammation; Lipopolysaccharides; Mice; Microglia; Mifepristone; Pregnancy; Premature Birth | 2022 |
Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Chorionic Gonadotropin; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Ectopic; Retrospective Studies | 2022 |
Validation of a Spanish-language scale for evaluating perceived quality of care of medical abortions before 9 weeks gestation.
Topics: Abortion, Induced; Female; Humans; Language; Mifepristone; Misoprostol; Pregnancy; Surveys and Questionnaires | 2022 |
Medication for Early Pregnancy Termination.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 2022 |
Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product.
Topics: Abortion, Induced; Adolescent; Comprehension; Female; Humans; Mifepristone; Misoprostol; Nonprescription Drugs; Pregnancy | 2022 |
Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Chorionic Gonadotropin; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy | 2022 |
Analysis of the Clinical Efficacy of Conservative Treatment for an Unruptured Cornual Pregnancy.
Topics: Conservative Treatment; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Cornual; Retrospective Studies; Treatment Outcome | 2022 |
Complications of second-trimester medical termination of pregnancy for fetal anomalies compared with intrauterine fetal demise.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Fetal Death; Fetal Diseases; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Stillbirth | 2023 |
The effects of mifepristone on the structure of human decidua and chorion and Bax and Bcl-2 expression at early stage of pregnancy.
Topics: bcl-2-Associated X Protein; Chorionic Villi; Decidua; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Proto-Oncogene Proteins c-bcl-2 | 2022 |
A retrospective study of estrogen in the pretreatment for medical management of early pregnancy loss and the inference from intrauterine adhesion.
Topics: Abortion, Spontaneous; Carboprost; Estradiol; Estrogens; Female; Humans; Mifepristone; Pregnancy; Retrospective Studies; Suppositories | 2022 |
Mifepristone (RU-486
Topics: Abortion, Induced; COVID-19; COVID-19 Drug Treatment; Female; Humans; Mifepristone; Pandemics; Pregnancy; Public Policy; Women's Health | 2022 |
Surgical Treatment Following Failed Medical Treatment of an Interstitial Pregnancy.
Topics: Adult; Chorionic Gonadotropin, beta Subunit, Human; Fallopian Tubes; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Interstitial | 2022 |
The method for termination of mid-trimester pregnancy with placenta previa: A case study.
Topics: Cesarean Section; Ethacridine; Female; Humans; Mifepristone; Misoprostol; Placenta; Placenta Previa; Pregnancy; Retrospective Studies | 2022 |
Barriers to abortion provision in primary care in New England, 2019-2020: A qualitative study.
Topics: Abortion, Induced; Abortion, Legal; Female; Humans; Mifepristone; Pregnancy; Primary Health Care; Qualitative Research | 2023 |
Medication Abortion.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy | 2022 |
Efficacy of Qiancao () and Haipiaoxiao (), a traditional Chinese herb pair, on abnormal uterine bleeding in rats with incomplete abortion.
Topics: Abortion, Incomplete; Abortion, Induced; Animals; China; Female; Humans; Mifepristone; Pregnancy; Rats; Uterine Hemorrhage | 2022 |
Interstitial Pregnancy Treated with Mifepristone and Methotrexate with High Serum β-hCG Level in a Patient Wishing to Preserve Fertility: Time to Define Standardized Criteria for Medical/Surgical Therapy?
Topics: Adult; Female; Fertility; Humans; Laparoscopy; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Interstitial | 2022 |
Trend of serum beta-human chorionic gonadotropin levels after medical abortion in the early first trimester of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Infant; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2023 |
Nicotine ameliorates inflammatory mediators in RU486 induced preterm labor model through activating cholinergic anti-inflammatory pathway.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Cytokines; Female; Inflammation; Inflammation Mediators; Interleukin-10; Interleukin-4; Interleukin-6; Mifepristone; Neuroimmunomodulation; Nicotine; Obstetric Labor, Premature; Pregnancy; Premature Birth; Rats; Tumor Necrosis Factor-alpha | 2022 |
Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists.
Topics: Abortion, Induced; Canada; Female; Humans; Mifepristone; Misoprostol; Pharmacists; Pregnancy; Surveys and Questionnaires | 2022 |
Clinical Update on Uses for Mifepristone in Obstetrics and Gynecology.
Topics: Abortifacient Agents; Abortion, Induced; Female; Gynecology; Humans; Mifepristone; Obstetrics; Pregnancy; Receptors, Progesterone | 2022 |
Predictor assessment of complete miscarriage after medical treatment for early pregnancy loss in women with previous cesarean section.
Topics: Abortion, Spontaneous; Cesarean Section; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2022 |
Non-genomic uterorelaxant actions of corticosteroid hormones in rats: An in vitro and in vivo study.
Topics: Adrenal Cortex Hormones; Animals; Female; Guanosine 5'-O-(3-Thiotriphosphate); Mifepristone; Pregnancy; Rats; Uterine Contraction; Uterus | 2022 |
Mifepristone combined with ethacridine lactate for third-trimester stillbirth induction: a 5-year experience from Shanghai.
Topics: Abortion, Induced; China; Ethacridine; Female; Humans; Lactates; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Stillbirth | 2022 |
Visualization of preimplantation uterine fluid absorption in mice using Alexa Fluor™ 488 Hydrazide†.
Topics: Animals; Embryo Implantation; Estrogens; Female; Mice; Mifepristone; Pregnancy; Progesterone; Rodentia; Uterus | 2023 |
Development of a Spanish-language drug facts label prototype for a combination mifepristone and misoprostol medication abortion product.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Language; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Young Adult | 2023 |
Very early medical abortion: treatment with mifepristone and misoprostol before ultrasonographic visualisation of an intrauterine pregnancy.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Ectopic; Retrospective Studies | 2023 |
Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2022 |
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma.
Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Drug Repositioning; Female; Hormone Antagonists; Humans; Mifepristone; Pancreatic Neoplasms; Pregnancy; Receptors, OSM-LIF | 2022 |
Determination of Mifepristone (RU-486) and Its Metabolites in Maternal Blood Sample after Pharmacological Abortion.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Tandem Mass Spectrometry | 2022 |
[Single dose of misoprostol for abortion until 9 weeks of gestation].
Topics: Abortion, Induced; Administration, Intravaginal; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Pain Management; Pregnancy | 2023 |
How much will it hurt? Factors associated with pain experience in women undergoing medication abortion during the first trimester.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Dysmenorrhea; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2023 |
Comparing preference for and use of medication abortion in Texas after policy changes in 2014 and 2018.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Surveys and Questionnaires; Texas | 2023 |
Medication Abortion a Reasonable Option for Pregnancy of Unknown Location.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Pregnancy | 2022 |
Single dose letrozole and misoprostol for termination of pregnancy through 63 days' gestation: A pilot study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Female; Humans; Letrozole; Mifepristone; Misoprostol; Pilot Projects; Pregnancy | 2023 |
Transcriptomic profiling of canine decidualization and effects of antigestagens on decidualized dog uterine stromal cells.
Topics: Animals; Decidua; Dogs; Endometrium; Female; Mifepristone; Pregnancy; Progesterone; Receptors, Progesterone; Stromal Cells; Transcriptome | 2022 |
Integrative transcriptomics and proteomics analyses to reveal the therapeutic effect and mechanism of Buxue Yimu Pills in medical-induced incomplete abortion rats.
Topics: Abortion, Incomplete; Abortion, Induced; Abortion, Spontaneous; Animals; Dinoprost; Female; Matrix Metalloproteinase 7; Mifepristone; Misoprostol; Pregnancy; Proteomics; Rats; Transcriptome | 2023 |
Summary for Patients: Short-Term Adverse Outcomes After Mifepristone-Misoprostol Versus Procedural Induced Abortion.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 2023 |
Short-Term Adverse Outcomes After Mifepristone-Misoprostol Versus Procedural Induced Abortion : A Population-Based Propensity-Weighted Study.
Topics: Abortion, Induced; Abortion, Spontaneous; Adult; Cohort Studies; Female; Humans; Mifepristone; Misoprostol; Ontario; Pregnancy; Pregnancy Trimester, First | 2023 |
MYB and ELF3 differentially modulate labor-inducing gene expression in myometrial cells.
Topics: Animals; DNA-Binding Proteins; Female; Gene Expression; Humans; Infant, Newborn; Labor, Obstetric; Mice; Mifepristone; Myometrium; Pregnancy; Proto-Oncogene Proteins c-ets; Transcription Factor AP-1; Transcription Factors; Uterine Contraction | 2023 |
At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Tests | 2023 |
Medical Methods for First-Trimester Abortion.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second | 2023 |
History and Politics of Medication Abortion in the United States and the Rise of Telemedicine and Self-Managed Abortion.
Topics: Abortion, Induced; COVID-19; Female; Humans; Mifepristone; Misoprostol; Pandemics; Politics; Pregnancy; Self-Management; Telemedicine; United States | 2023 |
In-country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; World Health Organization | 2023 |
Remote Reproductive Rights.
Topics: Abortion, Induced; Female; Health Services Accessibility; Humans; Mifepristone; Pregnancy; Reproductive Rights; Telemedicine; United States | 2022 |
Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States.
Topics: Abortion, Induced; Cohort Studies; Female; Humans; Mifepristone; Misoprostol; Pharmaceutical Services; Pharmacies; Pregnancy; United States | 2023 |
Advancing Reproductive Health through Policy-Engaged Research in Abortion Care.
Topics: Abortion, Spontaneous; Canada; Female; Health Policy; Humans; Mifepristone; Misoprostol; Pregnancy; Reproductive Health; United States | 2022 |
Telemedicine medical abortion service in Georgia: an evaluation of a strategy with reduced number of in-Clinic visits.
Topics: Ambulatory Care; Female; Georgia; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Self Administration; Telemedicine | 2023 |
In brief: Expanded acess to mifepristone.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2023 |
Mifepristone priming and subsequent misoprostol for second trimester medical abortion in women with previous caesarean delivery.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Cesarean Section; Female; Humans; Mifepristone; Misoprostol; Placenta; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Uterine Rupture | 2023 |
US lawsuit threatens access to abortion drug: the science behind the case.
Topics: Abortion, Induced; Abortion, Legal; Female; Humans; Mifepristone; Pregnancy; United States | 2023 |
Medication abortion with misoprostol-only: A sample protocol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2023 |
A prospective, comparative study of clinical outcomes following clinic-based versus self-use of medical abortion.
Topics: Abortion, Induced; Ambulatory Care Facilities; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies | 2023 |
Effectiveness and acceptability of home use of misoprostol for medical abortion up to 10 weeks of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Female; Humans; Infant; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies | 2023 |
News Brief: The FDA has loosened restrictions to mifepristone access.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2023 |
The indication and treatment outcome predictors of mifepristone treating ectopic pregnancy.
Topics: Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic; Retrospective Studies; Treatment Outcome | 2023 |
The association between abortion restrictions and patient-centered care for early pregnancy loss at US obstetrics-gynecology residency programs.
Topics: Abortion, Induced; Abortion, Spontaneous; Cross-Sectional Studies; Female; Gynecology; Humans; Internship and Residency; Mifepristone; Obstetrics; Patient-Centered Care; Pregnancy | 2023 |
The efficacy and influence factors analysis of Mifepristone combined with estrogen-progesterone in the treatment of incomplete abortion.
Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Estrogens; Female; Humans; Mifepristone; Pregnancy; Progesterone; Retrospective Studies | 2023 |
Opposing rulings on mifepristone in US leave access to medical abortion in jeopardy.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 2023 |
Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities.
Topics: Abortifacient Agents; Abortion, Induced; Drug Industry; Female; Health Services Accessibility; Humans; Internationality; Mifepristone; Misoprostol; Pregnancy; South Africa | 2023 |
Judicial interference with mifepristone.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Drug Approval; Female; Humans; Mifepristone; Pregnancy; Texas; United States | 2023 |
Science v. Ideology in Court: Mifepristone and the U.S. Food and Drug Administration.
Topics: Abortion, Induced; Female; Government Regulation; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2023 |
Shoutai Wan regulates glycolysis imbalance at the maternal-fetal interface in threatened abortion mice.
Topics: Abortion, Induced; Abortion, Spontaneous; Abortion, Threatened; Animals; Female; Humans; Hydrocortisone; Mice; Mifepristone; Pregnancy | 2023 |
Mifepristone remains available in US until midnight on 19 April.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2023 |
Advance provision of medication for induced abortion: A qualitative study of patient perspectives.
Topics: Abortion, Induced; Ambulatory Care Facilities; Female; Health Services Accessibility; Humans; Mifepristone; Pregnancy; Qualitative Research; Washington | 2023 |
Drug developers caution against US mifepristone ban.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2023 |
Implications of using home urine pregnancy tests versus facility-based tests for assessment of outcome following medication abortion provided via telemedicine.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Tests; Telemedicine; United States | 2023 |
Court Intrusion Into Science and Medicine-The Mifepristone Decisions.
Topics: Abortion, Induced; Female; Humans; Legislation, Medical; Medicine; Mifepristone; Pregnancy; Science; Supreme Court Decisions; United States | 2023 |
First trimester abortion protocols by facility type in Switzerland and potential barriers to accessing the service.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Physicians; Pregnancy; Pregnancy Trimester, First; Switzerland | 2023 |
Where Do We Stand With Mifepristone in the United States?: Making Sense of the Madness.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2023 |
Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Humans; Infant; Mifepristone; Misoprostol; Placenta; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2023 |
The Mifepristone Case and the Legitimacy of the FDA.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; United States; United States Food and Drug Administration | 2023 |
Have we overlooked the role of mifepristone for the medical management of tubal ectopic pregnancy?
Topics: Fallopian Tubes; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic; Pregnancy, Tubal | 2023 |
The effect of induced fetal demise on induction to expulsion interval during later medication abortion: A retrospective cohort.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Digoxin; Female; Fetal Death; Humans; Lidocaine; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2023 |
In brief: Alternatives to mifepristone for medication abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2023 |
Clinical outcomes of medication abortion using misoprostol-only: A retrospective chart review at an abortion provider organization in the United States.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; COVID-19; Female; Humans; Mifepristone; Misoprostol; Pandemics; Pregnancy; Retrospective Studies; United States | 2023 |
Approved but Unavailable: A Mystery-Caller Survey of Mifepristone Access in a Large Ontario City.
Topics: Abortion, Induced; Female; Health Services Accessibility; Humans; Mifepristone; Misoprostol; Ontario; Pregnancy; Prescriptions | 2023 |
Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Gynecologists; Humans; Massachusetts; Mifepristone; Misoprostol; Obstetricians; Pregnancy | 2023 |
Mifepristone use for early pregnancy loss: A qualitative study of barriers and facilitators among OB/GYNS in Massachusetts, USA.
Topics: Abortion, Induced; Abortion, Spontaneous; COVID-19; Female; Humans; Massachusetts; Mifepristone; Pandemics; Pregnancy; United States | 2023 |
Effectiveness of Self-Managed Medication Abortion Between 9 and 16 Weeks of Gestation.
Topics: Abortion, Induced; Ambulatory Care Facilities; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Self-Management | 2023 |
Progesterone-mediated reversal of mifepristone-induced pregnancy termination in a rat model: an exploratory investigation.
Topics: Abortion, Induced; Animals; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; Rats; Rats, Long-Evans | 2023 |
Trends in the Use of Mifepristone for Medical Management of Early Pregnancy Loss From 2016 to 2020.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2023 |
First and Second-Trimester Surgical Abortion Providers and Services in 2019: Results From the Canadian Abortion Provider Survey.
Topics: Abortion, Induced; Canada; Cross-Sectional Studies; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 2023 |
US federal court upholds limits on abortion drug mifepristone.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Pregnancy | 2023 |
Clinical analysis of the regimens for terminating the second-trimester pregnancy in cesarean section women.
Topics: Cesarean Section; Ethacridine; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2023 |
Preabortion ultrasound - a patient perspective.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Northern Ireland; Pregnancy; Surveys and Questionnaires | 2023 |
Next step in the development of mesoprogestins: the preclinical profile of EC313.
Topics: Animals; Endometriosis; Estrogens; Female; Guinea Pigs; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Mifepristone; Pregnancy; Progesterone; Progestins; Rabbits; Receptors, Progesterone | 2023 |
Role of Mifepristone in Trial of Labour after Previous Caesarean Delivery in Intrauterine Fetal Death.
Topics: Cesarean Section; Cross-Sectional Studies; Female; Fetal Death; Humans; Labor, Induced; Mifepristone; Pregnancy; Trial of Labor | 2023 |
Changes in Induced Medical and Procedural Abortion Rates in a Commercially Insured Population, 2018 to 2022 : An Interrupted Time-Series Analysis.
Topics: Abortion, Induced; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Mifepristone; Pandemics; Pregnancy; United States | 2023 |
Medical abortion in the second trimester - an update.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Prostaglandins | 2023 |
Explaining the Fifth Circuit Court of Appeals Ruling on Mifepristone Access.
Topics: Abortifacient Agents; Abortion, Induced; Family Planning Services; Female; Health Services Accessibility; Humans; Mifepristone; Pregnancy; United States | 2023 |
Medication Abortion Safety and Effectiveness With Misoprostol Alone.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies | 2023 |
The Benefits of a Guideline on Safe Termination of Pregnancy for Legal Indications: An Illustrative Case Report of a Hydranencephaly.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; Female; Humans; Hydranencephaly; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Treatment Outcome | 2019 |
Intubation and intensive care after laminaria anaphylaxis in second-trimester abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Anaphylaxis; Cervix Uteri; Critical Care; Dilatation; Emergency Service, Hospital; Female; Humans; Intubation, Intratracheal; Laminaria; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 2020 |
cGMP-dependent protein kinase II determines β-catenin accumulation that is essential for uterine decidualization in mice.
Topics: Animals; beta Catenin; Cell Proliferation; Cyclic AMP; Cyclic GMP-Dependent Protein Kinase Type II; Decidua; Estrogens; Female; Fulvestrant; Gene Expression Regulation; Glycogen Synthase Kinase 3 beta; Isoquinolines; Mice; Mifepristone; Ovariectomy; Phosphorylation; Pregnancy; Primary Cell Culture; Progesterone; Prolactin; Receptors, Estrogen; Receptors, Progesterone; Signal Transduction; Stromal Cells; Sulfonamides; Uterus | 2019 |
A comparison between labor induction with only Dilapan-S and a combination of mifepristone and Dilapan-S in nulliparous women: a prospective pilot study.
Topics: Cervical Ripening; Female; Humans; Infant, Newborn; Labor, Induced; Mifepristone; Misoprostol; Oxytocics; Parity; Pilot Projects; Polymers; Pregnancy; Prospective Studies | 2021 |
Clinical application of low-dose misoprostol in the induced labor of 16 to 28 weeks pathological pregnancies (a STROBE-compliant article).
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Asian People; China; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Oligohydramnios; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Time Factors; Uterine Rupture | 2019 |
Label comprehension of a combined mifepristone and misoprostol product for medical abortion: A pilot study in South Africa.
Topics: Abortifacient Agents; Adolescent; Adult; Drug Labeling; Drug Therapy, Combination; Female; Health Literacy; Humans; Middle Aged; Mifepristone; Misoprostol; Non-Randomized Controlled Trials as Topic; Pilot Projects; Pregnancy; South Africa; Young Adult | 2020 |
The impact of progesterone and RU-486 on classic pro-labour proteins & contractility in human myometrial tissues during 24-hour exposure to tension & interleukin-1β.
Topics: Adult; Biopsy; Connexin 43; Cyclooxygenase 2; Female; Humans; Labor, Obstetric; Maternal Age; Middle Aged; Mifepristone; Myometrium; Pregnancy; Progesterone; Receptors, Oxytocin; Stress, Mechanical; Tissue Culture Techniques; Up-Regulation | 2020 |
Mifepristone antagonization requires real studies to evaluate safety and efficacy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Progesterone; Progestins | 2019 |
Effect of the addition of osmotic dilators to medical induction of labor abortion: A before-and-after study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Labor, Induced; Mifepristone; Misoprostol; Polymers; Pregnancy; Retrospective Studies; Young Adult | 2020 |
Efficacy of mifepristone and misoprostol for medical treatment of missed miscarriage in clinical practice-A cohort study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Organ Size; Pregnancy; Pregnancy Trimesters; Treatment Outcome; Ultrasonography; Uterus; Young Adult | 2020 |
Inhibition of expression of glucocorticoids receptors may contribute to postpartum depression.
Topics: Animals; Depression, Postpartum; Female; Hippocampus; Mifepristone; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid | 2020 |
PURL: Early pregnancy loss: Pretreat with mifepristone?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Administration, Oral; Adult; Drug Therapy, Combination; Family Practice; Female; Humans; Mifepristone; Misoprostol; Practice Guidelines as Topic; Pregnancy | 2019 |
Leadership for success in transforming medical abortion policy in Canada.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; British Columbia; Drug Approval; Female; Health Policy; Humans; Leadership; Mifepristone; Pregnancy; Reproductive Health | 2020 |
Barriers and Facilitators to the Implementation of First Trimester Medical Abortion With Mifepristone in the Province of Québec: A Qualitative Investigation.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Attitude of Health Personnel; Canada; Female; Health Knowledge, Attitudes, Practice; Health Personnel; Health Policy; Health Services Accessibility; Humans; Implementation Science; Mifepristone; Pregnancy; Pregnancy Trimester, First; Qualitative Research; Quebec | 2020 |
"We've got rights and yet we don't have access": Exploring patient experiences accessing medication abortion in Australia.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Adult; Australia; Female; Health Services Accessibility; Humans; Male; Middle Aged; Mifepristone; Pregnancy; Qualitative Research; Reproductive Rights | 2020 |
Uterine aquaporin expression is dynamically regulated by estradiol and progesterone and ovarian stimulation disrupts embryo implantation without affecting luminal closure.
Topics: Animals; Aquaporins; Embryo Implantation; Embryo Transfer; Estradiol; Female; Gene Expression Regulation, Developmental; Mice; Mice, Inbred C57BL; Mifepristone; Ovulation Induction; Pregnancy; Progesterone; Pseudopregnancy; Uterus; Water | 2020 |
A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries.
Topics: Abortifacient Agents; Abortion, Induced; Alprostadil; Cross-Sectional Studies; Developing Countries; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Product Labeling; Treatment Outcome | 2020 |
When patients change their minds after starting an abortion: Guidance from the National Abortion Federation's Clinical Policies Committee.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Decision Making; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2020 |
Medication abortion use among low-income and rural Texans before and during state-imposed restrictions and after FDA-updated labeling.
Topics: Abortifacient Agents; Abortion, Induced; Ambulatory Care Facilities; Drug Labeling; Female; Geographic Mapping; Health Services Accessibility; Healthcare Disparities; Humans; Mifepristone; Misoprostol; Poverty; Pregnancy; Retrospective Studies; Rural Population; Spatial Analysis; Texas; Travel; United States; United States Food and Drug Administration | 2020 |
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Progesterone | 2020 |
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Progesterone | 2020 |
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Progesterone | 2020 |
In Reply.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Progesterone | 2020 |
"It gives you autonomy over your own choices": A qualitative study of Canadian abortion patients' experiences with mifepristone and misoprostol.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Canada; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2020 |
Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Diffusion of Innovation; Female; Humans; Implementation Science; Male; Middle Aged; Mifepristone; Physicians; Practice Patterns, Physicians'; Pregnancy; Qualitative Research; Quebec; Transtheoretical Model | 2020 |
Complication rates of dilation and evacuation and labor induction in second-trimester abortion for fetal indications: A retrospective cohort study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Dilatation; Female; Humans; Labor, Induced; Mifepristone; Misoprostol; Placenta; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2020 |
Effectiveness of self-managed medication abortion between 13 and 24 weeks gestation: A retrospective review of case records from accompaniment groups in Argentina, Chile, and Ecuador.
Topics: Abortion, Induced; Abortion, Spontaneous; Argentina; Chile; Ecuador; Female; Humans; Mifepristone; Misoprostol; Placenta; Pregnancy; Retrospective Studies | 2020 |
[A ruptured ectopic pregnancy during early termination of pregnancy before ultrasound confirmation].
Topics: Abortion, Induced; Chorionic Gonadotropin; Female; Humans; Mifepristone; Pregnancy; Pregnancy, Ectopic; Pregnancy, Tubal; Rupture; Ultrasonography | 2020 |
Mifepristone-misoprostol versus misoprostol-alone regimen for medication abortion at ≥24 weeks' gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies | 2020 |
Sonoelastography for the comparative assessment of cervical maturation after different approaches to cervical preparation ahead of labor induction.
Topics: Adult; Cervical Ripening; Cervix Uteri; Elasticity Imaging Techniques; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Prospective Studies; Prostaglandins; Young Adult | 2022 |
Angiopoietin-2 regulated by progesterone induces uterine vascular remodeling during pregnancy.
Topics: Angiopoietin-2; Animals; Cells, Cultured; Embryo Implantation; Endothelial Cells; Endothelium, Vascular; Female; Hormone Antagonists; Humans; Mice, Inbred C57BL; Mifepristone; Neovascularization, Physiologic; Pregnancy; Progesterone; Receptors, Progesterone; Spatio-Temporal Analysis; Uterus; Vascular Remodeling | 2020 |
A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64-70 and 71-77 days of gestation: A retrospective chart review.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Outpatients; Pregnancy; Prospective Studies; Retrospective Studies | 2020 |
2017-19 governmental decisions to allow home use of misoprostol for early medical abortion in the UK.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; United Kingdom | 2020 |
Risk of surgical evacuation and risk of major surgery following second-trimester medical abortion in Denmark: A nationwide cohort study.
Topics: Abortion, Induced; Cohort Studies; Denmark; Female; Humans; Infant, Newborn; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 2020 |
Evaluation of shorter mifepristone to misoprostol intervals for second trimester medical abortion: a retrospective cohort study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Infant; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2020 |
Ohio as a Window Into Recent US Trends on Abortion Access and Restrictions.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Female; Health Services Accessibility; Humans; Mifepristone; Ohio; Politics; Pregnancy; Telemedicine; United States | 2020 |
Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin, Number 225.
Topics: Abortifacient Agents; Abortion, Induced; Clinical Protocols; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; United States | 2020 |
Medication Abortion Up to 70 Days of Gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Clinical Protocols; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; United States; United States Food and Drug Administration | 2020 |
Medical management of miscarriage with mifepristone.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2020 |
Regulation of the Abortion Drug RU 486: The Collision of Politics, Ethics and Morals in Australia.
Topics: Abortion, Induced; Australia; Female; Humans; Mifepristone; Morals; Politics; Pregnancy | 2020 |
Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis.
Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Cost-Benefit Analysis; Dilatation and Curettage; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Monte Carlo Method; Practice Patterns, Physicians'; Pregnancy | 2020 |
Perspectives Among Canadian Physicians on Factors Influencing Implementation of Mifepristone Medical Abortion: A National Qualitative Study.
Topics: Abortion, Legal; Attitude of Health Personnel; Canada; Female; Health Plan Implementation; Humans; Mifepristone; Physicians; Pregnancy; Primary Health Care; Qualitative Research | 2020 |
Efficacy of mifepristone - Prostaglandin analogue combination in medical termination of pregnancy up to and beyond 7 weeks of amenorrhea: The RYMMa study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Amenorrhea; Female; France; Humans; Longitudinal Studies; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Young Adult | 2020 |
Uterine Rupture During Medical Induction for Second Trimester Abortion.
Topics: Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Nepal; Pregnancy; Pregnancy Trimester, Second; Uterine Rupture | 2020 |
Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin Summary, Number 225.
Topics: Abortifacient Agents; Abortion, Induced; Clinical Protocols; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Practice Guidelines as Topic; Pregnancy; Pregnancy Trimester, First; United States | 2020 |
Combination of medical and surgical management in successful treatment of caesarean scar pregnancy: a case report series.
Topics: Abortion, Induced; Adult; Cesarean Section; Cicatrix; Combined Modality Therapy; Curettage; Female; Fertility Preservation; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prospective Studies; Treatment Outcome; Ultrasonography, Doppler, Color; Uterine Artery Embolization; Uterine Hemorrhage; Uterus; Young Adult | 2020 |
Non-genomic actions of sex hormones on pregnant uterine contractility in rats: An in vitro study at term.
Topics: Animals; Dose-Response Relationship, Drug; Estradiol; Female; Flutamide; Fulvestrant; Mifepristone; Muscle Contraction; Potassium Chloride; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Testosterone; Uterine Contraction | 2020 |
Ensuring Safe Access to Mifepristone During the Pandemic and Beyond.
Topics: Abortion, Induced; COVID-19; Female; Humans; Menstruation-Inducing Agents; Mifepristone; Pandemics; Pregnancy | 2021 |
Self-managed medication abortion outcomes: results from a prospective pilot study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Prospective Studies; Self Administration; Self-Management; Treatment Outcome | 2020 |
Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone-misoprostol for medical abortion.
Topics: Abortion, Induced; Bangladesh; China; Cost-Benefit Analysis; Female; Humans; India; Mifepristone; Misoprostol; Pregnancy | 2020 |
Secretory leukocyte protease inhibitor and progranulin as possible regulators of cervical remodeling in pregnancy.
Topics: Adult; Animals; Cervix Mucus; Cervix Uteri; Disease Models, Animal; Female; Hormone Antagonists; Humans; Lipopolysaccharides; Maternal Age; Mice; Mifepristone; Models, Animal; Pregnancy; Pregnancy Trimester, Second; Premature Birth; Progesterone; Progranulins; Secretory Leukocyte Peptidase Inhibitor; Up-Regulation; Young Adult | 2021 |
Task-sharing in menstrual regulation services: Implementation efforts and lessons learned in Bangladesh.
Topics: Abortion, Induced; Bangladesh; Family Planning Services; Female; Humans; Menstrual Cycle; Mifepristone; Misoprostol; Pregnancy; Vacuum Curettage | 2020 |
Abortion Self-Care: A Forward-Looking Solution To Inequitable Access.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Unwanted; Self Care | 2020 |
Misoprostol before to first-trimester surgical abortion: do not jump on the bandwagon, not all evidence is created equal.
Topics: Abortifacient Agents, Nonsteroidal; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2020 |
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; COVID-19; Female; Health Services Accessibility; Humans; Mifepristone; Pandemics; Pregnancy; Reproductive Rights; United States; United States Food and Drug Administration | 2020 |
Contrast-Enhanced Ultrasound Evaluation of Mifepristone for Treatment of Low-Risk Cesarean Scar Pregnancy.
Topics: Adult; Cesarean Section; Cicatrix; Contrast Media; Female; Humans; Mifepristone; Pregnancy; Ultrasonography | 2020 |
Effect of Irisin on LIF and integrin αvβ3 in rats of implantation failure.
Topics: Animals; Embryo Implantation; Embryo Loss; Endometrium; Female; Fibronectins; Gene Expression Regulation; Injections, Intramuscular; Integrin alphaVbeta3; Leukemia Inhibitory Factor; Mifepristone; Pregnancy; Progestins; Rats; Rats, Wistar | 2021 |
Telemedicine medical abortion at home under 12 weeks' gestation: a prospective observational cohort study during the COVID-19 pandemic.
Topics: COVID-19; Female; Humans; Mifepristone; Pandemics; Pregnancy; Prospective Studies; Referral and Consultation; SARS-CoV-2; Telemedicine; Telephone | 2021 |
"False positive" urine pregnancy test results after successful medication abortion.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Tests | 2021 |
Second trimester medical abortion in a primigravida with lupus nephritis and rapidly progressive renal failure: challenges and outcome.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Lupus Nephritis; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Renal Insufficiency; Treatment Outcome | 2021 |
[Mifepristone in primary care: no impediments against its use in management of missed miscarriage].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Legal; Abortion, Missed; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Netherlands; Pilot Projects; Pregnancy; Primary Health Care | 2021 |
Conflicting Nongenomic Effects of Progesterone in the Myometrium of Pregnant Rats.
Topics: Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Female; Hormone Antagonists; Mifepristone; Myometrium; Nifedipine; Organ Culture Techniques; Oxytocin; Potassium Chloride; Pregnancy; Progesterone; Pyrroles; Rats, Wistar; Uterine Contraction; Verapamil | 2021 |
Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives.
Topics: Abortion, Induced; Bangladesh; Family Planning Services; Female; Humans; Menstruation; Mifepristone; Misoprostol; Pregnancy; Self-Management | 2021 |
Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois.
Topics: Abortion, Induced; Female; Health Services Accessibility; Humans; Illinois; Mifepristone; Pharmacy; Pregnancy; Primary Health Care | 2021 |
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; COVID-19; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Postal Service; Pregnancy; SARS-CoV-2; Telemedicine; United States; Young Adult | 2021 |
Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Aftercare; COVID-19; Female; Hawaii; Humans; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Pregnancy; Retrospective Studies; Telemedicine; Ultrasonography, Prenatal | 2021 |
Comparison of surgical versus medical termination of pregnancy between 13-20 weeks of gestation in Ethiopia: A quasi-experimental study.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Ethiopia; Extraction, Obstetrical; Female; Humans; Length of Stay; Logistic Models; Mifepristone; Non-Randomized Controlled Trials as Topic; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Preoperative Care; Surveys and Questionnaires; Young Adult | 2021 |
Obstetrician-gynecologist willingness to provide medication abortion with removal of the in-person dispensing requirement for mifepristone.
Topics: Abortion, Induced; Attitude of Health Personnel; Female; Gynecology; Health Personnel; Humans; Mifepristone; Obstetrics; Pharmacies; Pregnancy | 2021 |
Missing mifepristone at tribal health facilities serving native Americans.
Topics: Abortion, Induced; Abortion, Spontaneous; American Indian or Alaska Native; Female; Health Facilities; Humans; Mifepristone; Misoprostol; Pregnancy | 2021 |
Guam: The US territory where America's day begins but abortion access is still in the dark.
Topics: Abortion, Induced; Abortion, Legal; Female; Guam; Humans; Mifepristone; Pregnancy; Telemedicine; United States | 2021 |
Mifepristone and Misoprostol for Early Pregnancy Loss and Medication Abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prenatal Care | 2021 |
Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Pregnancy; Primary Health Care; Social Stigma; United States | 2021 |
The Supreme Court's Abortion Exceptionalism - Judicial Deference, Medical Science, and Mifepristone Access.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Female; Government Regulation; Health Services Accessibility; Humans; Mifepristone; Politics; Pregnancy; Supreme Court Decisions; United States; United States Food and Drug Administration | 2021 |
US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Health Services Accessibility; Humans; Mifepristone; Pregnancy; Primary Health Care; United States | 2021 |
The mifepristone REMS: A needless and unlawful barrier to care✰.
Topics: Abortion, Induced; Female; Health Services Accessibility; Humans; Mifepristone; Pharmaceutical Services; Pregnancy; United States; United States Food and Drug Administration | 2021 |
Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; COVID-19; Female; Humans; Mifepristone; Misoprostol; Pandemics; Pregnancy; SARS-CoV-2 | 2021 |
"I'll just deal with this on my own": a qualitative exploration of experiences with self-managed abortion in the United States.
Topics: Abortion, Induced; Abortion, Spontaneous; Adult; Female; Health Services Accessibility; Humans; Interviews as Topic; Mifepristone; Misoprostol; Motivation; Pregnancy; Qualitative Research; Self-Management; United States | 2021 |
Medication abortion: Advocating for mifepristone dispensing by pharmacists.
Topics: Abortion, Induced; Community Pharmacy Services; Female; Humans; Mifepristone; Pharmacies; Pharmacists; Pregnancy | 2021 |
Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks' gestation at British Pregnancy Advisory Service: A cross-sectional evaluation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Consultants; Cross-Sectional Studies; Female; Humans; Mifepristone; Misoprostol; Personal Satisfaction; Pregnancy; Referral and Consultation; Telemedicine; Telephone | 2021 |
The disproportionate burdens of the mifepristone REMS.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2021 |
Factors Associated With Use of an Online Telemedicine Service to Access Self-managed Medical Abortion in the US.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Cross-Sectional Studies; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Self-Management; Telemedicine; Young Adult | 2021 |
Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; COVID-19; Female; Health Services Accessibility; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Qualitative Research; SARS-CoV-2; Scotland; Self Administration; State Medicine; Telemedicine | 2021 |
Effect of maternal oxytocin on umbilical venous and arterial blood flows during physiological-based cord clamping in preterm lambs.
Topics: Animals; Animals, Newborn; Female; Mifepristone; Oxytocics; Oxytocin; Pregnancy; Regional Blood Flow; Sheep; Umbilical Arteries; Umbilical Veins; Uterine Contraction | 2021 |
Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Postal Service; Pregnancy; Telemedicine; Ultrasonography | 2021 |
Clinical analysis of second-trimester pregnancy termination after previous caesarean delivery in 51 patients with placenta previa and placenta accreta spectrum: a retrospective study.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cesarean Section; China; Female; Humans; Hysterotomy; Labor, Induced; Mifepristone; Misoprostol; Placenta Accreta; Placenta Previa; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Vaginal Birth after Cesarean; Young Adult | 2021 |
Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic.
Topics: Abortifacient Agents; Abortion, Induced; Adult; COVID-19; Female; Humans; Mifepristone; Pandemics; Patient Safety; Pregnancy; SARS-CoV-2; Telemedicine; Treatment Outcome; United States; Young Adult | 2021 |
Putting research into practice at the 2017 National Abortion Federation Annual Meeting.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Biomedical Research; Canada; Congresses as Topic; Female; Health Personnel; Humans; Mifepristone; Misoprostol; Pregnancy; United States | 2017 |
The costs and cost effectiveness of providing first-trimester, medical and surgical safe abortion services in KwaZulu-Natal Province, South Africa.
Topics: Abortion, Induced; Cost-Benefit Analysis; Female; Health Services Accessibility; Hospitals, Public; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; South Africa; Treatment Outcome; Vacuum Curettage | 2017 |
Over-the-counter medical termination of pregnancy: to be or not to be?
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Pregnancy | 2017 |
Progesterone Decreases in vitro Indoleamine 2, 3-dioxygenase Expression in Dendritic and CD4
Topics: Abortifacient Agents, Steroidal; Animals; Apoptosis; CD4-Positive T-Lymphocytes; Dendritic Cells; Embryo, Mammalian; Female; Gene Expression Regulation; Immune Tolerance; Immunophenotyping; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Maternal-Fetal Exchange; Mifepristone; Placenta; Pregnancy; Primary Cell Culture; Progesterone; Rats; Rats, Wistar; Receptors, Progesterone; Tryptophan; Uterus | 2017 |
Self-management of first trimester medical termination of pregnancy: a qualitative study of women's experiences.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Decision Making; Female; Humans; Mifepristone; Misoprostol; Nurse-Patient Relations; Pain Management; Patient Education as Topic; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Qualitative Research; Scotland; Self Administration; Self-Management; Young Adult | 2017 |
Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Follow-Up Studies; Gestational Age; Humans; Internet; Ireland; Middle Aged; Mifepristone; Misoprostol; Northern Ireland; Pregnancy; Self Report; Telemedicine; Treatment Outcome; Young Adult | 2017 |
Medroxyprogesterone acetate drives M2 macrophage differentiation toward a phenotype of decidual macrophage.
Topics: Butadienes; Cell Differentiation; Cytokines; Decidua; Endometritis; Enzyme Inhibitors; Female; Hormone Antagonists; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Macrophages; Medroxyprogesterone Acetate; Mifepristone; Monocytes; Nitric Oxide Synthase Type II; Nitriles; Pregnancy; Primary Cell Culture; Stromal Cells; Tetradecanoylphorbol Acetate; THP-1 Cells; Trophoblasts | 2017 |
Medical abortion is fundamental to women's health care.
Topics: Abortion, Induced; Australia; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Women's Health | 2017 |
Comparison of induction of labour regimes for termination of pregnancy, with and without mifepristone, from 20 to 41 weeks gestation.
Topics: Abortifacient Agents, Steroidal; Abortion, Eugenic; Adult; Female; Fetal Death; Gestational Age; Humans; Labor, Induced; Length of Stay; Mifepristone; Pregnancy; Retrospective Studies; Time Factors | 2017 |
Updates to the US Food and Drug Administration Regulations for Mifepristone: Implications for Clinical Practice and Access to Abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Drug and Narcotic Control; Drug Labeling; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Gestational Age; Government Regulation; Health Personnel; Humans; Midwifery; Mifepristone; Misoprostol; Nurse Midwives; Nurse Practitioners; Physician Assistants; Pregnancy; Professional Practice; United States; United States Food and Drug Administration | 2017 |
Water-extracted tubers of Cyperus rotundus L. enhance endometrial receptivity through leukemia inhibitory factor-mediated expression of integrin αVβ3 and αVβ5.
Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Survival; Cyperus; Embryo Implantation; Endometrium; Female; Humans; Integrin alphaVbeta3; Leukemia Inhibitory Factor; Male; Mice, Inbred C57BL; Mifepristone; Phosphatidylinositol 3-Kinases; Plant Extracts; Plant Tubers; Pregnancy; Proto-Oncogene Proteins c-akt; Receptors, Vitronectin; Water | 2017 |
Comparison of transvaginal surgery and methotrexate/mifepristone-combined transcervical resection in the treatment of cesarean scar pregnancy.
Topics: Adult; Blood Loss, Surgical; Cesarean Section; Chorionic Gonadotropin, beta Subunit, Human; Cicatrix; Female; Humans; Length of Stay; Methotrexate; Mifepristone; Operative Time; Pregnancy; Pregnancy, Ectopic; Retrospective Studies; Treatment Outcome; Uterine Artery Embolization | 2017 |
Transverse vaginal septum identified in a patient requesting second trimester abortion: a case report.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Delayed Diagnosis; Dilatation and Curettage; Female; Humans; Lost to Follow-Up; Mifepristone; Patient Acceptance of Health Care; Postoperative Complications; Pregnancy; Pregnancy Trimester, Second; Ultrasonography, Prenatal; Urogenital Abnormalities; Vagina; Young Adult | 2017 |
Medical treatment of second-trimester fetal miscarriage; A retrospective analysis.
Topics: Abortion, Spontaneous; Adult; Drug Administration Schedule; Female; Humans; Length of Stay; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2017 |
Feasibility of assessing the safety and effectiveness of menstrual regulation medications purchased from pharmacies in Bangladesh: a prospective cohort study.
Topics: Adult; Bangladesh; Feasibility Studies; Female; Humans; Menstruation-Inducing Agents; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Patient Acceptance of Health Care; Pharmaceutical Services; Pharmacies; Pregnancy; Prospective Studies | 2018 |
Case report of induced medical abortion following depot administration of medroxyprogesterone acetate.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Ambulatory Care; Contraception; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone Acetate; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 2017 |
Role of Oxytocin in Prolactin Secretion during Late Pregnancy.
Topics: Animals; Bodily Secretions; Female; Hormone Antagonists; Lactotrophs; Mifepristone; Naloxone; Narcotic Antagonists; Oxytocin; Pregnancy; Prolactin; Rats; Rats, Wistar | 2018 |
Growth regulation by estrogen in breast cancer 1 (GREB1) is a novel progesterone-responsive gene required for human endometrial stromal decidualization.
Topics: Animals; Cell Differentiation; Decidua; Epithelial Cells; Female; Fibroblasts; Forkhead Box Protein O1; Gene Expression Regulation, Developmental; Humans; Insulin-Like Growth Factor Binding Protein 1; Mice; Mice, Knockout; Mifepristone; Neoplasm Proteins; Nuclear Receptor Coactivator 2; Pregnancy; Primary Cell Culture; Progesterone; Prolactin; Receptors, Progesterone; RNA, Small Interfering; Signal Transduction; Stromal Cells; Wnt4 Protein | 2017 |
Barriers to accessing abortion services and perspectives on using mifepristone and misoprostol at home in Great Britain.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Health Services Accessibility; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Self Administration; United Kingdom; Young Adult | 2018 |
First trimester medication abortion practice in the United States and Canada.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Canada; Cross-Sectional Studies; Evidence-Based Practice; Female; Health Personnel; Humans; Male; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Surveys and Questionnaires; United States | 2017 |
Prostaglandin-Endoperoxide Synthase 1 Mediates the Timing of Parturition in Mice Despite Unhindered Uterine Contractility.
Topics: Abortifacient Agents, Steroidal; Animals; Cells, Cultured; Cervical Ripening; Cervix Uteri; Cyclooxygenase 1; Female; In Vitro Techniques; Luteolysis; Membrane Proteins; Mice, Inbred Strains; Mice, Knockout; Mifepristone; Myometrium; Ovariectomy; Oxytocics; Oxytocin; Pregnancy; Pregnancy, Prolonged; Progesterone; Uterine Contraction | 2018 |
Self-sourced online and self-directed at home: a new frontier for abortion in the United States.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Internet; Mifepristone; Misoprostol; Pregnancy; United States | 2018 |
Exploring the feasibility of obtaining mifepristone and misoprostol from the internet.
Topics: Abortion, Induced; Counterfeit Drugs; Drug Costs; Drug Therapy, Combination; Female; Health Services Accessibility; Humans; Internet; Mifepristone; Misoprostol; Pregnancy; United States | 2018 |
Mifepristone-misoprostol for menstrual regulation in public sector facilities in Bangladesh.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Bangladesh; Drug Therapy, Combination; Female; Hospitals, Public; Humans; Menstruation-Inducing Agents; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Treatment Outcome; Young Adult | 2018 |
Roles of Mifepristone on the Regulation of Cytotoxic Lymphocytes and Regulatory T Cells.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Decidua; Female; Humans; Killer Cells, Natural; Mifepristone; Pregnancy; T-Lymphocytes, Regulatory | 2017 |
Progesterone attenuates temporomandibular joint inflammation through inhibition of NF-κB pathway in ovariectomized rats.
Topics: Animals; Cytokines; Female; Humans; Mifepristone; NF-kappa B; Pregnancy; Pregnancy Complications; Progesterone; Rats; Rats, Sprague-Dawley; Signal Transduction; Synovial Membrane; Temporomandibular Joint; Temporomandibular Joint Disorders | 2017 |
Provision of medical abortion by midlevel healthcare providers in Kyrgyzstan: testing an intervention to expand safe abortion services to underserved rural and periurban areas.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Contraception; Female; Health Personnel; Humans; Kyrgyzstan; Medically Underserved Area; Midwifery; Mifepristone; Misoprostol; Nurse Midwives; Pregnancy; Rural Health Services; Rural Population; Urban Health Services | 2018 |
Combination therapy with mifepristone and misoprostol for the management of first trimester miscarriage: Improved success.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Adult; Cohort Studies; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Treatment Outcome | 2018 |
Simplified medical abortion screening: a demonstration project.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Administration, Sublingual; Adolescent; Adult; Female; Humans; Mexico; Mifepristone; Misoprostol; Moldova; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Pregnancy, Ectopic; Prospective Studies; Ultrasonography; United States; Uterus; Young Adult | 2018 |
Provision of menstrual regulation with medication among pharmacies in three municipal districts of Bangladesh: a situation analysis.
Topics: Adult; Bangladesh; Cities; Contraceptive Agents; Cross-Sectional Studies; Female; Humans; Menstruation-Inducing Agents; Mifepristone; Misoprostol; Pharmaceutical Services; Pharmacies; Pregnancy; Urban Health Services | 2018 |
Medical abortion pills have the potential to change everything about abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Personal Autonomy; Pregnancy | 2018 |
Self-assessment of medical abortion outcome using symptoms and home pregnancy testing.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Tests; Self-Assessment; Treatment Outcome; United States; Young Adult | 2018 |
Progesterone for preventing pregnancy termination after initiation of medical abortion with mifepristone.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adult; Female; Humans; Mifepristone; Patient Preference; Pregnancy; Pregnancy Outcome; Progesterone; Progestins | 2017 |
Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: A non-inferiority study in Nepal.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Health Services Accessibility; Humans; Mifepristone; Misoprostol; Nepal; Nurse Midwives; Pharmacies; Pregnancy; Public Health Nursing; Safety; Treatment Outcome; Young Adult | 2018 |
More doctors providing abortion after federal rules change.
Topics: Abortion, Induced; Abortion, Legal; Attitude of Health Personnel; Canada; Female; Government Regulation; Humans; Mifepristone; Pregnancy | 2018 |
Response to "Progesterone for preventing pregnancy termination after initiation of medical abortion with mifepristone": what's the real point here?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone | 2018 |
Simultaneous Compared With Interval Medical Abortion Regimens Where Home Use Is Restricted.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Databases, Factual; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Logistic Models; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Treatment Outcome; United Kingdom; Young Adult | 2018 |
The immunological effect of Galectin-9/TIM-3 pathway after low dose Mifepristone treatment in mice at 14.5 day of pregnancy.
Topics: Abortion, Induced; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Female; Galectins; Gestational Age; Hepatitis A Virus Cellular Receptor 2; Immune System; Male; Mice; Mice, Inbred BALB C; Mifepristone; Pregnancy; Signal Transduction | 2018 |
Providing women with full reproductive choice options: the point of researching medical abortion reversal.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Progesterone; Reproduction | 2018 |
Medical abortions performed by specialists in private practice.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Norway; Pain; Parity; Patient Safety; Patient Satisfaction; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Private Practice; Self Administration; Surveys and Questionnaires; Uterine Hemorrhage; Young Adult | 2018 |
Mifepristone.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Canada; Drug Therapy, Combination; Family Planning Services; Female; Guidelines as Topic; Humans; Insurance Coverage; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second | 2018 |
Abortion-Related Adverse Events by Facility Type: Reassurance From a National Analysis.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Pregnancy | 2018 |
The costs and cost effectiveness of providing second-trimester medical and surgical safe abortion services in Western Cape Province, South Africa.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Spontaneous; Adult; Cost-Benefit Analysis; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; South Africa | 2018 |
The steroid hormone dydrogesterone inhibits myometrial contraction independently of the progesterone/progesterone receptor pathway.
Topics: Animals; Calcium Channels; Dose-Response Relationship, Drug; Dydrogesterone; Female; Humans; Mifepristone; Myometrium; Oxytocin; Pregnancy; Pregnancy, Animal; Progesterone; Progestins; Rats; Rats, Wistar; Receptors, Progesterone; Uterine Contraction | 2018 |
Progesterone receptor expression in cajal-retzius cells of the developing rat dentate gyrus: Potential role in hippocampus-dependent memory.
Topics: Animals; Behavior, Animal; Dentate Gyrus; Female; gamma-Aminobutyric Acid; Hippocampus; Interneurons; Memory; Memory Disorders; Mifepristone; Neurogenesis; Neurons; Pregnancy; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Reelin Protein | 2018 |
ACOG Practice Bulletin No. 200: Early Pregnancy Loss.
Topics: Abortifacient Agents; Abortion, Spontaneous; Dilatation and Curettage; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Rh Isoimmunization; Rho(D) Immune Globulin; Ultrasonography; Watchful Waiting | 2018 |
Use of an at-home multilevel pregnancy test and an automated call-in system to follow-up the outcome of medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Female; Follow-Up Studies; Humans; Mexico; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Pilot Projects; Pregnancy; Pregnancy Tests; Prospective Studies; Telephone; Young Adult | 2019 |
Abortion "Reversal" - Legislating without Evidence.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Counseling; Disclosure; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; United States | 2018 |
Incidence of uterine rupture in second-trimester abortion with gemeprost alone compared to mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Cesarean Section; Drug Therapy, Combination; Female; Humans; Incidence; Italy; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Uterine Rupture; Young Adult | 2019 |
Haplotype-based association of two SNPs in miR-423 with unexplained recurrent pregnancy loss in a Chinese Han population.
Topics: 3' Untranslated Regions; Abortion, Habitual; Apoptosis; Asian People; Base Sequence; Cell Line; Cell Movement; Cell Proliferation; Ethnicity; Female; Gene Expression Regulation; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Humans; MicroRNAs; Mifepristone; Molecular Chaperones; Nucleic Acid Conformation; Polymorphism, Single Nucleotide; Pregnancy; Progesterone; Risk Factors | 2019 |
Protective role of GPR120 in the maintenance of pregnancy by promoting decidualization via regulation of glucose metabolism.
Topics: Abortion, Spontaneous; Adult; Animals; Cell Line; Decidua; Disease Models, Animal; Down-Regulation; Fatty Acids, Omega-3; Female; Glucose; Humans; Lipopolysaccharides; Mice; Mifepristone; Pentose Phosphate Pathway; Pregnancy; Receptors, G-Protein-Coupled; Stromal Cells | 2019 |
Dosing interval between mifepristone and misoprostol in second and third trimester termination.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies | 2019 |
Serum hCG threshold to assess medical abortion success.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Chorionic Gonadotropin; Female; Gestational Age; Humans; Logistic Models; Mifepristone; Misoprostol; Odds Ratio; Outcome Assessment, Health Care; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Reference Values; Treatment Outcome | 2018 |
ACOG Practice Bulletin No. 200 Summary: Early Pregnancy Loss.
Topics: Abortifacient Agents; Abortion, Spontaneous; Dilatation and Curettage; Female; Humans; Mifepristone; Misoprostol; Practice Guidelines as Topic; Pregnancy; Pregnancy Trimester, First; Rh Isoimmunization; Rho(D) Immune Globulin; Ultrasonography; Watchful Waiting | 2018 |
Could second-trimester medical abortion be offered as a day service? Assessing the feasibility of a 1-day outpatient procedure using pooled data from six clinical studies.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Ambulatory Care; Feasibility Studies; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic; Time Factors; Young Adult | 2019 |
Rebound of medication abortion in Texas following updated mifepristone label.
Topics: Abortion, Induced; Ambulatory Care Facilities; Drug Labeling; Female; Humans; Legislation, Drug; Mifepristone; Pregnancy; Texas; United States; United States Food and Drug Administration | 2019 |
Risk factors for surgical intervention of early medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Cesarean Section; Cohort Studies; Delivery, Obstetric; Female; Gestational Age; Humans; Maternal Age; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Risk Factors; Vacuum Curettage; Young Adult | 2019 |
Medical abortion: it is time to lift restrictions.
Topics: Abortion, Induced; Abortion, Legal; Australia; Female; Humans; Mifepristone; Pregnancy; Right to Health | 2019 |
Patients' Motivation for Surgical Versus Medical Abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Mifepristone; Motivation; Ontario; Pregnancy; Young Adult | 2019 |
Involvement of glucocorticoid and mineralocorticoid receptors in lipid accumulation and depressed G6PD activity in the livers of rats treated with postpartum oral estrogen-progestin.
Topics: Animals; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Female; Glucose; Glucosephosphate Dehydrogenase; Levonorgestrel; Lipid Metabolism; Liver; Mifepristone; Mineralocorticoid Receptor Antagonists; Pregnancy; Progestins; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 2019 |
Medical management of first trimester missed miscarriage: the efficacy and complication rate.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Adolescent; Adult; Chorionic Gonadotropin, beta Subunit, Human; Curettage; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Uterine Hemorrhage; Young Adult | 2019 |
Abortion providers' experiences and views on self-managed medication abortion: an exploratory study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Adult; Female; Gestational Age; Humans; Logistic Models; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Reproductive Health; Self Administration; Young Adult | 2019 |
Could implementation of mifepristone address Canada's urban-rural abortion access disparity: a mixed-methods implementation study protocol.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Canada; Female; Health Services Accessibility; Healthcare Disparities; Humans; Mifepristone; Pregnancy; Prospective Studies; Qualitative Research; Rural Population; Urban Population | 2019 |
Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Oral; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Young Adult | 2019 |
Pathways to seeking medication abortion care: A qualitative research in Uttar Pradesh, India.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Decision Making; Female; Gynecology; Health Knowledge, Attitudes, Practice; Humans; India; Male; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Pharmacies; Pregnancy; Qualitative Research; Young Adult | 2019 |
Medical abortion with mifepristone and vaginal misoprostol between 64 and 70 days' gestation.
Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Treatment Outcome; United Kingdom; Young Adult | 2019 |
TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Patient Satisfaction; Pregnancy; Self Administration; Telemedicine; United States; Young Adult | 2019 |
Self-assessment of success of early medical abortion using a self-performed urine pregnancy test.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Pregnancy Tests; Self-Assessment | 2019 |
Current and future expectations of mifepristone treatment in early pregnancy failure: a survey among Dutch gynaecologists.
Topics: Abortifacient Agents; Abortion, Spontaneous; Female; Gynecology; Humans; Mifepristone; Misoprostol; Netherlands; Pregnancy; Surveys and Questionnaires | 2019 |
Time to Reevaluate U.S. Mifepristone Restrictions.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Drug and Narcotic Control; Drug Approval; Female; Government Regulation; Health Services Accessibility; History, 20th Century; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2019 |
Study of effects of mifepristone on full-term pregnancies.
Topics: Adult; Cervical Ripening; Female; Hormone Antagonists; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Term Birth; Treatment Outcome | 2020 |
Telemedicine for medication abortion.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Telemedicine; United States | 2019 |
Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone.
Topics: Animals; Anti-Inflammatory Agents; Dietary Supplements; Embryo Loss; Female; Gene Expression Regulation; Leukemia Inhibitory Factor; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mifepristone; Nitric Oxide; Pregnancy; Progesterone; Receptors, Progesterone; RNA, Messenger; Uterus | 2013 |
Emergency contraception.
Topics: China; Contraception, Postcoital; Contraceptive Agents; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Ethinyl Estradiol; European Union; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Norpregnadienes; Ovulation; Pregnancy; Pregnancy, Ectopic; Receptors, Progesterone; Time Factors | 2013 |
Reviewer's commentary on 'Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study'.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Teratogens | 2013 |
The association between serum progesterone and outcome of medical management of early fetal demise: a pilot study.
Topics: Abortifacient Agents; Abortion, Missed; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Progesterone; Prospective Studies; Treatment Failure; Young Adult | 2013 |
Serum angiopoietin-2 and β-hCG as predictors of prolonged uterine bleeding after medical abortion in the first trimester.
Topics: Abortion, Induced; Adult; Angiopoietin-2; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Uterine Hemorrhage; Young Adult | 2013 |
[Selective progesterone receptor modulators and their therapeutical use].
Topics: Abortion, Induced; Endometriosis; Female; Hormone Antagonists; Humans; Leiomyoma; Mifepristone; Norpregnadienes; Pregnancy; Progesterone; Receptors, Progesterone | 2013 |
Cortisol stimulates proliferation and apoptosis in the late gestation fetal heart: differential effects of mineralocorticoid and glucocorticoid receptors.
Topics: Animals; Apoptosis; Canrenoic Acid; Cardiomegaly; Caspase 3; Cell Proliferation; Female; Fetal Heart; Gestational Age; Hydrocortisone; Infusions, Intravenous; Ki-67 Antigen; Mifepristone; Mineralocorticoid Receptor Antagonists; Pregnancy; Proto-Oncogene Proteins c-kit; Purkinje Fibers; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Sheep; Stem Cells | 2013 |
Epimorphin is a novel regulator of the progesterone receptor isoform-a.
Topics: Animals; Apoptosis; Blotting, Western; Cell Proliferation; Female; Gene Expression Regulation; Hormone Antagonists; Humans; Male; Mammary Glands, Animal; Membrane Glycoproteins; Mice; Mice, Transgenic; Mifepristone; Milk Proteins; Phenotype; Pregnancy; Real-Time Polymerase Chain Reaction; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2013 |
Medical abortion: a path to safe, high-quality abortion care in Latin America and the Caribbean.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Legal; Adolescent; Adult; Caribbean Region; Female; Health Services Accessibility; Humans; Latin America; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Unwanted | 2013 |
Labor induction outcomes in third-trimester stillbirths.
Topics: Adolescent; Adult; Amnion; Cervical Ripening; Delivery, Obstetric; Female; Humans; Labor, Induced; Mifepristone; Misoprostol; Oxytocics; Oxytocin; Postpartum Hemorrhage; Pregnancy; Pregnancy Trimester, Third; Retrospective Studies; Stillbirth; Time Factors; Urinary Catheterization; Young Adult | 2013 |
Progesterone elicits an inhibitory effect upon LPS-induced innate immune response in pre-labor human amniotic epithelium.
Topics: Amnion; beta-Defensins; Cells, Cultured; Cytokines; Epithelium; Female; Gene Expression Regulation; Hormone Antagonists; Humans; Immune Tolerance; Immunity, Innate; Inflammation Mediators; Lipopolysaccharides; Mifepristone; Myeloid Differentiation Factor 88; Pregnancy; Progesterone; Toll-Like Receptor 4 | 2014 |
Efficacy of mifepristone for cervical priming for second-trimester surgical termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Laminaria; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2014 |
A pilot study on the combined use of letrozole, mifepristone and misoprostol in termination of first trimester pregnancy up to 9 weeks' gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Aromatase Inhibitors; Female; Humans; Letrozole; Mifepristone; Misoprostol; Nitriles; Pilot Projects; Pregnancy; Triazoles | 2013 |
Prostaglandins are essential for cervical ripening in LPS-mediated preterm birth but not term or antiprogestin-driven preterm ripening.
Topics: Animals; Cervical Ripening; Cervix Uteri; Female; Flow Cytometry; Gene Expression Regulation; Lipopolysaccharides; Mice; Mifepristone; Misoprostol; Obstetric Labor, Premature; Pregnancy; Pregnancy, Animal; Premature Birth; Progestins; Prostaglandins; Pyrazoles; Steroids; Sulfonamides; Term Birth | 2014 |
Elevated expression levels of matrix metalloproteinase-9 in placental villi and tissue inhibitor of metalloproteinase-2 in decidua are associated with prolonged bleeding after mifepristone-misoprostol medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Chorionic Villi; Decidua; Female; Follow-Up Studies; Gene Expression Regulation, Enzymologic; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mifepristone; Misoprostol; Postoperative Hemorrhage; Pregnancy; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Young Adult | 2014 |
Medical abortion in Canada: behind the times.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Canada; Female; Health Services Accessibility; Humans; Mifepristone; Pregnancy | 2014 |
The Bax/Bcl-2 apoptotic pathway is not responsible for the increase in apoptosis in the RU486-treated rat uterus during early pregnancy.
Topics: Analysis of Variance; Animals; Apoptosis; bcl-2-Associated X Protein; DNA Primers; Embryo Implantation; Endometrium; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Developmental; Mifepristone; Pregnancy; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Trypan Blue; Uterus | 2013 |
[Pregnancy termination in Bulgaria – past, present and future perspectives. Drugs induced abortion – guidelines by WHO].
Topics: Abortifacient Agents; Abortion, Induced; Bulgaria; Female; History, 20th Century; History, 21st Century; Humans; Mifepristone; Misoprostol; Practice Guidelines as Topic; Pregnancy; World Health Organization | 2013 |
[Again about the drug induced abortion].
Topics: Abortifacient Agents; Abortion, Induced; Bulgaria; Female; Gestational Age; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy | 2013 |
Medical management of early pregnancy failure (EPF): a retrospective analysis of a combined protocol of mifepristone and misoprostol used in clinical practice.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Adolescent; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Logistic Models; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Young Adult | 2014 |
Knowledge and provision practices regarding medical abortion among public providers in Hanoi, Khanh Hoa, and Ho Chi Minh City, Vietnam.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Attitude of Health Personnel; Cross-Sectional Studies; Female; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Rural Health Services; Surveys and Questionnaires; Urban Health Services; Vietnam; Young Adult | 2014 |
Cervical preparation for second-trimester surgical abortion prior to 20 weeks' gestation: SFP Guideline #2013-4.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Labor Stage, First; Laminaria; Magnesium Sulfate; Mifepristone; Misoprostol; Polymers; Polyvinyl Alcohol; Pregnancy; Pregnancy Trimester, Second | 2014 |
Impaired imprinting and social behaviors in chicks exposed to mifepristone, a glucocorticoid receptor antagonist, during the final week of embryogenesis.
Topics: Aggression; Animals; Body Weight; Brain; Chick Embryo; Female; Imprinting, Psychological; Learning Disabilities; Mifepristone; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Glucocorticoid; Social Behavior Disorders; Vocalization, Animal | 2014 |
The effect of mifepristone (RU486) on the endocannabinoid system in human plasma and first-trimester trophoblast of women undergoing termination of pregnancy.
Topics: Abortion, Induced; Adolescent; Adult; Case-Control Studies; Endocannabinoids; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Trophoblasts; Young Adult | 2014 |
Dexamethasone decreases insulin-like growth factor-I and -II via a glucocorticoid receptor dependent mechanism in developing rat brain.
Topics: Animals; Animals, Newborn; Brain; Brain-Derived Neurotrophic Factor; Dexamethasone; Disease Models, Animal; Drug Interactions; Female; Glucocorticoids; Hormone Antagonists; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Mifepristone; Nerve Growth Factor; Neurodegenerative Diseases; Organ Size; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid | 2013 |
Effect of acupuncture on CXCL8 receptors in rats suffering from embryo implantation failure.
Topics: Acupuncture Therapy; Animals; Blotting, Western; Embryo Implantation; Endometrium; Female; Gene Expression Regulation, Developmental; Hormone Antagonists; Immunohistochemistry; Mifepristone; Pregnancy; Progestins; Random Allocation; Rats; Rats, Wistar; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Treatment Outcome; Up-Regulation | 2014 |
[Medical abortion for first-trimester termination of the pregnancy].
Topics: Abortifacient Agents; Abortion, Induced; Bulgaria; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 2013 |
Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; Ambulatory Care; Feasibility Studies; Female; Follow-Up Studies; Gestational Age; Humans; Mifepristone; Misoprostol; Nigeria; Patient Satisfaction; Pregnancy; Quality of Health Care; Young Adult | 2014 |
Second-trimester induced abortions in two tertiary centres in Rome.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Alprostadil; Congenital Abnormalities; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, Second; Rome; Socioeconomic Factors | 2014 |
Practice bulletin no. 143: medical management of first-trimester abortion.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Clinical Protocols; Directive Counseling; Drug Administration Schedule; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Patient Selection; Pregnancy; Pregnancy Trimester, First; Tamoxifen | 2014 |
Changes in sexual function after medical or surgical termination of pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Coitus; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Pregnancy; Pregnancy Trimester, First; Prospective Studies | 2014 |
Achievements of the FIGO Initiative for the Prevention of Unsafe Abortion and its Consequences in South-Southeast Asia.
Topics: Abortion, Incomplete; Abortion, Induced; Aftercare; Asia, Southeastern; Contraception; Drug Approval; Female; Humans; International Agencies; Midwifery; Mifepristone; Misoprostol; Pregnancy; Vacuum Curettage | 2014 |
Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Therapy, Combination; Female; Gestational Age; Health Services Accessibility; Humans; Mifepristone; Misoprostol; Odds Ratio; Pain; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Prospective Studies; Self Administration; Travel; Uterine Hemorrhage | 2014 |
Clinical analysis of diagnosis and treatment of 13 cases with cesarean scar pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Cesarean Section; Chorionic Gonadotropin; Cicatrix; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic; Ultrasonography, Doppler, Color; Uterine Artery Embolization; Young Adult | 2014 |
Medical management of first-trimester abortion.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Chorionic Gonadotropin; Counseling; Evidence-Based Medicine; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; United States; United States Food and Drug Administration | 2014 |
When pregnancy must end in the second trimester.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2014 |
Pregnancy-associated plasma protein A up-regulated by progesterone promotes adhesion and proliferation of trophoblastic cells.
Topics: Adult; Cell Adhesion; Cell Line; Cell Proliferation; Cells, Cultured; Down-Regulation; Epithelial Cells; Female; Humans; Mifepristone; Pregnancy; Pregnancy-Associated Plasma Protein-A; Progesterone; Receptors, Progesterone; RNA, Small Interfering; Trophoblasts; Up-Regulation; Uterus | 2014 |
MicroRNA-200a locally attenuates progesterone signaling in the cervix, preventing embryo implantation.
Topics: 20-alpha-Hydroxysteroid Dehydrogenase; Animals; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cervix Uteri; Down-Regulation; Embryo Implantation; Embryo Implantation, Delayed; Endometrium; Estrogens; Female; Humans; Ki-67 Antigen; Male; MCF-7 Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Mifepristone; Pregnancy; Progesterone; Receptors, Progesterone; STAT5 Transcription Factor; Stromal Cells; Tacrolimus Binding Proteins; Up-Regulation; Uterus | 2014 |
Opioid modulation of prolactin secretion induced by stress during late pregnancy. Role of ovarian steroids.
Topics: Analgesics, Opioid; Animals; Estradiol; Female; Mifepristone; Naloxone; Naltrexone; Narcotic Antagonists; Ovary; Pregnancy; Progesterone; Prolactin; Rats; Rats, Wistar; Steroids; Tamoxifen | 2014 |
Effects of a prolonged, 72 hours, interval between mifepristone and gemeprost in second trimester termination of pregnancy: a retrospective analysis.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Adult; Alprostadil; Curettage; Drug Administration Schedule; Female; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Lifetime-dependent effects of bisphenol A on asthma development in an experimental mouse model.
Topics: Animals; Asthma; Benzhydryl Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Water; Endocrine Disruptors; Female; Mice; Mice, Inbred BALB C; Mifepristone; Ovalbumin; Phenols; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Glucocorticoid; Time Factors | 2014 |
Caesarean scar ectopic pregnancy successfully treated with methotrexate and mifepristone.
Topics: Abortifacient Agents; Adult; Cesarean Section; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic | 2015 |
Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Azerbaijan; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Self Administration; Young Adult | 2014 |
Postcoital administration of RU486 induces a hormonally under-stimulated rat endometrium.
Topics: Animals; Contraceptives, Postcoital, Synthetic; Embryo Implantation; Endometrium; Estrogen Receptor Antagonists; Female; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation, Developmental; Injections, Subcutaneous; Mifepristone; Pregnancy; Progesterone; Protein Transport; Rats, Wistar; Receptors, Progesterone; Signal Transduction | 2014 |
Synthesis and biological evaluation of 11' imidazolyl antiprogestins and mesoprogestins.
Topics: Animals; Cell Line; Female; Guinea Pigs; Hormone Antagonists; Humans; Mifepristone; Models, Molecular; Pregnancy; Progesterone; Progestins; Uterus | 2014 |
Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Attitude of Health Personnel; Community Pharmacy Services; Ethics, Pharmacy; Female; Health Care Surveys; Humans; Legislation, Drug; Mifepristone; New South Wales; Nonprescription Drugs; Patient Education as Topic; Pharmacists; Pharmacy Service, Hospital; Pregnancy; Professional Competence; Professional Role; Urban Health Services; Workforce | 2015 |
Prolonged pregnancy in women is associated with attenuated myometrial expression of progesterone receptor co-regulator Krüppel-like Factor 9.
Topics: Adult; Cell Line; Female; Gene Expression; Hormone Antagonists; Humans; Kruppel-Like Transcription Factors; Mifepristone; Myometrium; Parturition; Pregnancy; Pregnancy, Prolonged; Receptors, Progesterone; RNA, Small Interfering; Signal Transduction | 2015 |
Chemotactic activity of gestational tissues through late pregnancy, term labor, and RU486-induced preterm labor in Guinea pigs.
Topics: Amniotic Fluid; Animals; Decidua; Extraembryonic Membranes; Female; Fetal Membranes, Premature Rupture; Gestational Age; Guinea Pigs; Leukocytes; Mifepristone; Myometrium; Obstetric Labor, Premature; Placenta; Pregnancy; Pregnancy Trimester, Third; Progesterone; Term Birth | 2015 |
Sequential use of mifepristone and misoprostol in treatment of early pregnancy failure appears more effective than misoprostol alone: a retrospective study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Administration, Intravaginal; Administration, Oral; Adult; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Treatment Outcome | 2014 |
Medical management of unwanted pregnancy in France: modalities and outcomes. The aMaYa study.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Drug Therapy, Combination; Female; France; Humans; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Pregnancy, Unwanted; Prospective Studies; Treatment Outcome; Young Adult | 2015 |
Follow-up after medical abortion: does simple equal safe?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Diagnostic Self Evaluation; Female; Humans; Mifepristone; Pregnancy; Prostaglandins | 2015 |
Sirh7/Ldoc1 knockout mice exhibit placental P4 overproduction and delayed parturition.
Topics: Animals; DNA Primers; Female; Genotype; In Situ Hybridization; Mice; Mice, Knockout; Mifepristone; Parturition; Placenta; Placental Lactogen; Polymerase Chain Reaction; Pregnancy; Progesterone; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Time Factors | 2014 |
Functional study of one nucleotide mutation in pri-miR-125a coding region which related to recurrent pregnancy loss.
Topics: 3' Untranslated Regions; Abortion, Habitual; Asian People; Case-Control Studies; Cells, Cultured; Endometrium; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Haplotypes; Humans; MicroRNAs; Mifepristone; Mutation; Polymorphism, Single Nucleotide; Pregnancy; RNA Stability; Stromal Cells | 2014 |
[Medical abortion--evidence-based practice].
Topics: Abortifacient Agents; Abortion, Induced; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimesters | 2014 |
Intra-abortion contraception with etonogestrel subdermal implant.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Contraception Behavior; Contraceptive Agents, Female; Desogestrel; Female; Humans; Mifepristone; Pregnancy; Prospective Studies; Young Adult | 2015 |
Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Adolescent; Adult; Cohort Studies; Drug Therapy, Combination; Evidence-Based Medicine; Female; Gestational Age; Humans; Logistic Models; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Treatment Outcome; Young Adult | 2015 |
Baicalin can attenuate the inhibitory effects of mifepristone on Wnt pathway during peri-implantation period in mice.
Topics: Abortifacient Agents, Steroidal; Animals; Embryo Implantation; Estradiol; Female; Flavonoids; Gene Expression Regulation; Mice; Mifepristone; Pregnancy; Progesterone; Tocolytic Agents; Wnt Signaling Pathway | 2015 |
Uterine rupture disguised by urinary retention following a second trimester induced abortion: a case report.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Cesarean Section; Cicatrix; Dilatation and Curettage; Female; Humans; Laparoscopy; Mifepristone; Placenta; Pregnancy; Pregnancy Trimester, Second; Tissue Adhesions; Treatment Outcome; Urinary Retention | 2015 |
Clinical analyses of 66 cases of mid-trimester pregnancy termination in women with prior cesarean.
Topics: Abortion, Induced; Cesarean Section; Ethacridine; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimesters; Retrospective Studies; Uterine Rupture | 2015 |
Expanding access to medical abortion: challenges and opportunities.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Attitude of Health Personnel; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Mifepristone; Physicians; Pregnancy; Primary Health Care; Women's Health | 2015 |
Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Ambulatory Care Facilities; Cambodia; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Male; Mifepristone; Misoprostol; Patient Satisfaction; Pharmacists; Pregnancy; Sexual Partners; Young Adult | 2015 |
The introduction of first trimester medical abortion in Armenia.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Armenia; Drug Combinations; Female; Humans; Interviews as Topic; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Young Adult | 2015 |
Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Drug Combinations; Female; Humans; Mexico; Middle Aged; Mifepristone; Misoprostol; Outpatients; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Public Sector; Treatment Outcome; Young Adult | 2015 |
Pharmacy workers in Nepal can provide the correct information about using mifepristone and misoprostol to women seeking medication to induce abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Clinical Competence; Drug Combinations; Education, Pharmacy, Continuing; Female; Humans; Male; Mifepristone; Misoprostol; Nepal; Pharmacists; Pregnancy | 2015 |
[Cesarean scar ectopic pregnancies: combined modality therapies with uterine artery embolization before surgical procedure].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Blood Loss, Surgical; Cesarean Section; Cicatrix; Combined Modality Therapy; Curettage; Female; Gestational Age; Humans; Hysterectomy; Methotrexate; Mifepristone; Pregnancy; Pregnancy Trimester, First; Pregnancy, Ectopic; Uterine Artery Embolization | 2015 |
Early serum human chorionic gonadotropin (hCG) trends after medication abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Chorionic Gonadotropin; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies | 2015 |
Delivering medical abortion at scale: a study of the retail market for medical abortion in Madhya Pradesh, India.
Topics: Abortion, Induced; Abortion, Spontaneous; Adult; Female; Humans; India; Male; Mifepristone; Misoprostol; Pharmacists; Pregnancy; Private Sector | 2015 |
What is the right timing for ultrasound evaluation after pregnancy termination with mifepristone?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Age Factors; Female; Humans; Mifepristone; Pregnancy; Retrospective Studies; Time Factors; Treatment Outcome; Ultrasonography, Prenatal; Young Adult | 2015 |
Association between ultrasonographic parameters of Cesarean scar defect and outcome of early termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Cesarean Section; Cicatrix; Female; Humans; Mifepristone; Misoprostol; Myometrium; Postoperative Complications; Pregnancy; Retrospective Studies; Ultrasonography | 2016 |
Uterine artery Doppler in the management of early pregnancy loss: a prospective, longitudinal study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Spontaneous; Adult; Cohort Studies; Dilatation and Curettage; Disease Management; Female; Humans; Longitudinal Studies; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prognosis; Prospective Studies; Pulsatile Flow; Ultrasonography, Doppler; Uterine Artery; Vascular Resistance; Young Adult | 2015 |
Corticosteroid responses following hypoxic preconditioning provide neuroprotection against subsequent hypoxic-ischemic brain injury in the newborn rats.
Topics: Adrenal Cortex Hormones; Analysis of Variance; Animals; Animals, Newborn; Brain Edema; Caspase 3; Female; Hormone Antagonists; Hypoxia-Ischemia, Brain; Ischemic Preconditioning; Male; Mifepristone; Pregnancy; Rats; Rats, Sprague-Dawley; Time Factors | 2015 |
Placental claudin expression and its regulation by endogenous sex steroid hormones.
Topics: Animals; Claudins; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression; Gene Expression Regulation; Male; Mice, Inbred ICR; Mifepristone; Placenta; Pregnancy; Receptors, Progesterone | 2015 |
Progesterone Receptor Expression in the Developing Mesocortical Dopamine Pathway: Importance for Complex Cognitive Behavior in Adulthood.
Topics: Animals; Animals, Newborn; Benzofurans; Cognition Disorders; Dopamine; Female; Gene Expression Regulation; Hormone Antagonists; Male; Mice; Mice, Transgenic; Mifepristone; Phenotype; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Sex Factors; Signal Transduction; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2016 |
If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of the office in medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Off-Label Use; Office Visits; Pregnancy; Self Administration; United States; United States Food and Drug Administration | 2015 |
Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data.
Topics: Abdominal Pain; Abortifacient Agents, Steroidal; Abortion, Induced; Evidence-Based Medicine; Female; Fever; Hemorrhage; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2015 |
Mifepristone by prescription: a dream in the United States but reality in Australia.
Topics: Abortifacient Agents; Abortion, Induced; Australia; Certification; Female; Humans; Mifepristone; Misoprostol; Nonprescription Drugs; Pharmacies; Pharmacists; Physicians; Pregnancy; United States | 2015 |
Medical abortion: the hidden revolution.
Topics: Abortifacient Agents; Abortion, Induced; Commerce; Drug Utilization; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2015 |
Mifepristone label laws and trends in use: recent experiences in four US states.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; California; Contraception; Drug Labeling; Female; Humans; Mifepristone; New York; Ohio; Pregnancy; Texas; United States; United States Food and Drug Administration | 2015 |
Reaching women where they are: eliminating the initial in-person medical abortion visit.
Topics: Abortifacient Agents; Abortion, Induced; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Office Visits; Pregnancy; Telemedicine; United States; United States Food and Drug Administration; Women's Health | 2015 |
From qualified physician to licensed health care professional: the time has come to change mifepristone's label.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Drug Labeling; Female; Health Personnel; Humans; Licensure; Mifepristone; Physicians; Pregnancy; United States; United States Food and Drug Administration | 2015 |
Off-label indications for mifepristone in gynecology and obstetrics.
Topics: Abortifacient Agents; Abortion, Induced; Drug Therapy, Combination; Evidence-Based Medicine; Female; Gynecology; Humans; Mifepristone; Misoprostol; Obstetrics; Off-Label Use; Pregnancy | 2015 |
Fifteen years: looking back and looking forward.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Contraception; Female; Forecasting; History, 20th Century; History, 21st Century; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2015 |
Introducing medication abortion into public sector facilities in KwaZulu-Natal, South Africa: an operations research study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Contraception; Feasibility Studies; Female; Humans; Mifepristone; Misoprostol; Operations Research; Patient Satisfaction; Pregnancy; South Africa; Treatment Outcome; Young Adult | 2015 |
Medication abortion failure in women with and without previous cesarean delivery.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Cesarean Section; Female; Humans; Logistic Models; Mifepristone; Misoprostol; Parity; Pregnancy; Retrospective Studies; Treatment Failure; Young Adult | 2015 |
The Evolution of Medication Abortion Care: Using Science to Achieve Quality.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2015 |
Modulation of Cytokine Production by the Dydrogesterone Metabolite Dihydrodydrogesterone.
Topics: Abortion, Habitual; Cytokines; Dydrogesterone; Female; Hormone Antagonists; Humans; Leukocytes, Mononuclear; Mifepristone; Pregnancy; Progesterone | 2015 |
[Practical guidance for termination of pregnancy at 8 to 16 weeks gestation with mifepristone and misoprostol].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Practice Guidelines as Topic; Pregnancy; Pregnancy Trimester, First; Treatment Outcome | 2015 |
Comment on the combination of mifepristone and misoprostol for the termination of second-trimester pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2015 |
Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
Topics: Abortifacient Agents; Adolescent; Adult; Chorionic Gonadotropin; Contraceptive Agents; Drug Therapy, Combination; Female; Humans; Menstrual Cycle; Menstruation; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome; Young Adult | 2015 |
Deletion of Lysophosphatidic Acid Receptor 3 (Lpar3) Disrupts Fine Local Balance of Progesterone and Estrogen Signaling in Mouse Uterus During Implantation.
Topics: Animals; Cell Proliferation; Embryo Implantation; Estradiol; Estrogens; Female; Mice, Inbred C57BL; Mifepristone; Pregnancy; Progesterone; Receptors, Lysophosphatidic Acid; Receptors, Progesterone; Up-Regulation; Uterus | 2015 |
Pain during medical abortion: a multicenter study in France.
Topics: Abdominal Pain; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Age Factors; Analgesics; Female; France; Gravidity; Humans; Middle Aged; Mifepristone; Misoprostol; Pain Measurement; Pain, Postoperative; Pregnancy; Surveys and Questionnaires; Young Adult | 2015 |
Novel Medical Therapy of Cesarean Scar Pregnancy With a Viable Embryo Combining Multidose Methotrexate and Mifepristone: A Case Report.
Topics: Abortifacient Agents; Adult; Cesarean Section; Cicatrix; Female; Gestational Age; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic | 2015 |
The expression of thyroid hormone receptors (THR) is regulated by the progesterone receptor system in first trimester placental tissue and in BeWo cells in vitro.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Cell Line, Tumor; Decidua; Down-Regulation; Female; Gene Expression Regulation; Humans; Immunohistochemistry; In Vitro Techniques; Mifepristone; Placenta; Pregnancy; Pregnancy Trimester, First; Progesterone; Progestins; Real-Time Polymerase Chain Reaction; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta; Trophoblasts; Up-Regulation | 2015 |
Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2015 |
In Reply.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2015 |
First-trimester medical abortion service in Hong Kong.
Topics: Abdominal Pain; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Clinical Protocols; Diarrhea; Drug Hypersensitivity; Female; Fever; Hong Kong; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Treatment Failure; Young Adult | 2015 |
[Methods of induction of labor in termination of pregnancy after 22weeks: About 3procedures].
Topics: Abortifacient Agents; Abortion, Induced; Adult; Female; Humans; Labor, Induced; Laminaria; Mifepristone; Misoprostol; Outcome and Process Assessment, Health Care; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies | 2016 |
Short versus Standard Mifepristone and Misoprostol Regimen for Second- and Third-Trimester Termination of Pregnancy for Fetal Anomaly.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Female; Fetal Diseases; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies | 2016 |
Clinical experience and perception of abortion: A cross-sectional survey of gynecologists in Japan.
Topics: Abortifacient Agents; Abortion, Induced; Attitude of Health Personnel; Cross-Sectional Studies; Dilatation and Curettage; Female; Gynecology; Humans; Insurance, Health; Japan; Mifepristone; Pain Management; Physicians; Pregnancy; Pregnancy Trimester, First; Surveys and Questionnaires; Vacuum Curettage | 2015 |
Role of laparoscopy as a minimally invasive procedure in treatment of ruptured uterine scar during second-trimester induction of abortion.
Topics: Abortion, Induced; Adult; Cesarean Section; Cicatrix; Female; Humans; Laparoscopy; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Ultrasonography; Uterine Rupture | 2016 |
The Reversal of Mifepristone With Progesterone.
Topics: Abnormalities, Drug-Induced; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Progesterone; Progestins | 2015 |
[Therapeutic methods and their effects on patients with cornual pregnancy].
Topics: Abortion, Induced; Female; Humans; Laparoscopy; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Cornual; Retrospective Studies | 2015 |
[Medical termination of pregnancy by mifepristone and misoprostol - evaluation of succes rate, complications and satisfaction of patients].
Topics: Abortifacient Agents; Abortion, Induced; Adult; Cohort Studies; Dilatation and Curettage; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Nausea; Personal Satisfaction; Pregnancy; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome; Uterine Hemorrhage; Vomiting | 2015 |
Feasibility of self-performed urine pregnancy testing for follow-up after medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Aftercare; Chorionic Gonadotropin; Feasibility Studies; Female; Humans; Longitudinal Studies; Lost to Follow-Up; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Pregnancy Tests; Prospective Studies; Young Adult | 2016 |
Progestin-based contraceptive on the same day as medical abortion.
Topics: Abortion, Induced; Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Progestins; Retrospective Studies; South Africa; Time Factors; Young Adult | 2016 |
Efficacy of early induced medical abortion with mifepristone when beginning progestin-only contraception on the same day.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Contraception; Female; Gravidity; Humans; Mexico; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Progestins; Self Administration; Ultrasonography; Vacuum Curettage; Young Adult | 2016 |
[Medical management of interstitiel pregnancy by in situ methotrexate].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adult; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Cornual; Retrospective Studies; Treatment Outcome | 2016 |
Woman in Northern Ireland who bought abortion pills online is given suspended sentence.
Topics: Abortifacient Agents; Abortion, Criminal; Abortion, Spontaneous; Female; Humans; Internet; Mifepristone; Misoprostol; Northern Ireland; Pregnancy; Punishment; Young Adult | 2016 |
Uncomplicated abortion with mifepristone and misoprostol in a hemophilia A carrier.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Female; Hemophilia A; Humans; Mifepristone; Misoprostol; Pregnancy; Young Adult | 2016 |
Comparing office and telephone follow-up after medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; California; Female; Follow-Up Studies; Gestational Age; Humans; Lost to Follow-Up; Middle Aged; Mifepristone; Misoprostol; Office Visits; Patient Satisfaction; Pregnancy; Telephone; Young Adult | 2016 |
Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Health Knowledge, Attitudes, Practice; Humans; Interviews as Topic; Mifepristone; Misoprostol; Ontario; Pregnancy; Qualitative Research; Quebec; Young Adult | 2016 |
[Influence of early amniotomy and parity on induction-to-delivery interval during termination of pregnancy].
Topics: Abortion, Induced; Adult; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Time Factors; Treatment Outcome | 2016 |
Improving access to safe abortion in a rural primary care setting in India: experience of a service delivery intervention.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Female; Health Services Accessibility; Humans; India; Mifepristone; Pregnancy; Pregnancy, Unwanted; Primary Health Care; Rural Population | 2016 |
Progesterone Receptor-Mediated Actions Regulate Remodeling of the Cervix in Preparation for Preterm Parturition.
Topics: Animals; Cell Count; Cervical Ripening; Cervix Uteri; Female; Gonanes; Macrophages; Mice; Mifepristone; Neutrophils; Ovariectomy; Pregnancy; Premature Birth; Receptors, Progesterone | 2016 |
A New Label for Mifepristone.
Topics: Abortifacient Agents, Steroidal; Drug Labeling; Female; Government Regulation; Humans; Mifepristone; Pregnancy; State Government; United States; United States Food and Drug Administration | 2016 |
Refocusing the Undue Burden Test: Inconsistent Interpretations Pose a Substantial Obstacle to Constitutional Legislation.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Off-Label Use; Pregnancy; United States; United States Food and Drug Administration | 2016 |
Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks of pregnancy in Kazakhstan.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Ambulatory Care; Female; Humans; Kazakhstan; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Women's Health Services; Young Adult | 2016 |
"They made me go through like weeks of appointments and everything": Documenting women's experiences seeking abortion care in Yukon territory, Canada.
Topics: Abortion, Induced; Abortion, Legal; Adult; Appointments and Schedules; Female; Health Services Accessibility; Humans; Interviews as Topic; Mifepristone; Patient Satisfaction; Pregnancy; Qualitative Research; Rural Population; Women's Health Services; Yukon Territory | 2016 |
Assessing abortion coverage in nurse practitioner programs in Canada: a national survey of program directors.
Topics: Abortion, Induced; Abortion, Spontaneous; Canada; Curriculum; Female; Humans; Male; Mifepristone; Misoprostol; Nurse Practitioners; Physician Executives; Pregnancy; Reproductive Health Services; Surveys and Questionnaires | 2016 |
Interleukin (IL)-1 in rat parturition: IL-1 receptors 1 and 2 and accessory proteins abundance in pregnant rat uterus at term - regulation by progesterone.
Topics: Animals; Cervix Uteri; Cyclooxygenase 2; Female; Gene Expression Regulation; Gestational Age; Hormone Antagonists; Interleukin-1; Interleukin-1 Receptor Accessory Protein; Interleukin-1beta; Mifepristone; Neoplasm Proteins; Ovary; Parturition; Placenta; Pregnancy; Progesterone; Rats, Long-Evans; Receptors, Interleukin-1 Type I; Receptors, Interleukin-1 Type II; RNA, Messenger; Uterus | 2016 |
Medical abortion in women with large uterine fibroids: a case series.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Adult; Drug Administration Schedule; Female; Gestational Age; Humans; Leiomyoma; Maryland; Mifepristone; Misoprostol; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, First; Pregnancy Trimester, Second; Uterine Neoplasms | 2016 |
Mifepristone and misoprostol is safe and effective method in the second-trimester pregnancy termination.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Young Adult | 2016 |
Marked improvement in the success rate of medical management of early pregnancy failure following the implementation of a novel institutional protocol and treatment guidelines: a follow-up study.
Topics: Abortifacient Agents; Abortion, Spontaneous; Administration, Intravaginal; Adolescent; Adult; Clinical Protocols; Female; Follow-Up Studies; Humans; Middle Aged; Mifepristone; Misoprostol; Practice Guidelines as Topic; Pregnancy; Retrospective Studies | 2016 |
Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.
Topics: Abortion, Induced; Adult; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Legislation, Drug; Mifepristone; Misoprostol; Ohio; Pregnancy; Retrospective Studies; Treatment Outcome; United States; United States Food and Drug Administration; Young Adult | 2016 |
Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Treatment Outcome; Young Adult | 2016 |
Factors related to completeness of medical abortion with mifepristone and misoprostol.
Topics: Abortion, Induced; Adolescent; Adult; Female; Humans; Insulin-Like Growth Factor I; Mifepristone; Misoprostol; Pregnancy; Receptors, Estrogen; RNA, Messenger; Vascular Endothelial Growth Factor A; Young Adult | 2017 |
Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Chorionic Gonadotropin; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Time Factors; United States; Young Adult | 2017 |
Women's experiences of having an early medical abortion at home.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Access to Information; Adolescent; Adult; Cross-Sectional Studies; Female; Gravidity; Hemorrhage; Humans; Middle Aged; Mifepristone; Pain; Patient Satisfaction; Pregnancy; Surveys and Questionnaires; Young Adult | 2016 |
Mifepristone combined with ethacridine lactate for the second-trimester pregnancy termination in women with placenta previa and/or prior cesarean deliveries.
Topics: Abortion, Induced; Adult; Cesarean Section; Ethacridine; Female; Humans; Mifepristone; Placenta Previa; Pregnancy; Pregnancy Trimester, Second | 2017 |
Role of Estradiol in the Regulation of Prolactin Secretion During Late Pregnancy.
Topics: Animals; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Hypothalamus, Middle; Mifepristone; Naloxone; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Receptors, Progesterone; Receptors, Prolactin; Tyrosine 3-Monooxygenase | 2016 |
Requiring physicians to dispense mifepristone: an unnecessary limit on safety and access to medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Canada; Drug and Narcotic Control; Female; Health Services Accessibility; Humans; Mifepristone; Patient Safety; Pharmacists; Physicians; Pregnancy | 2016 |
Second trimester medical abortion with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Buccal; Adult; Armenia; Drug Administration Schedule; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Time Factors; Treatment Outcome | 2017 |
How can a state control swallowing? The home use of abortion pills in Ireland.
Topics: Abortifacient Agents, Steroidal; Abortion, Criminal; Abortion, Induced; Administration, Oral; Contraception, Postcoital; Deglutition; Ethics, Medical; Female; Housing; Humans; Interviews as Topic; Ireland; Mifepristone; Politics; Pregnancy; Pregnancy, Unwanted; Religion and Medicine; Telemedicine | 2016 |
Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Drug Therapy, Combination; Female; Gestational Age; Health Services Accessibility; Humans; Logistic Models; Middle Aged; Mifepristone; Misoprostol; Multivariate Analysis; Norway; Patient Satisfaction; Pregnancy; Prospective Studies; Registries; Self Administration; Surveys and Questionnaires; Young Adult | 2017 |
Serial multilevel urine pregnancy testing to assess medical abortion outcome: a meta-analysis.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Chorionic Gonadotropin; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Tests; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2017 |
PIBF positive uterine NK cells in the mouse decidua.
Topics: Animals; Cells, Cultured; Cytoplasmic Granules; Decidua; DNA-Binding Proteins; Female; Interleukin Receptor Common gamma Subunit; Killer Cells, Natural; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Mifepristone; Perforin; Pregnancy; Pregnancy Proteins; Progesterone; Protein Transport | 2017 |
The Feasibility of Conservative Management for Morbidly Adherent Placenta Accidentally Encountered after Vaginal Delivery.
Topics: Abortifacient Agents; Adult; Balloon Occlusion; Blood Transfusion; Conservative Treatment; Delivery, Obstetric; Drugs, Chinese Herbal; Feasibility Studies; Female; Humans; Hysterectomy; Methotrexate; Mifepristone; Placenta; Placenta Accreta; Placenta, Retained; Postpartum Hemorrhage; Pregnancy; Retrospective Studies; Uterine Artery Embolization; Vagina | 2017 |
Abortion choices among women in Cambodia after introduction of a socially marketed medicated abortion product.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Cambodia; Choice Behavior; Cross-Sectional Studies; Female; Humans; Maternal Mortality; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Social Marketing; Surveys and Questionnaires; Vacuum Curettage; Young Adult | 2017 |
[Repeat induced abortion: A multicenter study on medical abortions in France in 2014].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; France; Humans; Mifepristone; Pain Measurement; Pregnancy; Socioeconomic Factors; Surveys and Questionnaires | 2017 |
Medical termination of pregnancy in general practice in Australia: a descriptive-interpretive qualitative study.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Attitude of Health Personnel; Australia; Female; Focus Groups; Follow-Up Studies; General Practitioners; Humans; Male; Mifepristone; Pregnancy; Qualitative Research | 2017 |
Efficacy and safety of mifepristone-buccal misoprostol for early medical abortion in an Australian clinical setting.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Administration, Oral; Adolescent; Adult; Australia; Female; Gestational Age; Humans; Maternal Age; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Young Adult | 2017 |
Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases.
Topics: Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Humans; Mifepristone; Misoprostol; Oxytocin; Pregnancy; Pregnancy Trimester, Second; Safety; Treatment Outcome | 2008 |
First trimester medical termination of pregnancy: The Nottingham experience.
Topics: Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adult; Ambulatory Care; Cohort Studies; Female; Follow-Up Studies; Humans; Middle Aged; Mifepristone; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Risk Assessment; Treatment Outcome; United Kingdom; Vacuum Curettage | 2008 |
Implantation-related expression of epidermal growth factor family molecules and their regulation by progesterone in the pregnant rat.
Topics: 3T3 Cells; Amphiregulin; Animals; EGF Family of Proteins; Embryo Implantation; Epidermal Growth Factor; ErbB Receptors; Female; Gene Expression Regulation, Developmental; Glycoproteins; Intercellular Signaling Peptides and Proteins; Male; Mice; Mifepristone; Multigene Family; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Fibroblast Growth Factor; Transforming Growth Factor alpha | 2008 |
Monocyte chemoattractant protein-1 (CCL-2) integrates mechanical and endocrine signals that mediate term and preterm labor.
Topics: Animals; Chemokine CCL2; Female; Gravidity; Hormone Antagonists; Labor, Obstetric; Macrophages; Mifepristone; Myometrium; Obstetric Labor, Premature; Pregnancy; Progesterone; Rats; Rats, Wistar; Signal Transduction; Up-Regulation | 2008 |
Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Administration, Oral; Adolescent; Adult; Drug Therapy, Combination; Female; Health Services Accessibility; Humans; Internet; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Telemedicine | 2008 |
High failure rates of medical termination of pregnancy after introduction to a large teaching hospital.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Follow-Up Studies; Gestational Age; Hospitals, Teaching; Humans; Israel; Medical Staff, Hospital; Mifepristone; Pregnancy; Professional Competence; Retrospective Studies; Treatment Failure; Ultrasonography, Prenatal; Uterine Contraction; Young Adult | 2009 |
Progesterone regulation of glutathione S-transferase Mu2 expression in mouse uterine luminal epithelium during preimplantation period.
Topics: Animals; Blastocyst; Embryo Implantation; Epithelial Cells; Estradiol; Female; Gene Expression Regulation, Enzymologic; Glutathione Transferase; In Situ Hybridization; Mice; Mice, Inbred Strains; Mifepristone; Ovariectomy; Pregnancy; Pregnancy, Animal; Progesterone; Pseudopregnancy; Reverse Transcriptase Polymerase Chain Reaction; Uterus | 2009 |
Pituitary changes involved in prolactin secretion induced by mifepristone and naloxone during late pregnancy.
Topics: Animals; Female; Lactotrophs; Mifepristone; Naloxone; Pituitary Gland; Pregnancy; Prolactin; Rats; Rats, Wistar; RNA, Messenger; Time Factors | 2009 |
Relationship between gene expression and function of uterotonic systems in the rat during gestation, uterine activation and both term and preterm labour.
Topics: Animals; Connexin 43; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprost; Endothelin-1; Female; Gene Expression; Gene Expression Profiling; Gestational Age; Male; Mifepristone; Myography; Nitric Oxide Synthase Type II; Oxytocin; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Receptors, Oxytocin; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Uterine Contraction; Uterus | 2008 |
Sonography of uterine cavity contents after medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Case-Control Studies; Female; Humans; Mifepristone; Pregnancy; Ultrasonography; Uterus; Vacuum Curettage; Young Adult | 2009 |
Medical abortion practices: a survey of National Abortion Federation members in the United States.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Ambulatory Care Facilities; Female; Health Care Surveys; Humans; Mifepristone; Misoprostol; Practice Patterns, Physicians'; Pregnancy; Pregnancy Trimester, First; Surveys and Questionnaires; United States; United States Food and Drug Administration | 2008 |
Re: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Health Services Accessibility; Humans; Mifepristone; Misoprostol; Pregnancy; Telemedicine | 2008 |
Mifepristone-induced abortion and placental complications in subsequent pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Cohort Studies; Female; Humans; Incidence; Mifepristone; Placenta Diseases; Pregnancy; Risk Factors | 2009 |
Re: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Ethics, Medical; Female; Health Services Accessibility; Humans; Mifepristone; Misoprostol; Pregnancy; Telemedicine | 2008 |
First and second trimester induced abortions in women with cardiac disorders: a 12-year analysis from a developing country.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Developing Countries; Female; Heart Diseases; Humans; India; Mifepristone; Misoprostol; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, First; Pregnancy Trimester, Second; Retrospective Studies | 2008 |
How much supervision is necessary for women taking mifepristone and misoprostol for early medical abortion?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Administration Schedule; Drug Utilization; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 2008 |
RXFP1-inactive relaxin activates human glucocorticoid receptor: further investigations into the relaxin-GR pathway.
Topics: Animals; Cell Line; Cell Nucleus; Cyclic AMP; Cytokines; Cytoplasm; Dose-Response Relationship, Drug; Endothelial Cells; Endotoxins; Female; HeLa Cells; HT29 Cells; Humans; Interleukin-6; Mifepristone; Pregnancy; Receptors, G-Protein-Coupled; Receptors, Glucocorticoid; Receptors, Peptide; Relaxin; Swine; Transfection; Tumor Necrosis Factor-alpha | 2009 |
Relationship of obesity to outcome of medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Body Mass Index; Female; Humans; Mifepristone; Obesity; Pregnancy; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult | 2009 |
The role of parity in medical abortion up to 49 days of amenorrhoea.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Amenorrhea; Chorionic Gonadotropin; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Parity; Pregnancy; Retrospective Studies; Risk Factors; ROC Curve; Young Adult | 2008 |
Uterine perforation and bowel incarceration following surgical abortion during the first trimester.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Ileal Diseases; Mifepristone; Obstetrical Forceps; Pregnancy; Uterine Perforation | 2008 |
[Phenolic acids from Arnebia euchroma mifepristone in anti-early pregnancy of SD rattus norvegicus].
Topics: Abortifacient Agents; Animals; Boraginaceae; Female; Hydroxybenzoates; Male; Mifepristone; Pregnancy; Progesterone; Radioimmunoassay; Rats; Rats, Sprague-Dawley | 2008 |
Collaborative work on evaluation of ovarian toxicity. 2) Two- or four-week repeated dose studies and fertility study of mifepristone in female rats.
Topics: Administration, Oral; Animals; Drug Administration Schedule; Embryonic Development; Estrous Cycle; Female; Fertility; Hormone Antagonists; Infertility, Female; Japan; Male; Mifepristone; Ovarian Cysts; Ovary; Pregnancy; Public-Private Sector Partnerships; Rats; Rats, Sprague-Dawley; Societies, Scientific; Specific Pathogen-Free Organisms; Toxicity Tests; Vagina | 2009 |
Setting up a medical abortion service for failure.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Treatment Failure | 2009 |
Effect of previous live birth and prior route of delivery on the outcome of early medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cesarean Section; Delivery, Obstetric; Drug Combinations; Female; Humans; Live Birth; Logistic Models; Mifepristone; Misoprostol; Multivariate Analysis; Parity; Pregnancy; Retrospective Studies; Risk Factors; Treatment Outcome | 2009 |
Frequency and risk factors for repeat abortions after surgical compared with medical termination of pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Age Factors; Cohort Studies; Dilatation and Curettage; Female; Gestational Age; Humans; Marital Status; Maternal Age; Middle Aged; Mifepristone; Misoprostol; Parity; Pregnancy; Registries; Risk Factors; Social Class; Socioeconomic Factors; Vacuum Extraction, Obstetrical; Young Adult | 2009 |
The guinea pig as an animal model for developmental and reproductive toxicology studies.
Topics: Abortifacient Agents; Animal Husbandry; Animals; Breeding; Embryo Implantation; Estrous Cycle; Female; Fertility; Guinea Pigs; Litter Size; Male; Mifepristone; Models, Animal; Organ Size; Pilot Projects; Pregnancy; Pregnancy Rate; Species Specificity; Spermatozoa; Toxicology; Uterus | 2009 |
Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Cross-Sectional Studies; Female; Humans; Matrix Metalloproteinase 9; Mifepristone; Misoprostol; Pregnancy; Tissue Inhibitor of Metalloproteinase-1; Uterine Hemorrhage | 2009 |
Trends in abortion in the United States.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Adult; Female; Humans; Marital Status; Medicaid; Mifepristone; Pregnancy; United States; Young Adult | 2009 |
Understanding women's experiences with medical abortion: In-depth interviews with women in two Indian clinics.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Humans; Interviews as Topic; Mifepristone; Misoprostol; Pregnancy; Women; Young Adult | 2010 |
Choosing medical or surgical terminations of pregnancy in the first trimester: what is the difference?
Topics: Abortifacient Agents; Abortion, Induced; Adult; Choice Behavior; Drug Administration Schedule; Drug Therapy, Combination; Female; Gravidity; Humans; Mifepristone; Misoprostol; New Zealand; Patient Participation; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Vacuum Curettage; Young Adult | 2009 |
Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys.
Topics: Animals; Embryo Implantation; Endometrium; Female; Gene Expression; Gene Expression Profiling; Hormone Antagonists; Immunohistochemistry; Janus Kinase 1; Luteal Phase; Macaca mulatta; Mifepristone; Oligonucleotide Array Sequence Analysis; Pregnancy; Progesterone; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; Transcription, Genetic | 2009 |
Nongenomic uterine relaxing effect of RU 486 (mifepristone) prior to its antiprogesterone activity in the human pregnancy.
Topics: Calcium; Calcium Channel Blockers; Electric Conductivity; Female; Hormone Antagonists; Humans; In Vitro Techniques; Ion Channel Gating; Mifepristone; Muscle Relaxation; Oxytocin; Potassium Chloride; Pregnancy; Progesterone; Prostaglandins; Protein Biosynthesis; Term Birth; Time Factors; Transcription, Genetic; Uterine Contraction; Uterus | 2009 |
Mifepristone and Misoprostol for the management of placenta accreta - a new alternative approach.
Topics: Administration, Oral; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Oxytocics; Placenta Accreta; Pregnancy | 2009 |
Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Administration, Sublingual; Adult; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Turkey; Young Adult | 2009 |
Effect of mifepristone on the corpus luteum in early pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Case-Control Studies; Chorionic Gonadotropin, beta Subunit, Human; Corpus Luteum; Female; Humans; Injections, Intramuscular; Longitudinal Studies; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; Prospective Studies; Risk Assessment; Treatment Outcome; Young Adult | 2009 |
Preterm and term cervical ripening in CD1 Mice (Mus musculus): similar or divergent molecular mechanisms?
Topics: Analysis of Variance; Animals; Cervical Ripening; Cervix Uteri; Cytokines; Databases, Genetic; Desmoglein 1; Disease Models, Animal; Female; Gestational Age; Immunohistochemistry; Inflammation; Lipopolysaccharides; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mifepristone; Oligonucleotide Array Sequence Analysis; Pregnancy; Premature Birth; Principal Component Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tissue Inhibitor of Metalloproteinase-2 | 2009 |
Emergency contraception with mifepristone 10 mg in Thai women.
Topics: Abortifacient Agents, Steroidal; Adult; Buddhism; Confidence Intervals; Contraception Behavior; Contraception, Postcoital; Female; Health Knowledge, Attitudes, Practice; Humans; Mifepristone; Pregnancy; Pregnancy, Unwanted; Thailand | 2009 |
Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Adult; Female; Gestational Age; Humans; Logistic Models; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Urban Population; Young Adult | 2009 |
Unexpected heaping in reported gestational age for women undergoing medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Ultrasonography, Prenatal; Urban Population | 2009 |
Effect of mifepristone on abortion access in the United States.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Drug Approval; Drug Utilization; Female; Health Services Accessibility; Humans; Mifepristone; Pregnancy; United States | 2009 |
Enhanced expression of P2X4 and P2X7 purinergic receptors in the myometrium of pregnant rats in preterm delivery models.
Topics: Animals; Blotting, Western; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Female; Gestational Age; Lipopolysaccharides; Mifepristone; Myometrium; Pregnancy; Premature Birth; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X4; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation | 2009 |
Hormonal regulation of prostaglandin E2 receptors: localization and expression in rat cervical tissue.
Topics: Animals; Cervical Ripening; Cervix Uteri; Dinoprostone; Epithelium; Female; Gene Expression; Hormone Antagonists; Immunohistochemistry; Mifepristone; Muscle, Smooth; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype; RNA, Messenger; Uterine Contraction | 2010 |
Laparoscopic salpingocentesis using methotrexate in combination with oral mifepristone for successful treatment of interstitial pregnancy: a case report.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Administration, Oral; Adult; Amniotic Fluid; Combined Modality Therapy; Fallopian Tubes; Female; Humans; Laparoscopy; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Tubal; Suction | 2009 |
[Determination of serum antioxidant capacity after induced abortion].
Topics: Abortifacient Agents; Abortion, Induced; Adult; Antioxidants; Female; Humans; Mifepristone; Misoprostol; Oxidative Stress; Pregnancy; Serum; Time Factors; Young Adult | 2009 |
Effect of progesterone antagonist RU486 on uterine progesterone receptor mRNA expression, embryonic development and ovarian function during early pregnancy in pigs.
Topics: Animals; Embryonic Development; Female; Mifepristone; NF-kappa B; Ovary; Pregnancy; Pregnancy, Animal; Progesterone; RANK Ligand; Receptors, Progesterone; RNA, Messenger; Swine; Uterus | 2009 |
Involvement of connexin 43 in the acupuncture effect of improving rat blastocyst implantation.
Topics: Acupuncture Therapy; Animals; Blastocyst; Connexin 43; Disease Models, Animal; Embryo Implantation; Embryo Implantation, Delayed; Female; Infertility, Female; Mifepristone; Pregnancy; Pregnancy Rate; Rats; Rats, Wistar; RNA Interference; RNA, Messenger | 2010 |
[Termination of pregnancy in the 2nd trimester: mifepriston/misoprostol preferable to sulprostone].
Topics: Abortifacient Agents; Abortion, Induced; Adult; Cohort Studies; Dinoprostone; Female; Fetal Diseases; Humans; Middle Aged; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2009 |
Antenatal glucocorticoid therapy accelerates ATP production with creatine kinase increase in the growth-enhanced fetal rat heart.
Topics: Adenosine Triphosphate; Animals; Cell Proliferation; Cells, Cultured; Creatine Kinase, MB Form; Dexamethasone; Female; Fetal Development; Glucocorticoids; Heart; Mifepristone; Models, Animal; Myocardium; Myocytes, Cardiac; PPAR gamma; Pregnancy; Rats; Rats, Wistar; Receptors, Glucocorticoid; RNA, Messenger | 2010 |
Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
Topics: Abortifacient Agents; Abortion, Incomplete; Abortion, Induced; Cesarean Section; Curettage; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2010 |
Women's opinions on the home management of early medical abortion in the UK.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Attitude to Health; Female; Health Surveys; Humans; Logistic Models; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Self Care; Surveys and Questionnaires; United Kingdom; Young Adult | 2010 |
Mifepristone.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Canada; Female; Humans; Mifepristone; Pregnancy; Societies, Medical | 2009 |
Alternatives to a routine follow-up visit for early medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Continuity of Patient Care; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Ultrasonography; Uterus | 2010 |
Mifepristone-misoprostol midtrimester abortion: impact of gestational age on the induction-to-abortion interval.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Time Factors; Treatment Outcome | 2010 |
Feasibility of telephone follow-up after medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Cohort Studies; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Tests; Prospective Studies; Telephone; Treatment Outcome | 2010 |
Re: Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Dose-Response Relationship, Drug; Female; Humans; Meta-Analysis as Topic; Mifepristone; Pregnancy; Prostaglandins | 2010 |
Aldosterone and cortisol acutely stimulate Na+/H+ exchanger activity in the syncytiotrophoblast of the human placenta: effect of fetal sex.
Topics: Aldosterone; Female; Humans; Hydrocortisone; Infant, Newborn; Male; Mifepristone; Placenta; Pregnancy; Sex Factors; Sodium-Hydrogen Exchangers; Spironolactone; Trophoblasts | 2010 |
Inflammation-induced preterm birth alters neuronal morphology in the mouse fetal brain.
Topics: Amniotic Fluid; Animals; Brain; Cell Survival; Cells, Cultured; Cytokines; Disease Models, Animal; Female; Inflammation Mediators; Lipopolysaccharides; Mice; Mifepristone; Neurons; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; RNA, Messenger | 2010 |
A comparison of transabdominal and transvaginal ultrasonography for determination of gestational age and clinical outcomes in women undergoing early medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pilot Projects; Pregnancy; Treatment Outcome; Ultrasonography, Prenatal | 2010 |
Is there evidence for tripling the dose of 200 mg mifepristone for medical abortion?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy | 2010 |
Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Ambulatory Care Facilities; Female; Gestational Age; Home Care Services; Humans; Middle Aged; Mifepristone; Misoprostol; Outpatient Clinics, Hospital; Patient Satisfaction; Pregnancy; Prospective Studies; Self Administration; Surveys and Questionnaires; Young Adult | 2010 |
Progesterone receptor-mediated up-regulation of transthyretin in preimplantation mouse uterus.
Topics: Animals; Embryo Implantation; Female; Mice; Mice, Inbred C57BL; Mifepristone; Prealbumin; Pregnancy; Progesterone; Receptors, Lysophosphatidic Acid; Receptors, Progesterone; Up-Regulation; Uterus | 2010 |
Sonographic quantification of endometrial changes after abortion with computer-assisted image analysis.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Endometrium; Female; Humans; Image Processing, Computer-Assisted; Least-Squares Analysis; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Sensitivity and Specificity; Ultrasonography | 2010 |
Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Congenital Abnormalities; Critical Pathways; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Length of Stay; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Western Australia | 2010 |
Acute coronary artery vasospasm associated with misoprostol for termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Analgesics; Chest Pain; Coronary Vasospasm; Coronary Vessels; Female; Humans; Ketoprofen; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Tromethamine | 2010 |
Issues in second trimester induced abortion (medical/surgical methods).
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Selection; Pregnancy; Pregnancy Trimester, Second; Vacuum Curettage | 2010 |
Late termination of pregnancy and foetal reduction for foetal anomaly.
Topics: Abortifacient Agents; Administration, Intravaginal; Administration, Oral; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Reduction, Multifetal; Pregnancy Trimester, Second; United Kingdom; Vacuum Curettage | 2010 |
Progesterone is primary regulator of Cdk2ap1 gene expression and tissue-specific expression in the uterus.
Topics: Animals; Cell Proliferation; Endometrium; Estradiol; Female; Fulvestrant; Gene Expression Regulation, Enzymologic; Hormone Antagonists; Male; Mice; Mifepristone; Organ Specificity; Ovariectomy; Pregnancy; Progesterone; Protein Kinases; Tissue Distribution; Tumor Suppressor Proteins; Uterus | 2010 |
Medical abortion in lactating women--low levels of mifepristone in breast milk.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; Breast Feeding; Dose-Response Relationship, Drug; Female; Humans; Lactation; Mifepristone; Milk, Human; Pregnancy; Pregnancy, Unwanted; Prospective Studies; Radioimmunoassay; Risk Assessment; Safety Management; Time Factors; Treatment Outcome | 2010 |
[Induced termination of second and third trimester pregnancy in women with scarred uterus].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Carboprost; Cesarean Section; Cicatrix; Ethacridine; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Suppositories; Treatment Outcome; Uterine Rupture; Uterus | 2010 |
Medical abortion becomes available in Italy.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Female; Humans; Italy; Mifepristone; Pregnancy | 2010 |
[Diagnosis and therapy of extra-uterine pregnancy].
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Adult; Age Factors; Algorithms; Contraceptives, Oral; Drug Therapy, Combination; Education, Medical, Continuing; Endosonography; Female; France; Humans; Incidence; Intrauterine Devices; Laparoscopy; Methotrexate; Mifepristone; Pelvic Infection; Pregnancy; Pregnancy, Ectopic; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Treatment Outcome | 2010 |
Medical abortion at 63 to 90 days of gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Case-Control Studies; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Young Adult | 2010 |
Mifepristone-induced abortion and duration of third stage labour in a subsequent pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Age Factors; China; Cohort Studies; Female; Humans; Labor Stage, Third; Maternal Exposure; Mifepristone; Odds Ratio; Pregnancy; Pregnancy Outcome; Time Factors; Young Adult | 2010 |
Three years on: a review of medical terminations of pregnancy performed in a sexual health service.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Ambulatory Care Facilities; Confidence Intervals; Female; Health Services Accessibility; Humans; Mifepristone; Odds Ratio; Pregnancy; Pregnancy Trimester, First; Queensland; Referral and Consultation; Retrospective Studies; Surveys and Questionnaires; Young Adult | 2010 |
Is there evidence to decrease the approved dose of 600 mg of mifepristone for medical abortion?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Meta-Analysis as Topic; Mifepristone; Misoprostol; Pregnancy | 2010 |
Feticide followed by mifepristone-misoprostol regimen for midtrimester termination of pregnancy in two cases of complete placenta previa.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Oral; Female; Humans; Mifepristone; Misoprostol; Placenta Previa; Postpartum Hemorrhage; Potassium Chloride; Pregnancy; Pregnancy Trimester, Second | 2010 |
Progesterone withdrawal, and not increased circulating relaxin, mediates the decrease in myometrial relaxin receptor (RXFP1) expression in late gestation in rats.
Topics: Animals; Antibodies, Monoclonal; Down-Regulation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression Regulation; Gestational Age; Hormone Antagonists; Mifepristone; Myometrium; Pregnancy; Progesterone; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Peptide; Relaxin; RNA, Messenger; Vascular Endothelial Growth Factors | 2010 |
Evaluation of the introduction of a new treatment for the termination of pregnancy in The Netherlands.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Missed; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gynecology; Humans; Mifepristone; Misoprostol; Netherlands; Obstetrics; Off-Label Use; Practice Patterns, Physicians'; Pregnancy; Pregnancy Trimesters; Premedication; Surveys and Questionnaires; Vacuum Curettage | 2010 |
The pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic stem cell proliferation and differentiation into neuroectodermal rosettes.
Topics: Biological Transport; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cholesterol; Chorionic Gonadotropin; Embryonic Stem Cells; Female; Hormone Antagonists; Humans; Mifepristone; Nestin; Neural Plate; Neurulation; Phosphoproteins; Pregnancy; Progesterone; Receptors, LH; Receptors, Progesterone; Rosette Formation; Signal Transduction | 2010 |
Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice.
Topics: Animals; Blotting, Western; Cells, Cultured; Estradiol; Female; Fulvestrant; Lymphocyte Count; Mice; Mifepristone; Pregnancy; Progesterone; Radioimmunoassay; T-Lymphocytes, Regulatory; Uterus | 2010 |
Potentiation of the uterus-relaxing effects of β-adrenergic agonists with nifedipine: studies on rats and the human myometrium.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mifepristone; Models, Animal; Myometrium; Nifedipine; Oxytocics; Pregnancy; Premature Birth; Progesterone; Rats; Rats, Sprague-Dawley; Salmeterol Xinafoate; Tocolysis; Tocolytic Agents; Uterine Contraction | 2010 |
Uterine progesterone receptor expression, conceptus development, and ovarian function in pigs treated with RU 486 during early pregnancy.
Topics: Animals; Female; Gene Expression Regulation; Hormone Antagonists; Mifepristone; Ovary; Pregnancy; RANK Ligand; Receptors, Progesterone; RNA, Messenger; Swine; Time Factors; Uterus | 2011 |
Foetal hypoxia increases cardiac AT(2)R expression and subsequent vulnerability to adult ischaemic injury.
Topics: Age Factors; Angiotensin II Type 2 Receptor Blockers; Animals; Binding Sites; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fetal Hypoxia; Gestational Age; Glucocorticoids; Hormone Antagonists; Imidazoles; Male; Mifepristone; Myocardial Reperfusion Injury; Myocardium; Organ Culture Techniques; Pregnancy; Promoter Regions, Genetic; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Glucocorticoid; RNA, Messenger; Up-Regulation; Ventricular Function, Left; Ventricular Pressure | 2011 |
Fatal Clostridium sordellii infections after medical abortions.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Adult; Antibiotic Prophylaxis; Clostridium Infections; Clostridium sordellii; Fatal Outcome; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy in Diabetics; Shock, Septic; Young Adult | 2010 |
Progesterone modulates integrin {alpha}2 (ITGA2) and {alpha}11 (ITGA11) in the pregnant cervix.
Topics: Animals; Cervix Uteri; Collagen; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Female; Hormone Antagonists; Integrin alpha Chains; Integrin alpha2; MAP Kinase Signaling System; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Stromal Cells | 2011 |
Repeated medical abortions and the risk of preterm birth in the subsequent pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; China; Cohort Studies; Female; Humans; Logistic Models; Maternal Exposure; Mifepristone; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Premature Birth; Risk Factors; Young Adult | 2011 |
Clinical efficacy of mifepristone and misoprostol in second trimester pregnancy termination.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Cohort Studies; Drug Therapy, Combination; Female; Finland; Follow-Up Studies; Humans; Logistic Models; Mifepristone; Misoprostol; Multivariate Analysis; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Second; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Treatment Outcome; Young Adult | 2010 |
The effect of parity and gravidity on the outcome of medical termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Cohort Studies; Female; Gravidity; Humans; Israel; Mifepristone; Misoprostol; Parity; Pregnancy; Retrospective Studies; Treatment Outcome | 2010 |
The contraceptive implant for long acting reversible contraception in patients undergoing first trimester medical termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Cutaneous; Adolescent; Adult; Contraceptive Agents, Female; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Observation; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Pregnancy, Unplanned; Progestins; Prospective Studies; Treatment Outcome; United Kingdom; Young Adult | 2010 |
Progesterone receptor antagonist therapy has therapeutic potential even in cancer restricted to males as evidenced from murine testicular and prostate cancer studies.
Topics: Animals; Antineoplastic Agents; Female; Hormone Antagonists; Male; Mice; Mice, Inbred C57BL; Mifepristone; Pregnancy; Progesterone; Prostatic Neoplasms; Receptors, Progesterone; Testicular Neoplasms | 2010 |
The molecular mechanisms of cervical ripening differ between term and preterm birth.
Topics: Animals; Cervical Ripening; Cervix Uteri; Female; Gene Expression Regulation; Hormone Antagonists; Lipopolysaccharides; Mice; Mifepristone; Pregnancy; Premature Birth; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Progesterone maintains amniotic tight junctions during midpregnancy in mice.
Topics: Amnion; Animals; Claudin-3; Claudin-4; Epithelium; Female; Gene Expression; Hormone Antagonists; Membrane Proteins; Mice; Mice, Inbred ICR; Mifepristone; Permeability; Pregnancy; Pregnancy, Animal; Progesterone; Receptors, Progesterone; Tight Junctions; Tissue Culture Techniques | 2011 |
Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Adult; Ambulatory Care Facilities; Amenorrhea; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Netherlands Antilles; Pregnancy; Prospective Studies; Self Administration; Treatment Outcome; Young Adult | 2011 |
Mifepristone and misoprostol for early pregnancy failure: a cohort analysis.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adolescent; Adult; Cohort Studies; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 2011 |
The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Proliferation; Embryo Implantation; Endometrium; Epithelial Cells; Epithelium; Estradiol; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Fibroblast Growth Factors; Gene Expression Profiling; Mice; Mice, Inbred C57BL; Mice, Knockout; Mifepristone; Mucin-1; Phosphorylation; Pregnancy; Progesterone; Receptors, Fibroblast Growth Factor; Receptors, Progesterone; Signal Transduction; Stromal Cells; Transcription, Genetic | 2011 |
[Early home abortion and immediate contraception with Evra® patch].
Topics: Abortion, Induced; Adolescent; Adult; Contraception, Postcoital; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Mifepristone; Norgestrel; Pregnancy; Transdermal Patch; Young Adult | 2011 |
Abortion incidence and access to services in the United States, 2008.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Adolescent; Adult; Ambulatory Care Facilities; Female; Health Services Accessibility; Hospitals; Humans; Incidence; Mifepristone; Physicians' Offices; Pregnancy; Surveys and Questionnaires; United States; Young Adult | 2011 |
Time to misoprostol after mifepristone: still a bone of contention!
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Time Factors | 2011 |
Severity of infection following the introduction of new infection control measures for medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Doxycycline; Female; Humans; Infection Control; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies | 2011 |
Pain during medical abortion: predicting factors from gynecologic history and medical staff evaluation of severity.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Medical Staff; Mifepristone; Misoprostol; Pain; Pain Measurement; Pregnancy; Statistics, Nonparametric; Surveys and Questionnaires; Young Adult | 2011 |
Use of mifepristone for medical abortion in Australia, 2006-2009.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Australia; Female; Humans; Mifepristone; Pregnancy | 2011 |
Misoprostol: life-saving.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Young Adult | 2011 |
Early medical abortion at home.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Decision Making; Female; Home Care Services; Humans; Mifepristone; Pilot Projects; Practice Guidelines as Topic; Pregnancy; Time Factors | 2011 |
A novel optical method to assess cervical changes during pregnancy and use to evaluate the effects of progestins on term and preterm labor.
Topics: 17-alpha-Hydroxyprogesterone; Animals; Cervix Uteri; Female; Labor, Obstetric; Mifepristone; Obstetric Labor, Premature; Photography; Pregnancy; Pregnancy Outcome; Progesterone; Progestins; Rats; Rats, Sprague-Dawley | 2011 |
Private medical providers' knowledge and practices concerning medical abortion in Nigeria.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Aftercare; Attitude of Health Personnel; Clinical Competence; Female; Humans; Interviews as Topic; Male; Middle Aged; Mifepristone; Nigeria; Patient Education as Topic; Physicians; Postoperative Care; Pregnancy; Pregnancy Trimesters; Sex Education; Young Adult | 2011 |
Comparison of rates of adverse events in adolescent and adult women undergoing medical abortion: population register based study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Adolescent; Adult; Age Distribution; Chlamydia Infections; Female; Finland; Hemorrhage; Humans; Incidence; Mifepristone; Misoprostol; Pregnancy; Pregnancy Complications, Cardiovascular; Registries; Risk Factors; Young Adult | 2011 |
Medical abortion for adolescents.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2011 |
Second- and third-trimester management of medical termination of pregnancy and fetal death in utero after prior caesarean section.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; Cesarean Section; Dose-Response Relationship, Drug; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Risk Factors; Time Factors; Uterine Rupture | 2011 |
Medical abortion in women with impaired renal function.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Kidney Diseases; Mifepristone; Misoprostol; Pregnancy; Pregnancy Complications; Severity of Illness Index | 2011 |
Medical abortion and the 'golden rule' of statutory interpretation. BPAS v the Secretary of State for Health [2011] EWHC 235.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Safety; Self Administration; Time Factors; United Kingdom | 2011 |
Mifepristone in South Australia -- the first 1343 tablets.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; General Practice; Humans; Mifepristone; Pregnancy; Retrospective Studies; South Australia | 2011 |
Client preferences and acceptability for medical abortion and MVA as early pregnancy termination method in northwest Ethiopia.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Choice Behavior; Developing Countries; Drug Administration Schedule; Educational Status; Ethiopia; Female; Humans; Marital Status; Mifepristone; Patient Preference; Patient Satisfaction; Pregnancy; Prospective Studies; Vacuum Curettage; Young Adult | 2011 |
Clinical guidelines. Labor induction abortion in the second trimester.
Topics: Abortifacient Agents; Abortion, Induced; Cesarean Section; Drug Administration Routes; Female; Gestational Age; Humans; Labor Stage, Third; Labor, Induced; Laminaria; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Uterine Rupture | 2011 |
Early medical abortion at home.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Decision Making; Female; Humans; Mifepristone; Pregnancy; Wales | 2011 |
α-fetoprotein involvement during glucocorticoid-induced precocious maturation in rat colon.
Topics: alpha-Fetoproteins; Animals; Animals, Suckling; Anti-Inflammatory Agents; Colon; Female; Glucocorticoids; Hormone Antagonists; Hydrocortisone; Mifepristone; Pregnancy; Rats; Rats, Sprague-Dawley; Vimentin | 2011 |
[Medical abortion from 12 through 14 weeks' gestation: a retrospective study with 126 patients].
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Retrospective Studies; Vacuum Curettage; Young Adult | 2011 |
Re: Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Vacuum Extraction, Obstetrical | 2011 |
Mifepristone (RU 486) induces vasodilation and inhibits platelet aggregation: nongenomic and genomic action to cause hemorrhage.
Topics: Adenosine Diphosphate; Animals; Aorta, Thoracic; Endothelium, Vascular; Female; Gene Expression Regulation; Hemorrhage; Humans; In Vitro Techniques; Male; Mifepristone; Platelet Aggregation; Potassium Chloride; Pregnancy; Rats; Rats, Wistar; Serotonin; Umbilical Arteries; Vasodilation | 2011 |
Effectiveness and acceptability of medical abortion provided through telemedicine.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Administration, Oral; Adolescent; Adult; Cohort Studies; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Telemedicine; Voluntary Health Agencies; Young Adult | 2011 |
CyPPA, a positive modulator of small-conductance Ca(2+)-activated K(+) channels, inhibits phasic uterine contractions and delays preterm birth in mice.
Topics: Abortifacient Agents; Animals; Apamin; Calcium; Dinoprost; Female; Mice; Mice, Inbred C57BL; Mifepristone; Myometrium; Obstetric Labor, Premature; Oxytocin; Potassium Channels, Calcium-Activated; Pregnancy; Premature Birth; Pyrazoles; Pyrimidines; Uterine Contraction | 2011 |
Mesenchymal stem cells derived from Wharton jelly of the human umbilical cord ameliorate damage to human endometrial stromal cells.
Topics: Adult; Cell Proliferation; Cells, Cultured; Coculture Techniques; Endometrium; Female; Humans; Mesenchymal Stem Cells; Middle Aged; Mifepristone; Pregnancy; Stromal Cells; Umbilical Cord | 2011 |
The state-of-the-art of emergency contraception with the cutting edge drug.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Estrenes; Female; Gonanes; Humans; Mifepristone; Norpregnadienes; Oximes; Pregnancy; Receptors, Progesterone | 2011 |
Uterine and chorioallantoic angiogenesis and changes in the uterine epithelium during gestation in the viviparous lizard, niveoscincus conventryi (Squamata: Scincidae).
Topics: Allantois; Animals; Biological Evolution; Chorion; Epithelial Cells; Epithelium; Female; Hormone Antagonists; Humans; Lizards; Microscopy, Electron, Scanning; Mifepristone; Neovascularization, Physiologic; Pregnancy; Progesterone; Uterus; Viviparity, Nonmammalian; Yolk Sac | 2012 |
The combination of mifepristone and misoprostol for the termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Therapy, Combination; Female; Fetal Death; Gestational Age; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy | 2011 |
Second trimester abortion in women with and without previous uterine scar: Eleven years experience from a developing country.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Case-Control Studies; Cicatrix; Developing Countries; Dinoprost; Female; Humans; India; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Uterine Diseases; Uterine Rupture | 2011 |
Effects of RU486 in the expression of progesterone receptor isoforms in the hypothalamus and the preoptic area of the rat during postpartum estrus.
Topics: Abortifacient Agents, Steroidal; Analysis of Variance; Animals; Blotting, Western; Densitometry; Electric Stimulation; Estradiol; Estrus; Female; Hypothalamus; Mifepristone; Postpartum Period; Pregnancy; Preoptic Area; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Progesterone | 2011 |
Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicine.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Follow-Up Studies; Gestational Age; Gynecologic Surgical Procedures; Humans; Logistic Models; Middle Aged; Mifepristone; Misoprostol; Outcome Assessment, Health Care; Patient Satisfaction; Pregnancy; Prospective Studies; Self Administration; Surveys and Questionnaires; Telemedicine; Young Adult | 2012 |
Use of mifepristone along with methotrexate in medical management of unruptured ectopic pregnancy.
Topics: Abortifacient Agents; Adult; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic | 2011 |
Medical versus surgical abortion methods for pregnancy in China: a cost-minimization analysis.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; China; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome; Vacuum Curettage; Young Adult | 2011 |
Outcomes of medical abortion through 63 days in women with twin gestations.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Humans; Mifepristone; Misoprostol; Pain Measurement; Postoperative Complications; Pregnancy; Pregnancy, Multiple; Randomized Controlled Trials as Topic; Treatment Outcome; Twins; Uterine Hemorrhage | 2011 |
Effects of leonurine hydrochloride on medically induced incomplete abortion in early pregnancy rats.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Animals; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Estradiol; Female; Gallic Acid; In Vitro Techniques; Mifepristone; Misoprostol; Organ Size; Pregnancy; Random Allocation; Rats; Rats, Sprague-Dawley; Uterine Contraction; Uterine Hemorrhage; Uterus | 2011 |
Clinical outcomes from a prospective study evaluating the role of ambulation during medical termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Patient Preference; Pregnancy; Prospective Studies; Treatment Outcome; United Kingdom; Walking | 2012 |
Mifepristone+misoprostol vs. misoprostol alone for early medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2012 |
Mifepristone may shorten the induction-to-abortion time for termination of second-trimester pregnancies by ethacridine lactate.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Anti-Infective Agents, Local; Ethacridine; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Young Adult | 2012 |
Can women accurately assess the outcome of medical abortion based on symptoms alone?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Case-Control Studies; Diagnostic Self Evaluation; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Treatment Failure; Young Adult | 2012 |
Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; China; Cohort Studies; Curettage; Female; Follow-Up Studies; Humans; Mifepristone; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, First; Pregnancy Trimester, Second; Prospective Studies; Risk; Surveys and Questionnaires; Uterine Hemorrhage; Young Adult | 2011 |
Obstetrician-gynecologists' knowledge of and attitudes toward medical abortion in Guatemala.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Attitude of Health Personnel; Data Collection; Dose-Response Relationship, Drug; Female; Guatemala; Gynecology; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Logistic Models; Male; Middle Aged; Mifepristone; Misoprostol; Multivariate Analysis; Obstetrics; Physicians; Pregnancy | 2012 |
'Let the computer choose?': the experience of participants in a randomised preference trial of medical versus surgical termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Choice Behavior; Female; Follow-Up Studies; Health Status; Humans; Mental Health; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Reproductive Medicine; Vacuum Extraction, Obstetrical | 2012 |
Medication abortions among New York City residents, 2001-2008.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Educational Status; Female; Health Services Accessibility; Humans; Mifepristone; New York City; Population Surveillance; Pregnancy; Socioeconomic Factors | 2011 |
Attitudes and preferences toward the provision of medication abortion in an urban academic internal medicine practice.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Academic Medical Centers; Adolescent; Adult; Ambulatory Care Facilities; Attitude to Health; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Internal Medicine; Middle Aged; Mifepristone; New York City; Patient Preference; Pregnancy; Reproductive Health; Urban Health Services; Young Adult | 2012 |
Effects of acupuncture on LIF and IL-12 in rats of implantation failure.
Topics: Abortifacient Agents, Steroidal; Acupuncture Therapy; Animals; Embryo Implantation; Endometrium; Female; Interleukin-12; Leukemia Inhibitory Factor; Mifepristone; Pregnancy; Progestins; Rats; Rats, Wistar; Receptors, OSM-LIF; RNA, Messenger | 2012 |
Pharmacy workers' knowledge and provision of abortifacients in Ho Chi Minh City, Vietnam.
Topics: Abortifacient Agents; Abortion, Criminal; Adult; Cross-Sectional Studies; Data Collection; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Mifepristone; Misoprostol; Patient Simulation; Pharmaceutical Services; Pregnancy; Vietnam | 2012 |
Glucocorticoid receptor mediates the effect of progesterone on uterine natural killer cells.
Topics: Animals; Cells, Cultured; CpG Islands; Decidua; Female; Hormone Antagonists; Humans; Interferon-gamma; Interleukin-12; Killer Cells, Natural; Mice; Mice, Inbred C57BL; Mifepristone; NF-kappa B; Norpregnadienes; Pregnancy; Progesterone; Progestins; Receptors, Glucocorticoid; Receptors, Progesterone; Spleen; STAT4 Transcription Factor | 2012 |
Induction of delivery by mifepristone and misoprostol in termination of pregnancy and intrauterine fetal death: 2nd and 3rd trimester induction of labour.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Fetal Death; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third | 2012 |
[Mifepristone inhibits the progesterone-induced expressions of HLA-G, -E, -F genes in trophoblasts during first trimester].
Topics: Cells, Cultured; Female; Histocompatibility Antigens Class I; HLA-E Antigens; HLA-G Antigens; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; RNA, Messenger; Trophoblasts | 2012 |
Junctional adhesion molecule 2 mediates the interaction between hatched blastocyst and luminal epithelium: induction by progesterone and LIF.
Topics: Animals; Blastocyst; Cell Adhesion Molecules; Embryo Implantation; Epithelium; Female; Intercellular Junctions; Leukemia Inhibitory Factor; Mice; Mifepristone; Pregnancy; Progesterone; Uterus | 2012 |
MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor.
Topics: 20-alpha-Hydroxysteroid Dehydrogenase; Animals; Cells, Cultured; Female; Gene Expression; Hormone Antagonists; Humans; Immunoblotting; Labor, Obstetric; Male; Mice; Mice, Inbred ICR; MicroRNAs; Mifepristone; Myometrium; Obstetric Labor, Premature; Ovariectomy; Pregnancy; Progesterone; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; STAT5 Transcription Factor; Uterus | 2012 |
Ob/Gyn training in abortion care: results from a national survey.
Topics: Abortifacient Agents; Abortion, Induced; Female; Gynecology; Health Care Surveys; Humans; Internship and Residency; Male; Mifepristone; Misoprostol; Obstetrics; Physicians; Postoperative Complications; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Reproductive Health Services; United States; Vacuum Curettage; Workforce | 2012 |
Mifepristone increases the cytotoxicity of uterine natural killer cells by acting as a glucocorticoid antagonist via ERK activation.
Topics: Adult; Blotting, Western; Butadienes; Cell Survival; Cells, Cultured; Decidua; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Female; Flavonoids; Glucocorticoids; Hormone Antagonists; Humans; Hydrocortisone; K562 Cells; Killer Cells, Natural; Mifepristone; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Perforin; Phosphorylation; Pregnancy; Up-Regulation; Young Adult | 2012 |
Trends in use of medical abortion in the United States: reanalysis of surveillance data from the Centers for Disease Control and Prevention, 2001-2008.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Centers for Disease Control and Prevention, U.S.; Female; History, 21st Century; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Public Health Surveillance; United States | 2012 |
Prospective study of medical abortion in Nepal Medical College Teaching Hospital (NMCTH). A one year experience.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Female; Gestational Age; Hospitals, Teaching; Humans; Mifepristone; Misoprostol; Nepal; Pregnancy; Prospective Studies; Time Factors; Young Adult | 2011 |
Differential expression and regulation of angiopoietin-3 in mouse uterus during preimplantation period.
Topics: Angiopoietins; Animals; Embryo Implantation; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Developmental; In Situ Hybridization; Mice; Mifepristone; Neovascularization, Physiologic; Pregnancy; Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Uterus | 2012 |
Early medical abortion--available and safe.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2012 |
Use of medicines changing the face of abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Female; Global Health; Health Services Accessibility; Health Services Needs and Demand; Humans; Mifepristone; Pregnancy; Prostaglandins | 2012 |
Effect of interpregnancy interval after a mifepristone-induced abortion on neonatal outcomes in subsequent pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Birth Intervals; China; Cohort Studies; Female; Humans; Infant, Newborn; Infant, Small for Gestational Age; Mifepristone; Odds Ratio; Pregnancy; Premature Birth; Time Factors; Young Adult | 2013 |
Medical termination of pregnancy in cynomolgus macaques.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Female; Gestational Age; Macaca fascicularis; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 2012 |
Repeated abortion affects subsequent pregnancy outcomes in BALB/c mice.
Topics: Abortion, Induced; Abortion, Spontaneous; Animals; Birth Weight; Female; Gene Expression Regulation; Litter Size; Male; Mice; Mice, Inbred BALB C; Mifepristone; Placenta; Pregnancy; Pregnancy Outcome; Safety; Sex Ratio; Sperm Motility; Time Factors | 2012 |
Medical versus surgical termination of pregnancy in primigravid women--is the next delivery differently at risk? A population-based register study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Birth Intervals; Dilatation and Curettage; Drug Combinations; Female; Gravidity; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Small for Gestational Age; Maternal Age; Mifepristone; Misoprostol; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Registries; Risk Factors; Socioeconomic Factors; Young Adult | 2013 |
Silent rupture of an unscarred uterus at third-trimester abortion correlated with an unrecognized perforation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Third; Suture Techniques; Uterine Perforation; Uterine Rupture | 2012 |
Effectiveness of early medical abortion using low-dose mifepristone and buccal misoprostol in women with no defined intrauterine gestational sac.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Administration, Buccal; Administration, Oral; Adolescent; Adult; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy, Ectopic; Retrospective Studies; Treatment Failure; Ultrasonography, Prenatal; Uterus; Young Adult | 2013 |
The Th1/Th2/Th17/Treg paradigm induced by stachydrine hydrochloride reduces uterine bleeding in RU486-induced abortion mice.
Topics: Abortion, Induced; Animals; Cytokines; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred BALB C; Mifepristone; Molecular Targeted Therapy; Pregnancy; Progesterone; Proline; Spleen; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Th2 Cells; Transcription Factors; Uterine Hemorrhage | 2013 |
Progesterone use to reverse the effects of mifepristone.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Injections, Intramuscular; Mifepristone; Pregnancy; Pregnancy Outcome; Progesterone; Receptors, Progesterone; Young Adult | 2012 |
Myometrial immune cells contribute to term parturition, preterm labour and post-partum involution in mice.
Topics: Animals; Cell Differentiation; Cell Movement; Female; Gene Expression; Humans; Lipopolysaccharides; Macrophages; Mice; Mifepristone; Monocytes; Myometrium; Neutrophils; Obstetric Labor, Premature; Postpartum Period; Pregnancy; Term Birth | 2013 |
Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial.
Topics: Abortifacient Agents; Abortion, Induced; Female; Gestational Age; Humans; Labor Stage, First; Mifepristone; Pregnancy | 2013 |
Significant adverse events and outcomes after medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Incomplete; Abortion, Induced; Anti-Bacterial Agents; Blood Transfusion; Communicable Diseases; Emergency Treatment; Evidence-Based Medicine; Female; Humans; Maternal Mortality; Mifepristone; Misoprostol; Patient Admission; Pregnancy; Pregnancy, Ectopic | 2013 |
[Medical termination of pregnancy in a patient with severe cystic fibrosis. Possible effect of the antiglucocorticoid action of mifepristone on the respiratory disease].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cystic Fibrosis; Female; Humans; Intraoperative Complications; Mifepristone; Monitoring, Intraoperative; Pregnancy; Pregnancy Complications | 2013 |
Abortion restrictions increase at state level in US.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Therapeutic; Female; Gestational Age; Humans; Insurance, Health; Mifepristone; Patient Protection and Affordable Care Act; Pregnancy; State Government; United States | 2013 |
Chronic glucocorticoid exposure potentiates placental chorionic plate artery constriction: implications for aberrant fetoplacental vascular resistance in fetal growth restriction.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arteries; Carbenoxolone; Chorion; Dexamethasone; Female; Fetal Growth Retardation; Glucocorticoids; Humans; Hydrocortisone; Mifepristone; Placenta; Placental Circulation; Pregnancy; Vasoconstriction; Vasodilation | 2013 |
Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study.
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Congenital Abnormalities; Female; Follow-Up Studies; France; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Premature Birth; Prospective Studies | 2013 |
Infiltration of myeloid cells into decidua is a critical early event in the labour cascade and post-partum uterine remodelling.
Topics: Animals; Cell Differentiation; Chemokines; Cytokines; Decidua; Female; Flow Cytometry; Hormone Antagonists; Immunoenzyme Techniques; Leukocytes; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred ICR; Mifepristone; Myeloid Cells; Obstetric Labor, Premature; Postpartum Period; Pregnancy; Pregnancy, Animal; Progesterone; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Uterus | 2013 |
Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Adult; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Pregnant Women; Prospective Studies; Self Administration; Uzbekistan; Young Adult | 2013 |
The role of glucocorticoid receptors in dexamethasone-induced apoptosis of neuroprogenitor cells in the hippocampus of rat pups.
Topics: Animals; Apoptosis; Blotting, Western; Body Weight; Brain; Dexamethasone; Female; Hippocampus; Immunohistochemistry; In Situ Nick-End Labeling; Mifepristone; Neural Stem Cells; Organ Size; Pregnancy; Rats; Rats, Wistar; Receptors, Glucocorticoid | 2013 |
Users' perspectives on medical abortion in Finland.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Attitude to Health; Female; Finland; Gestational Age; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy | 2002 |
[Apoptosis and expression of relative genes in early pregnant chorionic villi and decidua].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Apoptosis; bcl-2-Associated X Protein; Chorionic Villi; Decidua; Fas Ligand Protein; fas Receptor; Female; Humans; Membrane Glycoproteins; Mifepristone; Pregnancy; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger | 2002 |
Progesterone prevents the pregnancy-related decline in protein kinase A association with rat myometrial plasma membrane and A-kinase anchoring protein.
Topics: A Kinase Anchor Proteins; Adaptor Proteins, Signal Transducing; Animals; Blotting, Western; Carrier Proteins; Cell Membrane; Cyclic AMP-Dependent Protein Kinases; Female; Hormone Antagonists; Mifepristone; Myometrium; Precipitin Tests; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Signal Transduction | 2002 |
Europe finds abortion pill is no magic cure-all.
Topics: Abortion, Legal; Europe; Female; France; Government Regulation; Humans; Internationality; Mifepristone; Pregnancy; United States | 2000 |
Dutch ship offers abortions; to make Ireland its first call.
Topics: Abortion, Legal; Female; Humans; Internationality; Ireland; Mifepristone; Netherlands; Pregnancy; Ships | 2001 |
How safe is emergency contraception?
Topics: Congenital Abnormalities; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Drug Administration Schedule; Drug Interactions; Estrogens; Female; Fertility; Humans; Intrauterine Devices, Copper; Mifepristone; Pregnancy; Progestins; Public Health; Risk Assessment; Sexually Transmitted Diseases; United States; United States Food and Drug Administration; World Health Organization | 2002 |
Clinicians' perception of sonogram indication for mifepristone abortion up to 63 days.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Attitude of Health Personnel; Female; Gestational Age; Humans; Mifepristone; Physical Examination; Pregnancy; Prospective Studies; Referral and Consultation; Ultrasonography, Prenatal; United States | 2002 |
[Abortion].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimesters; Prostaglandins E, Synthetic; Risk Factors; Time Factors; Vacuum Curettage | 2001 |
[Clinical trial of pregnancy terminations in 353 patients where amenorrhea was present for less than 49 days by 600 mg of RU 486 (administered orally) and 500 mg of sulprostone (Nalador) administered intramuscularly].
Topics: Abortifacient Agents; Abortion Applicants; Abortion, Induced; Biology; Developed Countries; Endocrine System; Europe; Family Planning Services; France; Hormone Antagonists; Hormones; Mifepristone; Physiology; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Prostaglandins, Synthetic; Reproduction | 1989 |
The clinical use of RU 486 (Mefipristone).
Topics: Abortifacient Agents; Abortion, Induced; Biology; Contraception; Economics; Endocrine System; Family Planning Services; Hormone Antagonists; Hormones; Mifepristone; Ovulation; Physiology; Pregnancy; Pregnancy Trimester, First; Reproduction; Research; Technology | 1989 |
[Abortion induced by mifepristone and sulprostone combination: attempting analgesia with acetominophen or dipropyline].
Topics: Abortion, Induced; Analgesia; Biology; Demography; Developed Countries; Disease; Double-Blind Method; Endocrine System; Europe; Family Planning Services; France; Hormone Antagonists; Hormones; Mifepristone; Pain; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Prostaglandins, Synthetic; Reproduction; Research; Signs and Symptoms; Therapeutics; Time Factors | 1990 |
Clinton repeals antiabortion policies as activists map out new strategies.
Topics: Abortion, Induced; Administrative Personnel; Americas; Biology; Developed Countries; Endocrine System; Evaluation Studies as Topic; Extraembryonic Membranes; Family Planning Policy; Family Planning Services; Fetus; Government; Hormone Antagonists; Hormones; Human Rights; Legislation as Topic; Mifepristone; North America; Organization and Administration; Physiology; Politics; Pregnancy; Public Opinion; Public Policy; Reproduction; Research; United States | 1993 |
USA President Clinton acts to ensure reproductive health.
Topics: Abortion, Induced; Administrative Personnel; Ambulatory Care Facilities; Americas; Biology; Catholicism; Christianity; Counseling; Developed Countries; Developing Countries; Endocrine System; Extraembryonic Membranes; Family Planning Policy; Family Planning Services; Fetus; Government; Government Agencies; Health; Health Planning; Hormone Antagonists; Hormones; Human Rights; International Agencies; Latin America; Legislation as Topic; Mexico; Mifepristone; North America; Organization and Administration; Organizations; Physiology; Pregnancy; Public Policy; Religion; Reproduction; Reproductive Medicine; Research; United States | 1993 |
Expression and regulation of calcitonin gene-related Peptide receptor in rat placentas.
Topics: Animals; Antibodies, Monoclonal; Blotting, Western; Endothelium, Vascular; Estradiol; Female; Fluorescent Antibody Technique; Fulvestrant; Gene Expression Regulation; Gestational Age; Labor, Obstetric; Mifepristone; Muscle, Smooth, Vascular; Placenta; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Calcitonin Gene-Related Peptide; Tissue Distribution; Trophoblasts | 2002 |
Abortion.
Topics: Abortion, Induced; Ambulatory Care Facilities; Americas; Biology; Consumer Product Safety; Delivery of Health Care; Developed Countries; Economics; Endocrine System; Extraembryonic Membranes; Family Planning Services; Fetus; Financial Management; Financing, Government; Health; Health Facilities; Hormone Antagonists; Hormones; Human Rights; Individuality; Informed Consent; Insurance, Health; Legislation as Topic; Licensure; Mifepristone; North America; Physiology; Pregnancy; Reproduction; Research; Third-Party Consent; United States | 1992 |
[RU 486 (mifepristone): a new tool for labor induction women at term with live fetus].
Topics: Biology; Delivery, Obstetric; Developed Countries; Double-Blind Method; Endocrine System; Europe; France; Hormone Antagonists; Hormones; Human Experimentation; Labor Stage, First; Mifepristone; Physiology; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Third; Pregnancy, Prolonged; Prospective Studies; Reproduction; Research; Therapeutics | 1992 |
Early electioneering highlights party differences on key issues of choice.
Topics: Abortion, Induced; Administrative Personnel; Americas; Biology; Developed Countries; Economics; Endocrine System; Extraembryonic Membranes; Family Planning Services; Fetus; Financial Management; Financing, Government; Government; Hormone Antagonists; Hormones; Insurance, Health; Legislation as Topic; Mifepristone; North America; Organization and Administration; Physiology; Politics; Pregnancy; Public Opinion; Reproduction; Research; United States | 1992 |
[Pharmacokinetic study on RU 486 and its metabolites after oral administration of various doses in pregnant and non-pregnant women].
Topics: Asia; Asia, Eastern; Biology; China; Clinical Laboratory Techniques; Developing Countries; Diagnosis; Endocrine System; Hormone Antagonists; Hormones; Mifepristone; Physiology; Pregnancy; Reproduction | 1992 |
Messenger RNA for progesterone receptor isoforms in the late-gestation rat uterus.
Topics: Animals; Female; Gestational Age; Hormone Antagonists; Mifepristone; Pregnancy; Progesterone; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Uterus | 2002 |
Emergency contraception by low-dose mifepristone: observation of 150 cases.
Topics: Administration, Oral; Adult; Contraception; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Female; Humans; Mifepristone; Pregnancy; Treatment Outcome | 2002 |
Intracrine induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by glucocorticoid potentiates prostaglandin production in the human chorionic trophoblast.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Cells, Cultured; Chorion; Cortisone; Cyclooxygenase 2; Dexamethasone; Dinoprostone; Enzyme Induction; Female; Glucocorticoids; Hormone Antagonists; Humans; Hydroxysteroid Dehydrogenases; Isoenzymes; Membrane Proteins; Mifepristone; Pregnancy; Prostaglandin-Endoperoxide Synthases; Receptors, Glucocorticoid; RNA, Messenger; Trophoblasts | 2002 |
Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Prospective Studies; Vacuum Curettage | 2002 |
Effect of mifepristone on pregnancy, pregnancy-specific protein B (PSPB), progesterone, estradiol-17beta, prostaglandin F2alpha (PGF2alpha) and prostaglandin E (PGE) in ovariectomized 90-day pregnant ewes.
Topics: Abortion, Induced; Animals; Aspartic Acid Endopeptidases; Dinoprost; Estradiol; Female; Mifepristone; Ovariectomy; Ovary; Pregnancy; Pregnancy Maintenance; Pregnancy Proteins; Pregnancy, Animal; Prostaglandins E; Receptors, Progesterone; Sheep | 2002 |
Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation.
Topics: Animals; Blood Glucose; Cell Count; Cell Division; Cell Size; Diabetes Mellitus, Experimental; Diabetes, Gestational; Female; Glucose; Glucose Tolerance Test; Homeostasis; Hormone Antagonists; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mifepristone; Organ Size; Pregnancy; Progesterone; Receptors, Progesterone; Sex Characteristics; Signal Transduction | 2002 |
[Medical abortion with mifepristone and misoprostol: study of the efficacy, somatic tolerance and perception of medical abortion].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Eugenic; Adaptation, Psychological; Adolescent; Adult; Counseling; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Prospective Studies; Switzerland | 2002 |
Protection of RU-486 as contraception, emergency contraception and as an abortifacient under the law of contraception.
Topics: Abortifacient Agents; Abortion, Legal; Contraception; Contraceptives, Postcoital; Female; Feminism; Humans; Internationality; Jurisprudence; Mifepristone; Personal Autonomy; Pregnancy; Privacy; Supreme Court Decisions; United States; Women's Rights | 2000 |
Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Drug Therapy, Combination; Female; Humans; Logistic Models; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Regression Analysis; Tablets; Treatment Outcome | 2002 |
A genomic approach to identify novel progesterone receptor regulated pathways in the uterus during implantation.
Topics: Animals; Blotting, Northern; Embryo Implantation; Embryonic Development; Epithelium; Estradiol; Female; Gene Expression Regulation; Kinetics; Mice; Mice, Knockout; Mifepristone; Oligonucleotide Array Sequence Analysis; Ovariectomy; Pregnancy; Progesterone; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stromal Cells; Uterus | 2002 |
Time to relax the rules about administration of mifepristone.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 2001 |
Current perspectives on emergency contraception.
Topics: Contraception Behavior; Contraceptives, Postcoital; Drug Prescriptions; Emergencies; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Hong Kong; Humans; Intrauterine Devices; Levonorgestrel; Mifepristone; Nonprescription Drugs; Patient Education as Topic; Pregnancy; Pregnancy, Unwanted; Self Administration | 2002 |
Termination of pregnancy with mifepristone and prostaglandin suppresses transiently circulating glucocorticoid bioactivity.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Biological Assay; Drug Synergism; Female; Glucocorticoids; Humans; Hydrocortisone; Mifepristone; Misoprostol; Pregnancy | 2003 |
Effect of mifegin on the content of cyclic nucleotides in the cervical myometrium in full-term pregnancy.
Topics: Administration, Oral; Adult; Cyclic AMP; Cyclic GMP; Drug Administration Schedule; Female; Humans; Labor, Obstetric; Mifepristone; Myometrium; Pregnancy; Pregnancy Outcome | 2002 |
Medical termination of pregnancy at 9-12 weeks of gestation.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prostaglandins E, Synthetic; Retrospective Studies | 2002 |
[Effect of total glycoside from Clinopodium polycephalum on uterine bleeding quantity in drug abortion model rats].
Topics: Abortion, Induced; Animals; Drugs, Chinese Herbal; Female; Glycosides; Hemostatics; Lamiaceae; Male; Mifepristone; Misoprostol; Phytotherapy; Plants, Medicinal; Pregnancy; Rats; Rats, Wistar; Uterine Hemorrhage | 2002 |
RETIRED: Mifepristone.
Topics: Adult; Canada; Contraceptives, Postcoital, Synthetic; Female; Health Policy; Humans; Mifepristone; Pregnancy | 2003 |
The learning curve is rapid in medical termination of pregnancy--first-year results from the Helsinki area.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Analgesia; Female; Finland; Hemorrhage; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Surveys and Questionnaires | 2003 |
The use of lidocaine for fetocide in late termination of pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Amides; Analgesia, Patient-Controlled; Analgesics, Opioid; Anti-Arrhythmia Agents; Drug Combinations; Female; Fetal Death; Gestational Age; Heart Arrest; Humans; Injections, Intravenous; Lidocaine; Mifepristone; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Ropivacaine; Sufentanil; Umbilical Veins | 2003 |
Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Self Administration; Time Factors; Treatment Outcome | 2003 |
Legal termination of pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Legal; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; South Africa | 2003 |
Expression of survivin in early villus and decidua and its implication.
Topics: Apoptosis; Chorionic Villi; Decidua; Female; Gene Expression Regulation; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Mifepristone; Neoplasm Proteins; Pregnancy; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survivin; Trophoblasts | 2002 |
Changes in circulating concentrations of inhibins A and pro-alpha C during first trimester medical termination of pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Chorionic Gonadotropin; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Hormone Antagonists; Humans; Inhibins; Mifepristone; Osmolar Concentration; Pregnancy; Pregnancy Trimester, First; Progesterone; Protein Precursors | 2003 |
Persistent ascites after ovarian hyperstimulation syndrome and administration of mifepristone (RU 486) for the termination of pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Ascites; Female; Fertilization in Vitro; Humans; Mifepristone; Ovarian Hyperstimulation Syndrome; Pregnancy; Sperm Injections, Intracytoplasmic; Ultrasonography | 2003 |
Early abortion services in the United States: a provider survey.
Topics: Abortifacient Agents; Abortion, Induced; Attitude to Health; Family Planning Services; Female; Health Care Surveys; Humans; Methotrexate; Mifepristone; Pregnancy; United States; Vacuum Curettage; Women's Health Services | 2003 |
Gestational trophoblastic tumor after medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adult; Antineoplastic Agents; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Mifepristone; Misoprostol; Oxytocics; Pregnancy; Pregnancy Trimester, First | 2003 |
Normalizing the exceptional: incorporating the "abortion pill" into mainstream medicine.
Topics: Abortion, Induced; Contraceptives, Postcoital, Synthetic; Diffusion of Innovation; Drug Approval; Drug Industry; Female; France; Humans; Legislation, Drug; Mifepristone; Politics; Pregnancy; Pregnancy Trimester, First; Social Values; Sociology, Medical; United States; United States Food and Drug Administration | 2003 |
Medical abortion at 64 to 91 days of gestation: a review of 483 consecutive cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Administration Schedule; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retreatment; Treatment Outcome; Vacuum Curettage | 2003 |
Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
Topics: Animals; Calcitonin Receptor-Like Protein; Estradiol; Female; Gene Expression Regulation; Hormone Antagonists; Intracellular Signaling Peptides and Proteins; Labor, Obstetric; Membrane Proteins; Mifepristone; Ovariectomy; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Receptor Activity-Modifying Protein 1; Receptor Activity-Modifying Protein 2; Receptor Activity-Modifying Protein 3; Receptor Activity-Modifying Proteins; Receptors, Adrenomedullin; Receptors, Calcitonin; Receptors, Peptide; Steroids; Uterus | 2003 |
Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Anti-Bacterial Agents; Blood Transfusion; Female; Gestational Age; Humans; Hypersensitivity; Infections; Mifepristone; Misoprostol; Pregnancy; United States; Uterine Hemorrhage; Vacuum Curettage | 2003 |
Effects of prostaglandins E2 and F2alpha (PGE2; PGF2alpha), trilostane, mifepristone, palmitic acid (PA), indomethacin (INDO), ethamoxytriphetol (MER-25), PGE2 + PA, or PGF2alpha + PA on PGE2, PGF2alpha, and progesterone secretion by bovine corpora lutea
Topics: Abortifacient Agents, Steroidal; Animals; Cattle; Corpus Luteum; Dihydrotestosterone; Dinoprost; Dinoprostone; Drug Synergism; Enzyme Inhibitors; Estrogen Antagonists; Ethamoxytriphetol; Female; In Vitro Techniques; Indomethacin; Mifepristone; Oxytocics; Palmitic Acid; Pregnancy; Progesterone; Tocolytic Agents | 2002 |
[Large variation in clinical regimens use to induce medical abortion in Denmark].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Denmark; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Practice Patterns, Physicians'; Pregnancy; Surveys and Questionnaires | 2003 |
Late gestation modulation of fetal glucocorticoid effects requires the receptor for leukemia inhibitory factor: an observational study.
Topics: Abnormalities, Multiple; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Bone Diseases, Metabolic; Corticosterone; Female; Fetal Diseases; Fetus; Genes, Lethal; Gestational Age; Homeostasis; Hormone Antagonists; Hypothalamo-Hypophyseal System; Interleukin-6; Leukemia Inhibitory Factor; Leukemia Inhibitory Factor Receptor alpha Subunit; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mifepristone; Muscle, Skeletal; Neuroglia; Neuroimmunomodulation; Pituitary-Adrenal System; Pregnancy; Proteins; Receptors, Cytokine; Receptors, Glucocorticoid; Receptors, OSM-LIF; Specific Pathogen-Free Organisms; Spinal Cord | 2003 |
Expression of calcitonin gene-related peptide receptor components, calcitonin receptor-like receptor and receptor activity modifying protein 1, in the rat placenta during pregnancy and their cellular localization.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Receptor-Like Protein; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Fulvestrant; Gestational Age; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mifepristone; Placenta; Pregnancy; Progesterone; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptor Activity-Modifying Proteins; Receptors, Calcitonin; Receptors, Calcitonin Gene-Related Peptide; Up-Regulation | 2003 |
Mifepristone and misoprostol for medical termination of pregnancy: the effectiveness of a flexible regimen.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Administration, Intravaginal; Adolescent; Adult; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Time Factors; Treatment Outcome; United Kingdom | 2003 |
Mouse calbindin-D(9k) gene expression in the uterus during late pregnancy and lactation.
Topics: Animals; Calbindins; Estrogen Receptor alpha; Female; Gene Expression Profiling; Gene Expression Regulation; Lactation; Male; Mice; Mifepristone; Pregnancy; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; S100 Calcium Binding Protein G; Tamoxifen | 2003 |
Dual roles of progesterone in embryo implantation in mouse.
Topics: Animals; Cells, Cultured; Coculture Techniques; Decidua; Dose-Response Relationship, Drug; Embryo Implantation; Epithelial Cells; Female; Hormone Antagonists; Male; Mice; Mifepristone; Placenta; Pregnancy; Progesterone; Trophoblasts; Uterus | 2003 |
Effect of progesterone, mifepristone, and estrogen treatment during early pregnancy on conceptus development and uterine capacity in Swine.
Topics: Animals; Embryonic and Fetal Development; Estrogens; Female; Gestational Age; Litter Size; Luteolytic Agents; Mifepristone; Pregnancy; Pregnancy Rate; Progesterone; Swine; Uterus | 2004 |
Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse.
Topics: Animals; Contraceptives, Oral, Synthetic; Embryo Implantation; Estrogens; Female; Gene Expression; Male; Mice; Mice, Inbred Strains; Mifepristone; Oligodeoxyribonucleotides, Antisense; Pregnancy; Progesterone; Proteins; Receptors, Progesterone; RNA, Messenger; Uterus | 2003 |
[Mifepristone for induction of second trimester abortion].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Prospective Studies | 2003 |
A single dose of mifepristone (200 mg) in the immediate preovulatory phase offers contraceptive potential without cycle disruption.
Topics: Adult; Biopsy; Contraceptives, Oral, Synthetic; Endometrium; Estradiol; Female; Humans; Luteal Phase; Luteinizing Hormone; Menstrual Cycle; Mifepristone; Ovarian Follicle; Ovulation; Pregnancy; Ultrasonography | 2003 |
[Medical termination of pregnancy with mifepristone--initial experience at the Sheba Medical Center].
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Adolescent; Adult; Female; Follow-Up Studies; Humans; Israel; Middle Aged; Mifepristone; Pregnancy; Safety | 2003 |
Medical abortion. defining success and categorizing failures.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Alprostadil; Denmark; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Treatment Failure | 2003 |
Synergistic effects of DL111-IT in combination with mifepristone and misoprostol on termination of early pregnancy in preclinical studies.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Columbidae; Drug Synergism; Drug Therapy, Combination; Female; Guinea Pigs; Male; Mice; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Rats; Rats, Sprague-Dawley; Triazoles; Uterus; Vomiting | 2003 |
Platelet-activating factor antagonist WEB-2170 inhibits lipopolysaccharide-induced, but not antiprogestin-induced, preterm cervical ripening in timed-pregnant rats.
Topics: Animals; Azepines; Cervical Ripening; Female; Hormone Antagonists; Lipopolysaccharides; Mifepristone; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; Pregnancy; Progestins; Rats; Rats, Sprague-Dawley; Triazoles | 2003 |
[Medical abortion--the first Norwegian experiences].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2003 |
Clinical practice. Emergency contraception.
Topics: Adult; Contraceptives, Postcoital; Drug Prescriptions; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Intrauterine Devices, Copper; Mifepristone; Nonprescription Drugs; Practice Guidelines as Topic; Pregnancy; Pregnancy Outcome | 2003 |
Progesterone and gravidity differentially regulate expression of extracellular matrix components in the pregnant rat myometrium.
Topics: Animals; Extracellular Matrix Proteins; Female; Gene Expression Regulation; Gravidity; Hormone Antagonists; Labor, Obstetric; Mifepristone; Myometrium; Obstetric Labor, Premature; Parturition; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Wistar; Receptors, Progesterone | 2004 |
Impairment of inflammatory response in adult rats submitted to maternal undernutrition during early lactation: role of insulin and glucocorticoid.
Topics: Animals; Blood Glucose; Carrageenan; Cell Movement; Edema; Endothelium; Energy Intake; Feeding Behavior; Female; Fetus; Glucocorticoids; Immunohistochemistry; Inflammation; Insulin; Intercellular Adhesion Molecule-1; Lactation; Leukocytes; Male; Malnutrition; Mifepristone; Neutrophils; Nutrition Disorders; Pleurisy; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar | 2003 |
Report from the Faculty of Family Planning and Reproductive Health Care AGM, May 2003: Medical termination of pregnancy in the late first trimester.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Legal; Administration, Intravaginal; Administration, Oral; Adult; Cohort Studies; Family Planning Services; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Time Factors; Treatment Outcome; United Kingdom | 2003 |
Differential kinetics of serum and cervical insulin-like growth factor-binding protein-1 during mifepristone-misoprostol-induced medical termination of early pregnancy.
Topics: Abortifacient Agents, Steroidal; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Kinetics; Mifepristone; Misoprostol; Pregnancy; Somatomedins | 2004 |
Female sex steroid hormones and pregnancy regulate receptors for calcitonin gene-related peptide in rat mesenteric arteries, but not in aorta.
Topics: Animals; Aorta; Calcitonin Gene-Related Peptide; Calcitonin Receptor-Like Protein; Down-Regulation; Drug Combinations; Estradiol; Female; Hormone Antagonists; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mesenteric Arteries; Mifepristone; Osmolar Concentration; Ovariectomy; Pregnancy; Progesterone; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptor Activity-Modifying Protein 1; Receptor Activity-Modifying Proteins; Receptors, Calcitonin; Receptors, Calcitonin Gene-Related Peptide; RNA, Messenger; Up-Regulation | 2004 |
Medical management of first trimester miscarriage (blighted ovum and missed abortion): is it effective?
Topics: Abortion, Missed; Abortion, Spontaneous; Administration, Oral; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Risk Assessment; Treatment Outcome | 2004 |
Induction of cytotoxic T-lymphocyte antigen-2beta, a cysteine protease inhibitor in decidua: a potential regulator of embryo implantation.
Topics: Animals; Antigens, Differentiation; Baculoviridae; Blotting, Northern; Cathepsin L; Cathepsins; Cell Division; Cell Line; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Decidua; DNA, Complementary; Down-Regulation; Embryo Implantation; Female; Immunohistochemistry; In Situ Hybridization; Insecta; Mice; Mice, Knockout; Mifepristone; Oligonucleotide Array Sequence Analysis; Pregnancy; Pregnancy, Animal; Receptors, Progesterone; Recombinant Proteins; RNA, Messenger; Signal Transduction; T-Lymphocytes, Cytotoxic; Time Factors; Uterus | 2004 |
Medical treatment of miscarriage in a district general hospital is safe and effective up to 12 weeks' gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Female; Hospitals, District; Hospitals, General; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Ultrasonography; United Kingdom | 2003 |
Prediction of late failure after medical abortion from serial beta-hCG measurements and ultrasonography.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Area Under Curve; Chorionic Gonadotropin, beta Subunit, Human; Endometrium; Female; Humans; Mifepristone; Predictive Value of Tests; Pregnancy; Treatment Failure; Ultrasonography | 2004 |
The use of mifepristone to reduce unwanted pregnancy and associated health and social risks.
Topics: Contraceptives, Postcoital, Synthetic; Female; Humans; Luteal Phase; Menstruation; Mifepristone; Pregnancy; Pregnancy, Unwanted | 2003 |
A multiparametric study of the action of mifepristone used in emergency contraception using the Rhesus monkey as a primate model.
Topics: Animals; Contraceptives, Oral; Contraceptives, Postcoital, Synthetic; Endometrium; Female; Glycoproteins; Gonadal Steroid Hormones; In Situ Nick-End Labeling; Interleukin-6; Leukemia Inhibitory Factor; Macaca mulatta; Male; Menstrual Cycle; Mifepristone; Models, Animal; Molecular Chaperones; Pregnancy; Pregnancy Proteins; Proliferating Cell Nuclear Antigen; Proteins; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2003 |
Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Obstetric Surgical Procedures; Parity; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Treatment Outcome | 2004 |
The medical abortion experiences of married and unmarried women in Tunis, Tunisia.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Home Care Services; Humans; Marital Status; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Surveys and Questionnaires; Tunisia | 2004 |
Challenges to the FDA approval of mifepristone.
Topics: Drug Approval; Female; Humans; Mifepristone; Pregnancy; Product Surveillance, Postmarketing; Public Opinion; United States | 2004 |
Induction of labor with RU 486 (mifepristone) in relaxin-deficient rats: antepartum administration of relaxin facilitates delivery and increases pup survival.
Topics: Animals; Animals, Newborn; Birth Rate; Drug Synergism; Female; Hormone Antagonists; Injections, Subcutaneous; Labor, Induced; Labor, Obstetric; Mifepristone; Pregnancy; Pregnancy Outcome; Rats; Rats, Sprague-Dawley; Relaxin; Survival; Time Factors | 2004 |
Advanced cervical pregnancy: uterus-sparing therapy initiated with a combination of methotrexate and mifepristone followed by evacuation and local hemostatic measures.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adult; Cervix Uteri; Drug Therapy, Combination; Female; Hemostasis, Surgical; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic | 2004 |
Self-administration of misoprostol for termination of pregnancy: safety and efficacy.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Self Administration; Treatment Outcome | 2004 |
[Effect of RU486 on apoptosis and p53 expression at the boundary of fetal-maternal interface of rhesus monkey (Macaca mulatta)].
Topics: Abortifacient Agents, Steroidal; Animals; Apoptosis; Chorionic Villi; Female; Macaca mulatta; Mifepristone; Placentation; Pregnancy; Proto-Oncogene Mas; Tumor Suppressor Protein p53 | 2004 |
One- and 2-day mifepristone-misoprostol intervals are both effective in medical termination of second-trimester pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Time Factors | 2004 |
Mifepristone-induced abortion and birth weight in the first subsequent pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Birth Weight; Female; Humans; Infant, Newborn; Logistic Models; Mifepristone; Pregnancy; Prospective Studies | 2004 |
Role of routine ultrasonography in monitoring the outcome of medical abortion in a clinical setting.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Ambulatory Care Facilities; Diagnostic Tests, Routine; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy; Reproducibility of Results; Retrospective Studies; Treatment Outcome; Ultrasonography; Uterus | 2004 |
[Medical termination of pregnancy at 9-14 weeks gestation. Prospective study of 105 cases in Saint-Laurent-du-Maroni (French Guyana)].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Administration, Intravaginal; Administration, Oral; Administration, Sublingual; Adolescent; Adult; Analgesics, Opioid; Drug Therapy, Combination; Female; Humans; Length of Stay; Mifepristone; Misoprostol; Nalbuphine; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Safety; Time Factors; Treatment Outcome | 2004 |
The moral permissibility of using RU-486 as an abortifacient of the preimplanted zygote.
Topics: Abortifacient Agents; Abortion, Induced; Beginning of Human Life; Blastocyst; Contraception, Postcoital; Embryonic and Fetal Development; Embryonic Development; Female; Humans; Mifepristone; Personhood; Pregnancy; Zygote | 2002 |
Role of ERK1/2 in uterine contractility and preterm labor in rats.
Topics: Animals; Butadienes; Calmodulin-Binding Proteins; Enzyme Inhibitors; Female; Fetal Weight; Hormone Antagonists; Humans; Infant, Newborn; Infant, Premature; Mifepristone; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myometrium; Myosin Light Chains; Nitriles; Phosphorylation; Pregnancy; Rats; Rats, Sprague-Dawley; Uterine Contraction; Uterus | 2004 |
[Clinical observation on 45 patients with ectopic gestation treated conservatively by integrative Chinese and Western medicine].
Topics: Adult; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Methotrexate; Mifepristone; Phytotherapy; Pregnancy; Pregnancy, Ectopic | 2004 |
A woman's choice.
Topics: Abortifacient Agents; Abortion, Induced; Choice Behavior; Female; Humans; Medical Audit; Medicine, Traditional; Mifepristone; New Zealand; Pregnancy; Women's Health; Women's Rights | 2004 |
Social context and the experience of a sample of U.S. women taking RU-486 (mifepristone) for early abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adaptation, Psychological; Adolescent; Adult; Attitude to Health; Decision Making; Female; Follow-Up Studies; Humans; Mifepristone; New York; Pregnancy; Social Values | 2004 |
Cycle-dependent endometrial expression and hormonal regulation of the fibulin-1 gene.
Topics: Amino Acid Sequence; Animals; Base Sequence; Calcium-Binding Proteins; Cells, Cultured; Endometrium; Epidermal Growth Factor; Estrogens; Estrous Cycle; Extracellular Matrix Proteins; Female; Gene Expression Regulation; Humans; Menstrual Cycle; Mice; Mifepristone; Molecular Sequence Data; Pregnancy; Progesterone; Rats; Stromal Cells | 2004 |
Involvement of opioid receptor subtypes in both stimulatory and inhibitory effects of the opioid peptides on prolactin secretion during pregnancy.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; beta-Endorphin; Brain; Circadian Rhythm; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Estrus; Female; Hypothalamo-Hypophyseal System; Injections, Intraventricular; Male; Mifepristone; Narcotic Antagonists; Opioid Peptides; Pregnancy; Pregnancy, Animal; Prolactin; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2004 |
[Effect of mifepristone on the expression of chorionic gonadotropin beta subunit and collagen type IV in female rhesus monkey decidua and villus at early gestation].
Topics: Animals; Chorionic Gonadotropin, beta Subunit, Human; Chorionic Villi; Collagen Type IV; Decidua; Female; Immunohistochemistry; Macaca mulatta; Mifepristone; Pregnancy | 2004 |
Beware: failed medical termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Diagnosis, Differential; Douglas' Pouch; Female; Humans; Laparotomy; Mifepristone; Pregnancy; Pregnancy, Tubal; Rupture, Spontaneous | 2004 |
Mifepristone (Ru486) antagonizes monocyte chemotactic protein-3 down-regulation at early mouse pregnancy revealing immunomodulatory events in Ru486 induced abortion.
Topics: Abortion, Induced; Animals; Blastomeres; Chemokine CCL7; Cytokines; Down-Regulation; Embryo Implantation; Female; Hormones; Immunohistochemistry; Mice; Mifepristone; Models, Animal; Monocyte Chemoattractant Proteins; Pregnancy; Pregnancy, Animal; Time Factors; Uterus | 2004 |
Mifepristone-induced early abortion and outcome of subsequent wanted pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Case-Control Studies; China; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Maternal Exposure; Mifepristone; Pregnancy; Pregnancy Outcome | 2004 |
[Mifepristone combined with methotrexate for conservative treatment of tubal ectopic pregnancy].
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Tubal | 2004 |
Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Feasibility Studies; Female; Home Care Services; Humans; Mifepristone; Patient Satisfaction; Pregnancy; Urban Health; Vietnam | 2004 |
Identification of the pregnancy hormone relaxin as glucocorticoid receptor agonist.
Topics: Active Transport, Cell Nucleus; Binding Sites; Cell Line; Cell Nucleus; Cytokines; DNA; Endotoxins; Female; Fluorescence Polarization; Genes, Reporter; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Immunoprecipitation; Inflammation Mediators; Mifepristone; Pregnancy; Protein Binding; Receptors, Glucocorticoid; Relaxin; Response Elements; Up-Regulation | 2004 |
Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
Topics: Abortifacient Agents; Abortion, Induced; Dinoprostone; Female; Fetal Death; Fetal Diseases; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Treatment Outcome | 2004 |
Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Analgesia; Analgesia, Obstetrical; Analgesics; Female; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Pregnancy Trimester, Second; Regression Analysis; Retrospective Studies | 2004 |
[Effect of Qinggong Zhixue Granule on low immunity mice].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Drugs, Chinese Herbal; Female; Hemolysin Proteins; Mice; Mifepristone; Plant Preparations; Pregnancy; Random Allocation; Uterine Hemorrhage | 2004 |
[Obstetrical prognosis of labour induction with mifepristone after 41 weeks of gestation].
Topics: Adult; Cesarean Section; Dinoprostone; Female; Gestational Age; Humans; Labor, Induced; Mifepristone; Pregnancy; Prognosis; Retrospective Studies | 2004 |
[Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Placenta, Retained; Pregnancy | 2004 |
Rupture in an unscarred uterus during second trimester pregnancy termination with mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Uterine Rupture | 2004 |
Regulation of progesterone levels during pregnancy and parturition by signal transducer and activator of transcription 5 and 20alpha-hydroxysteroid dehydrogenase.
Topics: 20-alpha-Hydroxysteroid Dehydrogenase; Adrenal Glands; Animals; Blotting, Northern; Blotting, Western; Cloprostenol; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Female; Genetic Vectors; Genotype; Hematopoiesis; Hematopoietic Stem Cells; Kidney; Mammary Glands, Animal; Mice; Mifepristone; Milk Proteins; Models, Genetic; Mutation; Ovary; Parturition; Pregnancy; Pregnancy, Animal; Progesterone; Radioimmunoassay; Receptors, Prostaglandin; STAT5 Transcription Factor; Time Factors; Trans-Activators | 2005 |
Medical abortion: the Tunisian experience.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome; Tunisia | 2004 |
Increased risk for medical abortion failure for multiparous women.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Finland; Humans; Medical Records; Mifepristone; Misoprostol; Parity; Pregnancy; Retrospective Studies; Risk Factors; Treatment Failure | 2004 |
Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adult; Female; Health Services Accessibility; Humans; Mifepristone; Office Visits; Patient Satisfaction; Pregnancy; Safety; Tunisia | 2004 |
Effect of proteasome pathway on initiation of mouse labor induced by antiprogesterone.
Topics: Abortifacient Agents, Steroidal; Acetylcysteine; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Electrophoretic Mobility Shift Assay; Female; Gene Expression Regulation; Interleukin-1; Male; Membrane Proteins; Mice; Mice, Inbred ICR; Mifepristone; NF-kappa B; Parturition; Pregnancy; Prostaglandin-Endoperoxide Synthases; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Receptors, Oxytocin; Receptors, Prostaglandin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Uterus | 2004 |
Effects of glucocorticoids on Fas gene expression in bovine blood neutrophils.
Topics: Animals; Apoptosis; Caspase 8; Caspases; Cattle; Cells, Cultured; Dexamethasone; fas Receptor; Female; Gene Expression; Glucocorticoids; Hydrocortisone; Labor, Obstetric; Leukocyte Count; Male; Mifepristone; Neutrophils; Pregnancy; Receptors, Glucocorticoid; RNA, Messenger | 2004 |
Accounting for time: insights from a life-table analysis of the efficacy of medical abortion.
Topics: Abortifacient Agents; Abortion, Therapeutic; Adolescent; Adult; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gestational Age; Humans; India; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Probability; Risk Assessment; Statistics as Topic; Treatment Outcome | 2004 |
Management of late intrauterine death using a combination of mifepristone and misoprostol--experience of two regimens.
Topics: Abortifacient Agents; Delivery, Obstetric; Drug Therapy, Combination; Female; Fetal Death; Gestational Age; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy; Time Factors; Treatment Outcome | 2005 |
The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Costs and Cost Analysis; Female; Follow-Up Studies; Humans; India; Mifepristone; Misoprostol; Pregnancy; United States | 2005 |
Effect of a single dose of mifepristone on expression of pinopodes in endometrial surface of mice.
Topics: Animals; Contraceptives, Postcoital, Synthetic; Embryo Implantation; Endometrium; Epithelial Cells; Female; Male; Mice; Microscopy, Electron, Scanning; Microvilli; Mifepristone; Pregnancy | 2005 |
Progesterone increases blood pressure in spontaneous gestational hypertension in rats.
Topics: Animals; Aspartate Aminotransferases; Blood Pressure; Body Weight; Creatinine; Disease Models, Animal; Estrogens; Female; Hypertension, Pregnancy-Induced; Kidney; Male; Mifepristone; Pregnancy; Progesterone; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Systole | 2005 |
"You can't do that 'round here": a case study of the introduction of medical abortion care at a University Medical Center.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Academic Medical Centers; Family Practice; Female; Gestational Age; Gynecology; Health Occupations; Humans; Mifepristone; New Mexico; Obstetrics; Patient Care; Pregnancy; Pregnancy Trimester, First; Ultrasonography, Prenatal | 2005 |
Birth control: more & safer choices.
Topics: Abortion, Induced; Condoms; Consumer Behavior; Consumer Product Safety; Contraception; Contraceptive Agents, Female; Estrogens; Female; Humans; Insurance Coverage; Male; Mifepristone; Misoprostol; Pregnancy; Progestins; Sterilization, Reproductive | 2005 |
Interactions between 11beta-hydroxysteroid dehydrogenase and COX-2 in kidney.
Topics: 17-Hydroxysteroid Dehydrogenases; Animals; Animals, Newborn; Animals, Suckling; Blood Pressure; Cyclooxygenase 2; Enzyme Inhibitors; Female; Glycyrrhizic Acid; Hormone Antagonists; Hypertension; Immunoblotting; Immunohistochemistry; Kidney; Kidney Cortex; Kidney Medulla; Mifepristone; Pregnancy; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley | 2005 |
Failed medical termination of twin pregnancy with mifepristone: a case report.
Topics: Abortifacient Agents, Steroidal; Adult; Female; Humans; Mifepristone; Pregnancy; Pregnancy Outcome; Treatment Outcome; Twins | 2005 |
Dose response of RU486 in a novel rabbit model of noninfectious preterm birth: comparative efficacy of 3 routes of administration.
Topics: Abortifacient Agents, Steroidal; Animals; Cytokines; Disease Models, Animal; Female; Hydrocortisone; Injections, Intramuscular; Injections, Intraperitoneal; Injections, Subcutaneous; Mifepristone; Pregnancy; Premature Birth; Progesterone; Rabbits | 2005 |
Hematosalpinx: an unusual complication after medical abortion with oral mifepristone and misoprostol.
Topics: Abortifacient Agents; Adult; Fallopian Tube Diseases; Female; Hematometra; Humans; Mifepristone; Misoprostol; Pregnancy | 2005 |
Uterine electromyography characteristics for early diagnosis of mifepristone-induced preterm labor.
Topics: Abortifacient Agents, Steroidal; Animals; Electromyography; Female; Mifepristone; Obstetric Labor, Premature; Pregnancy; Prenatal Diagnosis; Rats; Rats, Sprague-Dawley; Uterine Contraction | 2005 |
Leukocyte populations and steroid receptor expression in human first-trimester decidua; regulation by antiprogestin and prostaglandin E analog.
Topics: Abortifacient Agents; Alprostadil; Decidua; Female; Hormone Antagonists; Humans; Immunohistochemistry; Killer Cells, Natural; Leukocyte Count; Macrophages; Mifepristone; Neutrophils; Pregnancy; Pregnancy Trimester, First; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone | 2005 |
A qualitative study of insurers' coverage for mifepristone-induced abortion.
Topics: Abortion, Induced; Drug Labeling; Evidence-Based Medicine; Female; Humans; Insurance Coverage; Managed Care Programs; Mifepristone; Pregnancy; Qualitative Research; United States | 2005 |
Medical abortion at 9-13 weeks' gestation: a review of 1076 consecutive cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Missed; Administration, Intravaginal; Adult; Drug Administration Schedule; Drug Combinations; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies | 2005 |
[Clinical observation on triple-therapy for terminating ectopic pregnancy].
Topics: Abortifacient Agents, Nonsteroidal; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Follow-Up Studies; Humans; Methotrexate; Mifepristone; Phytotherapy; Pregnancy; Pregnancy, Ectopic; Retrospective Studies; Treatment Outcome | 2005 |
Viable cervical pregnancy with levonorgestrel containing intrauterine device, treated successfully with methotrexate and mifepristone.
Topics: Abortifacient Agents; Cervix Uteri; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic | 2005 |
Clinical use of relaxin to facilitate birth: reasons for investigating the premise.
Topics: Animals; Cervix Uteri; Cesarean Section; Female; Humans; Mifepristone; Organ Size; Parturition; Pregnancy; Relaxin | 2005 |
The effects of blocking the actions of estrogen and progesterone on the rates of proliferation and apoptosis of cervical epithelial and stromal cells during the second half of pregnancy in rats.
Topics: Animals; Apoptosis; Cell Proliferation; Cervix Uteri; Epithelial Cells; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Hormone Antagonists; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Relaxin; Stromal Cells | 2005 |
The effect of herbal medicine Toki-shakuyaku-san on blood pressure in an Nomega-nitro-L-arginine methyl ester-induced pre-eclampsia rat model during pregnancy and the postpartum period.
Topics: Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Disease Models, Animal; Drugs, Chinese Herbal; Estradiol; Female; Male; Mifepristone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pre-Eclampsia; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley | 2005 |
Some new problems in biomedical regulation.
Topics: Abortifacient Agents; Anencephaly; Australia; Bioethical Issues; Catholicism; Embryo Research; Euthanasia, Passive; Female; Heroin Dependence; Humans; Mifepristone; Pregnancy; Pregnant Women; Tissue and Organ Procurement; Treatment Refusal; Vaccines, Contraceptive | 1990 |
[Mifepristone 100 mg for early medical abortion].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Retrospective Studies; Treatment Outcome | 2005 |
Delay of preterm birth in sheep by THG113.31, a prostaglandin F2alpha receptor antagonist.
Topics: Animals; Delivery, Obstetric; Dinoprost; Dinoprostone; Electromyography; Female; Fetal Blood; Hydrocortisone; In Vitro Techniques; Mifepristone; Myometrium; Peptides; Pregnancy; Pregnancy, Animal; Premature Birth; Receptors, Progesterone; Receptors, Prostaglandin; Sheep; Time Factors; Tocolytic Agents; Uterine Contraction; Uterus | 2005 |
Introduction of early medical abortion in New Zealand: an audit of the first 67 cases.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Adolescent; Adult; Child; Dilatation and Curettage; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gestational Age; Humans; Length of Stay; Medical Audit; Middle Aged; Mifepristone; Misoprostol; New Zealand; Pregnancy; Treatment Outcome | 2005 |
HLA-G in murine peripheral blood after interruption of pregnancy.
Topics: Animals; Female; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Lymphocytes; Mice; Mice, Transgenic; Mifepristone; Pregnancy; Pregnancy, Animal; Time Factors | 2005 |
Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol--United States and Canada, 2001-2005.
Topics: Abortifacient Agents; Abortion, Induced; Canada; Clostridium Infections; Clostridium sordellii; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Shock, Septic; United States | 2005 |
Septic shock after medical abortions with mifepristone (Mifeprex, RU 486) and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Canada; Clostridium Infections; Clostridium sordellii; Fatal Outcome; Female; Humans; Mifepristone; Pregnancy; Shock, Septic; United States; United States Food and Drug Administration | 2005 |
Abortion procedures in a tertiary care institution in India.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Dinoprostone; Female; Humans; India; Mifepristone; Misoprostol; Oxytocics; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Retrospective Studies | 2005 |
Her accidental legacy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; California; Fatal Outcome; Female; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2003 |
[Expression of T-lymphocytes and cytokines in the decidua of mifepristone with misoprostol for terminating early pregnancy].
Topics: Abortifacient Agents; Abortion, Induced; Case-Control Studies; Cytokines; Decidua; Drug Therapy, Combination; Female; Flow Cytometry; Humans; Killer Cells, Natural; Lymphocytes; Lymphotoxin-alpha; Mifepristone; Misoprostol; Pregnancy; T-Lymphocyte Subsets; Tumor Necrosis Factor-alpha | 2001 |
RU-486 and abortion strategies.
Topics: Abortion, Induced; Attitude of Health Personnel; Drug Approval; Female; Humans; Mifepristone; Physicians; Politics; Pregnancy; United States | 1991 |
RU-486: the "abortion pill".
Topics: Abortion, Induced; Catholicism; Contraception; Developed Countries; Developing Countries; Female; Humans; Mifepristone; Population Control; Pregnancy; Privacy; Prostaglandins E, Synthetic; Reproductive Rights | 1991 |
In vitro and in vivo effects of progesterone on Trichinella spiralis newborn larvae.
Topics: Animals; Dose-Response Relationship, Drug; Female; Larva; Leukocytes; Mifepristone; Muscle, Skeletal; Pregnancy; Pregnancy Complications, Parasitic; Progesterone; Rats; Rats, Wistar; Trichinella spiralis; Trichinellosis | 2005 |
Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; Female; Humans; Lymphocytes; Mifepristone; Pregnancy; Pregnancy Proteins; Pregnancy Trimester, First; Suppressor Factors, Immunologic | 2005 |
Mifepristone (RU486) inhibits lateral perforant path long-term potentiation in hippocampal slices from prenatally morphine-exposed female rats.
Topics: Analgesics, Opioid; Animals; Diestrus; Electric Stimulation; Electrodes; Female; Hippocampus; Hormone Antagonists; In Vitro Techniques; Long-Term Potentiation; Mifepristone; Morphine; Neuronal Plasticity; Perforant Pathway; Pregnancy; Prenatal Exposure Delayed Effects; Proestrus; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid | 2005 |
Deaths associated with medication abortion.
Topics: Abortion, Induced; Clostridium Infections; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2005 |
Emergency contraception.
Topics: Adolescent; Contraception; Contraceptives, Oral; Contraceptives, Postcoital; Emergencies; Female; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices, Copper; Mifepristone; Pregnancy; Pregnancy in Adolescence; Progestins; Risk Factors; Treatment Outcome | 2005 |
Medical abortion for Australian women: it's time.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Australia; Female; Health Services Accessibility; Humans; Mifepristone; Patient Education as Topic; Patient Satisfaction; Pregnancy; Rural Health Services | 2005 |
Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro.
Topics: Cells, Cultured; Choriocarcinoma; Female; Gene Expression; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Hormone Antagonists; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; RNA, Messenger; Trophoblasts; Up-Regulation | 2006 |
The development of the undue burden standard in Stenberg v. Carhart: will proposed RU-486 legislation survive?
Topics: Abortion, Induced; Female; Fetal Development; Government Regulation; Humans; Mifepristone; Nebraska; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; State Government; Supreme Court Decisions; United States; Women's Rights | 2002 |
An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Female; Follow-Up Studies; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Pregnancy Trimester, First; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2005 |
Successful conservative management of cervical ectopic pregnancy with combination of methotrexate, mifepristone, surgical evacuation and tamponade using a double balloon three-way catheter.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adult; Balloon Occlusion; Catheterization; Cervix Uteri; Drug Therapy, Combination; Equipment Design; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic | 2005 |
[Molecular and genetic study of the role of hormones, receptors, and enzymes in regulation of reproduction, lipid metabolism, and other human physiological functions].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Animals; Appetite; beta-Lipotropin; Cattle; Diabetes Mellitus, Type 1; Female; Genetic Engineering; Glutamate Decarboxylase; Humans; Leptin; Lipid Metabolism; Male; Mifepristone; Mutation; Obesity; Pregnancy; Receptors, Estrogen; Receptors, Melanocortin; Receptors, Progesterone; Reproduction; Research; RNA, Messenger; Sterol Esterase; Swine; Uterus | 2005 |
Expression and hormonal regulation of calcyclin-binding protein (CacyBP) in the mouse uterus during early pregnancy.
Topics: Animals; Apoptosis; Calcium-Binding Proteins; Cells, Cultured; Decidua; Drug Antagonism; Estradiol; Female; Gene Expression Regulation; Mice; Mifepristone; Oligonucleotides, Antisense; Ovariectomy; Pregnancy; Progesterone; Pseudopregnancy; RNA, Messenger; Stromal Cells; Tamoxifen; Trophoblasts; Uterus | 2006 |
Availability of medical abortion pills and the role of chemists: a study from Bihar and Jharkhand, India.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Data Collection; Female; Humans; India; Male; Mifepristone; Misoprostol; Pharmacists; Pregnancy; Professional Role | 2005 |
Availability and acceptability of medical abortion in Nepal: health care providers' perspectives.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Aged; Aged, 80 and over; Attitude of Health Personnel; Female; Humans; Interviews as Topic; Male; Middle Aged; Mifepristone; Misoprostol; Nepal; Pregnancy | 2005 |
Study supports the introduction of early medical abortion in Turkey.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Choice Behavior; Data Collection; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Turkey | 2005 |
Making unsafe abortion safe: medical method.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Therapeutic; Drug Therapy, Combination; Female; Humans; Mifepristone; Nepal; Pregnancy; Prostaglandins, Synthetic; Safety; Treatment Outcome | 2004 |
Fatal infections associated with mifepristone-induced abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Clostridium Infections; Clostridium sordellii; Female; Humans; Maternal Mortality; Mifepristone; Pregnancy; United States | 2005 |
Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion.
Topics: Abdominal Pain; Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Clostridium Infections; Clostridium sordellii; Diagnosis, Differential; Endometritis; Fatal Outcome; Female; Humans; Hypotension; Mifepristone; Misoprostol; Polymerase Chain Reaction; Pregnancy; Pregnancy Trimester, First; RNA, Ribosomal, 16S; Shock, Septic; Tachycardia; Uterus; Vomiting | 2005 |
Medical vs. surgical management of early pregnancy failure.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Spontaneous; Clostridium Infections; Clostridium sordellii; Endometritis; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Shock, Septic | 2005 |
Consistency of medical abortion efficacy from 5 through 14 weeks' gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Animals; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Retrospective Studies; Treatment Outcome | 2006 |
Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cell Survival; Drug Synergism; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Mifepristone; Mitoxantrone; Neoplasm Proteins; Placenta; Pregnancy; Progesterone; Receptors, Progesterone | 2006 |
Medical abortion: a fact sheet.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Contraindications; Developed Countries; Developing Countries; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimesters | 2005 |
Failed medical termination of twin pregnancy with mifepristone: a case report.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Twins | 2006 |
First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Sublingual; Adolescent; Adult; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Mifepristone; Pilot Projects; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Probability; Prospective Studies; Risk Assessment; Treatment Outcome | 2005 |
Mifepristone (RU-486) and limits to abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Australia; Drug Approval; Female; Humans; Mifepristone; Pregnancy | 2006 |
Termination of pregnancy in patients with previous cesarean section.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Cesarean Section; Dinoprost; Female; France; Humans; Mifepristone; Misoprostol; Oxytocics; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Ultrasonography, Prenatal | 2006 |
Health minister is stripped of his right to veto use of abortion pill.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Australia; Female; Humans; Mifepristone; Pregnancy | 2006 |
Italian doctors defy restrictions on abortion pill.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Female; Humans; Italy; Mifepristone; Pregnancy | 2006 |
Debate on abortion pill in Australia becomes personal.
Topics: Abortion, Induced; Australia; Female; Government Regulation; Humans; Legislation, Drug; Mifepristone; Pregnancy | 2005 |
RU 486 examined: impact of a new technology on an old controversy.
Topics: Abortifacient Agents; Abortion, Induced; Contraception; Contraceptive Agents; Female; Humans; Mifepristone; Pregnancy; Supreme Court Decisions; United States; Women's Rights | 1997 |
Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced medical abortion.
Topics: Abortion, Induced; Adult; Analgesics, Opioid; Anti-Bacterial Agents; Female; Gonorrhea; Humans; Leukocyte Count; Mifepristone; Neisseria gonorrhoeae; Pelvic Inflammatory Disease; Pregnancy; Streptococcal Infections; Tachycardia | 2006 |
The inapplicability of parental involvement laws to the distribution of mifepristone (RU-486) to minors.
Topics: Abortion, Criminal; Abortion, Legal; Adolescent; Contraception, Postcoital; Female; Government Regulation; Humans; Informed Consent; Judicial Role; Mifepristone; Minors; Parental Consent; Parental Notification; Pregnancy; Reproductive Rights; Self Medication; Supreme Court Decisions; United States | 2002 |
Increases in preproenkephalin mRNA levels in the Syrian hamster: the influence of glucocorticoids is dependent on age and tissue.
Topics: Adrenal Glands; Age Factors; Animals; Animals, Newborn; Corpus Striatum; Cricetinae; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; Female; Gene Expression Regulation, Developmental; Glucocorticoids; Hormone Antagonists; Hypophysectomy; Male; Metyrapone; Mifepristone; Phenylethanolamine N-Methyltransferase; Pregnancy; Protein Precursors; RNA, Messenger | 2006 |
Deaths from Clostridium sordellii after medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Antibiotic Prophylaxis; Clostridium Infections; Clostridium sordellii; Endometritis; Female; France; Humans; Mifepristone; Misoprostol; Pregnancy | 2006 |
Deaths from Clostridium sordellii after medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Oral; Antibiotic Prophylaxis; Clostridium Infections; Clostridium sordellii; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2006 |
Meloxicam effectively inhibits preterm labor uterine contractions in a chronically catheterized pregnant sheep model: impact on fetal blood flow and fetal-maternal physiologic parameters.
Topics: Abortifacient Agents, Steroidal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Electromyography; Female; Fetus; Intestines; Kidney; Labor, Induced; Meloxicam; Mifepristone; Models, Animal; Obstetric Labor, Premature; Osmolar Concentration; Pregnancy; Random Allocation; Regional Blood Flow; Sheep; Thiazines; Thiazoles; Tocolytic Agents; Urine; Uterine Contraction | 2006 |
Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2006 |
Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy | 2006 |
Early abortion in Ontario: options and costs.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Ambulatory Care Facilities; Female; Humans; Methotrexate; Mifepristone; Ontario; Outpatient Clinics, Hospital; Pregnancy; Vacuum Curettage | 2006 |
Mifepristone (RU38486) influences the core temperature response of term pregnant rats to intraperitoneal lipopolysaccharide.
Topics: Animals; Body Temperature; Body Temperature Regulation; Female; Fever; Glucocorticoids; Immunologic Factors; Injections, Intraperitoneal; Lipopolysaccharides; Mifepristone; Pregnancy; Rats; Receptors, Glucocorticoid | 2006 |
Mifepristone-induced cervical ripening: structural, biomechanical, and molecular events.
Topics: Animals; Cervical Ripening; Cervix Uteri; Collagen; Extracellular Matrix; Female; Gestational Age; Hormone Antagonists; Matrix Metalloproteinase 2; Microscopy, Electron; Microscopy, Polarization; Mifepristone; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tensile Strength | 2006 |
Death after RU-486.
Topics: Abortifacient Agents; Abortion, Induced; Death, Sudden; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnant Women | 2006 |
[First trimester medical abortion: a good method that is seldom used in The Netherlands].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Netherlands; Pregnancy; Pregnancy Trimester, First; Safety | 2006 |
Mifepristone-induced nitric oxide release and expression of nitric oxide synthases in the human cervix during early pregnancy.
Topics: Abortion, Induced; Adult; Cervix Uteri; Female; Humans; Immunohistochemistry; Mifepristone; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pregnancy; Pregnancy Trimester, First | 2006 |
Progesterone regulates HLA-G gene expression through a novel progesterone response element.
Topics: Breast Neoplasms; Cell Line; Cell Line, Tumor; Choriocarcinoma; DNA Primers; Female; Gene Expression Regulation; Genes, Reporter; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Humans; Mifepristone; Pregnancy; Progesterone; Promoter Regions, Genetic; Receptors, Progesterone; Uterine Neoplasms | 2006 |
First trimester medical termination of pregnancy: an alternative for New Zealand women.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Ambulatory Care Facilities; Child; Female; Humans; Medical Audit; Medical Records; Mifepristone; New Zealand; Outcome Assessment, Health Care; Postoperative Complications; Pregnancy; Pregnancy Trimester, First; Retrospective Studies | 2006 |
infectious disease. RU-486-linked deaths open debate about risky bacteria.
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Abortion, Therapeutic; Animals; Clostridioides difficile; Clostridium Infections; Clostridium sordellii; Enterocolitis, Pseudomembranous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Complications, Infectious | 2006 |
Contra-contraception: a growing number of conservatives see birth control as part of an ailing culture that overemphasizes sex and devalues human life. Is this the beginning of the next culture war?
Topics: Abortion, Induced; Christianity; Condoms; Contraception; Contraceptives, Postcoital; Cultural Diversity; Europe; Female; Government Regulation; Humans; Internationality; Legislation as Topic; Levonorgestrel; Mifepristone; Morals; Nonprescription Drugs; Politics; Pregnancy; Public Policy; Reproductive Rights; Sex Education; Sexual Abstinence; Sexual Behavior; Sexually Transmitted Diseases; United States; United States Food and Drug Administration; Value of Life | 2006 |
Use of mifepristone for treatment of ectopic pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Contraindications; Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic | 2006 |
Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
Topics: Abnormalities, Drug-Induced; Abortifacient Agents, Steroidal; Adult; Female; Humans; Mifepristone; Mobius Syndrome; Pregnancy; Pregnancy Outcome; United States; United States Food and Drug Administration | 2006 |
Mifepristone (RU-486) and limits to abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Australia; Drug Approval; Female; Humans; Mifepristone; Pregnancy | 2006 |
Frequently asked questions about medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Consensus Development Conferences as Topic; Contraception; Counseling; Female; Gestational Age; Health Personnel; Humans; Italy; Mifepristone; Pregnancy; Prostaglandins; Uterine Hemorrhage | 2006 |
Mifepristone and prostaglandin for termination of pregnancy: contraindications for use, reasons and rationale.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Cardiovascular Diseases; Contraindications; Female; History, 20th Century; Humans; Legislation, Drug; Mifepristone; Pregnancy; Prostaglandins; Risk Factors | 2006 |
[Medicamentous abortion with mifepristone and misoprostol in Serbia and Montenegro].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2006 |
Early abortion in Ontario: options and costs.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Drug Synergism; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Ontario; Pregnancy; Treatment Outcome | 2006 |
Risks of mifepristone abortion in context.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Risk Factors | 2006 |
Risks of mifepristone abortion in context.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Risk Factors | 2006 |
Providing medication abortion information to diverse communities: use patterns of a multilingual web site.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Information Services; Internet; Language; Methotrexate; Mifepristone; Misoprostol; Pregnancy | 2006 |
[Antiprogesterone for medical abortion].
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Abortion, Therapeutic; Adolescent; Adult; Female; Hormone Antagonists; Humans; Middle Aged; Mifepristone; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Progesterone | 2006 |
Mortality associated with mifepristone-misoprostol medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2006 |
Advanced cervical pregnancy: diagnostic and management challenges.
Topics: Abortion, Induced; Adult; Cervix Uteri; Female; Humans; Laparoscopy; Methotrexate; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Trimester, Second; Pregnancy, Ectopic; Ultrasonography | 2007 |
[Ambulatory medical abortion performed in a family planning center].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Ambulatory Care; Ambulatory Care Facilities; Female; France; Humans; Mifepristone; Pregnancy | 2006 |
The abortion debate in Australia.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Australia; Dissent and Disputes; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Mifepristone; Pregnancy | 2006 |
Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Gonorrhea; Humans; Mifepristone; Pelvic Inflammatory Disease; Pregnancy | 2006 |
Early medical abortion in Australia: more common than statistics suggest?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Australia; Female; Health Services Accessibility; Humans; Mifepristone; Patient Education as Topic; Pregnancy | 2006 |
Ultrasound diagnosis of uterine dehiscence following mifepristone/misoprostol regime in early second trimester termination.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Ultrasonography; Uterine Rupture | 2006 |
Isolated one-sided cerebellar agenesis following an attempted medical termination of pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Adult; Cerebellum; Female; Humans; Mifepristone; Pregnancy; Ultrasonography, Prenatal | 2006 |
Amniotic band syndrome with limb amputation after exposure to mifepristone in early pregnancy.
Topics: Abortifacient Agents, Steroidal; Adult; Amniotic Band Syndrome; Arm; Female; Humans; Infant, Newborn; Mifepristone; Pregnancy | 2007 |
Effects of mineralocorticoid and glucocorticoid receptor blockade on hypothalamic-pituitary-adrenal function in female rats prenatally exposed to ethanol.
Topics: Adrenocorticotropic Hormone; Animals; Body Weight; Central Nervous System Depressants; Ethanol; Feedback; Female; Hormone Antagonists; Hydrocortisone; Hypothalamo-Hypophyseal System; Lactation; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Pituitary-Adrenal System; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Restraint, Physical; Spironolactone; Stress, Psychological | 2006 |
Self-administration of vaginal misoprostol after mifepristone for termination of pregnancy: patient acceptability.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Self Administration | 2006 |
Mifepristone-induced abortion in one horn and a growing fetus in another horn in a patient with a twin pregnancy in a bicornuate uterus.
Topics: Abortion, Induced; Adult; Female; Humans; Mifepristone; Pregnancy; Pregnancy, Multiple; Treatment Outcome; Twins; Uterus; Vacuum Curettage | 2006 |
Clostridium sordellii infection in medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Clostridium Infections; Clostridium sordellii; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2006 |
Dopaminergic mechanisms involved in prolactin release after mifepristone and naloxone treatment during late pregnancy in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Enzyme Inhibitors; Female; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Hormone Antagonists; Hydrazines; Hypothalamus; Mifepristone; Naloxone; Narcotic Antagonists; Pregnancy; Pregnancy, Animal; Prolactin; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 2006 |
Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Medical Audit; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2006 |
Provider practice models for and costs of delivering medication abortion -- evidence from 11 US abortion care settings.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Costs and Cost Analysis; Data Collection; Female; Health Expenditures; Health Facilities; Humans; Mifepristone; Patient Satisfaction; Practice Patterns, Physicians'; Pregnancy; United States | 2007 |
Psychiatric outcomes following medical and surgical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Antidepressive Agents; Depression; Female; Humans; Hydrocortisone; Mifepristone; Mood Disorders; Pregnancy; Saliva; Vacuum Curettage | 2007 |
Changes in rat uterine and cervical phospholipase A2 activity following progesterone agonist or antagonist administration at term.
Topics: Animals; Cervix Uteri; Female; Hormone Antagonists; Labor, Obstetric; Medroxyprogesterone Acetate; Mifepristone; Phospholipases A; Phospholipases A2; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Wistar; Uterus | 2007 |
Thrombotic thrombocytopenic purpura secondary to mifepristone in a patient of medical termination in early pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Fatal Outcome; Female; Humans; Mifepristone; Pregnancy; Purpura, Thrombotic Thrombocytopenic | 2007 |
Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay.
Topics: Animals; Colon; Corticotropin-Releasing Hormone; Female; Hormone Antagonists; Immunohistochemistry; Intestinal Mucosa; Male; Mast Cells; Maternal Deprivation; Mifepristone; Nerve Growth Factor; Peptide Fragments; Permeability; Pregnancy; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Thiazoles | 2007 |
Monitoring medical abortion using mifepristone/misoprostol combination with ultrasonogram and serum human chorionic gonadotropin.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Adult; Chorionic Gonadotropin; Drug Combinations; Female; Humans; Logistic Models; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Ultrasonography | 2006 |
Mifepristone and misoprostol in the induction of labor at term.
Topics: Adult; Cervical Ripening; Delivery, Obstetric; Drug Therapy, Combination; Female; Hormone Antagonists; Humans; Labor, Induced; Mifepristone; Misoprostol; Oxytocics; Pilot Projects; Pregnancy; Prospective Studies; Term Birth | 2007 |
Influence of epidural analgesia on labor in mid and late termination of pregnancy: an observational study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Age Factors; Amides; Analgesia, Epidural; Analgesia, Obstetrical; Anesthetics, Intravenous; Anesthetics, Local; Female; Humans; Labor, Induced; Mifepristone; Misoprostol; Pain; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Ropivacaine; Sufentanil | 2007 |
Mifepristone in Italy: the case of a drug trapped between ethics and clinical practice.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Contraceptives, Postcoital; Drug Approval; Ethics, Medical; Female; Humans; Italy; Mifepristone; Practice Patterns, Physicians'; Pregnancy; Religion and Medicine; Social Medicine | 2007 |
Progesterone, but not luteal estrogen, is required for the establishment of pregnancy in the new world monkey Cebus apella.
Topics: Animals; Aromatase Inhibitors; Cebus; Embryo Implantation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Letrozole; Luteal Phase; Male; Mifepristone; Nitriles; Pregnancy; Pregnancy Rate; Pregnancy, Animal; Progesterone; Triazoles | 2007 |
[Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Fetal Death; Fetal Diseases; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2007 |
Medication abortion in the private sector in South Africa.
Topics: Abortifacient Agents; Abortion, Induced; Female; Gynecology; Health Services Accessibility; Humans; Mifepristone; Misoprostol; Practice Patterns, Physicians'; Pregnancy; Private Practice; South Africa; Women's Health Services | 2006 |
Risk factors for unsuccessful medical abortion with mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Adolescent; Adult; Chorionic Gonadotropin, beta Subunit, Human; Drug Therapy, Combination; Female; Humans; Logistic Models; Middle Aged; Mifepristone; Misoprostol; Parity; Pregnancy; Retrospective Studies; Risk Factors; Treatment Failure; Treatment Outcome; Ultrasonography; Uterus | 2007 |
Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adolescent; Adult; Drug Therapy, Combination; Female; Fetal Death; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Statistics, Nonparametric | 2007 |
Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center.
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Feasibility Studies; Female; Health Services Accessibility; Humans; India; Mifepristone; Misoprostol; Pregnancy; Primary Health Care; Rural Health Services; Safety Management; Women's Health Services | 2007 |
Can mifepristone medication abortion be successfully integrated into medical practices that do not offer surgical abortion?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Academic Medical Centers; Adult; Ambulatory Care Facilities; Female; Humans; Internship and Residency; Mifepristone; Patient Participation; Pregnancy; Retrospective Studies | 2007 |
Secretory and cytosolic phospholipase A2 activities and expression are regulated by oxytocin and estradiol during labor.
Topics: Animals; Cytosol; Dinoprost; Estradiol; Estrogen Antagonists; Female; Gene Expression; Isoenzymes; Labor, Obstetric; Mifepristone; Oxytocin; Phospholipases A2; Pregnancy; Progesterone; Rats; Rats, Wistar; Receptors, Oxytocin; Reverse Transcriptase Polymerase Chain Reaction; Tamoxifen; Uterus; Vasotocin | 2007 |
[Effects of acupuncture promoting embryo implantation and development in the rat with dysfunctional embryo implantation].
Topics: Acupuncture Therapy; Animals; Embryo Implantation; Embryonic Development; Female; Mifepristone; Pregnancy; Rats | 2007 |
Different roles of alpha2-adrenoceptor subtypes in non-pregnant and late-pregnant uterine contractility in vitro in the rat.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blotting, Western; Cyclic AMP; Dioxanes; Female; Imidazoles; In Vitro Techniques; Isoindoles; Isoquinolines; Labor, Induced; Mifepristone; Myometrium; Norepinephrine; Piperazines; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Reverse Transcriptase Polymerase Chain Reaction; Spiro Compounds; Uterine Contraction | 2007 |
The expression of transforming growth factor beta in pregnant rat myometrium is hormone and stretch dependent.
Topics: Animals; Blotting, Western; Female; Gene Expression; Gravidity; Immunohistochemistry; Labor, Obstetric; Medroxyprogesterone Acetate; Mifepristone; Myometrium; Obstetric Labor, Premature; Pregnancy; Pregnancy, Animal; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Stress, Mechanical; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta3 | 2007 |
One or two day mifepristone-misoprostol interval for second trimester abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Cohort Studies; Female; Gestational Age; Gravidity; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Time Factors; Treatment Outcome | 2007 |
Uterine stretch regulates temporal and spatial expression of fibronectin protein and its alpha 5 integrin receptor in myometrium of unilaterally pregnant rats.
Topics: Animals; Female; Fibronectins; Interleukin-5 Receptor alpha Subunit; Menstruation-Inducing Agents; Mifepristone; Myometrium; Pregnancy; Rats; Rats, Inbred Strains; RNA, Messenger; Uterine Contraction; Uterus | 2007 |
Up-regulation of Per1 expression by estradiol and progesterone in the rat uterus.
Topics: Animals; Cell Cycle Proteins; Circadian Rhythm; Endometrium; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression; Hormone Antagonists; In Situ Hybridization; Microscopy, Fluorescence; Mifepristone; Myometrium; Ovariectomy; Period Circadian Proteins; Pregnancy; Progesterone; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation; Uterus | 2007 |
Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Chorionic Gonadotropin; Endometrium; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Norway; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Time Factors; Treatment Outcome; Ultrasonography | 2007 |
Role of luteal glucocorticoid metabolism during maternal recognition of pregnancy in women.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Cells, Cultured; Chorionic Gonadotropin; Corpus Luteum; Female; Gene Expression; Glucocorticoids; Granulosa Cells; Humans; Hydrocortisone; Immunohistochemistry; Matrix Metalloproteinase 2; Mifepristone; Pregnancy; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Rapid effect of progesterone on transepithelial resistance of human fetal membranes: evidence for non-genomic action.
Topics: Cell Membrane Permeability; Cholesterol; Dose-Response Relationship, Drug; Electric Impedance; Extraembryonic Membranes; Female; Gestational Age; Hormone Antagonists; Humans; In Vitro Techniques; Mifepristone; Pregnancy; Progesterone; Receptors, Progesterone; Time Factors | 2008 |
[Induced abortion at home].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adult; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Patient Education as Topic; Patient Satisfaction; Pregnancy; Self Administration; Self Care; Socioeconomic Factors; Surveys and Questionnaires | 2007 |
Pathopharmacology of excessive hemorrhage in mifepristone abortions.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Female; Hemorrhage; Hemostasis; Humans; Mifepristone; Nitric Oxide; Pregnancy; Receptors, Glucocorticoid; Uterus | 2007 |
Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion.
Topics: Abortifacient Agents; Abortion, Therapeutic; Administration, Intravaginal; Bacterial Toxins; Clostridium Infections; Clostridium perfringens; Clostridium sordellii; Fatal Outcome; Female; Humans; Laminaria; Mifepristone; Misoprostol; Necrosis; Pregnancy; Shock, Septic; Uterus | 2007 |
[Clinical value of transcervical resection under hysteroscope for placental remnants].
Topics: Abortifacient Agents, Nonsteroidal; Adult; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Electrosurgery; Female; Humans; Hysteroscopy; Methotrexate; Mifepristone; Misoprostol; Placenta, Retained; Pregnancy; Retrospective Studies; Treatment Outcome; Ultrasonography | 2007 |
[Clinical study of terminating biochemical pregnancy and early clinical pregnancy with mifepristone and misoprostol].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Chorionic Gonadotropin, beta Subunit, Human; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Treatment Outcome | 2007 |
Treatment with an inhibitor of catechol-O-methyltransferase activity reduces preterm birth and impedes cervical resistance to stretch in pregnant rats.
Topics: Animals; Benzophenones; Biomarkers; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cervical Ripening; Cervix Uteri; Estradiol; Estriol; Female; Hydroxyestrones; Immunohistochemistry; In Vitro Techniques; Mifepristone; Models, Animal; Obstetric Labor, Premature; Pregnancy; Rats; Rats, Sprague-Dawley | 2007 |
Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Choriocarcinoma; Dose-Response Relationship, Drug; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Luciferases; Mifepristone; Mutation; Neoplasm Proteins; Placenta; Pregnancy; Progesterone; Promoter Regions, Genetic; Protein Isoforms; Receptors, Progesterone; Response Elements; Statistics as Topic; Transcription, Genetic; Transfection; Uterine Neoplasms | 2008 |
Introducing early medical abortion in Australia: there is a need to update abortion laws.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Australia; Family Planning Services; Female; Government Regulation; Humans; Legislation as Topic; Mifepristone; Pregnancy; Pregnancy Trimester, First; Public Opinion; Women's Rights | 2007 |
A high resolution SEM study of the effects of RU486, used as a postcoital contraceptive, on the rat uterus during early pregnancy.
Topics: Animals; Cell Polarity; Cell Surface Extensions; Contraceptives, Postcoital; Epithelial Cells; Female; Microscopy, Electron, Scanning; Microvilli; Mifepristone; Pregnancy; Rats; Uterus | 2008 |
Delayed parturition and altered myometrial progesterone receptor isoform A expression in mice null for Krüppel-like factor 9.
Topics: Abortifacient Agents, Steroidal; Animals; Base Sequence; DNA Primers; Estrogen Receptor alpha; Female; Gene Expression; Kruppel-Like Transcription Factors; Mice; Mice, Knockout; Mice, Mutant Strains; Mifepristone; Myometrium; Obstetric Labor Complications; Parturition; Pregnancy; Receptors, Progesterone; Signal Transduction; Transcription Factor RelA | 2008 |
Gestagen treatment enhances the tocolytic effect of salmeterol in hormone-induced preterm labor in the rat in vivo.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Dinoprostone; Female; Mifepristone; Obstetric Labor, Premature; Pregnancy; Progestins; Rats; Rats, Sprague-Dawley; Salmeterol Xinafoate; Tocolysis | 2008 |
Sub-chronic stimulation of glucocorticoid receptor impairs and mineralocorticoid receptor protects cytosolic Ca2+ responses to glucose in pancreatic beta-cells.
Topics: Aldosterone; Animals; Calcium; Corticosterone; Cytosol; Dose-Response Relationship, Drug; Female; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mifepristone; Pertussis Toxin; Pregnancy; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 2008 |
Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure.
Topics: Abnormalities, Drug-Induced; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Infant, Newborn; Male; Mifepristone; Misoprostol; Mobius Syndrome; Pregnancy; Pregnancy Trimester, First | 2008 |
Cardiac corticosteroid receptors mediate the enlargement of the ovine fetal heart induced by chronic increases in maternal cortisol.
Topics: Adrenocorticotropic Hormone; Animals; Anti-Inflammatory Agents; Canrenoic Acid; Cardiomegaly; Female; Fetal Heart; Hydrocortisone; Immunohistochemistry; Mifepristone; Mineralocorticoid Receptor Antagonists; Pregnancy; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Steroid; Sheep | 2008 |
[Medical treatment of extra-uterine pregnancy with RU 486. A means to avoid surgery].
Topics: Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy, Ectopic; Receptors, Progesterone | 1984 |
[The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy. Supplementary note].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Chemical Phenomena; Chemistry; Estrenes; Female; Humans; Mifepristone; Pregnancy; Progesterone | 1983 |
Inhibition of sexual behavior in female guinea pigs by a progestin receptor antagonist.
Topics: Animals; Castration; Cell Nucleus; Cytosol; Estradiol; Estrenes; Estrus; Female; Guinea Pigs; Hypothalamus, Middle; Mifepristone; Pregnancy; Preoptic Area; Progesterone; Receptors, Progesterone; Sexual Behavior, Animal | 1984 |
[Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Legal; Adolescent; Adult; Drug Evaluation; Estrenes; Female; Glucocorticoids; Humans; Menstruation; Mifepristone; Pituitary-Adrenal System; Pregnancy; Progesterone; Time Factors | 1983 |
Termination of very early pregnancy by RU 486--an antiprogestational compound.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Estrenes; Female; Humans; Hydrocortisone; Mifepristone; Pregnancy; Progesterone | 1984 |
[The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Animals; Chorionic Gonadotropin; Dexamethasone; Estradiol; Estrenes; Female; Humans; Menstruation; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; Receptors, Progesterone | 1982 |
[Antiprogesterones--new prospects in induced abortion].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Contraindications; Female; Humans; Mifepristone; Pregnancy; Progesterone; Tablets; Time Factors | 1994 |
Anti-progesterone effects on maternal recognition and behaviour imprinted during first pregnancy in mice.
Topics: Animals; Antibodies, Monoclonal; Behavior, Animal; Female; Hormone Antagonists; Immunization, Passive; Lactation; Maternal Behavior; Mice; Mice, Inbred BALB C; Mifepristone; Pregnancy; Progesterone | 1995 |
Changes in rat cervical collagen during gestation and after antiprogesterone treatment as measured in vivo with light-induced autofluorescence.
Topics: Analysis of Variance; Animals; Cervix Uteri; Collagen; Connective Tissue; Female; Gestational Age; Hormone Antagonists; Mifepristone; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence; Time Factors | 1995 |
Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; alpha-Fetoproteins; Alprostadil; Chorionic Gonadotropin; Estradiol; Female; Fetomaternal Transfusion; Humans; Mifepristone; Placental Hormones; Pregnancy; Progesterone; Time Factors | 1993 |
Analysis of 369 abortions conducted by mifepristone (RU486) associated with sulprostone in a French family planning center.
Topics: Abortion, Induced; Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Dinoprostone; Female; France; Humans; Mifepristone; Peptide Fragments; Pregnancy; Regression Analysis; Retrospective Studies; Time Factors | 1994 |
Uterine rupture during therapeutic abortion in the second trimester using mifepristone and prostaglandin.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Alprostadil; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Uterine Rupture | 1995 |
Abortions in rural Idaho: physicians' attitudes and practices.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Attitude of Health Personnel; Family Practice; Female; General Surgery; Gynecology; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Idaho; Mifepristone; Obstetrics; Practice Patterns, Physicians'; Pregnancy; Rural Health Services; Surveys and Questionnaires | 1995 |
Changes in prostaglandin synthesis and metabolism associated with labour, and the influence of dexamethasone, RU 486 and progesterone.
Topics: Amnion; Analysis of Variance; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Chorion; Culture Techniques; Dexamethasone; Dinoprost; Dinoprostone; Female; Hormone Antagonists; Humans; Indomethacin; Labor, Obstetric; Mifepristone; Pregnancy; Progesterone; Prostaglandins; Radioimmunoassay; Tetradecanoylphorbol Acetate | 1995 |
Influence of progesterone and its antagonist mifepristone (RU 486) on collagen content in uterine cervix in pregnant rats.
Topics: Animals; Body Water; Cervix Uteri; Collagen; Female; Mifepristone; Pregnancy; Progesterone; Rats; Rats, Wistar | 1995 |
Uterine rupture during therapeutic abortion in the second trimester using mifepristone and prostaglandin.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Alprostadil; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Uterine Rupture | 1995 |
Aberrant maternal behaviour in mice treated with a progesterone receptor antagonist during pregnancy.
Topics: Animals; Female; Lactation; Maternal Behavior; Mice; Mice, Inbred BALB C; Mifepristone; Pregnancy; Pregnancy, Animal; Receptors, Progesterone | 1995 |
Inhibition of aromatase activity in human placental microsomes by 13-retro-antiprogestins.
Topics: Aromatase Inhibitors; Estrenes; Estrone; Female; Gonanes; Humans; Microsomes; Mifepristone; Placenta; Pregnancy; Progestins | 1995 |
Pharmacological properties of a new selective antiprogestagen: Org 33628.
Topics: Adrenal Glands; Animals; Cell Line; Estrenes; Female; Furans; Gonanes; Guinea Pigs; Humans; In Vitro Techniques; Mifepristone; Ovulation; Pregnancy; Progestins; Receptors, Cell Surface; Receptors, Progesterone; Structure-Activity Relationship | 1995 |
Role of 17 beta-estradiol and progesterone in the regulation of synthesis and secretion of chorionic gonadotropin by the first trimester human placenta.
Topics: Androstatrienes; Chorionic Gonadotropin; Estradiol; Female; Gene Expression; Humans; In Vitro Techniques; Mifepristone; Placenta; Pregnancy; Pregnancy Trimester, Third; Progesterone; RNA, Messenger; Tamoxifen; Transcription, Genetic | 1995 |
Induction of catechol-O-methyltransferase in the luminal epithelium of rat uterus by progesterone: inhibition by RU-486.
Topics: Animals; Catechol O-Methyltransferase; Enzyme Induction; Epithelium; Female; Mifepristone; Pregnancy; Progesterone; Rats; Uterus | 1995 |
Expression and steroid hormonal control of Muc-1 in the mouse uterus.
Topics: Animals; Binding Sites; Embryo Implantation; Estradiol; Estrus; Female; Genitalia, Female; Immune Sera; Membrane Glycoproteins; Mice; Mice, Inbred Strains; Mifepristone; Mucin-1; Mucins; Precipitin Tests; Pregnancy; Progesterone; RNA, Messenger; Uterus; Wheat Germ Agglutinins | 1995 |
Early abortion induction by a combination of mifepristone and oral misoprostol.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1995 |
Luteolytic and antiluteolytic effect of the antiprogestagen RU486 in pseudopregnant rats.
Topics: Animals; Corpus Luteum; Corpus Luteum Maintenance; Female; Luteinizing Hormone; Mifepristone; Organ Size; Ovary; Pituitary Gland; Pregnancy; Progesterone; Prolactin; Pseudopregnancy; Rats; Rats, Wistar; Time Factors | 1995 |
Effects of gemeprost and mifepristone on the mechanical properties of the cervix prior to first trimester termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Alprostadil; Cervix Uteri; Female; Humans; Mifepristone; Obstetrics; Pessaries; Pregnancy; Pregnancy Trimester, First | 1995 |
Mid-trimester termination for fetal abnormality: advantages of a new regimen using mifepristone and misoprostol.
Topics: Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Female; Fetus; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 1995 |
RU 486.
Topics: Abortion, Induced; Contraindications; Drug Approval; Female; France; Humans; Mifepristone; Patient Advocacy; Pregnancy; United States | 1995 |
Non-surgical abortion: who's for methotrexate?
Topics: Abortifacient Agents; Abortion, Induced; Drug-Related Side Effects and Adverse Reactions; Federal Government; Female; Government; Government Regulation; Human Experimentation; Humans; Methods; Methotrexate; Mifepristone; Misoprostol; Pharmaceutical Preparations; Physicians; Pregnancy; Pregnant Women; Professional Competence; Risk; Risk Assessment; Social Control, Formal; United Kingdom; United States; United States Food and Drug Administration | 1995 |
"RU 486": a luncheon speech.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Contraception Behavior; Dinoprostone; Drug Industry; Female; Humans; Mifepristone; Politics; Pregnancy; United States | 1994 |
[Histopathology appearance of intrauterine residue after medical abortion by mifepristone and prostaglandin analogue].
Topics: Abortion, Induced; Carboprost; Dilatation and Curettage; Drug Synergism; Endometrium; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage | 1994 |
Calcitonin gene expression in the rat uterus during pregnancy.
Topics: Animals; Calcitonin; Embryo Implantation; Embryonic Development; Female; Gene Expression; Mifepristone; Pregnancy; Pregnancy, Animal; Rats; Uterus | 1995 |
[Sex hormone receptors, prostaglandins and cAMP, in functional activity of the uterus].
Topics: Abortion, Induced; Abortion, Spontaneous; Cyclic AMP; Decidua; Dinoprost; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Receptors, Estrogen; Receptors, Progesterone | 1994 |
RU 486.
Topics: Abortion, Therapeutic; Female; Humans; Mifepristone; Patient Education as Topic; Pregnancy | 1995 |
Anordiol and RU486 synergize to produce preimplantation pregnancy loss by increasing embryo transport (rat).
Topics: Abortion, Induced; Animals; Body Weight; Drug Synergism; Embryonic Development; Female; Fetus; Mifepristone; Norandrostanes; Ovum Transport; Pregnancy; Rats; Rats, Wistar | 1995 |
Molecular mechanisms of the antihormonal and antiimplantation effects of norethisterone and its A-ring reduced metabolites.
Topics: Animals; Biotransformation; Dose-Response Relationship, Drug; Embryo Implantation; Endometrium; Estradiol; Female; Fertilization; Male; Mifepristone; Norethindrone; Pregnancy; Rabbits; Time Factors; Uteroglobin; Uterus | 1995 |
Luteolytic action of RU486: modulation of luteal 3 beta-hydroxysteroid dehydrogenase and 20 alpha-hydroxysteroid dehydrogenase activities in late pregnant rats.
Topics: 20-alpha-Hydroxysteroid Dehydrogenase; 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Animals; Corpus Luteum; Diclofenac; Female; Luteolysis; Luteolytic Agents; Mifepristone; Obstetric Labor, Premature; Pregnancy; Progesterone; Rats; Rats, Wistar | 1995 |
Cervical mucus concentration of prostaglandins E2 and F2 alpha after pretreatment with mifepristone in the first trimester of pregnancy.
Topics: Abortion, Legal; Adult; Cervix Mucus; Cervix Uteri; Chlamydia Infections; Chlamydia trachomatis; Dilatation and Curettage; Dinoprost; Dinoprostone; Female; Gestational Age; Humans; Mifepristone; Nausea; Pregnancy; Pregnancy Trimester, First; Time Factors; Vaginosis, Bacterial | 1995 |
Early abortifacient action of RU 486 by continuous intravenous infusion in rat.
Topics: Abortion, Induced; Animals; Corpus Luteum; Female; Infusions, Intravenous; Mifepristone; Organ Size; Ovary; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Time Factors | 1995 |
Decrease in human plasma gravidin levels after medical abortion.
Topics: Abortion, Induced; Antibodies; Blotting, Western; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin A; Mifepristone; Pregnancy; Pregnancy Proteins | 1994 |
Prostaglandin production during spontaneous labor and after treatment with RU486 in pregnant rhesus macaques.
Topics: Amnion; Animals; Chorion; Decidua; Dinoprost; Dinoprostone; Female; Kinetics; Labor, Obstetric; Macaca mulatta; Mifepristone; Myometrium; Pregnancy; Prostaglandins | 1994 |
Corticotrophin-releasing factor immunostaining is present in placenta and fetal membranes from the first trimester onwards and is not affected by labour or administration of mifepristone.
Topics: Cesarean Section; Corticotropin-Releasing Hormone; Extraembryonic Membranes; Female; Humans; Immunohistochemistry; Labor, Obstetric; Mifepristone; Placenta; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Progesterone | 1994 |
Properties of a progesterone-induced relaxation in human placental arteries and veins.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Arginine; Arteries; Female; Humans; Indomethacin; Methylene Blue; Mifepristone; Nitroarginine; Placenta; Pregnancy; Progesterone; Vasodilation; Vasomotor System; Veins | 1995 |
Effect of RU486 on ovarian progesterone production at pro-oestrus and during pregnancy: a possible dual regulation of the biosynthesis of progesterone.
Topics: 3-Hydroxysteroid Dehydrogenases; Animals; Corpus Luteum; Estradiol; Female; Luteinizing Hormone; Mifepristone; Ovary; Pregnancy; Proestrus; Progesterone; Prolactin; Rats; Rats, Wistar; Stimulation, Chemical; Tamoxifen | 1994 |
Glomerular hemodynamics during abortion induced by RU 486 and sepsis in rats.
Topics: Abortion, Induced; Abortion, Septic; Analysis of Variance; Animals; Female; Glomerular Filtration Rate; Hemodynamics; Kidney Glomerulus; Lipopolysaccharides; Mifepristone; Pregnancy; Rats; Rats, Wistar | 1994 |
Glucocorticoids stimulate the expression of prostaglandin endoperoxide H synthase-2 in amnion cells.
Topics: Amnion; Cells, Cultured; Cycloheximide; Dactinomycin; Dexamethasone; Dinoprostone; Drug Synergism; Female; Gene Expression; Humans; Mifepristone; Pregnancy; Prostaglandin-Endoperoxide Synthases; Ribonucleases; RNA Probes; RNA, Messenger | 1995 |
Holoprosencephaly in a long-tailed macaque (Macaca fascicularis): a case report.
Topics: Abortion, Veterinary; Animals; Female; Gestational Age; Head; Holoprosencephaly; Macaca fascicularis; Mifepristone; Nose; Pregnancy; Primate Diseases; Teratogens; Ultrasonography, Prenatal | 1994 |
[Mifepristone (RU 486): present status, prospectives].
Topics: Abortion, Legal; Abortion, Therapeutic; Female; Forecasting; Humans; Labor, Induced; Mifepristone; Pregnancy | 1995 |
Sex hormone modulation of flow velocity in the parametrial artery of the pregnant rat.
Topics: Androstenedione; Animals; Arteries; Blood Flow Velocity; Estradiol; Female; Gonadal Steroid Hormones; Mifepristone; Models, Biological; Placental Circulation; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Time Factors; Uterus | 1995 |
RU486 combined with PGE1 analog in voluntary termination of early pregnancy--a comparison of recent findings with gemeprost or misoprostol.
Topics: Abortion, Induced; Adult; Alprostadil; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Time Factors; Uterine Hemorrhage | 1994 |
Expression of calbindin-D9k in the early pregnant rat uterus: effects of RU 486 and correlation to estrogen receptor mRNA.
Topics: Actins; Animals; Base Sequence; Blotting, Northern; Calbindins; DNA, Complementary; Estrogens; Female; Gene Expression Regulation; Mifepristone; Molecular Sequence Data; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; RNA, Messenger; S100 Calcium Binding Protein G; Uterus | 1994 |
Fertility control in wild mice after feeding with RU486 or methyl testosterone.
Topics: Animals; Animals, Wild; Chemosterilants; Female; Fertility; Litter Size; Male; Methyltestosterone; Mice; Mifepristone; Pest Control, Biological; Pregnancy | 1994 |
Progesterone stimulates calcitonin gene expression in the uterus during implantation.
Topics: Animals; Base Sequence; Blotting, Northern; Calcitonin; Calcium; Embryo Implantation; Estrogens; Female; Gene Expression; Homeostasis; Immunohistochemistry; Male; Mifepristone; Molecular Sequence Data; Ovariectomy; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Uterus | 1994 |
Pharmacology of two new very selective antiprogestagens: Org 31710 and Org 31806.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Abortifacient Agents, Steroidal; Abortion, Induced; Androgen Antagonists; Animals; Estrenes; Female; Furans; Gonanes; Macaca; Male; Mammary Neoplasms, Experimental; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Progestins; Rats; Receptors, Glucocorticoid; Receptors, Progesterone | 1994 |
Potential acceptability of ovulation detection kits and RU-486 at two college campuses.
Topics: Abortion, Induced; Adult; Attitude; California; Contraception; Female; Humans; Mifepristone; Ovulation Detection; Pregnancy; Sexual Behavior; Surveys and Questionnaires | 1994 |
Novel regulation of pregnant human myometrial smooth muscle cell gap junctions by human chorionic gonadotropin.
Topics: Antibodies, Monoclonal; Chorionic Gonadotropin; Connexin 43; Female; Gap Junctions; Hormones; Humans; Luteinizing Hormone; Mifepristone; Muscle, Smooth; Myometrium; Pregnancy; RNA, Messenger; Signal Transduction | 1994 |
[Advances in hormonal contraception].
Topics: Contraception; Contraceptive Agents, Female; Female; Humans; Mifepristone; Pregnancy | 1993 |
RU 486: an alternative to surgical abortion.
Topics: Abortion, Induced; Breast Neoplasms; Endometrium; Ethics, Professional; Female; Humans; Mifepristone; Patient Education as Topic; Pregnancy | 1994 |
Pregnancy-related modifications of rat myometrial Gs proteins: ADP ribosylation, immunoreactivity and gene expression studies.
Topics: Adenosine Diphosphate Ribose; Adenylyl Cyclases; Animals; Base Sequence; Cholera Toxin; DNA Probes; Estradiol; Female; Gene Expression; GTP-Binding Proteins; Mifepristone; Molecular Sequence Data; Molecular Weight; Myometrium; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1994 |
[Abortion, induced. Medical techniques].
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Prostaglandins, Synthetic | 1994 |
[Antifertility effects of mifepristone and epostane alone and in combination in rats].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Androstenols; Animals; Drug Synergism; Female; Fertility; Mice; Mice, Inbred ICR; Mifepristone; Pregnancy; Random Allocation; Rats; Rats, Sprague-Dawley; Sodium Dodecyl Sulfate | 1993 |
Medical abortion in Britain.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Incomplete; Abortion, Induced; Alprostadil; Day Care, Medical; Drug Costs; Female; Humans; Mifepristone; Patient Acceptance of Health Care; Pregnancy | 1994 |
Immunocytochemical colocalization of progesterone receptor and prolactin in individual stromal cells of human decidua.
Topics: Cell Nucleus; Cytoplasm; Decidua; Female; Humans; Immunohistochemistry; Mifepristone; Pregnancy; Prolactin; Receptors, Progesterone; Tissue Distribution | 1994 |
Suppression of interleukin 8 production by progesterone in rabbit uterine cervix.
Topics: Animals; Cervix Uteri; Collagenases; Enzyme Precursors; Female; In Vitro Techniques; Interleukin-1; Interleukin-6; Interleukin-8; Metalloendopeptidases; Mifepristone; Pregnancy; Progesterone; Rabbits; RNA, Messenger; Tumor Necrosis Factor-alpha | 1994 |
Termination of a molar pregnancy using mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Female; Humans; Hydatidiform Mole; Mifepristone; Pregnancy; Uterine Neoplasms | 1994 |
Synthesis and biological testing of 4'-(dimethylamino)-17 beta-hydroxy-17 alpha-(1-propynyl)benzo[12,12a]-11 alpha,18-cyclo-12a,12b-dihomo-13 alpha-estr-4-en-3-one: an interesting RU 38 486 analog.
Topics: Abortion, Induced; Animals; Binding, Competitive; Female; Free Radicals; Mifepristone; Molecular Structure; Pregnancy; Progesterone; Rabbits; Rats; Rats, Wistar; Receptors, Progesterone; Structure-Activity Relationship | 1994 |
A comparison of the pregnancy-terminating potencies of three anti-progestins in guinea-pigs, and the effects of sulprostone.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Dinoprostone; Drug Evaluation, Preclinical; Drug Synergism; Estrenes; Female; Guinea Pigs; Mifepristone; Norpregnadienes; Pregnancy; Pregnenediones; Progestins | 1994 |
Birth control in Japan: realities and prognosis.
Topics: Abortion, Legal; Acquired Immunodeficiency Syndrome; Condoms; Contraceptives, Oral; Drug Approval; Family Planning Services; Female; Government Regulation; Health Knowledge, Attitudes, Practice; Humans; Internationality; Japan; Legislation, Drug; Male; Mifepristone; Pregnancy; Risk Assessment | 1994 |
Luteal phase contraception with mifepristone (RU 486) in the rhesus monkey.
Topics: Animals; Embryo Implantation; Estradiol; Female; Hormones; Luteal Phase; Macaca mulatta; Male; Menstruation; Mifepristone; Ovulation; Pregnancy; Progesterone | 1994 |
A modulatory role of endogenous opioids on prolactin secretion at the end of pregnancy in the rat.
Topics: Animals; Bromocriptine; Endorphins; Female; Gestational Age; Mifepristone; Naloxone; Oxymorphone; Pregnancy; Pregnancy, Animal; Proestrus; Progesterone; Prolactin; Rats; Rats, Wistar | 1994 |
Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route.
Topics: Abortion, Induced; Administration, Oral; Adult; Diarrhea; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Time Factors; Vagina; Vomiting | 1994 |
Inhibition of progesterone receptor function results in loss of basic fibroblast growth factor expression and stromal cell proliferation during uterine remodelling in the pregnant rat.
Topics: Animals; Cell Differentiation; Cell Division; Embryo Implantation; Female; Fibroblast Growth Factor 2; Immunohistochemistry; Mifepristone; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Uterus | 1994 |
Effects of the anti-progestin and anti-glucocorticoid steroid RU486 on cell proliferation in oviductal embryos of lactating mice.
Topics: Animals; Cell Division; Dexamethasone; Embryo, Mammalian; Embryonic Development; Female; Gestational Age; Gonadotropin-Releasing Hormone; Lactation; Medroxyprogesterone Acetate; Mice; Mice, Inbred Strains; Mifepristone; Pregnancy; Progesterone | 1994 |
[Treatment in miscarriage and abortion. Widened use of drugs has many advantages].
Topics: Abortion, Missed; Abortion, Spontaneous; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Receptors, Progesterone | 1994 |
Cardiogenic pulmonary oedema: presentation of pre-eclampsia exacerbated by prostaglandin abortifacients.
Topics: Abortifacient Agents, Nonsteroidal; Adolescent; Alprostadil; Critical Care; Female; Humans; Mifepristone; Pre-Eclampsia; Pregnancy; Prostaglandins E, Synthetic; Pulmonary Edema | 1994 |
[New indications for mifepristone (RU 486), an antiprogesterone].
Topics: Abortion, Induced; Contraceptives, Postcoital; Female; Humans; Labor, Induced; Mifepristone; Pregnancy | 1993 |
Further acceptability evaluation of RU486 and ONO 802 as abortifacient agents in a Chinese population.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; China; Female; Humans; Mifepristone; Pregnancy | 1993 |
Late vaginal induced abortion after a previous cesarean birth: potential for uterine rupture.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Cesarean Section; Female; Humans; Labor, Induced; Mifepristone; Oxytocin; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Uterine Rupture | 1993 |
Investigation of the endocrine control of parturition in the dog by application of an antigestagen.
Topics: Animals; Dinoprost; Dogs; Female; Labor, Obstetric; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone | 1993 |
The regulation of fibroid growth: time for a re-think?
Topics: Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Mifepristone; Pregnancy; Progesterone; Uterine Neoplasms | 1993 |
Mifepristone (RU 486).
Topics: Antineoplastic Agents; Cervix Uteri; Female; Humans; Mifepristone; Politics; Pregnancy; Progesterone | 1993 |
Immunohistochemical localization of estradiol and progesterone receptors in human uterus throughout pregnancy: expression in endometrial blood vessels.
Topics: Adult; Blood Vessels; Endometrium; Female; Humans; Immunohistochemistry; Mifepristone; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Receptors, Estradiol; Receptors, Progesterone; Tissue Distribution; Uterus | 1994 |
Medical management of miscarriage with RU486.
Topics: Abortion, Induced; Contraceptives, Postcoital; Ethics, Medical; Female; Global Health; Humans; Mifepristone; Philosophy; Pregnancy | 1993 |
Methods for implanting steroid-containing cannulae into the paraventricular nucleus of neonatal rats.
Topics: Animals; Animals, Newborn; Catheterization; Cholesterol; Corticotropin-Releasing Hormone; Female; Gene Expression; Mifepristone; Paraventricular Hypothalamic Nucleus; Pregnancy; Rats; Rats, Sprague-Dawley; Weight Gain | 1993 |
The effects of mifepristone (RU486) on prostaglandin dehydrogenase in decidual and chorionic tissue in early pregnancy.
Topics: Abortion, Induced; Adult; Chorionic Villi; Decidua; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Immunohistochemistry; Mifepristone; Pregnancy | 1993 |
Progesterone antagonist RU 486 accommodates but does not induce labour and delivery in primates.
Topics: Animals; Cervix Uteri; Female; Labor, Induced; Labor, Obstetric; Macaca fascicularis; Mifepristone; Milk; Pregnancy; Uterine Contraction | 1993 |
Medical management of miscarriage with RU486.
Topics: Abortion, Induced; Australia; Contraceptives, Postcoital; Female; Humans; Legislation, Drug; Mifepristone; Pregnancy | 1993 |
[Drugs. An abortion pill on the way in Denmark].
Topics: Female; Humans; Mifepristone; Pregnancy | 1993 |
[Controversies regarding approval and use of mifepristone (RU 486)].
Topics: Contraindications; Drug Approval; Female; Germany; Humans; Mifepristone; Pregnancy | 1993 |
Termination of early pregnancy in the rat, rabbit, and hamster with RU 486 and anordrin.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Contraceptives, Postcoital; Cricetinae; Drug Interactions; Estradiol; Female; Mifepristone; Norandrostanes; Pregnancy; Progesterone; Rabbits; Rats; Species Specificity | 1993 |
Anordiol is more potent than anordrin for terminating pregnancy when administered with RU 486.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Drug Interactions; Drug Synergism; Estradiol; Female; Mifepristone; Norandrostanes; Organ Size; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Uterus | 1993 |
RU-486: legal and policy issues confronting the Food and Drug Administration.
Topics: Abortion, Legal; Drug Approval; Family Planning Policy; Federal Government; Female; Government Regulation; Humans; Internationality; Judicial Role; Legislation, Drug; Mifepristone; Pregnancy; Risk Assessment; Supreme Court Decisions; United States; United States Food and Drug Administration | 1993 |
Effects of a specific glucocorticoid receptor antagonist on corticotropin releasing hormone gene expression in the paraventricular nucleus of the neonatal rat.
Topics: Animals; Animals, Newborn; Body Weight; Cholesterol; Corticotropin-Releasing Hormone; Cortisone; DNA Probes; Drug Implants; Female; Gene Expression; In Situ Hybridization; Male; Mifepristone; Paraventricular Hypothalamic Nucleus; Pregnancy; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; RNA, Messenger; Stress, Physiological; Up-Regulation | 1993 |
[The use of sulprostone (Nalador) in the evacuation of uterine contents. Apropos of 32 cases at the Department of Gynecology, University Hospital Center, Nîmes, over 2 years (a retrospective study)].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Cicatrix; Contraindications; Dinoprostone; Drug Tolerance; Female; France; Gestational Age; Humans; Hydatidiform Mole; Infusions, Intravenous; Injections, Intramuscular; Injections, Intravenous; Mifepristone; Misoprostol; Polyhydramnios; Pregnancy; Retrospective Studies; Time Factors; Uterine Diseases; Uterine Neoplasms | 1993 |
Medical management of miscarriage with RU486.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Fetal Death; Humans; Mifepristone; Pregnancy | 1993 |
Glucocorticoid suppression of human placental fibronectin expression: implications in uterine-placental adherence.
Topics: Blotting, Northern; Cells, Cultured; Chorionic Gonadotropin; Dexamethasone; Female; Fibronectins; Gene Expression; Glucocorticoids; Humans; Hydrocortisone; Immunosorbent Techniques; Mifepristone; Nucleic Acid Hybridization; Placenta; Pregnancy; RNA, Messenger; Trophoblasts; Uterus | 1993 |
The effect of mifepristone (RU486) on the immunohistochemical distribution of prostaglandin E and its metabolite in decidual and chorionic tissue in early pregnancy.
Topics: Chorionic Villi; Cytoplasm; Decidua; Dinoprostone; Endothelium, Vascular; Epithelium; Female; Humans; Immunohistochemistry; Kinetics; Mifepristone; Pregnancy; Prostaglandins E; Trophoblasts | 1993 |
Dose-response relationships of RU 486.
Topics: Abortion, Induced; Adrenocorticotropic Hormone; Cervix Uteri; Dose-Response Relationship, Drug; Female; Follicular Phase; Humans; Mifepristone; Pregnancy | 1993 |
Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Alprostadil; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Pessaries; Pregnancy | 1993 |
Regulation of transcripts encoding the myometrial gap junction protein, connexin-43, by estrogen and progesterone.
Topics: Animals; Connexins; Estradiol; Female; Membrane Proteins; Mifepristone; Ovariectomy; Pregnancy; Progesterone; Rats; Rats, Wistar; RNA, Messenger; Transcription, Genetic; Uterine Contraction | 1993 |
Induction of second trimester abortion with mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Alprostadil; Female; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Time Factors; Treatment Outcome | 1993 |
Termination of pregnancy with mifepristone.
Topics: Abortion, Induced; Dose-Response Relationship, Drug; Female; Humans; Mifepristone; Pregnancy | 1993 |
[RU 486: safe and wrongfully maligned].
Topics: Abortion, Induced; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 1993 |
Correlation of growth hormone secretion during pregnancy with circulating prolactin in rats.
Topics: Animals; Female; Growth Hormone; Mifepristone; Ovariectomy; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Rats; Rats, Wistar; Stress, Physiological; Tamoxifen | 1993 |
Clinical use of mifepristone (RU 486).
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1993 |
Contranidatory activity of early luteal phase administration of mifepristone in the rhesus monkey.
Topics: Animals; Dose-Response Relationship, Drug; Embryo Implantation; Estrogens; Female; Luteal Phase; Macaca mulatta; Male; Menstrual Cycle; Mifepristone; Pregnancy; Progesterone | 1993 |
Additive effect of RU 486 and anordrin on pregnancy interruption in the mouse.
Topics: Abortion, Induced; Animals; Contraceptives, Postcoital; Dose-Response Relationship, Drug; Drug Synergism; Female; Fetal Resorption; Injections, Subcutaneous; Mice; Mifepristone; Norandrostanes; Ovulation; Pregnancy; Pregnancy, Animal; Progesterone | 1993 |
Attenuation of antepartum relaxin surge and induction of parturition by antiprogesterone RU 486 in sheep.
Topics: Animals; Female; Labor, Induced; Mifepristone; Pregnancy; Progesterone; Relaxin; Sheep | 1993 |
Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.
Topics: Abortion, Induced; Administration, Oral; Adult; Female; Humans; Injections, Intramuscular; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 1993 |
Mifepristone (RU 486) in the United States. What does the future hold?
Topics: Abortion, Induced; Female; France; Health Policy; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; United States; United States Food and Drug Administration | 1993 |
Mifepristone (RU 486)--an abortifacient to prevent abortion?
Topics: Abortifacient Agents; Adolescent; Embryo Implantation; Female; Humans; Mifepristone; Pregnancy; Pregnancy in Adolescence; Pregnancy, Unwanted | 1993 |
Managing miscarriage medically.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1993 |
Anti-nidatory effect of a single, early post-ovulatory administration of mifepristone (RU 486) in the rhesus monkey.
Topics: Animals; Drug Evaluation, Preclinical; Embryo Implantation; Estrogens; Female; Luteal Phase; Macaca mulatta; Menstrual Cycle; Mifepristone; Pregnancy; Pregnancy Outcome; Progesterone | 1993 |
Progesterone and mifepristone modify principally the responses of circular myometrium to oxytocin in preparturient rats: comparison with responses to acetylcholine and to calcium.
Topics: Acetylcholine; Animals; Calcium; Drug Interactions; Female; In Vitro Techniques; Labor, Induced; Mifepristone; Myometrium; Nifedipine; Oxytocin; Pregnancy; Progesterone; Rats; Rats, Wistar; Receptors, Muscarinic | 1993 |
Potentiating effect of epostane on pregnancy terminating activity of RU 486 in the rat.
Topics: Abortion, Induced; Androstenols; Animals; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Estradiol; Female; Male; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Uterus | 1993 |
Effectors of cyclic adenosine 5'-monophosphate up-regulating-oxytocin receptors in rabbit amnion cells: isoproterenol, parathyroid hormone-related protein, and potentiation by cortisol.
Topics: Adenylyl Cyclases; Amnion; Animals; Colforsin; Cyclic AMP; DNA; Drug Synergism; Female; Gonanes; Hormone Antagonists; Hydrocortisone; Isoproterenol; Mifepristone; Parathyroid Hormone-Related Protein; Pregnancy; Proteins; Rabbits; Receptors, Glucocorticoid; Receptors, Oxytocin | 1995 |
Methotrexate and misoprostol to terminate early pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy | 1996 |
Methotrexate and misoprostol to terminate early pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Neoplasms; Pregnancy | 1996 |
Dual regulation of luteal progesterone production by androstenedione during spontaneous and RU486-induced luteolysis in pregnant rats.
Topics: 17-Hydroxysteroid Dehydrogenases; 20-alpha-Hydroxysteroid Dehydrogenase; 20-Hydroxysteroid Dehydrogenases; Adrenalectomy; Androstenedione; Animals; Aromatase Inhibitors; Cells, Cultured; Corpus Luteum; Dihydrotestosterone; Estradiol; Female; Hormone Antagonists; Luteolysis; Luteolytic Agents; Menstruation-Inducing Agents; Mifepristone; Organ Size; Polyunsaturated Alkamides; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Wistar; Testosterone | 1995 |
A progesterone-induced protein increases the synthesis of asymmetric antibodies.
Topics: Animals; Antibodies, Blocking; Female; Humans; Hybridomas; Mice; Mice, Inbred BALB C; Mifepristone; Pregnancy; Pregnancy Proteins; Progesterone; Suppressor Factors, Immunologic; Tumor Necrosis Factor-alpha | 1996 |
Glucocorticoid stimulation interacts with sympathetic innervation to affect cardiac development in oculo.
Topics: Animals; Anterior Chamber; Dexamethasone; Female; Fetal Heart; Fetal Tissue Transplantation; Glucocorticoids; Heart Rate; Hormone Antagonists; Mifepristone; Organ Size; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Sympathetic Nervous System; Transplantation, Heterotopic | 1995 |
Clinical, hormonal and sonographic predictors of successful RU-486-induced abortions.
Topics: Abortifacient Agents; Abortion, Induced; Chorionic Gonadotropin; Estradiol; Female; Hemoglobins; Humans; Hydrocortisone; Mifepristone; Predictive Value of Tests; Pregnancy; Progesterone; Ultrasonography; Uterus | 1995 |
Amphiregulin is an implantation-specific and progesterone-regulated gene in the mouse uterus.
Topics: Amino Acid Sequence; Amphiregulin; Animals; Base Sequence; Blastocyst; Cloning, Molecular; Dexamethasone; EGF Family of Proteins; Embryo Implantation; Epithelial Cells; ErbB Receptors; Estrus; Female; Gene Expression Regulation; Genes; Gestational Age; Glycoproteins; Gonadal Steroid Hormones; Growth Substances; Intercellular Signaling Peptides and Proteins; Male; Mice; Mifepristone; Molecular Sequence Data; Nucleic Acid Hybridization; Ovariectomy; Phosphorylation; Pregnancy; Progesterone; Protein Processing, Post-Translational; Pseudopregnancy; Uterus | 1995 |
Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor.
Topics: Animals; Base Sequence; Cell Line; Cytokines; DNA Primers; Female; Gene Expression Regulation; HeLa Cells; Humans; Immune Tolerance; Mifepristone; Molecular Sequence Data; Neoplasms; NF-kappa B; Phosphorylation; Pregnancy; Pregnancy Maintenance; Progesterone; Progestins; Receptors, Progesterone; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 1996 |
Toxic epidermal necrolysis after mifepristone/gemeprost-induced abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Alprostadil; Female; Hormone Antagonists; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic; Stevens-Johnson Syndrome | 1996 |
The effects of the antihormones RU486 and tamoxifen on fetoplacental development and placental bed vascularisation in the rat: a model for intrauterine fetal growth retardation.
Topics: Abortifacient Agents, Steroidal; Animals; Body Weight; Embryo Implantation; Embryonic and Fetal Development; Estrogen Antagonists; Female; Immunohistochemistry; Mifepristone; Placenta; Placentation; Pregnancy; Rats; Rats, Wistar; Tamoxifen | 1996 |
Reproductive function in rats after mifepristone-induced termination of pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Female; Luteinizing Hormone; Mifepristone; Ovulation; Pregnancy; Proestrus; Progesterone; Prolactin; Rats; Rats, Wistar; Reproduction; Sexual Behavior, Animal | 1996 |
Uterine rupture during second trimester termination of pregnancy using mifepristone and a prostaglandin.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Uterine Rupture | 1996 |
New applications of mifepristone (RU 486). Foreword.
Topics: Abortifacient Agents, Steroidal; Female; Humans; Mifepristone; Pregnancy | 1996 |
Mifepristone: cervical ripening and induction of labor.
Topics: Animals; Female; Hormone Antagonists; Humans; Labor Stage, First; Labor, Induced; Mifepristone; Pregnancy; Randomized Controlled Trials as Topic | 1996 |
Mifepristone (RU 486) and its incidence on amniotic fluid volume in near term fetal macaque monkeys.
Topics: Amniotic Fluid; Animals; Female; Gestational Age; Hormone Antagonists; Macaca; Mifepristone; Pregnancy; Time Factors | 1996 |
Tamoxifen and RU39411 synergize with mifepristone to produce preimplantation pregnancy loss by increasing embryo transport (rat).
Topics: Abortifacient Agents, Steroidal; Administration, Oral; Animals; Blastocyst; Corpus Luteum; Drug Combinations; Drug Synergism; Embryo Implantation; Embryo Loss; Embryonic Development; Estradiol; Estrogen Antagonists; Female; Mifepristone; Pregnancy; Rats; Rats, Wistar; Tamoxifen; Time Factors | 1996 |
Effects of two antiprogestins on early pregnancy in the long-tailed macaque (Macaca fascicularis).
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Animals; Female; Gestational Age; Macaca fascicularis; Mifepristone; Norpregnadienes; Pregnancy; Pregnenediones; Progesterone; Progestins | 1996 |
Ova recovery, and in vivo and in vitro fertilization of ova from RU486-treated PMSG/hCG-primed mice.
Topics: Animals; Chorionic Gonadotropin; Culture Media; Female; Fertilization; Fertilization in Vitro; Gonadotropins, Equine; Hormone Antagonists; Male; Mice; Mifepristone; Ovulation Induction; Pregnancy; Superovulation; Zygote | 1995 |
Gap junction regulation during preterm labor in the rat: multiple effects of the antiprogesterone RU486.
Topics: Amino Acid Sequence; Animals; Blotting, Northern; Connexins; Estradiol; Female; Gap Junctions; Hormone Antagonists; Image Processing, Computer-Assisted; Immunohistochemistry; Labor, Obstetric; Microscopy, Confocal; Mifepristone; Molecular Sequence Data; Poly A; Pregnancy; Progesterone; Rats; Rats, Wistar | 1996 |
Induction of preterm birth in mice by RU486.
Topics: Abortifacient Agents, Steroidal; Animals; Dinoprost; Dinoprostone; Female; Interleukin-6; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mifepristone; Obstetric Labor, Premature; Pregnancy | 1996 |
Expression of xanthine oxidoreductase in mouse mammary epithelium during pregnancy and lactation: regulation of gene expression by glucocorticoids and prolactin.
Topics: Animals; Cycloheximide; Dactinomycin; Dexamethasone; Epithelium; Female; Gene Expression Regulation, Enzymologic; Genistein; In Situ Hybridization; Isoflavones; Lactation; Mammary Glands, Animal; Mice; Mice, Inbred Strains; Mifepristone; Pregnancy; Pregnancy, Animal; Prolactin; RNA, Messenger; Time Factors; Transcription, Genetic; Vanadates; Xanthine Oxidase | 1996 |
Anti-implantation activity of antiestrogens and mifepristone.
Topics: Administration, Oral; Animals; Contraceptives, Postcoital; Embryo Implantation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Injections, Subcutaneous; Male; Mifepristone; Norandrostanes; Pregnancy; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1996 |
Sex steroid regulation of leukocyte traffic in human decidua.
Topics: Decidua; Female; Hormone Antagonists; Humans; Immunohistochemistry; Interleukin-8; Leukocyte Count; Leukocytes; Macrophages; Mifepristone; Pregnancy; Progesterone | 1996 |
Placental proopiomelanocortin gene expression, adrenocorticotropin tissue concentrations, and immunostaining increase throughout gestation and are unaffected by prostaglandins, antiprogestins, or labor.
Topics: Adrenocorticotropic Hormone; Corticotropin-Releasing Hormone; Female; Gene Expression; Hormone Antagonists; Humans; Immunohistochemistry; In Situ Hybridization; Labor, Obstetric; Mifepristone; Placenta; Pregnancy; Pro-Opiomelanocortin; Prostaglandins; RNA, Messenger | 1996 |
The influence of estrogens, progesterone and their antagonists on the collagen content in the pregnant rat uterus.
Topics: Animals; Collagen; Estradiol; Female; Hormone Antagonists; Mifepristone; Pregnancy; Progesterone; Rats; Rats, Wistar; Tamoxifen; Uterus | 1996 |
Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
Topics: Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adult; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Scotland; Vacuum Extraction, Obstetrical | 1996 |
Analysis of failure in medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Treatment Failure; Vacuum Curettage | 1996 |
Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression.
Topics: Cells, Cultured; Endometrium; Estradiol; Female; Gene Expression; Hormone Antagonists; Humans; Matrix Metalloproteinase 3; Medroxyprogesterone Acetate; Mifepristone; Pregnancy; Progesterone; Progestins; Prolactin; RNA, Messenger; Stromal Cells | 1997 |
The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study--final results.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Alprostadil; Female; Humans; Middle Aged; Mifepristone; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; United Kingdom | 1997 |
Comparative effectiveness of three antiprogestins alone and in combination with anordiol in terminating pregnancy in the rat.
Topics: Abortion, Induced; Administration, Oral; Animals; Cohort Studies; Contraceptives, Postcoital; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Estradiol; Estrenes; Female; Furans; Gonanes; Hormone Antagonists; Male; Mifepristone; Norandrostanes; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley | 1997 |
Regulation of vascular adaptation during pregnancy and post-partum: effects of nitric oxide inhibition and steroid hormones.
Topics: Androgens; Animals; Blood Pressure; Enzyme Inhibitors; Estradiol; Female; Hemodynamics; Hormone Antagonists; Hormones; Male; Mifepristone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Postpartum Period; Pregnancy; Pregnancy, Animal; Progestins; Rats; Time Factors | 1996 |
Pharmacists' beliefs about abortion and RU-486.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Attitude of Health Personnel; Ethics, Pharmacy; Female; Humans; Male; Mifepristone; Pharmacists; Pregnancy; Religion and Medicine; Surveys and Questionnaires; United States | 1996 |
Anti-implantation activity of luteal phase mifepristone administration is not mimicked by prostaglandin synthesis inhibitor or prostaglandin analogue in the rhesus monkey.
Topics: Abortifacient Agents, Steroidal; Animals; Chorionic Gonadotropin; Diclofenac; Dose-Response Relationship, Drug; Embryo Implantation; Endometrium; Estradiol; Female; Injections, Subcutaneous; Luteal Phase; Macaca mulatta; Male; Menstrual Cycle; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Progesterone; Prostaglandin Antagonists; Prostaglandins; Prostaglandins, Synthetic; Random Allocation | 1997 |
Vaginal misoprostol administered at home after mifepristone (RU486) for abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Prospective Studies; Self Administration; United States; Uterine Hemorrhage | 1997 |
Progestins prevent apoptosis in a rat endometrial cell line and increase the ratio of bcl-XL to bcl-XS.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Cell Line; Dexamethasone; Endometrium; Epithelial Cells; Epithelium; Female; Kinetics; Microscopy, Electron; Mifepristone; Pregnancy; Progesterone Congeners; Promegestone; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rabbits; Rats; Receptors, Progesterone; Recombinant Proteins; Transcription, Genetic | 1997 |
Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Time Factors | 1996 |
Early luteal phase administration of mifepristone inhibits preimplantation embryo development and viability in the rhesus monkey.
Topics: Animals; Blastocyst; Embryo Transfer; Embryonic and Fetal Development; Female; Hormone Antagonists; Luteal Phase; Macaca mulatta; Male; Mifepristone; Pregnancy; Progestins | 1997 |
Boycott threat forces French company to abandon RU486.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Drug Industry; Female; France; Humans; Mifepristone; Pregnancy | 1997 |
The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity.
Topics: Abortion, Spontaneous; Animals; Antibodies, Monoclonal; Cytotoxicity, Immunologic; Female; Fetal Resorption; Killer Cells, Natural; Male; Mice; Mice, Inbred BALB C; Mifepristone; Pregnancy; Pregnancy Proteins; Progesterone; Rabbits; Suppressor Factors, Immunologic | 1997 |
The hydrocortisone-induced transcriptional down-regulation of beta-galactoside alpha2,6-sialyltransferase in the small intestine of suckling rats is suppressed by mifepristone (RU-38.486).
Topics: Animals; Anti-Inflammatory Agents; beta-D-Galactoside alpha 2-6-Sialyltransferase; Cell Membrane; Down-Regulation; Female; Hormone Antagonists; Hydrocortisone; Ileum; Intestinal Mucosa; Intestine, Small; Jejunum; Microvilli; Mifepristone; Pregnancy; Rats; Rats, Wistar; Receptors, Glucocorticoid; RNA, Messenger; Sialyltransferases; Solubility; Sucking Behavior; Transcription, Genetic; Weaning | 1997 |
Effects of RU486 on estrogen, progesterone, oxytocin, and their receptors in the rat uterus during late gestation.
Topics: Animals; Dinoprost; Dinoprostone; Estradiol; Estrogens; Female; Hormone Antagonists; Labor, Obstetric; Mifepristone; Oxytocin; Pregnancy; Pregnancy, Animal; Progesterone; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Oxytocin; Receptors, Progesterone; RNA, Messenger; Uterus | 1997 |
Effect of mifepristone and antiestrogens on uterine PGF2 alpha and PGE2 concentrations in ovariectomized and pregnant rats.
Topics: Abortifacient Agents, Steroidal; Animals; Contraceptives, Postcoital, Synthetic; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Embryonic Development; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Mifepristone; Norandrostanes; Organ Size; Ovariectomy; Pregnancy; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1997 |
The possible use of antiprogestins for contraception.
Topics: Contraceptives, Oral, Synthetic; Endometrium; Estrenes; Female; Gonanes; Hormone Antagonists; Humans; Mifepristone; Pregnancy; Progesterone | 1997 |
Clinical pharmacokinetics of mifepristone.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Breast Neoplasms; Contraception; Endometriosis; Female; Humans; Labor, Induced; Leiomyoma; Meningioma; Mifepristone; Pregnancy; Progestins | 1997 |
Regulation of human papillomavirus type 18 in vivo: effects of estrogen and progesterone in transgenic mice.
Topics: Animals; beta-Galactosidase; DNA, Viral; Estrogens; Female; Mice; Mice, Transgenic; Mifepristone; Papillomaviridae; Pregnancy; Progesterone; Transcriptional Activation | 1997 |
[The effect of mifepristone on progesterone and estrogen receptors in human decidua and serum hormone levels].
Topics: Abortifacient Agents, Steroidal; Adult; Chorionic Gonadotropin, beta Subunit, Human; Decidua; Female; Humans; Mifepristone; Pregnancy; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Testosterone | 1996 |
Abortion procedure.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Morals; Pregnancy | 1997 |
Abortion procedure.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Ethics, Medical; Female; Humans; Mifepristone; Pregnancy | 1997 |
Maternal pituitary gonadotroph function in relation to GnRH receptor and LH beta mRNA content during pregnancy in ewes.
Topics: Animals; Estradiol; Female; Gonadotropin-Releasing Hormone; In Vitro Techniques; Luteinizing Hormone; Mifepristone; Perfusion; Pituitary Gland, Anterior; Pregnancy; Pregnancy, Animal; Progesterone; Receptors, LHRH; Receptors, Progesterone; RNA, Messenger; Sheep | 1997 |
Effect of follicular phase administration of mifepristone (RU486) on blastocyst implantation in the rhesus monkey.
Topics: Animals; Blastocyst; Embryo Implantation; Female; Follicular Phase; Hormone Antagonists; Macaca mulatta; Mifepristone; Pregnancy; Progesterone | 1997 |
Mifepristone (RU486) and abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion Applicants; Abortion, Induced; Australia; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy | 1997 |
Progesterone regulates osteopontin expression in human trophoblasts: a model of paracrine control in the placenta?
Topics: Aminoglutethimide; Blotting, Northern; Cell Communication; Cell Differentiation; Cells, Cultured; Chorionic Villi; Female; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation; Humans; Immunohistochemistry; Mifepristone; Osteopontin; Placenta; Pregnancy; Progesterone; RNA, Messenger; Sialoglycoproteins; Trophoblasts | 1997 |
Progesterone inhibits 20alpha-hydroxysteroid dehydrogenase expression in the rat corpus luteum through the glucocorticoid receptor.
Topics: 20-Hydroxysteroid Dehydrogenases; Animals; Base Sequence; Cell Line, Transformed; Corpus Luteum; Dexamethasone; DNA; Dose-Response Relationship, Drug; Down-Regulation; Female; Flow Cytometry; Gene Expression Regulation, Enzymologic; Mifepristone; Polymerase Chain Reaction; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, Progesterone; RNA, Messenger | 1997 |
A single dose of mifepristone induces ovulation in pseudopregnant rats.
Topics: Animals; Female; Luteolytic Agents; Mifepristone; Ovulation; Pregnancy; Progesterone; Prolactin; Pseudopregnancy; Rats | 1997 |
Regulation of progesterone biosynthesis in the human placenta by estradiol 17 beta and progesterone.
Topics: Estradiol; Fadrozole; Female; Fulvestrant; Gonanes; Homeostasis; Hormone Antagonists; Humans; Mifepristone; Placenta; Pregnancy; Progesterone | 1997 |
RU486 inhibits synthesis of an endogenous inhibitor of cell arachidonate release from choriodecidua tissue.
Topics: Adult; Arachidonic Acid; Blotting, Western; Chorion; Cycloheximide; Dactinomycin; Decidua; Enzyme Inhibitors; Female; Glucocorticoids; Hormone Antagonists; Humans; Mifepristone; Placenta; Pregnancy; Pregnancy Proteins; Progesterone | 1997 |
[Labour induction in women at term with mifepristone and misoprostol].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adult; Drug Synergism; Female; Humans; Labor, Induced; Mifepristone; Misoprostol; Pregnancy | 1996 |
Treating colporrhagia after medical abortion with modified shenghua tang.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Animals; Blood Viscosity; Drugs, Chinese Herbal; Female; Humans; Mifepristone; Pregnancy; Rabbits; Uterine Hemorrhage | 1996 |
Opioidergic regulation of prolactin secretion during pregnancy: role of ovarian hormones.
Topics: Animals; Estradiol; Estrogen Antagonists; Female; Gestational Age; Hormone Antagonists; Mifepristone; Naloxone; Narcotic Antagonists; Opioid Peptides; Pregnancy; Progesterone; Prolactin; Rats; Rats, Wistar; Tamoxifen | 1997 |
Fertility impairment after mifepristone treatment to rats at proestrus. Actions on the hypothalamic-hypophyseal-ovarian axis.
Topics: Animals; Cohort Studies; Female; Hormone Antagonists; Injections, Subcutaneous; Luteinizing Hormone; Male; Mifepristone; Ovulation; Pregnancy; Proestrus; Progesterone; Prolactin; Rats; Rats, Wistar; Sexual Behavior, Animal | 1997 |
Release of prorenin and placental hormones from superfused minced chorion laeve.
Topics: Analysis of Variance; Angiotensin II; Cesarean Section; Chorion; Diltiazem; Enzyme Precursors; Estradiol; Female; Humans; In Vitro Techniques; Mifepristone; Placenta; Pregnancy; Progesterone; Renin; Tamoxifen | 1997 |
[Should antiprogesterone be used in pregnancy termination?].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Receptors, Progesterone | 1998 |
Tamoxifen-mediated anti-cellular effect against a choriocarcinoma cell line.
Topics: Cell Line; Cell Survival; Choriocarcinoma; Estrogen Antagonists; Female; Hormone Antagonists; Humans; Kinetics; Mifepristone; Pregnancy; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Trophoblasts; Uterine Neoplasms | 1998 |
Pilot study on the use of a two-week course of oral misoprostol in patients after termination of pregnancy with mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Diarrhea; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Parity; Pilot Projects; Pregnancy | 1998 |
Regulation of the progesterone receptor and estrogen receptor in decidua basalis by progesterone and estradiol during pregnancy.
Topics: Animals; Blotting, Northern; Blotting, Western; Cell Division; Decidua; Estradiol; Female; Hormone Antagonists; Immunohistochemistry; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Stromal Cells | 1998 |
Embryonic abnormalities at medical termination of pregnancy with mifepristone and misoprostol during first trimester: observational study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adolescent; Drug Combinations; Female; Fetus; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 1998 |
Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in müllerian duct by the synthetic estrogen diethylstilbestrol (DES).
Topics: Animals; Cycloheximide; Diethylstilbestrol; DNA-Binding Proteins; Drosophila Proteins; Embryo Implantation; Estradiol; Female; Gene Expression Regulation; Genes, Homeobox; Homeobox A10 Proteins; Homeodomain Proteins; Hormone Antagonists; Humans; In Situ Hybridization; Mice; Mifepristone; Mullerian Ducts; Pregnancy; Progesterone; Uterus | 1998 |
Unsuccessful treatment of missed abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Female; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Uterine Hemorrhage | 1998 |
Immunolocalization of Le(y) oligosaccharide in endometrium during menstrual cycle and effect of early luteal phase mifepristone administration on its expression in implantation stage endometrium of the rhesus monkey.
Topics: Animals; Carbohydrate Sequence; Embryo Implantation; Endometrium; Epithelium; Female; Hormone Antagonists; Immunohistochemistry; Lewis Blood Group Antigens; Luteal Phase; Macaca mulatta; Male; Menstrual Cycle; Mice; Mifepristone; Molecular Sequence Data; Oligosaccharides; Pregnancy; Pregnancy, Animal; Progestins | 1998 |
Abortion, revised: participants in the U.S. clinical trials evaluate mifepristone.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Attitude; Clinical Trials as Topic; Female; Focus Groups; Humans; Mifepristone; Pregnancy; United States | 1998 |
Differential effects of dexamethasone and RU 486, an antigestagen and antiglucocorticoid, on progesterone and relaxin secretion in hysterectomized pigs with aging corpora lutea.
Topics: Animals; Corpus Luteum; Dexamethasone; Female; Glucocorticoids; Hormone Antagonists; Hysterectomy; Mifepristone; Pregnancy; Progesterone; Relaxin; Swine | 1998 |
Differential effects of 5 alpha-norethisterone on the histomorphology of the oviduct and uterus of the pregnant rabbit.
Topics: Animals; Fallopian Tubes; Female; Hormone Antagonists; Injections, Subcutaneous; Mifepristone; Necrosis; Norethindrone; Periodic Acid-Schiff Reaction; Pregnancy; Progesterone; Progesterone Congeners; Rabbits; Stromal Cells; Uterus | 1998 |
Progesterone and estrogen regulation of rat decidual cell expression of proliferating cell nuclear antigen.
Topics: Animals; Cell Division; Decidua; Estrogens; Female; Immunohistochemistry; Mifepristone; Mitotic Index; Pregnancy; Progesterone; Proliferating Cell Nuclear Antigen; Rats; Uterus | 1998 |
Fetal malformation and failed medical termination of pregnancy.
Topics: Abnormalities, Drug-Induced; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prostaglandins E, Synthetic; Risk Factors; Treatment Failure | 1998 |
Regulation of interleukin 8 production in the term human placenta during labor and by antigestagens.
Topics: Culture Techniques; Estrenes; Female; Gonanes; Hormone Antagonists; Humans; Immunohistochemistry; Interleukin-8; Labor, Obstetric; Mifepristone; Placenta; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Progestins | 1998 |
Toward safe and effective medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Biomedical Research; Delivery of Health Care; Developing Countries; Female; Humans; Internationality; Legislation, Drug; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Risk Assessment; Therapeutic Human Experimentation; Women's Health | 1998 |
Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Analgesics; Diarrhea; Female; Follow-Up Studies; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage; Vomiting | 1998 |
Mifepristone and misoprostol for termination of early pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Clinical Trials as Topic; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Reproducibility of Results; United States | 1998 |
Antiovulatory and postcoital antifertility activity of the antiprogestin CDB-2914 when administered as single, multiple, or continuous doses to rats.
Topics: Animals; Contraceptives, Postcoital, Synthetic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fertility; Mifepristone; Norpregnadienes; Ovulation; Pregnancy; Rats; Rats, Sprague-Dawley | 1998 |
Update on early medical and surgical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Male; Methotrexate; Mifepristone; Misoprostol; Patient Selection; Pregnancy; Pregnancy Trimester, First; Vacuum Curettage | 1998 |
Synergistic effects on pregnancy-termination activity of DL111-IT in combination with mifepristone.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Cells, Cultured; Decidua; Drug Synergism; Female; Humans; Mifepristone; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Triazoles; Uterus | 1996 |
Mifepristone-misoprostol medical abortion: who will use it and why?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1998 |
Role of carboxy-extended forms of oxytocin in the rat uterus in the process of parturition.
Topics: Animals; Estrogen Antagonists; Female; Gestational Age; Hormone Antagonists; Labor, Obstetric; Mifepristone; Oxytocin; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin; Tamoxifen; Uterus | 1998 |
Medical methods of early abortion in developing countries. Consensus statement. The Population Council.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Developing Countries; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 1998 |
Steroid regulation of prostaglandin dehydrogenase activity and expression in human term placenta and chorio-decidua in relation to labor.
Topics: Cells, Cultured; Chorion; Decidua; Dexamethasone; Dihydrotestosterone; Dinoprostone; Female; Humans; Hydrocortisone; Hydroxyprostaglandin Dehydrogenases; Labor, Obstetric; Mifepristone; Placenta; Pregnancy; Progesterone; RNA, Messenger; Steroids; Trophoblasts | 1999 |
The effects of progesterone on oxytocin mRNA levels in the paraventricular nucleus of the female rat can be altered by the administration of diazepam or RU486.
Topics: Animals; Brain Chemistry; Diazepam; Female; GABA Modulators; gamma-Aminobutyric Acid; Gene Expression; Hormone Antagonists; Hypothalamus; In Situ Hybridization; Mifepristone; Ovariectomy; Oxytocin; Paraventricular Hypothalamic Nucleus; Pituitary Gland; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1999 |
Gestational regulation of granulocyte-colony stimulating factor receptor expression in the human placenta.
Topics: Abortifacient Agents, Steroidal; Alprostadil; Blotting, Western; Decidua; Female; Gene Expression Regulation; Gestational Age; Humans; Immunohistochemistry; Mifepristone; Oxytocin; Placenta; Pregnancy; Receptors, Granulocyte Colony-Stimulating Factor; Ribonucleases; RNA, Messenger; Trophoblasts | 1999 |
Procedures on handling mifepristone (RU 486) in France.
Topics: Abortion, Induced; Drug and Narcotic Control; Drug Prescriptions; Female; France; Humans; Informed Consent; Mifepristone; Pharmacy Service, Hospital; Pregnancy | 1990 |
RU 486: the politics of choice.
Topics: Abortion, Legal; Contraceptives, Postcoital, Hormonal; Decision Making; Drug Approval; Ethics, Medical; Female; Humans; Mifepristone; Politics; Pregnancy; United States; United States Food and Drug Administration; Women's Rights | 1991 |
Political, economic and ethical aspects of use of medical abortifacients.
Topics: Abortion, Induced; Cost-Benefit Analysis; Ethics, Medical; Female; Health Services Accessibility; Humans; Legislation, Medical; Liability, Legal; Mifepristone; Politics; Pregnancy; Prostaglandins | 1994 |
Warning on low dose mifepristone use.
Topics: Abortion, Induced; Drug Therapy, Combination; Female; France; Humans; Legislation, Drug; Liability, Legal; Mifepristone; Misoprostol; Pregnancy | 1994 |
Side effects of mifepristone-misoprostol abortion versus surgical abortion. Data from a trial in China, Cuba, and India.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Legal; Adult; China; Cuba; Drug Therapy, Combination; Female; Hemorrhage; Humans; India; Mifepristone; Misoprostol; Pain; Pregnancy | 1999 |
Expression of intracellular progesterone receptors in rat brain during different reproductive states, and involvement in maternal behavior.
Topics: Analysis of Variance; Animals; Brain Chemistry; Female; Hormone Antagonists; Immunohistochemistry; Maternal Behavior; Mifepristone; Pregnancy; Rats; Receptors, Progesterone; Reproduction | 1999 |
Mifepristone and methotrexate: the combination for medical treatment of ectopic pregnancy.
Topics: Drug Therapy, Combination; Female; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic | 1999 |
Progesterone regulation of epidermal growth factor receptor in rat decidua basalis during pregnancy.
Topics: Animals; Decidua; ErbB Receptors; Estradiol; Female; Gestational Age; Hormone Antagonists; Immunoblotting; Immunohistochemistry; Mifepristone; Ovariectomy; Phosphorylation; Phosphotyrosine; Pregnancy; Progesterone; Rats; Stromal Cells | 1999 |
Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cohort Studies; Female; Humans; Mifepristone; Pregnancy; Prospective Studies; Treatment Outcome; Vacuum Curettage | 1999 |
A progesterone antagonist cannot prevent fetal survival if the uterine horn is incised.
Topics: Animals; Female; Fetus; Hormone Antagonists; Mifepristone; Organ Size; Ovariectomy; Placenta; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Survival Rate; Uterus | 1998 |
Antisteroidal compounds and steroid withdrawal down-regulate cadherin-11 mRNA and protein expression levels in human endometrial stromal cells undergoing decidualisation in vitro.
Topics: Cadherins; Cells, Cultured; Decidua; Down-Regulation; Endometrium; Estradiol; Female; Fulvestrant; Hormone Antagonists; Humans; In Vitro Techniques; Mifepristone; Pregnancy; Progesterone; RNA, Messenger; Steroids; Stromal Cells | 1999 |
Fear of black market means no RU-486 for Canada until US approves drug.
Topics: Abortifacient Agents, Steroidal; Canada; Contraceptives, Oral, Synthetic; Drug and Narcotic Control; Drug Approval; Female; Humans; Mifepristone; Pregnancy; United States | 1999 |
Medical termination of pregnancy at 63 to 83 days gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Treatment Outcome | 1999 |
Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Analgesia, Obstetrical; Female; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Retrospective Studies; Time Factors | 1999 |
[Medical abortion].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy | 1999 |
The secretion of prolactin in intact and lutectomized pregnant ewes. Effect of the anti-progesterone steroid RU 486.
Topics: Animals; Corpus Luteum; Female; Mifepristone; Pregnancy; Pregnancy, Animal; Prolactin; Sheep; Time Factors | 1999 |
Regulation of calcitonin gene-related peptide receptors in the rat uterus during pregnancy and labor and by progesterone.
Topics: Animals; Blotting, Western; Estradiol; Female; Hormone Antagonists; Labor, Obstetric; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Calcitonin Gene-Related Peptide; Uterus | 1999 |
Progesterone-regulated determinants of stromal cell survival and death in uterine decidua are linked to protein kinase C activity.
Topics: Animals; Cell Cycle; Cell Death; Cell Survival; Female; Mifepristone; Phorbol Esters; Pregnancy; Progesterone; Protein Kinase C; Rats; Rats, Sprague-Dawley; Stromal Cells; Tetradecanoylphorbol Acetate; Uterus | 1999 |
Expression of cyclo-oxygenase in human endometrium during the implantation period.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Embryo Implantation; Endometrium; Female; Hormone Antagonists; Humans; Immunohistochemistry; Isoenzymes; Membrane Proteins; Mice; Mifepristone; Pregnancy; Progesterone; Prostaglandin-Endoperoxide Synthases | 1999 |
[Price and quality of early medical abortion].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Denmark; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1999 |
Medical abortion still not available in most countries.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Global Health; Humans; Mifepristone; Pregnancy | 1999 |
Contraceptive efficacy of daily administration of 0.5 mg mifepristone.
Topics: Adult; Contraceptives, Oral, Synthetic; Embryo Implantation; Female; Humans; Menstrual Cycle; Mifepristone; Ovulation; Pregnancy | 1999 |
Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion.
Topics: Abortifacient Agents; Abortion, Induced; Clinical Trials as Topic; Crown-Rump Length; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Predictive Value of Tests; Pregnancy; Reference Values; Ultrasonography, Prenatal | 1999 |
Effects of progesterone receptor blockers on human granulosa-luteal cell culture secretion of progesterone, estradiol, and relaxin.
Topics: Cells, Cultured; Chorionic Gonadotropin; Estradiol; Female; Granulosa Cells; Humans; Luteal Cells; Mifepristone; Norpregnadienes; Pregnancy; Pregnenediones; Progesterone; Receptors, Progesterone; Relaxin; Time Factors | 2000 |
Preimplantation embryo morphology following early luteal phase anti-nidatory treatment with mifepristone (RU486) in the rhesus monkey.
Topics: Animals; Blastocyst; Embryo Implantation; Embryo, Mammalian; Embryonic and Fetal Development; Embryonic Development; Female; Hormone Antagonists; Luteal Phase; Macaca mulatta; Male; Mifepristone; Morula; Ovulation; Pregnancy; Progestins; Time Factors; Trophoblasts | 2000 |
Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Gestational Age; Guadeloupe; Humans; Mifepristone; Misoprostol; Patient Compliance; Pregnancy; Prospective Studies; Self Administration | 1999 |
Uterine anomalies and failed surgical termination of pregnancy: the role of routine preoperative transvaginal sonography.
Topics: Abortifacient Agents; Abortion, Legal; Adult; Female; Humans; Mass Screening; Mifepristone; Misoprostol; Pregnancy; Preoperative Care; Treatment Failure; Ultrasonography, Prenatal; Uterus; Vacuum Curettage; Vagina | 1999 |
Collaborative research and development on mifepristone in China to reduce unwanted pregnancies and recourse to abortion.
Topics: China; Contraceptives, Postcoital, Synthetic; Cooperative Behavior; Drug Industry; Emergencies; Family Planning Services; Female; Humans; Mifepristone; Pregnancy; Pregnancy, Unwanted; Private Sector; Program Development | 1999 |
[Mifepristone in the treatment of 47 ectopic pregnancy patients].
Topics: Abortifacient Agents, Steroidal; Adult; Female; Humans; Mifepristone; Pregnancy; Pregnancy, Ectopic | 1998 |
[Effects of mifepristone on proliferation and apoptosis in early chorionic villi].
Topics: Abortifacient Agents, Steroidal; Adult; Apoptosis; Cell Division; Chorionic Villi; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Proliferating Cell Nuclear Antigen | 1998 |
[Effects of mifepristone on ICE expression and Fas expression in early pregnant chorionic villi].
Topics: Abortifacient Agents, Steroidal; Adolescent; Adult; Apoptosis; Caspase 1; Chorionic Villi; fas Receptor; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1998 |
Pregnancy and exogenous steroid treatments modulate the expression of relaxant EP(2) and contractile FP receptors in the rat uterus.
Topics: Animals; Estradiol; Estrogen Antagonists; Female; Gene Expression Regulation; Hormone Antagonists; Labor, Obstetric; Mifepristone; Polyunsaturated Alkamides; Postpartum Period; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Steroids; Uterine Contraction; Uterus | 2000 |
Attenuated hypotensive response to proadrenomedullin N-terminal 20 peptide in pregnant rats: modulation by steroid hormones.
Topics: Adrenomedullin; Animals; Blood Pressure; Dose-Response Relationship, Drug; Estradiol; Female; Hormone Antagonists; Hypotension; Mifepristone; Ovariectomy; Peptide Fragments; Peptides; Pregnancy; Pregnancy, Animal; Progesterone; Proteins; Rats; Rats, Wistar; Tamoxifen; Time Factors | 1999 |
Mifepristone regulation of leukemia inhibitory factor and uterine receptivity in rabbits.
Topics: Animals; Embryo Implantation; Embryo Transfer; Estradiol; Female; Growth Inhibitors; Hormone Antagonists; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Mifepristone; Ovariectomy; Pregnancy; Progesterone; Rabbits; Uterus | 1999 |
[Modern noninvasive methods for terminating pregnancy in the 2nd trimester].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Time Factors | 1999 |
CDB-2914: anti-progestational/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits.
Topics: Animals; Contraceptives, Postcoital, Synthetic; Copulation; Female; Glucocorticoids; Hormone Antagonists; Male; Mifepristone; Norpregnadienes; Pregnancy; Progestins; Rabbits; Rats; Rats, Sprague-Dawley | 2000 |
[Reintroduction of medical abortion in Denmark].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Alprostadil; Denmark; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic; Retrospective Studies | 2000 |
[Effects of mifepristone on the serum nitric oxide level and uterine blood flow in early pregnant women].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Mifepristone; Nitric Oxide; Pregnancy; Pregnancy Trimester, First; Regional Blood Flow; Uterus | 1998 |
[Failure of mifepristone induced interruption of pregnancy: point mutation at genetic codon 722 in human progesterone receptor gene].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Pregnancy; Receptors, Progesterone; Treatment Failure | 1998 |
Predictors of analgesia use during supervised medical abortion. The Mifepristone Clinical Trials Group.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Analgesia; Analgesics, Opioid; Community Health Services; Ethnicity; Family Planning Services; Female; Gestational Age; Hospitals, University; Humans; Logistic Models; Mifepristone; Misoprostol; Parity; Pregnancy | 2000 |
Research on regimens for early medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; Prostaglandins; Women's Health | 2000 |
A comparison of the Abortion Rights Mobilization and Population Council trials.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Nausea; Office Visits; Pregnancy; Vomiting | 2000 |
Are US health professionals likely to prescribe mifepristone or methotrexate?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Approval; Family Practice; Female; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Male; Methotrexate; Mifepristone; Obstetrics; Practice Patterns, Physicians'; Pregnancy; United States; United States Food and Drug Administration | 2000 |
Is medical abortion acceptable to all American women: the impact of sociodemographic characteristics on the acceptability of mifepristone-misoprostol abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Attitude to Health; Demography; Educational Status; Ethnicity; Female; Health Care Surveys; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Social Class | 2000 |
Early medical abortion in India: three studies and their implications for abortion services.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Feasibility Studies; Female; Health Services Accessibility; Humans; India; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Rural Population; Urban Population | 2000 |
Medical termination of early pregnancy: the Swedish experience.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Alprostadil; Female; Humans; Mifepristone; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Public Opinion; Sweden; Vacuum Curettage | 2000 |
Medical abortion in China.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Abortion, Legal; China; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Public Opinion; Vacuum Curettage | 2000 |
Abortion reporting in the era of medical procedures: why is it important?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Data Collection; Female; Humans; Information Services; Mifepristone; Pregnancy; Pregnancy Trimesters; United States; Vital Statistics | 2000 |
Regression of the decidualized mesometrium and decidual cell apoptosis are associated with a shift in expression of Bcl2 family members.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Decidua; DNA Fragmentation; Female; Hormone Antagonists; Mifepristone; Myometrium; Pregnancy; Pregnancy, Animal; Progesterone; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats | 2000 |
Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cohort Studies; Curettage; Female; Humans; Mifepristone; Misoprostol; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Suction; Treatment Failure; United States | 2000 |
Emergency contraception in clinical practice: global perspectives.
Topics: Adolescent; Adult; Contraception; Contraceptives, Postcoital; Female; Gonadotropin-Releasing Hormone; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices; Levonorgestrel; Male; Mifepristone; Patient Compliance; Pregnancy; Pregnancy, Unwanted; Random Allocation; Sex Education | 2000 |
Estrogen and progesterone modulation of eosinophilic infiltration of the rat uterine cervix.
Topics: Animals; Cervical Ripening; Cervix Uteri; Chemotaxis, Leukocyte; Dactinomycin; Eosinophils; Estrogen Antagonists; Estrogens; Female; Mifepristone; Nucleic Acid Synthesis Inhibitors; Ovariectomy; Pregnancy; Progesterone; Pseudopregnancy; Rats; Rats, Wistar; Tamoxifen | 2000 |
Luteinizing hormone secretion elicited in a ligand-independent activation of progesterone receptor manner at pituitary level in the rat: differential effect of two selective estrogen receptor modulators.
Topics: Animals; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Mifepristone; Pituitary Gland, Anterior; Pregnancy; Prolactin; Raloxifene Hydrochloride; Rats; Rats, Wistar; Receptors, Progesterone; Tamoxifen | 2000 |
Progesterone inhibits in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss.
Topics: Abortion, Habitual; Animals; Cell Extracts; Cytokines; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Hormone Antagonists; Humans; Interleukin-10; Leukocytes, Mononuclear; Male; Mice; Mifepristone; Pregnancy; Progesterone; Reference Values; Reproductive History; Th1 Cells; Transforming Growth Factor beta; Trophoblasts | 2000 |
Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy.
Topics: Abortifacient Agents, Steroidal; Dilatation and Curettage; Female; Humans; Hydatidiform Mole; Mifepristone; Oxytocin; Pregnancy; Prostaglandins; Retrospective Studies; Uterine Neoplasms; Vacuum Curettage | 2000 |
Abortion pill withdrawn in germany after financial losses.
Topics: Abortifacient Agents, Steroidal; Female; Germany; Humans; Mifepristone; Pregnancy | 2000 |
Effect of progesterone on the activation of neurones of the supraoptic nucleus during parturition.
Topics: Analysis of Variance; Animals; Depression, Chemical; Female; Gene Expression; Genes, fos; Hormone Antagonists; Immunohistochemistry; Labor, Obstetric; Mifepristone; Naloxone; Narcotic Antagonists; Neurons; Oxytocin; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Supraoptic Nucleus | 2000 |
Termination of early pregnancy with a reduced oral dose of mifepristone and vaginal misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Legal; Administration, Intravaginal; Administration, Oral; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Treatment Outcome | 2000 |
Altered fetal pituitary-adrenal function in the ovine fetus treated with RU486 and meloxicam, an inhibitor of prostaglandin synthase-II.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenocorticotropic Hormone; Animals; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Female; Hydrocortisone; In Vitro Techniques; Isoenzymes; Labor, Induced; Meloxicam; Mifepristone; Pituitary-Adrenal System; Pregnancy; Prostaglandin-Endoperoxide Synthases; Sheep; Thiazines; Thiazoles; Tocolytic Agents; Uterine Contraction | 2000 |
Abortifacient drug approved for restricted, physician-only distribution.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Contraindications; Drug Approval; Female; Humans; Mifepristone; Physician's Role; Pregnancy; United States; United States Food and Drug Administration | 2000 |
The expression of glutaredoxin is increased in the human cervix in term pregnancy and immediately post-partum, particularly after prostaglandin-induced delivery.
Topics: Abortifacient Agents, Steroidal; Adult; Cervix Uteri; Delivery, Obstetric; Dinoprostone; Female; Gene Expression; Glutaredoxins; Humans; Labor, Induced; Labor, Obstetric; Middle Aged; Mifepristone; Oxidoreductases; Pregnancy; Protein Biosynthesis; Proteins; RNA, Messenger | 2000 |
The second abortion pill.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Legal; Drug Approval; Female; Humans; Methotrexate; Mifepristone; Misoprostol; Pregnancy; United States; United States Food and Drug Administration | 2000 |
Informed consent and emergency contraception.
Topics: Abortifacient Agents, Steroidal; Communication; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Emergency Treatment; Estrogens; Female; Humans; Informed Consent; Menstruation-Inducing Agents; Mifepristone; Ovulation; Physician-Patient Relations; Pregnancy; Progestins; Terminology as Topic; United States | 2000 |
Use of misoprostol in pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Cervical Ripening; Drug Industry; Drug Labeling; Female; Government Regulation; Gynecology; Humans; Labor, Induced; Mifepristone; Misoprostol; Obstetrics; Oxytocics; Practice Guidelines as Topic; Pregnancy; Pregnant Women; Societies, Medical; United States | 2001 |
Synergistic effects of DL111-IT combined with mifepristone on termination of early pregnancy in rhesus monkeys.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Veterinary; Animals; Drug Synergism; Female; Macaca mulatta; Male; Mifepristone; Pregnancy; Triazoles | 2000 |
Termination of early pregnancy in the mouse, rat and hamster with DL111-IT and RU486.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Veterinary; Animals; Cricetinae; Female; Male; Mesocricetus; Mice; Mifepristone; Pregnancy; Rats; Rats, Sprague-Dawley; Triazoles | 2000 |
Mifepristone as a late post-coital contraceptive.
Topics: Adult; Contraceptives, Postcoital; Female; Humans; Intrauterine Devices; Mifepristone; Parity; Pilot Projects; Pregnancy; Treatment Outcome | 2001 |
Supporting not punishing. A constructive approach to managing clinical errors.
Topics: Abortifacient Agents, Steroidal; Female; Fetal Death; Humans; Medication Errors; Mifepristone; Misoprostol; Nurse Midwives; Pregnancy; Risk Management | 2000 |
The long, winding road of RU-486.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Drug Approval; Female; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2000 |
A little pill but a big dispute.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Drug Approval; Female; Humans; Mifepristone; Politics; Pregnancy; United States; United States Food and Drug Administration; Women's Rights | 2000 |
Long-awaited abortion pill will offer more privacy--but no less controversy.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Drug Approval; Female; Humans; Mifepristone; Pregnancy; Privacy; United States | 2000 |
The pill arrives.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Choice Behavior; Female; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration; Women's Rights | 2000 |
The abortion pill.
Topics: Abortifacient Agents, Steroidal; Drug Approval; Female; Humans; Mifepristone; Politics; Pregnancy; United States; United States Food and Drug Administration | 2000 |
RU-486 and the right to choose.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Female; Humans; Mifepristone; Pregnancy; United States; Women's Rights | 2000 |
[Vasospastic angina pectoris following abortion induced by prostaglandin analogue].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Alprostadil; Angina Pectoris, Variant; Electrocardiography; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 2000 |
Can vaginal misoprostol be administered 1 to 3 days after mifepristone without loss of efficacy or an increase in adverse events?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Female; Humans; Mifepristone; Misoprostol; Multicenter Studies as Topic; Patient Satisfaction; Pregnancy; Randomized Controlled Trials as Topic | 2001 |
Will Canada follow US lead on RU 486?
Topics: Abortifacient Agents, Steroidal; Canada; Drug and Narcotic Control; Female; Humans; Mifepristone; Pregnancy; United States | 2001 |
Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Age Factors; Alprostadil; Contraceptives, Postcoital, Synthetic; Female; Gestational Age; Humans; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome | 2000 |
Mifepristone--controversy, beliefs, and politics--issues for everyone.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Humans; Legislation, Drug; Mifepristone; Politics; Pregnancy; United States; United States Food and Drug Administration | 2001 |
Mifepristone--a boom or a bust?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Approval; Female; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2001 |
Mifepristone: less obvious adverse effects.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Approval; Female; Humans; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 2001 |
Second trimester termination of pregnancy for fetal anomaly or death: comparing mifepristone/misoprostol to gemeprost.
Topics: Abnormalities, Multiple; Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Intravaginal; Administration, Oral; Adult; Alprostadil; Female; Fetal Death; Humans; Maternal Age; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Reproductive History; Retrospective Studies; Treatment Outcome | 2001 |
[Clinical study of four cases with malignant gestation trophoblastic tumor after mifepristone abortion].
Topics: Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Adult; Angiography, Digital Subtraction; Chorionic Gonadotropin; Diagnosis, Differential; Female; Humans; Middle Aged; Mifepristone; Pregnancy; Trophoblastic Neoplasms; Ultrasonography, Doppler | 2000 |
Effects of indomethacin, luteinizing hormone (LH), prostaglandin E2 (PGE2), trilostane, mifepristone, ethamoxytriphetol (MER-25) on secretion of prostaglandin E (PGE), prostaglandin F2alpha (PGF2alpha) and progesterone by ovine corpora lutea of pregnancy
Topics: 3-Hydroxysteroid Dehydrogenases; Animals; Corpus Luteum; Cyclooxygenase Inhibitors; Dihydrotestosterone; Dinoprost; Dinoprostone; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrus; Ethamoxytriphetol; Female; Hormone Antagonists; In Vitro Techniques; Indomethacin; Luteinizing Hormone; Mifepristone; Pregnancy; Progesterone; Prostaglandins E; Sheep | 2001 |
[Clinical application of mifepristone in obstetrics and gynecology].
Topics: Abortifacient Agents, Steroidal; Contraceptives, Postcoital, Synthetic; Endometriosis; Female; Humans; Leiomyoma; Mifepristone; Pregnancy; Uterine Neoplasms | 1999 |
[National symposium on clinical application of mifepristone in obstetrics and gynecology].
Topics: Abortifacient Agents, Steroidal; Contraceptives, Postcoital, Synthetic; Female; Humans; Mifepristone; Pregnancy; Pregnancy, Ectopic; Uterine Neoplasms | 1999 |
[Study of histopathology of endometrium following termination of early pregnancy using mifepristone].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Endometrium; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage | 1999 |
[Effect of mifepristone on cell-cycle kinetics of human placental chorio-trophoblastic and decidual cell].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cell Cycle; Chorionic Villi; Decidua; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1999 |
[The immunohistochemical studies on estradiol and progesterone receptors in human decidua after terminating early pregnancy by mifepristone].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Decidua; Female; Humans; Immunohistochemistry; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Receptors, Estradiol; Receptors, Progesterone | 1999 |
[Study on decidual and villous cells apoptosis and its control gene in medical abortion].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Apoptosis; bcl-2-Associated X Protein; Chorionic Villi; Decidua; Female; Gene Expression Regulation; Genes, bcl-2; Humans; Mifepristone; Misoprostol; Pregnancy; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2 | 1999 |
A two-stage increase in the dose of misoprostol improves the efficacy of medical abortion with mifepristone and prostaglandins.
Topics: Abortifacient Agents; Abortion, Induced; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2001 |
Can women in less-developed countries use a simplified medical abortion regimen?
Topics: Abortifacient Agents; Abortion, Induced; Adult; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Prospective Studies; Tunisia; Vietnam | 2001 |
[Investigation of the apoptosis and proliferation in endometriotic cells].
Topics: Adult; Apoptosis; Cell Division; Cells, Cultured; Endometriosis; ErbB Receptors; Estradiol; Female; Humans; Mifepristone; Pregnancy; Progesterone; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger | 1999 |
[Effects of mifepristone on choriocarcinoma cell line JAR in vitro].
Topics: Cell Division; Choriocarcinoma; Chorionic Gonadotropin; Female; Humans; Ki-67 Antigen; Mifepristone; Pregnancy; Tumor Cells, Cultured; Uterine Neoplasms | 1999 |
RU-486. Anti-choice extremists block HIV drug research.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Anti-HIV Agents; Chemistry, Pharmaceutical; Clinical Trials as Topic; Female; HIV Infections; Humans; Mifepristone; Pregnancy; Social Justice; United States | 1999 |
Temporal relationships among uterine pituitary adenylate cyclase-activating polypeptide, decidual prolactin-related protein and progesterone receptor mRNAs expressions during decidualization and gestation in rats.
Topics: Animals; Decidua; DNA Primers; Endometrium; Female; Glycoproteins; Hormone Antagonists; Male; Mifepristone; Neurotransmitter Agents; Pregnancy; Pregnancy Proteins; Pregnancy-Associated alpha 2-Macroglobulins; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Uterus | 2001 |
Curettage after mifepristone-induced abortion: frequency, timing, and indications.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Curettage; Female; Humans; Mifepristone; Misoprostol; Multicenter Studies as Topic; Pregnancy; Randomized Controlled Trials as Topic; Time Factors | 2001 |
The effects of mifepristone on uterine sensitivity to oxytocin and on fetal heart rate patterns.
Topics: Adult; Bradycardia; Female; Gestational Age; Heart Rate, Fetal; Hormone Antagonists; Humans; Labor, Induced; Logistic Models; Mifepristone; Odds Ratio; Oxytocin; Pregnancy; Progesterone; Prostaglandins; Retrospective Studies; Uterus | 2001 |
Effects of DL111-IT or combined with RU486 on uterine polyamines biosynthesis in rats during early gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Biogenic Polyamines; Decidua; Female; Histocytochemistry; Male; Mifepristone; Pregnancy; Random Allocation; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Triazoles; Uterus | 2001 |
Regulation of the strypsin-related proteinase ISP2 by progesterone in endometrial gland epithelium during implantation in mice.
Topics: Amino Acid Sequence; Animals; Embryo Implantation; Embryo, Mammalian; Endometrium; Epithelium; Female; Gene Expression Regulation, Enzymologic; Hormone Antagonists; Mice; Mifepristone; Molecular Sequence Data; Ovariectomy; Polymerase Chain Reaction; Pregnancy; Progesterone; Pseudopregnancy; RNA, Messenger; Sequence Analysis, DNA; Serine Endopeptidases; Zona Pellucida | 2001 |
Hormonal regulation of tight junction closure in the mouse mammary epithelium during the transition from pregnancy to lactation.
Topics: Animals; Female; Hormone Antagonists; Lactation; Mammary Glands, Animal; Mice; Mice, Inbred Strains; Mifepristone; Models, Animal; Ovariectomy; Pregnancy; Pregnancy, Animal; Progesterone; Tight Junctions | 2001 |
Medical management of early fetal demise using a combination of mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adult; Curettage; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Uterine Hemorrhage | 2001 |
Second trimester medical abortion with mifepristone and gemeprost: a review of 956 cases.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Female; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, Second; Treatment Outcome; United Kingdom | 2001 |
Antiprogestagen activity of 5H-progesterone metabolites and their analogues, 16alpha,17alpha-cyclohexane-5H-pregnan-3,20-diones.
Topics: Abortifacient Agents, Steroidal; Animals; Female; Mifepristone; Molecular Structure; Pregnancy; Pregnancy Maintenance; Pregnancy, Animal; Pregnanolone; Progesterone; Progestins; Rats | 2001 |
Effects of RU 486 on electrical activity, on sexual steroid and prostaglandin F2 alpha concentrations in the myometrium at mid-pregnancy in the rat.
Topics: Animals; Dinoprost; Electromyography; Estradiol; Female; Kinetics; Mifepristone; Myometrium; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Time Factors; Uterus | 2001 |
Luteal expression of cytochrome P450 side-chain cleavage, steroidogenic acute regulatory protein, 3beta-hydroxysteroid dehydrogenase, and 20alpha-hydroxysteroid dehydrogenase genes in late pregnant rats: effect of luteinizing hormone and RU486.
Topics: 20-alpha-Hydroxysteroid Dehydrogenase; 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Animals; Blotting, Northern; Cholesterol Side-Chain Cleavage Enzyme; Corpus Luteum; Female; Gene Expression; Gestational Age; Hormone Antagonists; Luteinizing Hormone; Mifepristone; Phosphoproteins; Pregnancy; Progesterone; Rats; Rats, Wistar; RNA, Messenger | 2001 |
Mifepristone (RU486) and voluntary termination of pregnancy: enigmatic variations or anecdotal religion-based attitudes?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Health Knowledge, Attitudes, Practice; Humans; Mifepristone; Pregnancy; Religion | 2001 |
Effects of leukaemia inhibitory factor on endometrial receptivity and its hormonal regulation in rabbits.
Topics: Animal Population Groups; Animals; Embryo Implantation; Endometrium; Estradiol; Female; Gonadal Steroid Hormones; Growth Inhibitors; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Rabbits | 2001 |
Mifepristone in treating ectopic pregnancy.
Topics: Abortifacient Agents, Steroidal; Adult; Chorionic Gonadotropin; Female; Humans; Mifepristone; Pregnancy; Pregnancy, Ectopic | 1999 |
[Effects of tyrosine alone and tyrosine in combination with RU486 on early pregnancy in mice and the mechanism of action].
Topics: Abortifacient Agents, Steroidal; Animals; Cells, Cultured; Corpus Luteum; Female; Mice; Mifepristone; Pregnancy; Progesterone; Rats; Tyrosine | 1997 |
PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro.
Topics: Adipocytes; Adipose Tissue; Animals; Cells, Cultured; Cytokines; DNA-Binding Proteins; Female; Immediate-Early Proteins; Insulin; Leptin; Mammary Glands, Animal; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mifepristone; Pregnancy; Prolactin; Proteins; Receptors, Leptin; Receptors, Prolactin; Repressor Proteins; RNA, Messenger; Sheep; Signal Transduction; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Trans-Activators; Transcription Factors | 2001 |
Acceptability of mifepristone for early pregnancy interruption.
Topics: Abortion, Induced; Attitude; California; Cultural Diversity; Developing Countries; Drug Industry; Female; France; Freedom; General Surgery; Humans; International Cooperation; Internationality; Mifepristone; Patient Participation; Patients; Personal Autonomy; Pharmaceutical Preparations; Placebos; Pregnancy; Pregnant Women; Privacy; Public Policy; Random Allocation; Research; Risk; Risk Assessment; Social Control, Formal; Social Values; Therapeutic Human Experimentation; United Kingdom; Women; Women's Health Services | 1992 |
Mifepristone opposed.
Topics: Abortion, Criminal; Abortion, Induced; Attitude; Developing Countries; Economics; Family Planning Services; Female; Human Experimentation; Humans; India; Mifepristone; Patient Compliance; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Privacy; Social Values; Socioeconomic Factors; Women | 1993 |
Feminism and reproductive technologies.
Topics: Abortion, Eugenic; Abortion, Induced; Child; Civil Rights; Communism; Contraception; Contracts; Economics; Embryo Research; Empathy; Female; Feminism; Fertilization in Vitro; Fetal Research; Freedom; Genetic Engineering; Health Care Rationing; Humans; Industry; Men; Mifepristone; Moral Development; Morals; Personal Autonomy; Pregnancy; Pregnant Women; Prejudice; Prenatal Diagnosis; Reproduction; Reproductive Techniques, Assisted; Research; Resource Allocation; Risk; Risk Assessment; Science; Sex Determination Analysis; Social Control, Formal; Social Dominance; Socioeconomic Factors; Sociology, Medical; Surrogate Mothers; Vulnerable Populations; Women; Women's Rights | 1994 |
Review of Australia's ethics committees.
Topics: Abortion, Induced; Australia; Ethics Committees; Ethics Committees, Research; Government Regulation; Human Experimentation; Humans; Informed Consent; Mifepristone; Pharmaceutical Preparations; Politics; Pregnancy; Pregnant Women; Public Policy; Reference Standards; Social Control, Formal | 1994 |
Expanding options for early abortions.
Topics: Abortion, Induced; Education; Female; Health Personnel; Humans; Methotrexate; Mifepristone; Organizational Policy; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Societies; Societies, Scientific; United States; Women's Health Services; Women's Rights | 1996 |
Legal trends in bioethics.
Topics: Abortion, Induced; Bioethical Issues; Bioethics; Conflict of Interest; Contraception; Embryo Disposition; Embryo Research; Euthanasia; Euthanasia, Active; Euthanasia, Passive; Federal Government; Fertilization in Vitro; Geography; Government; Government Regulation; Health Care Rationing; HIV Seropositivity; Human Experimentation; Humans; International Cooperation; Internationality; Jurisprudence; Liability, Legal; Managed Care Programs; Mifepristone; Organ Transplantation; Parental Notification; Parents; Patient Selection; Pharmaceutical Preparations; Physicians; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Research; Resource Allocation; Scientific Misconduct; Social Change; Social Control, Formal; State Government; Suicide, Assisted; Treatment Refusal; United States | 1999 |
Webster, privacy, and RU486.
Topics: Abortion, Induced; Civil Rights; Embryonic and Fetal Development; Fetus; Government Regulation; Humans; Jurisprudence; Legislation as Topic; Mifepristone; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Privacy; Reference Standards; Risk; Risk Assessment; Social Control, Formal; State Government; Supreme Court Decisions; United States | 1990 |
Medical abortion and the availability of RU486 -- are women's rights being ignored in developing countries?
Topics: Abortion, Criminal; Abortion, Induced; Developing Countries; Drug Industry; Economics; Female; Hormones; Humans; International Cooperation; Internationality; Jurisprudence; Mifepristone; Mortality; Patents as Topic; Pharmaceutical Preparations; Politics; Pregnancy; Pregnant Women; Religion; Risk; Risk Assessment; United States; Women's Health | 1992 |
Abortion politics, science, and research ethics: take down the wall of separation.
Topics: Aborted Fetus; Abortion, Induced; Advisory Committees; Altruism; Beneficence; Biomedical Research; Complicity; Embryo, Mammalian; Ethics; Federal Government; Fertilization in Vitro; Fetal Diseases; Fetal Research; Fetal Tissue Transplantation; Fetus; Financial Support; Genetic Therapy; Government; Government Regulation; Guidelines as Topic; Humans; Mifepristone; Morals; Motivation; National Institutes of Health (U.S.); Pharmaceutical Preparations; Policy Making; Pregnancy; Pregnant Women; Public Policy; Research; Risk; Risk Assessment; Social Control, Formal; Social Justice; Stress, Psychological; United States; United States Dept. of Health and Human Services | 1992 |
Accord opens way for abortion pill in U.S. in 2 years.
Topics: Abortion, Induced; Drug Industry; Federal Government; France; Government; Human Experimentation; Humans; International Cooperation; Internationality; Liability, Legal; Mifepristone; Patents as Topic; Pharmaceutical Preparations; Politics; Pregnancy; Pregnant Women; Public Policy; United States | 1994 |
France and China allow sale of a drug for early abortion.
Topics: Abortion, Induced; China; Drug Industry; Economics; France; Humans; Mifepristone; Pharmaceutical Preparations; Politics; Pregnancy; Pregnant Women; Public Policy; Risk; Risk Assessment; United States | 1988 |
This pill will change everything about abortion.
Topics: Abortion, Induced; Attitude; Counseling; Drug Industry; Embryonic and Fetal Development; France; Humans; International Cooperation; Internationality; Methods; Mifepristone; Pharmaceutical Preparations; Physicians; Politics; Pregnancy; Pregnant Women; Public Opinion; Public Policy; Research; Therapeutic Human Experimentation; United States; United States Food and Drug Administration | 1999 |
Benten v. Kessler.
Topics: Abortion, Induced; Federal Government; Government; Government Regulation; Humans; International Cooperation; Internationality; Jurisprudence; Mifepristone; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Social Control, Formal; United States; United States Food and Drug Administration | 1992 |
Growing into rights.
Topics: Abortion, Induced; Abortion, Therapeutic; Beginning of Human Life; Embryo, Mammalian; Embryonic and Fetal Development; Ethics; Fetal Viability; Fetus; Homicide; Human Rights; Humans; Individuality; Life; Mifepristone; Morals; Personhood; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Public Policy; United States | 1989 |
The abortion pill: a solution for unsafe abortions in developing countries?
Topics: Abortion, Criminal; Abortion, Induced; Attitude; Developing Countries; Female; Health Education; Health Facilities; Health Personnel; Hormones; Humans; International Cooperation; Internationality; Jurisprudence; Maternal Welfare; Mifepristone; Morbidity; Mortality; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Risk; Risk Assessment; Socioeconomic Factors; Women's Health | 1992 |
Licensed to pill.
Topics: Abortion, Induced; Drug-Related Side Effects and Adverse Reactions; France; Human Experimentation; Humans; International Cooperation; Internationality; Mifepristone; Patient Care; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Risk; Risk Assessment | 1992 |
Abortion and the Pied Piper of compromise.
Topics: Abortion, Induced; Civil Rights; Consensus; Decision Making; Embryonic and Fetal Development; Female; Fetus; Government Regulation; Humans; Jurisprudence; Mifepristone; Pharmaceutical Preparations; Politics; Pregnancy; Pregnant Women; Privacy; Public Policy; Social Control, Formal; Supreme Court Decisions; United States; Women's Rights | 1993 |
Abortion pills on trial.
Topics: Abortion, Induced; Evaluation Studies as Topic; Female; Human Experimentation; Humans; Iowa; Mifepristone; Nontherapeutic Human Experimentation; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Risk; Risk Assessment; Women | 1994 |
The abortion cocktail.
Topics: Abortion, Induced; Drug-Related Side Effects and Adverse Reactions; Ethics Committees; Ethics Committees, Research; Federal Government; Government; Government Regulation; Human Experimentation; Humans; Methotrexate; Mifepristone; Misoprostol; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Research Design; Research Personnel; Risk; Risk Assessment; Scientific Misconduct; Social Control, Formal | 1996 |
Looking beyond judicial deference to agency discretion: a fundamental right of access to RU 486?
Topics: Abortion, Induced; Civil Rights; Community Participation; Contraception; Delivery of Health Care; Federal Government; Female; Financing, Government; Government; Government Regulation; Hormones; Human Experimentation; Humans; International Cooperation; Internationality; Judicial Role; Jurisprudence; Men; Mifepristone; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Prejudice; Public Policy; Risk; Risk Assessment; Social Control, Formal; United States; United States Food and Drug Administration; Women; Women's Health | 1994 |
Cultural and technological obstacles to the mainstreaming of abortion.
Topics: Abortion, Induced; Abortion, Legal; Attitude; Counseling; Embryonic and Fetal Development; Empathy; Female; Fetus; Freedom; General Surgery; Health Facilities; Homicide; Humans; Information Dissemination; Information Services; Men; Methods; Mifepristone; Morals; Nurses; Paternalism; Patient Participation; Personal Autonomy; Pharmaceutical Preparations; Physicians; Pregnancy; Pregnant Women; Privacy; Social Dominance; Stereotyping; Stress, Psychological; Ultrasonography; United States; Women's Health Services; Women's Rights | 1993 |
Casey, Bray and beyond: religious liberty and the abortion debate.
Topics: Abortion, Induced; Adolescent; Civil Rights; Conscience; Decision Making; Disclosure; Embryonic and Fetal Development; Female; Fetal Viability; Fetus; Freedom; Government Regulation; Health Facilities; Humans; Individuality; Informed Consent; Jurisprudence; Maternal Welfare; Mifepristone; Minors; Morals; Parental Notification; Parents; Pennsylvania; Personal Autonomy; Personhood; Pharmaceutical Preparations; Physicians; Politics; Pregnancy; Pregnant Women; Privacy; Public Opinion; Public Policy; Religion; Reproduction; Social Control, Formal; Spouses; State Government; Stereotyping; Supreme Court Decisions; United States; Violence; Women's Health Services; Women's Rights | 1993 |
"There is no evidence to suggest...": changing the way we judge information for disclosure in the informed consent process.
Topics: Abortion, Induced; Australia; Cognition; Communication; Comprehension; Disclosure; Female; Feminism; Fertilization in Vitro; Freedom; HIV Seropositivity; Human Experimentation; Humans; Informed Consent; Jurisprudence; Mifepristone; Minority Groups; Personal Autonomy; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Probability; Reference Standards; Research Personnel; Research Subjects; Risk; Uncertainty; Women | 1997 |
Apoptosis induced by antigestagen RU486 in rat corpus luteum of pregnancy.
Topics: Animals; Apoptosis; Cell Nucleolus; Cell Nucleus; Chromatin; Corpus Luteum; Cytoplasm; Dinoprost; Female; In Situ Nick-End Labeling; Luteolysis; Luteolytic Agents; Microscopy, Electron; Mifepristone; Pregnancy; Progesterone; Rats | 2001 |
Differential role of PR-A and -B isoforms in transcription regulation of human GnRH receptor gene.
Topics: Aminoglutethimide; Animals; Blotting, Western; Dexamethasone; Enzyme Inhibitors; Female; Gene Expression Regulation; Glucocorticoids; Hormone Antagonists; Humans; Mice; Mifepristone; Mutagenesis, Site-Directed; Placenta; Pregnancy; Progesterone; Protein Isoforms; Receptors, LHRH; Receptors, Progesterone; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2001 |
Mifepristone regulates expression of apoptosis related genes Fas and FasL in mouse endometrium.
Topics: Abortifacient Agents, Steroidal; Animals; Apoptosis; Embryo Implantation; Endometrium; Fas Ligand Protein; fas Receptor; Female; Membrane Glycoproteins; Mice; Mifepristone; Pregnancy; RNA, Messenger | 2001 |
Curettage after mifepristone-induced abortion: frequency, timing, and indications.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Missed; Dilatation and Curettage; Female; Humans; Mifepristone; Parity; Pregnancy | 2001 |
Monitoring serum chorionic gonadotropin levels after mifepristone abortion.
Topics: Abortifacient Agents; Abortion, Induced; Chorionic Gonadotropin; Female; Humans; Mifepristone; Monitoring, Physiologic; Pregnancy; Time Factors | 2001 |
[Effect of mifepristone on the expression of tumor necrosis factor-alpha and transforming growth factor-beta in decidua of early pregnancy].
Topics: Abortifacient Agents, Steroidal; Decidua; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2001 |
Vascular endothelial growth factor mRNA and its protein expression in decidua after terminating early pregnancy by mifepristone plus misoprostol.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Decidua; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lymphokines; Mifepristone; Misoprostol; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
RU-486: is it hot, or is it not?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Attitude; Female; Humans; Mifepristone; Pregnancy; United States | 2001 |
Mifepristone: new preparation. Avoids or facilitates cervical dilatation before vacuum aspiration of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Cervical Ripening; Cervix Uteri; Clinical Trials as Topic; Dilatation; Female; France; Hormone Antagonists; Humans; Laminaria; Mifepristone; Misoprostol; Pregnancy; Prostaglandins | 2001 |
[Interrupted pregnancy, mifepristone and patient rights].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Female; Humans; Mifepristone; Norway; Pregnancy; Women's Rights | 2001 |
Regulation by endogenous opioids of suckling-induced prolactin secretion in pregnant and lactating rats: role of ovarian steroids.
Topics: Animals; Estrogen Antagonists; Female; Hormone Antagonists; Lactation; Maternal Behavior; Mifepristone; Naloxone; Narcotic Antagonists; Pregnancy; Progesterone; Prolactin; Rats; Rats, Wistar; Tamoxifen | 2002 |
In utero activation of K5.CrePR1 induces gene deletion.
Topics: Animals; Embryonic and Fetal Development; Epidermis; Female; Gene Deletion; Gene Expression Regulation; Integrases; Keratin-15; Keratin-5; Keratins; Mice; Mice, Transgenic; Mifepristone; Pregnancy; Promoter Regions, Genetic; Receptors, Progesterone; Tissue Distribution; Viral Proteins | 2002 |
In vivo tissue-specific regulation of the human papillomavirus type 18 early promoter by estrogen, progesterone, and their antagonists.
Topics: Animals; beta-Galactosidase; Cervix Uteri; Epithelium; Estradiol; Estrous Cycle; Female; Gene Expression Regulation, Viral; Hormone Antagonists; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Mifepristone; Ovariectomy; Papillomaviridae; Pregnancy; Progesterone; Promoter Regions, Genetic; Tamoxifen; Transgenes; Vagina; Viral Proteins | 2002 |
[Voluntary pharmacologic termination of pregnancy].
Topics: Abortifacient Agents; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2002 |
Progesterone receptors and the sexual differentiation of the medial preoptic nucleus.
Topics: Animals; Animals, Newborn; Female; Gonadal Steroid Hormones; Hormone Antagonists; Male; Mifepristone; Orchiectomy; Pregnancy; Preoptic Area; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Sex Characteristics; Testosterone | 2002 |
[Effects of methotrexate on early pregnancy in mice].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Animals; Female; Folic Acid Antagonists; Male; Methotrexate; Mice; Mice, Inbred ICR; Mifepristone; Pregnancy; Pregnancy, Animal | 1998 |
Complication of cesarean section: pregnancy on the cicatrix of a previous cesarean section.
Topics: Adult; Cesarean Section; Chorionic Gonadotropin, beta Subunit, Human; Cicatrix; Female; Humans; Methotrexate; Mifepristone; Myometrium; Phytotherapy; Plant Preparations; Postoperative Complications; Pregnancy; Trichosanthes; Ultrasonography; Uterine Rupture; Uterus | 2002 |
[Antiprogestin to clinical use].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Drug Approval; Female; Finland; Humans; Mifepristone; Pregnancy | 2000 |
Medical management of late intrauterine death using a combination of mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adult; Drug Therapy, Combination; Female; Fetal Death; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Scotland; Sepsis; Ultrasonography | 2002 |
Medical management of early fetal demise using sublingual misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Adolescent; Adult; Drug Therapy, Combination; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Prospective Studies; Scotland | 2002 |
Cervical pregnancy successfully treated with a sequential combination of methotrexate and mifepristone.
Topics: Adolescent; Cervix Uteri; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Pregnancy, Ectopic; Ultrasonography, Prenatal | 2002 |
Signal transducer and activator of transcription 3 is expressed in the decidualized mesometrium of pregnancy and associates with the progesterone receptor through protein-protein interactions.
Topics: Animals; Blotting, Western; Decidua; DNA-Binding Proteins; Female; Hormone Antagonists; Mifepristone; Precipitin Tests; Pregnancy; Pregnancy, Animal; Progesterone; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; STAT3 Transcription Factor; Trans-Activators; Uterus | 2002 |
Differential expression of activator protein-1 transcription factors in pregnant rat myometrium.
Topics: Animals; Blotting, Northern; DNA, Complementary; Female; Gravidity; Hormone Antagonists; Labor, Obstetric; Mifepristone; Myometrium; Pregnancy; Pregnancy, Animal; Progesterone; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; RNA, Messenger; Sterilization, Tubal; Transcription Factor AP-1 | 2002 |
Medical abortion with mifepristone and misoprostol: a clinical trial in Taiwanese women.
Topics: Abortion, Induced; Chorionic Gonadotropin; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Single-Blind Method | 2002 |
Progesterone transcriptionally regulates the beta 2-adrenergic receptor gene in pregnant rat myometrium.
Topics: Animals; Autoradiography; Blotting, Northern; Cycloheximide; Female; In Vitro Techniques; Mifepristone; Myometrium; Pregnancy; Progesterone; Radioligand Assay; Rats; Receptors, Adrenergic, beta; RNA, Messenger; Transcription, Genetic | 1992 |
An immunochemical and immunocytologic study of the increase in myometrial gap junctions (and connexin 43) in rats and humans during pregnancy.
Topics: Animals; Connexins; Delivery, Obstetric; Female; Gestational Age; Immunoblotting; Immunohistochemistry; Intercellular Junctions; Membrane Proteins; Mifepristone; Myocardium; Myometrium; Pregnancy; Pregnancy, Animal; Rats | 1992 |
Women's evaluation of three early abortion methods.
Topics: Abortion, Induced; Adolescent; Adult; Choice Behavior; Female; Humans; Middle Aged; Mifepristone; Patient Satisfaction; Postoperative Complications; Pregnancy; Pregnancy Trimester, First; Social Support; Sweden; Time Factors | 1992 |
Misoprostol, mifepristone, and abortion.
Topics: Abortion, Induced; Developing Countries; Drug Combinations; Family Planning Services; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1992 |
Choriodecidual production of interleukin-8 and mechanism of parturition.
Topics: Cells, Cultured; Chorion; Decidua; Female; Humans; Interleukin-8; Labor, Obstetric; Mifepristone; Pregnancy; Progesterone | 1992 |
Medical abortion.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy | 1992 |
Medical abortion.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy | 1992 |
Effect of the antiprogestin RU486 on uterine sensitivity to oxytocin in ewes in late pregnancy.
Topics: Animals; Dinoprost; Dinoprostone; Electromyography; Female; Gestational Age; Mifepristone; Oxytocin; Pregnancy; Pregnancy, Animal; Progestins; Sheep; Stimulation, Chemical; Uterus | 1992 |
Fetal viability and fetal growth after prolonged uterine contractions induced by progesterone withdrawal in late pregnancy in rats.
Topics: Animals; Embryonic and Fetal Development; Female; Fetal Death; Fetal Viability; Gestational Age; Mifepristone; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Time Factors; Uterine Contraction | 1992 |
Antiprogestin drugs: research and clinical use in Sweden.
Topics: Abortifacient Agents, Steroidal; Carboprost; Contraceptives, Oral, Synthetic; Drug Synergism; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Prostaglandins E, Synthetic; Risk Assessment; Sweden | 1992 |
Introduction of abortion technologies: a quality of care management approach.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Clinical Competence; Contraception; Diffusion of Innovation; Female; Humans; Information Dissemination; Internationality; Mifepristone; Pregnancy; Pregnant Women; Prostaglandins; Quality of Health Care; Risk Assessment | 1992 |
RU 486/prostaglandin: considerations for appropriate use in low-resource settings.
Topics: Abortifacient Agents, Steroidal; Adult; Consumer Product Safety; Cultural Diversity; Developing Countries; Drug Approval; Drug Costs; Drug Synergism; Europe; Female; France; Health Services Accessibility; Humans; Information Dissemination; Internationality; Maternal Mortality; Mifepristone; Patient Selection; Pregnancy; Pregnant Women; Prostaglandins E, Synthetic; Risk Assessment; Social Control, Formal; United States; Vacuum Curettage; Vulnerable Populations | 1992 |
RU 486: what physicians know, think and (might) do--a survey of California obstetrician/gynecologists.
Topics: Abortifacient Agents, Steroidal; Attitude of Health Personnel; California; Female; Gynecology; Health Knowledge, Attitudes, Practice; Humans; Mifepristone; Obstetrics; Pregnancy; Risk Assessment | 1992 |
"Inducing a miscarriage": women-centered perspectives on RU 486/prostaglandin as an early abortion method.
Topics: Abortion, Induced; Ambulatory Care Facilities; England; Female; France; Humans; Internationality; Mifepristone; Multicenter Studies as Topic; Paternalism; Personal Autonomy; Pregnancy; Pregnant Women; Prostaglandins E, Synthetic; Risk Assessment; Time Factors; Uterine Hemorrhage; Vacuum Curettage | 1992 |
Are adolescents good candidates for RU 486 as an abortion method?
Topics: Abortion, Induced; Adolescent; Decision Making; Female; Humans; Mifepristone; Patient Selection; Pregnancy; Pregnancy in Adolescence; Pregnant Women; Psychology, Adolescent; Risk Assessment; Time Factors | 1992 |
Antiprogestin drugs: ethical issues.
Topics: Drug Approval; Ethical Analysis; Ethical Theory; Ethics; Female; Health Services Accessibility; Humans; Information Dissemination; Internal-External Control; Mifepristone; Personal Autonomy; Pregnancy; Pregnant Women; Risk Assessment; Risk Factors; United States; Vulnerable Populations; Women's Rights | 1992 |
RU 486, the FDA and free enterprise.
Topics: Commerce; Drug Approval; Federal Government; Female; Government Regulation; Humans; Liability, Legal; Mifepristone; Pregnancy; United States; United States Food and Drug Administration | 1992 |
RU 486 in France and England: corporate ethics and compulsory licensing.
Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Consumer Organizations; Drug Approval; Drug Industry; England; Ethics; Female; France; Government Regulation; Humans; Internationality; Licensure; Mifepristone; Patient Selection; Patients; Pregnancy; Pregnant Women; Social Responsibility; United States; Value of Life | 1992 |
Benten v. Kessler: the RU 486 import case.
Topics: Drug Approval; Federal Government; Female; Government Regulation; Humans; Mifepristone; Personal Autonomy; Pregnancy; Pregnant Women; Supreme Court Decisions; United States; United States Food and Drug Administration | 1992 |
Prostaglandin E production by uteri of ovariectomized pregnant rats receiving antiprogesterone steroid or in which progesterone has been withdrawn.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Female; Gonanes; In Vitro Techniques; Mifepristone; Ovariectomy; Pregnancy; Progesterone; Prostaglandins E; Rats; Uterus | 1992 |
Effects of the progesterone antagonist RU486 on myometrial activity in vivo in early pregnant and pseudopregnant rats.
Topics: Animals; Copulation; Female; Mifepristone; Myometrium; Pregnancy; Progesterone; Pseudopregnancy; Rats; Rats, Wistar; Time Factors; Uterine Contraction | 1992 |
Induction of abortion with mifepristone and misoprostol in early pregnancy.
Topics: Abortion, Induced; Adolescent; Adult; Drug Administration Schedule; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Parity; Pregnancy | 1992 |
Medical management of missed abortion and anembryonic pregnancy.
Topics: Abortion, Induced; Abortion, Missed; Administration, Oral; Adult; Female; Humans; Mifepristone; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First | 1992 |
Medical abortion.
Topics: Abnormalities, Drug-Induced; Abortion, Legal; Female; Humans; Mifepristone; Pregnancy | 1992 |
[Cardiocirculatory arrest after administration of combined mifepristone (Mifegyne) and sulprostone (Nalador) for induced abortion. Possible role of coronary vasospasm].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Coronary Vasospasm; Dinoprostone; Drug Combinations; Electric Countershock; Electrocardiography; Female; Heart; Heart Arrest; Humans; Mifepristone; Pregnancy; Radionuclide Imaging; Risk Factors; Thallium Radioisotopes; Ventricular Fibrillation | 1992 |
Uterine contractile activity in rats induced by mifepristone (RU 486) in relation to changes in concentrations of prostaglandins E-2 and F-2 alpha.
Topics: Animals; Dinoprost; Dinoprostone; Female; Mifepristone; Pregnancy; Rats; Rats, Inbred Strains; Time Factors; Uterine Contraction | 1992 |
Mifepristone (RU 486) and vaginal induced abortion after two caesarean sections.
Topics: Abortion, Therapeutic; Adult; Female; Fetal Death; Humans; Meperidine; Mifepristone; Potassium Chloride; Pregnancy; Pregnancy Trimester, Second; Vaginal Birth after Cesarean | 1992 |
Medical abortion.
Topics: Abnormalities, Drug-Induced; Abortion, Legal; Female; Humans; Mifepristone; Pregnancy | 1992 |
Multiple fetal anomalies in the first trimester; detection using transvaginal ultrasound and therapeutic abortion using mifepristone (RU486) in conjunction with gemeprost vaginal pessaries.
Topics: Abnormalities, Multiple; Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Oral; Adult; Alprostadil; Female; Humans; Mifepristone; Pessaries; Pregnancy; Ultrasonography, Prenatal | 1992 |
RU 486 (mifepristone).
Topics: Abortion, Induced; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy, Ectopic | 1992 |
Effects of antiprogesterones on myometrial cell-to-cell coupling in pregnant guinea pigs.
Topics: Animals; Cell Communication; Electric Conductivity; Electrophysiology; Female; Fluorescent Dyes; Gonanes; Guinea Pigs; Hormone Antagonists; Isoquinolines; Microelectrodes; Mifepristone; Myometrium; Pregnancy; Progesterone; Time Factors | 1992 |
Regulation by progesterone of the high-affinity state of myometrial beta-adrenergic receptor and of adenylate cyclase activity in the pregnant rat.
Topics: Adenylyl Cyclases; Animals; Cell Membrane; Female; Iodocyanopindolol; Isoproterenol; Kinetics; Mifepristone; Myometrium; Pindolol; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Reference Values | 1991 |
Down-regulation of myometrial atrial natriuretic factor receptors by progesterone and pregnancy and up-regulation by oestrogen in rats.
Topics: Animals; Atrial Natriuretic Factor; Cell Membrane; Estrogens; Female; Mifepristone; Myometrium; Ovariectomy; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Inbred Strains; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface | 1991 |
Induction of labor and cervical maturation using mifepristone (RU 486) in the late pregnant rat. Influence of a cyclooxygenase inhibitor (Diclofenac).
Topics: Animals; Arachidonic Acids; Cervix Uteri; Diclofenac; Dinoprostone; Electrophoresis, Cellulose Acetate; Female; Glycosaminoglycans; Labor, Induced; Leukotriene B4; Mifepristone; Pregnancy; Radioimmunoassay; Rats; Rats, Inbred Strains | 1991 |
[Do antiprogestins substitute for surgical abortion?].
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Prostaglandins | 1990 |
Postcoital contraception.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Contraceptives, Postcoital; Cyclophosphamide; Epirubicin; Ethinyl Estradiol; Female; Humans; Mifepristone; Pregnancy | 1991 |
Development after exposure to mifepristone in early pregnancy.
Topics: Adult; Ectromelia; Embryo, Mammalian; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Pregnancy Outcome | 1991 |
Misoprostol and legal medical abortion.
Topics: Abortion, Legal; Clinical Trials as Topic; Costs and Cost Analysis; Developing Countries; Drug Therapy, Combination; Female; Humans; Internationality; Mifepristone; Misoprostol; Pregnancy; Pregnant Women; Risk Assessment | 1991 |
Development after in-utero exposure to mifepristone.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Female; Humans; Infant, Newborn; Mifepristone; Pregnancy | 1991 |
Mifepristone teratogenicity.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy | 1991 |
Arachidonic acid release from cultured human amnion cells: the effect of dexamethasone.
Topics: Amnion; Arachidonic Acid; Arachidonic Acids; Calcimycin; Cells, Cultured; Dactinomycin; Dexamethasone; Dose-Response Relationship, Drug; Female; Humans; Mifepristone; Phospholipids; Pregnancy | 1990 |
The efficacy of oral Mifepristone (RU 38,486) with a prostaglandin E1 analog vaginal pessary for the termination of early pregnancy: complications and patient acceptability.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adult; Alprostadil; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Female; Follow-Up Studies; Humans; Mifepristone; Patient Acceptance of Health Care; Peptide Fragments; Pessaries; Pregnancy; Pregnancy Trimester, First | 1990 |
Reduced risk of isoimmunisation in medical abortion.
Topics: Abortion, Induced; alpha-Fetoproteins; Female; Humans; Mifepristone; Pessaries; Pregnancy; Prostaglandins; Rh Isoimmunization; Risk Factors | 1990 |
Changes in circulating alphafetoprotein following administration of mifepristone in first trimester pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; alpha-Fetoproteins; Alprostadil; Female; Fetomaternal Transfusion; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1990 |
[Treatment of extrauterine pregnancy with RU 486. A case report].
Topics: Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Mifepristone; Peptide Fragments; Pregnancy; Pregnancy, Ectopic | 1990 |
Natural killer cell activity from pregnant subjects is modulated by RU 486.
Topics: Adolescent; Adult; Cytotoxicity, Immunologic; Female; Humans; Hydrocortisone; Killer Cells, Natural; Mifepristone; Pregnancy; Progesterone | 1992 |
Medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Legal; Alprostadil; Female; Humans; Mifepristone; Pregnancy; Risk Assessment; United Kingdom | 1992 |
P29, an oestrogen receptor-associated protein, is down-regulated by mifepristone in first trimester human placenta and decidua.
Topics: Abortion, Legal; Adolescent; Adult; Decidua; Down-Regulation; Female; Heat-Shock Proteins; Humans; Mifepristone; Phosphoproteins; Placenta; Pregnancy; Pregnancy Trimester, First; Receptors, Estrogen | 1991 |
Immunoreactive cytochrome P-450(17 alpha) in rat and guinea-pig gonads, adrenal glands and brain.
Topics: Adrenal Cortex; Animals; Brain; Chorionic Gonadotropin; Estradiol; Female; Guinea Pigs; Immunohistochemistry; Leydig Cells; Male; Mifepristone; Ovary; Pregnancy; Rats; Rats, Inbred Strains; Sexual Maturation; Steroid 17-alpha-Hydroxylase; Testis; Theca Cells | 1991 |
Is the antiprogestin RU486 luteolytic in rats?
Topics: Animals; Corpus Luteum; Dose-Response Relationship, Drug; Female; Injections, Subcutaneous; Mifepristone; Myometrium; Pregnancy; Progesterone; Pseudopregnancy; Rats; Rats, Inbred Strains; Vagina | 1991 |
Antiprogesterone compound, RU486 administration to terminate pregnancy in dogs and cats.
Topics: Abortion, Induced; Abortion, Veterinary; Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Female; Injections, Subcutaneous; Mifepristone; Pregnancy | 1991 |
A pilot study of acceptability of RU486 and ONO 802 in a Chinese population.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; China; Female; Humans; Mifepristone; Patient Acceptance of Health Care; Pilot Projects; Pregnancy; Vacuum Curettage | 1991 |
Hormonal and local factors control the immunohistochemical distribution of immunocytes in the rat uterus before conceptus implantation: effects of ovariectomy, fallopian tube section, and injection.
Topics: Animals; Blastocyst; Embryo Implantation; Fallopian Tubes; Female; Immunohistochemistry; Leukocyte Count; Macrophages; Mifepristone; Monocytes; Neutrophils; Ovariectomy; Pregnancy; Pregnancy, Animal; Progesterone; Pseudopregnancy; Rats; Rats, Inbred Strains; T-Lymphocytes; Uterus | 1991 |
Uterine production of prostaglandins F2 alpha and 6-keto-F1 alpha by ovariectomized pregnant rats receiving antiprogesterone steroid or in which progesterone has been withdrawn.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Drug Implants; Epoprostenol; Estradiol; Female; Gonanes; Mifepristone; Organ Size; Ovariectomy; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Inbred Strains; Uterus | 1991 |
French abortion drug RU 486: U.S. research battles heat up.
Topics: Female; Humans; Mifepristone; Pregnancy; Research; United States; United States Food and Drug Administration | 1991 |
[Induction of labor with mifepristone in case of premature rupture of membranes].
Topics: Adult; Female; Fetal Membranes, Premature Rupture; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 1991 |
Inhibition of the tocolytic activity of atrial natriuretic factor by progesterone and potentiation by progesterone receptor antagonist RU486 in rats.
Topics: Animals; Atrial Natriuretic Factor; Drug Synergism; Estrus; Female; In Vitro Techniques; Mifepristone; Ovary; Pregnancy; Progesterone; Rats; Rats, Inbred Strains; Receptors, Progesterone; Tocolytic Agents | 1991 |
Effects of RU486 on the interstitial collagenase in the process of cervical ripening in the pregnant rat.
Topics: Animals; Cervix Uteri; Collagenases; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Female; Matrix Metalloproteinase 1; Mifepristone; Obstetric Labor, Premature; Organ Size; Phenanthrolines; Pregnancy; Pregnancy, Animal; Rats; Rats, Wistar; Time Factors | 1991 |
Antiprogesterone, RU 486, facilitates parturition in cattle.
Topics: Animals; Birth Weight; Cattle; Female; Labor, Induced; Mifepristone; Pregnancy; Progesterone; Relaxin | 1991 |
Effect of RU486 on development and implantation of rat embryos.
Topics: Animals; Blastocyst; Dose-Response Relationship, Drug; Embryo Implantation; Embryo Transfer; Embryonic and Fetal Development; Female; Mifepristone; Pregnancy; Rats; Rats, Inbred Strains; Trophoblasts | 1991 |
Effects of mifepristone in vivo on decidual prostaglandin synthesis and metabolism.
Topics: Culture Techniques; Decidua; Dinoprost; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Prostaglandins; Radioimmunoassay | 1991 |
Improvements seen for RU-486 abortions.
Topics: Abortion, Induced; Female; Humans; Internationality; Mifepristone; Pregnancy; Pregnant Women; Risk Assessment | 1991 |
Feminist group dissents on RU-486 use for abortion.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; United States | 1991 |
The use of antiprogestin (RU 486) for termination of second trimester pregnancy.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 1991 |
Reduction of the intake of food and water is responsible for reduction of litter growth when dams are treated with a progesterone antagonist.
Topics: Animals; Animals, Newborn; Body Weight; Drinking; Eating; Female; Gonanes; Lactation; Male; Mifepristone; Milk; Ovariectomy; Pregnancy; Progesterone; Rats; Rats, Inbred Strains | 1991 |
Uterine activity and decidual prostaglandin production in women in early pregnancy in response to mifepristone with or without indomethacin in vivo.
Topics: Culture Techniques; Decidua; Female; Humans; Indomethacin; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prostaglandins F; Uterine Contraction; Uterus | 1991 |
Third World birth control--is it abortion? Drug combination gains support as alternative to surgical abortion.
Topics: Abortion, Legal; Developing Countries; Family Planning Policy; Female; Humans; Intention; Internationality; Mifepristone; Pregnancy; Prostaglandins; South Africa | 1991 |
Divergent effects of antiprogesterone, RU 486, on progesterone, relaxin, and prolactin secretion in pregnant and hysterectomized pigs with aging corpora lutea.
Topics: Animals; Corpus Luteum; Female; Hysterectomy; Mifepristone; Pregnancy; Progesterone; Prolactin; Receptors, Progesterone; Relaxin; Swine; Time Factors | 1991 |
Transplacental passage of mifepristone and its influence on maternal and fetal steroid concentrations in the second trimester of pregnancy.
Topics: Abortion, Induced; Adult; Female; Fetal Blood; Humans; Maternal-Fetal Exchange; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Steroids | 1991 |
Heterogeneity of oxytocin receptors in the pregnant rat myometrium near parturition.
Topics: Animals; Arginine Vasopressin; Female; In Vitro Techniques; Labor, Obstetric; Mifepristone; Myometrium; Oxytocin; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Oxytocin; Vasotocin | 1990 |
Effects of antiprogestogen (RU-486) treatment on myometrial and cervical alpha and beta-adrenoceptors in pregnant rabbits.
Topics: Animals; Cervix Uteri; Dihydroalprenolol; Female; Mifepristone; Myometrium; Prazosin; Pregnancy; Rabbits; Radioligand Assay; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Yohimbine | 1990 |
Normal development after exposure to mifepristone in early pregnancy.
Topics: Abortion, Induced; Adult; Embryonic and Fetal Development; Female; Humans; Infant; Infant, Newborn; Male; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1990 |
Reproductive health and mifepristone.
Topics: Abortion, Induced; Administration, Oral; Female; Humans; Mifepristone; Patient Advocacy; Pregnancy; Public Opinion | 1990 |
Regulation of interleukin-6 production in human fetal Kupffer cells.
Topics: Cells, Cultured; Dexamethasone; Female; Fetus; Humans; Interleukin-6; Kupffer Cells; Lipopolysaccharides; Mifepristone; Pregnancy | 1991 |
Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion.
Topics: Abortion, Therapeutic; Anxiety; Depression; Female; Humans; Mifepristone; Patient Acceptance of Health Care; Pregnancy; Prostaglandins; Psychological Tests; Time Factors; Vacuum Curettage | 1991 |
Prolactin receptor gene expression in rat mammary gland and liver during pregnancy and lactation.
Topics: Animals; Female; Gene Expression Regulation; Lactation; Liver; Male; Mammary Glands, Animal; Mifepristone; Osmolar Concentration; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred Strains; Receptors, Prolactin; RNA, Messenger | 1991 |
[Induced abortion using a progesterone antagonist--mifepristone (RU 486)].
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pregnancy | 1991 |
Human luteal function during implantation and early pregnancy.
Topics: Corpus Luteum; Embryo Implantation; Female; Humans; Mifepristone; Pregnancy; Progesterone; Prostaglandins | 1991 |
Involvement of the adrenergic system on the release of prolactin and lactogenesis at the end of pregnancy in the rat.
Topics: Animals; Caseins; Dinoprost; Female; Lactation; Lactose; Mammary Glands, Animal; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Sympatholytics | 1991 |
Effects of progesterone antagonists RU486 and ZK98734 on embryo transport, development and implantation in laboratory mice.
Topics: Animals; Dexamethasone; Dose-Response Relationship, Drug; Embryo Implantation; Embryo, Mammalian; Embryonic and Fetal Development; Embryonic Development; Epithelium; Estradiol; Estrenes; Female; Fetal Viability; Luteolysis; Mice; Mifepristone; Organ Size; Pregnancy; Progesterone; Progestins; Thymus Gland; Uterus | 1990 |
Amniotic fluid lipoxygenase metabolites during spontaneous labor and after RU486 treatment during late pregnancy in rhesus macaques.
Topics: Amniotic Fluid; Animals; Female; Labor, Obstetric; Lipoxygenase; Macaca mulatta; Mifepristone; Pregnancy; Pregnancy, Animal | 1990 |
Increased secretion of adrenal progesterone explains the lack of response of oviductal embryo transport to a short intravenous infusion of estradiol in the rat.
Topics: Adrenalectomy; Animals; Estradiol; Female; Hypophysectomy; Infusions, Intravenous; Mifepristone; Ovariectomy; Ovum Transport; Pregnancy; Progesterone; Radioimmunoassay; Rats; Rats, Inbred Strains | 1990 |
Mifepristone (RU 486) failure in an ovarian heterotopic pregnancy.
Topics: Abortion, Induced; Adult; Carboprost; Female; Humans; Laparoscopy; Mifepristone; Ovary; Pregnancy; Pregnancy, Ectopic | 1990 |
Steroid hormones modulate the release of immunoreactive gonadotropin-releasing hormone from cultured human placental cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Activins; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Inhibins; Mifepristone; Placenta; Pregnancy; Progesterone; Radioimmunoassay; Receptors, Opioid; Tamoxifen | 1990 |
Myometrial oxytocin receptors levels in the pregnant rat are higher in distal than in proximal portions of the horn and correlate with disparate oxytocin responsive myometrial contractility in these segments.
Topics: Animals; Estradiol; Female; Mifepristone; Myometrium; Oxytocin; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Oxytocin; Uterine Contraction | 1990 |
Predictors of failed attempted abortion with the antiprogestin mifepristone (RU 486).
Topics: Abortifacient Agents; Abortion, Induced; Adolescent; Adult; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Pregnancy Outcome; Statistics as Topic; Ultrasonography | 1990 |
The effects of the antiprogestin mifepristone, in vivo, and progesterone in vitro on prolactin production by the human decidua in early pregnancy.
Topics: Abortion, Induced; Decidua; Female; Humans; Immunoenzyme Techniques; In Vitro Techniques; Mifepristone; Pregnancy; Progesterone; Prolactin | 1990 |
Luteolytic effect of the antiprogestin and antiglucocorticoid agent RU486 in rats.
Topics: Algestone; Animals; Cells, Cultured; Chorionic Gonadotropin; Corpus Luteum; Dexamethasone; Female; Gestrinone; Glucocorticoids; Gonadotropins, Equine; Hypophysectomy; Mifepristone; Pregnancy; Progesterone; Progestins; Promegestone; Rats; Rats, Inbred Strains | 1990 |
[Fear of boycott keeps companies from registering early abortion drugs].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1990 |
A progesterone-induced blocking factor corrects high resorption rates in mice treated with antiprogesterone.
Topics: Abortion, Induced; Animals; Female; Fetal Resorption; Immune Tolerance; Litter Size; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mifepristone; Pregnancy; Progesterone | 1990 |
Progesterone suppression of pregnancy lymphocytes is not mediated by glucocorticoid effect.
Topics: Female; Glucocorticoids; Humans; Killer Cells, Natural; Lymphocytes; Mifepristone; Pregnancy; Progesterone; Receptors, Progesterone | 1990 |
Antiprogestagenic inhibition of uterine prostaglandin inactivation: a permissive mechanism for uterine stimulation.
Topics: Amino Acid Sequence; Animals; Cell Membrane; Cervix Uteri; Female; Guinea Pigs; Mifepristone; Molecular Sequence Data; Pregnancy; Prostaglandins; Uterus | 1990 |
Late luteal administration of the antiprogesterone RU486 in normal women: effects on the menstrual cycle events and fertility control in a long-term study.
Topics: Adult; Endocrine Glands; Family Planning Services; Female; Humans; Longitudinal Studies; Luteal Phase; Menstrual Cycle; Mifepristone; Pregnancy; Progesterone; Reference Values; Time Factors | 1990 |
Mifepristone (RU 486).
Topics: Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Prostaglandins | 1990 |
Treatment of premenstrual syndromes with progesterone antagonists (e.g., RU-486): political and methodological issues.
Topics: Abortion, Induced; Female; Humans; Luteal Phase; Mifepristone; Politics; Pregnancy; Premenstrual Syndrome | 1990 |
The use of mifepristone prior to prostaglandin-induced mid-trimester abortion.
Topics: Abortion, Induced; Adult; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Pressure; Uterus | 1990 |
Reproductive hormones during termination of early pregnancy with mifepristone.
Topics: 17-alpha-Hydroxyprogesterone; Abortion, Induced; Chorionic Gonadotropin; Dinoprost; Estradiol; Female; Humans; Hydroxyprogesterones; Mifepristone; Pregnancy; Progesterone | 1990 |
Uterine estrogen receptors are increased by RU486 in late pregnant rhesus macaques but not after spontaneous labor.
Topics: Amnion; Animals; Cell Nucleus; Centrifugation, Density Gradient; Chorion; Cytosol; Decidua; Extraembryonic Membranes; Female; Immunohistochemistry; Labor, Obstetric; Macaca mulatta; Mifepristone; Myometrium; Pregnancy; Receptors, Estrogen; Up-Regulation; Uterine Contraction; Uterus | 1990 |
RU-486.
Topics: Abortion, Induced; Ethics, Medical; Female; Fertilization; Humans; Mifepristone; Pregnancy; Risk Assessment | 1990 |
Morning-after pill creates controversy.
Topics: Abortifacient Agents; Abortion, Induced; Contraceptives, Postcoital, Hormonal; Embryo Implantation; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; France; Humans; Mifepristone; Norgestrel; Pregnancy; United States | 1990 |
The effects of RU-38486 on cervical ripening. Clinical studies.
Topics: Abortion, Induced; Adult; Cervix Uteri; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Random Allocation; Uterine Hemorrhage | 1990 |
Tolerance of perinidatory primate embryos to RU 486 exposure in vitro and in vivo.
Topics: Animals; Cell Survival; Culture Techniques; Embryo Implantation; Embryo, Mammalian; Embryonic and Fetal Development; Female; Humans; Macaca; Mifepristone; Pregnancy; Progesterone | 1990 |
Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Dinoprostone; Drug Evaluation; Female; Humans; Mifepristone; Pregnancy; Retrospective Studies; Time Factors; Uterine Hemorrhage | 1990 |
Mifepristone (RU 486)
Topics: Female; Humans; Mifepristone; Pregnancy; Prostaglandins, Synthetic; United States; United States Food and Drug Administration | 1990 |
In appreciation of Dr. Potts's article.
Topics: Abortion, Induced; Female; Humans; Mifepristone; Pennsylvania; Pregnancy | 1990 |
Orosomucoid in human pregnancy serum diminishes bioavailability of the progesterone antagonist RU 486 in rats.
Topics: Animals; Biological Availability; Female; Humans; Liver; Mifepristone; Orosomucoid; Pregnancy; Protein Binding; Rats | 1990 |
Termination of pregnancy and induction of premature luteolysis by the antiprogestagen, mifepristone, in dogs.
Topics: Abortion, Induced; Animals; Dogs; Female; Luteolysis; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Progestins | 1990 |
Could antiprogesterones be used as alternative cervical ripening agents?
Topics: Adult; Cervix Uteri; Dilatation; Female; Humans; Mifepristone; Pregnancy; Progesterone | 1990 |
The use of the antiprogestin RU486 (mifepristone) as an abortifacient in early pregnancy--clinical and pathological findings; predictive factors for efficacy.
Topics: Abortifacient Agents; Abortion, Therapeutic; Administration, Oral; Chorionic Gonadotropin; Decidua; Dose-Response Relationship, Drug; Estradiol; Evaluation Studies as Topic; Female; Humans; Hydrocortisone; Mifepristone; Pregnancy; Progesterone | 1990 |
Abortion. RU486 under attack.
Topics: Abortion, Induced; Female; France; Humans; Mifepristone; Pregnancy | 1990 |
[Primates in the study of mechanisms of pregnancy].
Topics: Animals; Animals, Laboratory; Female; Labor, Obstetric; Mifepristone; Models, Biological; Pregnancy; Pregnancy, Animal; Primates | 1990 |
RU 486.
Topics: Abortion, Induced; Animals; Developing Countries; Endometrium; Female; France; Humans; Mifepristone; Models, Molecular; Molecular Structure; Population Control; Pregnancy; Progesterone; Prostaglandins; Rabbits; Receptors, Glucocorticoid; Receptors, Progesterone; Uterine Hemorrhage; Uterus | 1990 |
Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancy.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortion, Induced; Administration, Oral; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemoglobins; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progestins; Prostaglandins E, Synthetic; Uterine Contraction | 1990 |
RU 486 interferes with egg transport and retards the in vivo and in vitro development of mouse embryos.
Topics: Animals; Dose-Response Relationship, Drug; Embryo Implantation; Embryo, Mammalian; Female; In Vitro Techniques; Mice; Mice, Inbred Strains; Mifepristone; Ovulation; Pregnancy | 1990 |
Induction of abortion in early pregnancy with mifepristone.
Topics: Abortion, Induced; Adolescent; Adult; Drug Evaluation; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1990 |
The effect of RU 38,486 on progesterone and oestrogen receptor concentrations in the decidua and placenta in early pregnancy.
Topics: Adult; Decidua; Female; Humans; Mifepristone; Placenta; Pregnancy; Pregnancy Trimester, First; Receptors, Estrogen; Receptors, Progesterone | 1990 |
Non-surgical expulsion of non-viable early pregnancy: a new application of RU 486.
Topics: Abortion, Missed; Adult; Female; Humans; Mifepristone; Pregnancy | 1990 |
Abortion pill. French pill for Britain?
Topics: Abortion, Spontaneous; Female; France; Humans; Legislation, Drug; Mifepristone; Pregnancy; United Kingdom | 1990 |
Termination of early pregnancy through a combination of the antiprogestin and prostaglandin analogue.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Legal; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Female; France; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prostaglandins E, Synthetic | 1990 |
Progesterone maintenance of the placental progesterone receptor and placental growth in ovariectomized rats.
Topics: Animals; Estradiol; Female; Mifepristone; Ovariectomy; Placenta; Placentation; Pregnancy; Progesterone; Protein Biosynthesis; Rats; Receptors, Progesterone | 1990 |
Progesterone-mediated immunosuppression and the maintenance of pregnancy.
Topics: Abortion, Spontaneous; Animals; Biological Factors; Female; Fetal Resorption; Humans; Immune Tolerance; Immunization, Passive; Lymphocyte Transfusion; Lymphocytes; Mice; Mice, Inbred BALB C; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Receptors, Progesterone; Spleen | 1990 |
Comparison of antiprogestin stimulation of uterine prostaglandin synthesis in vitro.
Topics: Animals; Female; Fertility Agents, Female; Gonanes; Guinea Pigs; In Vitro Techniques; Male; Mifepristone; Perfusion; Pregnancy; Prostaglandin Antagonists; Prostaglandins; Uterus | 1990 |
Progesterone dependence and extratrophoblastic origin of pregnancy-associated plasma protein-A (PAPP-A) in early pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Habitual; Abortion, Induced; Adolescent; Adult; Chorionic Gonadotropin; Culture Techniques; Decidua; Estrenes; Female; Humans; Hydatidiform Mole; Middle Aged; Mifepristone; Pregnancy; Pregnancy Proteins; Pregnancy Trimester, First; Pregnancy-Associated Plasma Protein-A; Progesterone; Prolactin; Trophoblasts; Uterine Neoplasms | 1986 |
Medical treatment of residual ectopic pregnancy: RU 486 and methotrexate.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Estrenes; Female; Glucocorticoids; Humans; Methotrexate; Mifepristone; Peptide Fragments; Pregnancy; Pregnancy, Tubal; Progesterone | 1987 |
Uses of RU 486 for contragestion: an update.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Contraceptives, Postcoital; Estrenes; Female; Glucocorticoids; Humans; Menstruation-Inducing Agents; Mifepristone; Peptide Fragments; Pregnancy | 1987 |
Trophoblastic and decidual response to RU486: effects on human chorionic gonadotrophin, human placental lactogen, prolactin and pregnancy-associated plasma protein-A production in vitro.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Culture Media; Decidua; Estrenes; Female; Humans; In Vitro Techniques; Mifepristone; Peptide Fragments; Placental Lactogen; Pregnancy; Pregnancy-Associated Plasma Protein-A; Progestins; Prolactin; Secretory Rate; Trophoblasts | 1986 |
Pregnancy-associated plasma protein-A in pregnant cynomolgus monkeys (Macaca fascicularis): radioimmunoassay, normal levels, effect of RU 486, and preliminary characterization.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Electrophoresis, Polyacrylamide Gel; Estrenes; Female; Humans; Macaca fascicularis; Mifepristone; Models, Biological; Molecular Weight; Pregnancy; Pregnancy Proteins; Pregnancy-Associated Plasma Protein-A; Pregnancy, Animal; Radioimmunoassay; Reference Values; Time Factors | 1989 |
RU 486 mediated leukocytic inflammatory reaction at the utero-placental interface.
Topics: Animals; Female; Inflammation; Maternal-Fetal Exchange; Mifepristone; Neutrophils; Placenta; Pregnancy; Pregnancy-Associated Plasma Protein-A; Progesterone; Uterus | 1989 |
[Effect of RU 486 on glycogen metabolism in endometrium].
Topics: Animals; Embryo Implantation; Endometrium; Estradiol; Female; Glycogen; Glycogen Synthase; Mifepristone; Phosphorylases; Pregnancy; Progesterone; Rats; Rats, Inbred Strains | 1989 |
Failure of two progesterone antagonists, mifepristone and onapristone, to affect luteal activity in lactating rats.
Topics: Algestone; Animals; Corpus Luteum; Female; Gonanes; Lactation; Luteolysis; Mifepristone; Ovulation; Pregnancy; Progesterone; Prolactin; Rats; Rats, Inbred Strains | 1989 |
[Use of mifepristone in the termination of early pregnancy. The experience in France].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Amenorrhea; Estrenes; Female; France; Humans; Mifepristone; Pregnancy; Prostaglandins | 1989 |
Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction.
Topics: Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; CD8 Antigens; Estrenes; Female; Humans; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocytes; Mifepristone; Pregnancy; Progesterone; Receptors, Progesterone; Suppressor Factors, Immunologic; T-Lymphocytes, Regulatory | 1989 |
[Results of organ-saving therapy in tubal pregnancy].
Topics: Female; Follow-Up Studies; Humans; Laparoscopy; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Tubal; Prostaglandins | 1989 |
[The use of mifepristone as a pretreatment in termination of pregnancy in the 2d trimester].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Premedication | 1989 |
Modulation of cell-cell and cell-antigen interactions by 1,25-dihydroxyvitamin D3 and vitamin D3 sulfate in vitro: a study on pregnancy lymphocytes and hybridoma cells.
Topics: Adult; Calcitriol; Cell Line; Cells, Cultured; Cholecalciferol; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Estrenes; Female; Fibroblasts; Humans; Hybridomas; In Vitro Techniques; Killer Cells, Natural; Lymphocytes; Mifepristone; Pregnancy | 1989 |
Functional status of the pituitary-adrenal axis during treatment of RU486 for termination of early pregnancy in combination with PGs in Chinese women.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adrenocorticotropic Hormone; Adult; Aldosterone; China; Corticosterone; Estrenes; Female; Humans; Hydrocortisone; Kinetics; Mifepristone; Pessaries; Pituitary-Adrenal System; Pregnancy; Prostaglandins | 1989 |
Beta 2-adrenoceptor response in the rat uterus at the end of gestation and after induction of labor with RU 486.
Topics: Albuterol; Animals; Epinephrine; Female; In Vitro Techniques; Iodine Radioisotopes; Iodocyanopindolol; Labor, Obstetric; Mifepristone; Myometrium; Oxytocics; Pindolol; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Uterine Contraction; Uterus | 1989 |
New analogues of mifepristone with more dissociated antiprogesterone activities.
Topics: Abortifacient Agents; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Female; Hormone Antagonists; Indicators and Reagents; Male; Mifepristone; Ovariectomy; Pituitary Gland; Pregnancy; Progesterone; Rats; Structure-Activity Relationship | 1989 |
Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Premedication; Uterine Hemorrhage | 1989 |
[Experiences with the antigestagen mifepristone (RU 486) in the interruption of early pregnancy].
Topics: Abortion, Induced; Adult; Drug Administration Schedule; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Pregnancy, Unwanted; Uterine Hemorrhage | 1989 |
Meet the experts--antiprogestins. Proceedings of a meeting. Rio de Janeiro, Brazil, 27 October 1988.
Topics: Female; Humans; Mifepristone; Pregnancy | 1989 |
Prostaglandins and antiprogestins.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Mifepristone; Pregnancy; Prostaglandins; Uterine Contraction | 1989 |
Termination of early pregnancy using mifepristone in combination with prostaglandin analogs.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1989 |
Trying RU 486 in Third World countries.
Topics: Developing Countries; Female; Humans; Mifepristone; Pregnancy | 1989 |
Suckling-induced prolactin release potentiates mifepristone-induced lactogenesis in pregnant rats.
Topics: Animals; Bromocriptine; Caseins; Female; Lactation; Lactose; Mammary Glands, Animal; Mifepristone; Pregnancy; Progesterone; Prolactin; Rats; Receptors, Progesterone | 1989 |
The safety of early abortion.
Topics: Abortion, Induced; Accident Prevention; Female; Humans; Mifepristone; Pregnancy; Safety; Time Factors; Uterine Hemorrhage | 1989 |
A practical guide to RU486.
Topics: Abortifacient Agents; Decidua; Female; Humans; Mifepristone; Pregnancy; Progesterone; Prostaglandins | 1989 |
[Antifertility effects of RU-486 in combination with anordrin in rats].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Contraceptives, Postcoital; Decidua; Drug Therapy, Combination; Female; Mifepristone; Norandrostanes; Pregnancy; Progesterone; Pseudopregnancy; Rabbits; Rats; Rats, Inbred Strains | 1989 |
The Molecule of the Year.
Topics: Abortion, Induced; Cystic Fibrosis; DNA; DNA-Directed DNA Polymerase; Female; Genetic Techniques; Humans; Microscopy, Electron, Scanning; Mifepristone; Nucleic Acid Amplification Techniques; Pregnancy; Research | 1989 |
Plasma levels of SP1-like immunoreactive material (SP1) and progesterone throughout pregnancy and following RU 486-induced early abortion in the cynomolgus monkey (Macaca fascicularis).
Topics: Abortion, Induced; Animals; Female; Gestational Age; Half-Life; Immunoenzyme Techniques; Macaca fascicularis; Mifepristone; Pregnancy; Pregnancy Proteins; Pregnancy-Specific beta 1-Glycoproteins; Pregnancy, Animal; Progesterone; Radioimmunoassay | 1989 |
Termination of early pregnancy with RU 486 (mifepristone) in combination with a prostaglandin analogue (sulprostone).
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Dinoprostone; Drug Combinations; Female; Humans; Mifepristone; Pregnancy; Prognosis; Ultrasonography | 1989 |
[RU 486 and interruption of pregnancy].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Estrenes; Female; Humans; Mifepristone; Pregnancy | 1989 |
Effects of progesterone on pulsatile luteinizing hormone (LH) secretion and LH subunit messenger ribonucleic acid during lactation in the rat.
Topics: Animals; Estradiol; Estrenes; Female; Lactation; Luteinizing Hormone; Mifepristone; Osmolar Concentration; Pregnancy; Progesterone; Pulsatile Flow; Rats; Rats, Inbred Strains; RNA, Messenger | 1989 |
A study of the effect of mifepristone (antiprogesterone) followed by prostaglandin on uterine activity and fetal heart rate in patients having a termination of pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Estrenes; Female; Heart Rate, Fetal; Humans; Mifepristone; Pregnancy; Prostaglandins; Uterine Contraction; Uterus | 1989 |
Circulating levels of placental protein 12 and chorionic gonadotrophin following RU 38486 and gemeprost for termination of first trimester pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Carrier Proteins; Chorionic Gonadotropin; Estrenes; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Mifepristone; Pregnancy; Pregnancy Proteins | 1989 |
[The synergistic abortive effect of anti-progestogen RU 38486 and aromatase inhibitors for pregnant rat].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Aminoglutethimide; Animals; Aromatase; Estrenes; Female; Genitalia, Female; Miconazole; Mifepristone; Ovary; Pregnancy; Progestins; Rats | 1989 |
Antiprogestins and egg-implantation.
Topics: Animals; Embryo Implantation; Estrenes; Female; Mifepristone; Ovariectomy; Pregnancy; Progestins; Rats; Reference Values | 1989 |
Anti-implantation effects of monoclonal anti-progesterone antibody.
Topics: Animals; Antibodies, Monoclonal; Embryo Implantation; Embryonic and Fetal Development; Estrenes; Female; Immunization, Passive; Mice; Mice, Inbred Strains; Mifepristone; Pregnancy; Progesterone; Progestins; Rats; Reference Values | 1989 |
[The antiprogesterone action of mifepristone].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Estrenes; Female; Humans; Mifepristone; Pregnancy; Progestins; Vacuum Curettage | 1989 |
Circulating levels of placental protein 14 and progesterone following Mifepristone (RU38486) and Gemeprost for termination of first trimester pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Estrenes; Female; Glycodelin; Glycoproteins; Humans; Mifepristone; Pregnancy; Pregnancy Proteins; Pregnancy Trimester, First; Progesterone | 1989 |
Mifepristone commentary ignores abortion controversy.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Estrenes; Ethics, Medical; Female; Humans; Mifepristone; Pregnancy | 1989 |
Contragestive effects of the antigestagenic agent, RU486, in rats and rabbits.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Animals; Contraceptives, Oral, Synthetic; Estrenes; Female; Mifepristone; Pregnancy; Pregnancy, Animal; Rabbits; Rats; Rats, Inbred Strains | 1989 |
The effect of the anti-progestin RU 486 on early pregnancy in the long-tailed macaque (Macaca fascicularis).
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Animals; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Corpus Luteum; Estrenes; Estrone; Female; Macaca fascicularis; Mifepristone; Placenta; Pregnancy; Progesterone | 1989 |
Embryo arrest: the "no-man's-land" between contraception and abortion.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Legal; Contraceptives, Oral, Synthetic; England; Estrenes; Female; Humans; Mifepristone; Pregnancy | 1989 |
[The effect of RU486 and progesterone on luteal function during pregnancy].
Topics: Animals; Corpus Luteum; Estradiol; Estrenes; Female; Luteinizing Hormone; Male; Mifepristone; Ovary; Pregnancy; Pregnancy Maintenance; Progesterone; Progestins; Prolactin; Rats; Rats, Inbred Strains; Receptors, LH | 1989 |
Abortifacient development should not be stifled.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; China; Drug Utilization; Estrenes; Female; France; Humans; Mifepristone; Pregnancy; United States | 1989 |
Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Animals; Drug Administration Schedule; Embryo Implantation; Estrenes; Female; Gene Expression Regulation; Glucocorticoids; Humans; Luteinizing Hormone; Mifepristone; Pregnancy; Progesterone; Receptors, Glucocorticoid; Receptors, Progesterone; Structure-Activity Relationship | 1989 |
[The importance of uterine vascular systems in the maintenance of pregnancy].
Topics: Abortion, Spontaneous; Animals; Culture Techniques; Female; Guinea Pigs; Mifepristone; Placenta; Pregnancy; Pregnancy, Animal; Uterus | 1989 |
Outpatient therapeutic abortion with mifepristone.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adult; Ambulatory Care; Chorionic Gonadotropin; Female; Humans; Mifepristone; Pregnancy | 1989 |
Clinical uses of the antiprogestin RU 486 (mifepristone). Proceedings of a Roussel-UCLAF satellite symposium. Singapore, 30th October 1986.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Contraceptives, Oral, Synthetic; Estrenes; Female; Humans; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Progestins | 1987 |
Induction of labour with mifepristone after intrauterine fetal death.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Adult; Estrenes; Female; Fetal Death; Humans; Mifepristone; Pregnancy | 1985 |
Transplacental passage of mifepristone.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Estrenes; Female; Fetus; Humans; Luteolytic Agents; Maternal-Fetal Exchange; Mifepristone; Pregnancy | 1985 |
Mifepristone--contragestive agent or medical abortifacient?
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Estrenes; Female; Humans; Mifepristone; Pregnancy | 1987 |
Mifepristone (RU 486) and second-trimester termination.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Dinoprostone; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Prostaglandins E | 1987 |
Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Therapeutic; Administration, Oral; Adolescent; Adult; Alprostadil; Chorionic Gonadotropin; Drug Evaluation; Estrenes; Female; Follow-Up Studies; Humans; Mifepristone; Pessaries; Pregnancy; Prostaglandins E, Synthetic | 1987 |
Acceptability of medical pregnancy termination.
Topics: Abortion, Induced; Alprostadil; Consumer Behavior; Dilatation and Curettage; Estrenes; Female; Humans; Mifepristone; Pregnancy; Vacuum Curettage | 1988 |
Progesterone antagonist (RU 486) for cervical dilation, labor induction, and delivery in monkeys: effectiveness in combination with oxytocin.
Topics: Animals; Cervix Uteri; Colostrum; Drug Therapy, Combination; Estrenes; Female; Immunoglobulins; Labor, Induced; Lactation; Macaca fascicularis; Mifepristone; Oxytocin; Pregnancy; Progesterone; Weight Gain | 1989 |
Cell-specific variations and hormonal regulation of immunoreactive cytochrome P-450scc in the rat ovary.
Topics: Animals; Corpus Luteum; Cytochrome P-450 Enzyme System; Estradiol; Estrenes; Estrus; Female; Mifepristone; Ovary; Pregnancy; Pseudopregnancy; Rats; Rats, Inbred Strains; Sexual Maturation; Theca Cells | 1989 |
Efficacy of the antiprogestin mifepristone (RU 486) prior to prostaglandin termination of pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Legal; Adult; Dinoprostone; Drug Evaluation; Estrenes; Female; Humans; Mifepristone; Pregnancy; Progestins | 1989 |
RU 486 abortions.
Topics: Abnormalities, Drug-Induced; Estrenes; Female; Humans; Mifepristone; Pregnancy | 1989 |
The presence of lipocortin in human embryonic skin fibroblasts and its regulation by anti-inflammatory steroids.
Topics: Abortifacient Agents, Steroidal; Annexins; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Cells, Cultured; Cycloheximide; Dactinomycin; Dexamethasone; Dinoprostone; Embryo, Mammalian; Estrenes; Female; Fibroblasts; Glycoproteins; Humans; Kinetics; Mifepristone; Pregnancy; Prostaglandins E; Skin; Tritium | 1985 |
[Termination of pregnancy with a mifepristone-sulprostone combination].
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Legal; Dinoprostone; Estrenes; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1987 |
Rabbit myometrial oxytocin and alpha 2-adrenergic receptors are increased by estrogen but are differentially regulated by progesterone.
Topics: Animals; Estradiol; Estrenes; Female; Kinetics; Mifepristone; Myometrium; Ovariectomy; Oxytocin; Pregnancy; Progesterone; Rabbits; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Receptors, Oxytocin | 1987 |
Antiprogesterone activity of RU 486 and its contragestive and other applications.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Contraceptive Agents, Female; Contraceptives, Postcoital; Estrenes; Female; Humans; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone | 1986 |
Interception. III: Postcoital luteal contragestion by an antiprogestin (mifepristone, RU 486) in 62 women.
Topics: Contraceptives, Postcoital; Drug Administration Schedule; Estrenes; Female; Humans; Menstruation; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Risk | 1987 |
Interception. IV: Failure of mifepristone (RU 486) as a monthly contragestive, "Lunarette".
Topics: Contraceptives, Postcoital; Drug Administration Schedule; Embryo Implantation; Estrenes; Female; Humans; Luteal Phase; Menstruation-Inducing Agents; Mifepristone; Pilot Projects; Pregnancy | 1987 |
[New data on the hormonal requirement of the pregnant rabbit: partial pregnancies and fetal abnormalities after treatment with a hormonal antagonist given at a sub-abortive dosage].
Topics: Abnormalities, Drug-Induced; Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Animals; Dose-Response Relationship, Drug; Estrenes; Female; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Rabbits | 1986 |
[Abortion induced by RU 486: importance of its combination with a prostaglandin derivative].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Administration, Oral; Alprostadil; Drug Interactions; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prostaglandins E, Synthetic; Suppositories | 1988 |
Glucocorticoids stimulate prostaglandin synthesis in human amnion cells by a receptor-mediated mechanism.
Topics: Amnion; Arachidonic Acid; Arachidonic Acids; Calcimycin; Cells, Cultured; Chorion; Dexamethasone; Dinoprostone; Estrenes; Female; Glucocorticoids; Humans; Mifepristone; Pregnancy; Receptors, Glucocorticoid | 1988 |
[Effects of RU38486, an antiprogesterone agent, on endometrium, fertilized ovum and serum sex steroid levels in rats].
Topics: Animals; Embryo Implantation; Endometrium; Estradiol; Estrenes; Female; Mifepristone; Pregnancy; Progesterone; Rats; Rats, Inbred Strains; Zygote | 1987 |
Effect of RU 486 on luteal function in the early pregnant rat.
Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Animals; Corpus Luteum; Embryo Implantation; Estradiol; Estrenes; Female; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Inbred Strains | 1988 |
The effects of the progesterone antagonist RU-486 on mouse preimplantation development in vitro and in vivo.
Topics: Animals; Chorionic Gonadotropin; Embryo Transfer; Embryo, Mammalian; Estrenes; Female; In Vitro Techniques; Mice; Mice, Inbred Strains; Mifepristone; Oviducts; Pregnancy; Uterus | 1988 |
Prostaglandins and antigestagens for the interruption of early pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Alprostadil; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1988 |
[Termination of early pregnancy with antiprogestin and prostaglandin].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone Congeners; Prostaglandins | 1988 |
The effects of progesterone antagonist RU 486 on mouse oocyte maturation, ovulation, fertilization, and cleavage.
Topics: Animals; Cell Survival; Cleavage Stage, Ovum; Embryo Implantation; Embryo Transfer; Estrenes; Female; Fertilization; Mice; Mice, Inbred Strains; Mifepristone; Oocytes; Ovulation; Pregnancy; Progesterone | 1988 |
Estrogen and progesterone receptors in the oviduct during egg transport in cyclic and pregnant rats.
Topics: Animals; Estradiol; Estrenes; Estrus; Fallopian Tubes; Female; Mifepristone; Ovum Transport; Pregnancy; Pregnancy, Animal; Progesterone; Progestins; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid | 1988 |
Why does RU486 fail to prevent implantation despite success in inducing menstruation?
Topics: Adult; Embryo Implantation; Endometrium; Estrenes; Female; Humans; Menstruation; Mifepristone; Pregnancy | 1988 |
[A study of progestin, glucocorticoid binding and glycogen content in rat endometrium before and after implantation: effect of antiprogesterone RU-38486].
Topics: Animals; Decidua; Dexamethasone; Embryo Implantation; Endometrium; Estrenes; Female; Glycogen; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Progestins; Rats; Rats, Inbred Strains; Trophoblasts | 1988 |
Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Adolescent; Adult; Dose-Response Relationship, Drug; Estrenes; Female; Humans; Middle Aged; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone | 1988 |
Pregnancy interruption with RU 486 in combination with dl-15-methyl-prostaglandin-F2 alpha-methyl ester: the Chinese experience.
Topics: Adult; Amenorrhea; Arbaprostil; China; Drug Evaluation; Drug Synergism; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy, Unwanted; Prostaglandins E, Synthetic | 1988 |
The use of anti-progesterones as a medical IUD.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Estrenes; Female; Humans; Luteal Phase; Male; Mifepristone; Pregnancy | 1988 |
[RU 486 and induction of labor in 3d trimester pregnancy interruptions. Preliminary clinical studies].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Estrenes; Female; Gestational Age; Humans; Maternal Age; Mifepristone; Pregnancy; Pregnancy Trimester, Third; Pregnancy, High-Risk; Progestins | 1988 |
The dynamic changes of several reproductive hormones during termination of early pregnancy by RU486 in combination with PG-05 in Chinese women.
Topics: Abortifacient Agents; Carboprost; China; Chorionic Gonadotropin; Dinoprost; Estrenes; Estrogens; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; Prostaglandins F, Synthetic | 1988 |
The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
Topics: Abortion, Therapeutic; Adult; Dinoprostone; Drug Synergism; Estrenes; Female; Humans; Mifepristone; Myometrium; Oxytocin; Pregnancy; Progestins; Prostaglandins E, Synthetic; Time Factors; Uterine Contraction | 1988 |
Progesterone abbreviates the nuclear retention of estrogen receptor in the rat oviduct and counteracts estrogen action on egg transport.
Topics: Animals; Estradiol; Estrenes; Estrogens; Female; Mifepristone; Oviducts; Ovum Transport; Pregnancy; Progesterone; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone | 1988 |
Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486.
Topics: Abortion, Therapeutic; Adult; Alprostadil; Dilatation and Curettage; Drug Therapy, Combination; Estrenes; Female; Follow-Up Studies; Humans; Mifepristone; Pessaries; Pregnancy; Pregnancy Trimester, First; Vacuum Curettage | 1988 |
Late postcoital treatment against pregnancy with antiprogesterone RU 486.
Topics: Adult; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Estrenes; Female; Humans; Mifepristone; Pregnancy | 1988 |
Effects of progesterone, promegestone and RU 486 on glucocorticoid receptor levels in primary cultures of mouse mammary epithelial cells.
Topics: Animals; Cells, Cultured; Epithelium; Estrenes; Female; Glucocorticoids; Kinetics; Mammary Glands, Animal; Mice; Mice, Inbred BALB C; Mifepristone; Norpregnadienes; Pregnancy; Progesterone; Promegestone; Receptors, Glucocorticoid; Reference Values | 1988 |
Transplacental passage of a progesterone antagonist in monkeys.
Topics: Animals; Estrenes; Female; Macaca fascicularis; Maternal-Fetal Exchange; Mifepristone; Placenta; Pregnancy; Progestins | 1988 |
Temporal changes in uterine activity and prostaglandin response to RU486 in rhesus macaques in late gestation.
Topics: Amniotic Fluid; Animals; Cervix Uteri; Estrenes; Female; Labor, Induced; Macaca mulatta; Mifepristone; Oxytocics; Pregnancy; Pregnancy, Animal; Progesterone; Prostaglandins; Time Factors; Uterine Contraction | 1987 |
Action of progesterone and RU38486 on protein synthesis in rat placenta.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Animals; Estrenes; Female; Kinetics; Mifepristone; Ovariectomy; Placenta; Pregnancy; Progesterone; Protein Biosynthesis; Rats; Uterus | 1987 |
The effect of RU486 on transport, development and implantation of mouse embryos.
Topics: Animals; Dose-Response Relationship, Drug; Embryo Implantation; Embryo, Mammalian; Embryonic and Fetal Development; Estrenes; Female; Mice; Mice, Inbred Strains; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone | 1987 |
The effect of the antiprogestins RU 486 and ZK 98734 on the synthesis and metabolism of prostaglandins F2 alpha and E2 in separated cells from early human decidua.
Topics: Cells, Cultured; Decidua; Dinoprost; Dinoprostone; Estrenes; Female; Humans; Mifepristone; Pregnancy; Progestins; Prostaglandins E; Prostaglandins F | 1987 |
Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs.
Topics: Abortion, Induced; Animals; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Embryo Implantation; Endometrium; Estrenes; Female; Gonanes; Guinea Pigs; Mifepristone; Myometrium; Pregnancy; Pregnancy, Animal; Progesterone; Prostaglandins E, Synthetic; Prostaglandins F; Uterine Contraction | 1987 |
Studies on the mechanisms of action of progesterone antagonists.
Topics: Abortifacient Agents, Steroidal; Animals; Dinoprostone; Embryo Implantation; Epoprostenol; Estrenes; Female; Guinea Pigs; Labor, Obstetric; Mifepristone; Pregnancy; Progesterone; Prostaglandins E, Synthetic; Uterine Contraction | 1986 |
A novel progesterone-induced messenger RNA in rabbit and human endometria. Cloning and sequence analysis of the complementary DNA.
Topics: Animals; Base Sequence; Clone Cells; Collodion; DNA; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Endometrium; Estradiol; Estrenes; Female; Humans; Injections; Mifepristone; Molecular Sequence Data; Molecular Weight; Nucleic Acid Hybridization; Pregnancy; Progesterone; Progestins; Rabbits; RNA, Messenger; Tamoxifen; Tissue Distribution | 1987 |
Inhibition of egg development and implantation in rats after post-coital administration of the progesterone antagonist RU 486.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Animals; Dose-Response Relationship, Drug; Embryo Implantation; Estrenes; Female; Mifepristone; Ovum; Ovum Transport; Pregnancy; Progesterone; Rats; Rats, Inbred Strains | 1987 |
Antiprogesterone and antiglucocorticoid actions of RU 486 on rabbit mammary gland explant cultures. Evidence for a persistent inhibitory action of residual progesterone upon the mammary tissue.
Topics: Animals; Caseins; Culture Techniques; Dexamethasone; DNA; Estrenes; Female; Glucocorticoids; Mammary Glands, Animal; Mifepristone; Pregnancy; Progesterone; Prolactin; Promegestone; Rabbits; Receptors, Glucocorticoid; Receptors, Progesterone | 1987 |
Effects of the antiprogesterone RU 486 on preterm birth in the rat.
Topics: Animals; Estrenes; Female; Intercellular Junctions; Mifepristone; Myometrium; Obstetric Labor, Premature; Pregnancy; Pregnancy Maintenance; Progesterone; Rats; Rats, Inbred Strains | 1987 |
Ovum transport in pregnant rats is little affected by RU486 and exogenous progesterone as compared to cycling rats.
Topics: Animals; Estradiol; Estrenes; Estrus; Female; Mifepristone; Ovum Transport; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Inbred Strains | 1987 |
Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Chorionic Gonadotropin; Drug Evaluation; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; Uterine Hemorrhage | 1986 |
Progesterone antagonism: science and society.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Estrenes; Female; Humans; Mifepristone; Pregnancy; Progesterone | 1986 |
[Effect of an antiprogesterone (RU 486) on extra-uterine pregnancy].
Topics: Chorionic Gonadotropin; Endoscopy; Estrenes; Fallopian Tubes; Female; Humans; Laparotomy; Mifepristone; Pregnancy; Pregnancy, Ectopic | 1986 |
Fertility control in women: results with RU 486 by the end of 1985.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Amenorrhea; Contraceptives, Postcoital; Estrenes; Female; Humans; Mifepristone; Models, Biological; Pregnancy | 1986 |
Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women.
Topics: Abortifacient Agents; Administration, Oral; Body Burden; Estrenes; Female; Humans; Kinetics; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1986 |
Control of birth in rats by RU 486, an antiprogesterone compound.
Topics: Animals; Birth Weight; Estrenes; Female; Labor, Obstetric; Light; Mifepristone; Pregnancy; Rats; Rats, Inbred Strains; Time Factors | 1987 |
Contragestion by antiprogestin: a new approach to human fertility control.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Cervix Uteri; Chorionic Gonadotropin; Contraceptives, Postcoital, Synthetic; Corpus Luteum Maintenance; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; Receptors, Progesterone | 1985 |
[Steroid anti-hormones: anti-progesterone activity of RU 486 and its contragestational and other applications].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Contraceptives, Postcoital; Estrenes; Female; Humans; Mifepristone; Pregnancy; Progesterone | 1985 |
The antiprogesterones are coming: menses induction, abortion, and labour?
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Cushing Syndrome; Estrenes; Female; Humans; Labor, Induced; Menstruation; Mifepristone; Pregnancy; Progesterone; Rabbits | 1985 |
[The value of an antiprogesterone steroid in the treatment of extra-uterine pregnancy. Preliminary results].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Chorionic Gonadotropin; Drug Evaluation; Estrenes; Female; Humans; Infertility, Female; Mifepristone; Pregnancy; Pregnancy, Ectopic | 1986 |
[Initial Dutch experiences with early pregnancy interruption using the antiprogesterone agent mifepriston].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Drug Evaluation; Estrenes; Female; Humans; Mifepristone; Pregnancy; Receptors, Glucocorticoid; Receptors, Progesterone | 1985 |
Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Dinoprostone; Drug Evaluation; Estrenes; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic; Receptors, Progesterone; Uterine Contraction | 1985 |
Interruption of early pregnancy by an anti-progestational compound, RU 486.
Topics: Abortion, Induced; Adult; Chorionic Gonadotropin; Contraceptives, Postcoital; Estradiol; Estrenes; Female; Humans; Hydrocortisone; Mifepristone; Pregnancy; Progesterone | 1985 |
Early ultrastructural changes in RU-486-exposed decidua.
Topics: Capillaries; Decidua; Edema; Estrenes; Female; Humans; Mifepristone; Pregnancy; Trophoblasts | 1985 |